1	Journal	NNP	O	Journal	_	0	SENT_1	[p1l46t81r152b106],
2	of	IN	O	of	_	0	SENT_1	[p1l163t81r195b112],
3	Thrombosis	NNP	O	Thrombosis	prep_of	1	SENT_1	[p1l204t81r362b106],
4	and	CC	O	and	_	0	SENT_1	[p1l374t81r425b106],
5	Haemostasis	NNP	PERSON	Haemostasis	prep_of	1	SENT_1	[p1l434t82r616b111],
6	,	,	O	,	_	0	SENT_1	[p1l434t82r616b111],
7	8	CD	NUMBER	8	appos	3	SENT_1	[p1l629t81r652b106],
8	:	:	O	:	_	0	SENT_1	[p1l629t81r652b106],
9	95	CD	NUMBER	95	number	10	SENT_1	[p1l666t81r764b106],
10	—	CD	NUMBER	—	num	11	SENT_1	[p1l666t81r764b106],
11	l00	NN	O	l00	dep	1	SENT_1	[p1l666t81r764b106],
12	DOI	NNP	O	DOI	dep	11	SENT_1	[p1l1556t81r1627b106],
13	:	:	O	:	_	0	SENT_1	[p1l1556t81r1627b106],
14	10.1	CD	NUMBER	10.1	num	15	SENT_1	[p1l1644t81r2114b112],
15	ll1/j	NN	O	ll1/j	dep	1	SENT_1	[p1l1644t81r2114b112],
16	.1538	CD	DURATION	.1538	num	17	SENT_1	[p1l1644t81r2114b112],
17	-7836.2009.03677	CD	DURATION	-7836.2009.03677	dep	15	SENT_1	[p1l1644t81r2114b112],
18	.	.	O	.	_	0	SENT_1	[p1l1644t81r2114b112],

1	X	NN	O	x	_	0	SENT_2	[p1l1644t81r2114b112],

1	ORIGINAL	JJ	O	original	amod	2	SENT_3	[p1l84t217r295b244],
2	ARTICLE	NN	O	article	_	0	SENT_3	[p1l313t217r489b244],

1	Ability	NN	O	ability	_	0	SENT_4	[p1l47t322r262b397],
2	of	IN	O	of	_	0	SENT_4	[p1l287t322r351b380],
3	VKORC1	NN	O	vkorc1	prep_of	1	SENT_4	[p1l374t326r656b380],
4	and	CC	O	and	_	0	SENT_4	[p1l692t322r805b380],
5	CYP2C9	NN	O	cyp2c9	prep_of	1	SENT_4	[p1l836t326r1098b380],
6	to	TO	O	to	aux	7	SENT_4	[p1l1124t327r1186b380],
7	predict	VB	O	predict	infmod	1	SENT_4	[p1l1215t322r1435b397],
8	therapeutic	JJ	O	therapeutic	amod	10	SENT_4	[p1l1458t322r1822b397],
9	warfarin	NN	O	warfarin	nn	10	SENT_4	[p1l1845t322r2109b380],
10	dose	NN	O	dose	dobj	7	SENT_4	[p1l49t408r198b466],
11	during	IN	O	during	_	0	SENT_4	[p1l227t408r435b483],
12	the	DT	DURATION	the	det	14	SENT_4	[p1l462t408r562b466],
13	initial	JJ	DURATION	initial	amod	14	SENT_4	[p1l594t408r771b466],
14	weeks	NNS	DURATION	week	prep_during	7	SENT_4	[p1l802t408r1002b467],
15	of	IN	O	of	_	0	SENT_4	[p1l1033t408r1096b466],
16	therapy	NN	O	therapy	prep_of	1	SENT_4	[p1l1122t408r1365b483],

1	N.	NNP	PERSON	N.	nn	3	SENT_5	[p1l49t538r85b566],
2	S.	NNP	PERSON	S.	nn	3	SENT_5	[p1l107t538r137b566],
3	FERDER	NNP	PERSON	FERDER	_	0	SENT_5	[p1l160t539r350b571],
4	,	,	O	,	_	0	SENT_5	[p1l160t539r350b571],
5	*	NNP	O	*	nn	8	SENT_5	[p1l160t539r350b571],
6	C.	NNP	PERSON	C.	nn	8	SENT_5	[p1l372t538r408b566],
7	S.	NNP	PERSON	S.	nn	8	SENT_5	[p1l430t538r459b566],
8	EBY	NNP	PERSON	EBY	appos	3	SENT_5	[p1l483t538r591b573],
9	,	,	O	,	_	0	SENT_5	[p1l483t538r591b573],
10	T	NN	O	t	nn	12	SENT_5	[p1l483t538r591b573],
11	E.	NNP	O	E.	nn	12	SENT_5	[p1l612t539r640b565],
12	DEYCH	NNP	O	DEYCH	appos	3	SENT_5	[p1l664t538r840b573],
13	,	,	O	,	_	0	SENT_5	[p1l664t538r840b573],
14	’	CD	NUMBER	’	appos	3	SENT_5	[p1l664t538r840b573],
15	l'	NNP	O	l'	nn	18	SENT_5	[p1l664t538r840b573],
16	J.	NNP	PERSON	J.	nn	18	SENT_5	[p1l859t539r883b566],
17	K.	NNP	PERSON	K.	nn	18	SENT_5	[p1l907t538r939b566],
18	HARRlS	NNP	PERSON	HARRlS	dep	14	SENT_5	[p1l963t538r1150b573],
19	,	,	O	,	_	0	SENT_5	[p1l963t538r1150b573],
20	I	PRP	O	I	appos	3	SENT_5	[p1l963t538r1150b573],
21	P.	FW	O	p.	nn	23	SENT_5	[p1l1172t539r1202b565],
22	M.	FW	O	m.	nn	23	SENT_5	[p1l1224t539r1271b566],
23	RlDKER	NN	O	rldker	dep	20	SENT_5	[p1l1294t538r1482b571],
24	,	,	O	,	_	0	SENT_5	[p1l1294t538r1482b571],
25	§	CD	NUMBER	§	appos	3	SENT_5	[p1l1294t538r1482b571],
26	P.	NNP	O	P.	nn	28	SENT_5	[p1l1504t539r1534b565],
27	E.	NNP	O	E.	nn	28	SENT_5	[p1l1557t539r1585b565],
28	M	NNP	O	M	nsubj	29	SENT_5	[p1l1607t538r1853b573],
29	|	VBD	O	|	rcmod	25	SENT_5	[p1l1607t538r1853b573],
30	LL	NNP	O	LL	nn	32	SENT_5	[p1l1607t538r1853b573],
31	|	NNP	O	|	nn	32	SENT_5	[p1l1607t538r1853b573],
32	GAN	NNP	ORGANIZATION	GAN	dobj	29	SENT_5	[p1l1607t538r1853b573],
33	,	,	O	,	_	0	SENT_5	[p1l1607t538r1853b573],
34	T	NN	O	t	appos	32	SENT_5	[p1l1607t538r1853b573],
35	S.	NNP	O	S.	dep	34	SENT_5	[p1l48t588r77b615],
36	2	CD	NUMBER	2	num	35	SENT_5	[p1l99t588r131b614],
37	.	.	O	.	_	0	SENT_5	[p1l99t588r131b614],

1	GOLDHABER	NNP	LOCATION	GOLDHABER	_	0	SENT_6	[p1l153t588r449b620],
2	,	,	O	,	_	0	SENT_6	[p1l153t588r449b620],
3	§	NNP	O	§	nn	8	SENT_6	[p1l153t588r449b620],
4	C.	NNP	PERSON	C.	nn	8	SENT_6	[p1l470t588r506b615],
5	R.	NNP	PERSON	R.	nn	8	SENT_6	[p1l529t588r562b615],
6	K	NNP	PERSON	K	nn	8	SENT_6	[p1l585t588r723b622],
7	|	NNP	O	|	nn	8	SENT_6	[p1l585t588r723b622],
8	NG	NNP	O	NG	appos	1	SENT_6	[p1l585t588r723b622],
9	,	,	O	,	_	0	SENT_6	[p1l585t588r723b622],
10	T	NN	O	t	nn	12	SENT_6	[p1l585t588r723b622],
11	T.	NNP	O	T.	nn	12	SENT_6	[p1l742t588r775b614],
12	GlRl	NNP	O	GlRl	appos	1	SENT_6	[p1l797t588r920b622],
13	,	,	O	,	_	0	SENT_6	[p1l797t588r920b622],
14	T	NN	O	t	nn	17	SENT_6	[p1l797t588r920b622],
15	H.	NNP	PERSON	H.	nn	17	SENT_6	[p1l941t588r978b614],
16	L.	NNP	PERSON	L.	nn	17	SENT_6	[p1l1001t588r1029b614],
17	MCLEOD	NNP	PERSON	MCLEOD	appos	1	SENT_6	[p1l1051t588r1296b622],
18	,	,	O	,	_	0	SENT_6	[p1l1051t588r1296b622],
19	i	FW	O	i	appos	1	SENT_6	[p1l1051t588r1296b622],
20	'	''	O	'	_	0	SENT_6	[p1l1051t588r1296b622],
21	1l	JJ	O	1l	amod	24	SENT_6	[p1l1051t588r1296b622],
22	R.	NNP	PERSON	R.	nn	24	SENT_6	[p1l1317t588r1349b615],
23	J.	NNP	PERSON	J.	nn	24	SENT_6	[p1l1370t588r1394b615],
24	GLYNN	NNP	PERSON	GLYNN	npadvmod	19	SENT_6	[p1l1417t588r1582b618],
25	§	NN	O	§	dep	33	SENT_6	[p1l1417t588r1582b618],
26	and	CC	O	and	_	0	SENT_6	[p1l1602t586r1658b615],
27	B.	NNP	PERSON	B.	nn	29	SENT_6	[p1l1676t588r1706b614],
28	F.	NNP	PERSON	F.	nn	29	SENT_6	[p1l1729t588r1757b614],
29	GAGET	NNP	PERSON	GAGET	conj_and	25	SENT_6	[p1l1779t588r1913b622],
30	*	CD	NUMBER	*	dep	33	SENT_6	[p1l48t636r135b661],
31	Saint	NNP	ORGANIZATION	Saint	nn	33	SENT_6	[p1l48t636r135b661],
32	Louis	NNP	ORGANIZATION	Louis	nn	33	SENT_6	[p1l146t637r221b661],
33	College	NNP	ORGANIZATION	College	dep	24	SENT_6	[p1l234t635r339b668],
34	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l352t635r383b661],
35	Pharmacy	NNP	ORGANIZATION	Pharmacy	prep_of	33	SENT_6	[p1l393t635r536b668],
36	,	,	O	,	_	0	SENT_6	[p1l393t635r536b668],
37	St	NNP	LOCATION	St	nn	38	SENT_6	[p1l552t636r580b661],
38	Louis	NNP	LOCATION	Louis	prep_of	33	SENT_6	[p1l591t637r671b665],
39	,	,	O	,	_	0	SENT_6	[p1l591t637r671b665],
40	MO	NNP	DURATION	MO	prep_of	33	SENT_6	[p1l686t636r753b665],
41	,	,	O	,	_	0	SENT_6	[p1l686t636r753b665],
42	"	``	O	"	punct	44	SENT_6	[p1l686t636r753b665],
43	Twashington	NNP	ORGANIZATION	Twashington	nn	44	SENT_6	[p1l767t635r953b668],
44	University	NNP	ORGANIZATION	University	prep_of	33	SENT_6	[p1l968t637r1116b668],
45	,	,	O	,	_	0	SENT_6	[p1l968t637r1116b668],
46	St	NNP	LOCATION	St	nn	47	SENT_6	[p1l1131t636r1160b661],
47	Louis	NNP	LOCATION	Louis	prep_of	33	SENT_6	[p1l1171t637r1250b665],
48	,	,	O	,	_	0	SENT_6	[p1l1171t637r1250b665],
49	MO	NNP	DURATION	MO	appos	47	SENT_6	[p1l1266t636r1332b665],
50	;	:	O	;	_	0	SENT_6	[p1l1266t636r1332b665],
51	:	:	O	:	_	0	SENT_6	[p1l1348t636r1434b667],
52	Saint	NNP	ORGANIZATION	Saint	nn	54	SENT_6	[p1l1348t636r1434b667],
53	Louis	NNP	ORGANIZATION	Louis	nn	54	SENT_6	[p1l1445t637r1520b661],
54	University	NNP	ORGANIZATION	University	prep_of	33	SENT_6	[p1l1533t637r1681b668],
55	,	,	O	,	_	0	SENT_6	[p1l1533t637r1681b668],
56	St	NNP	LOCATION	St	nn	57	SENT_6	[p1l1696t636r1725b661],
57	Louis	NNP	LOCATION	Louis	conj_and	35	SENT_6	[p1l1736t637r1815b665],
58	,	,	O	,	_	0	SENT_6	[p1l1736t637r1815b665],
59	MO	NNP	DURATION	MO	conj_and	35	SENT_6	[p1l1831t636r1897b665],
60	;	:	O	;	_	0	SENT_6	[p1l1831t636r1897b665],
61	§	CD	NUMBER	§	num	62	SENT_6	[p1l1910t635r2041b668],
62	Brigham	NNP	ORGANIZATION	Brigham	dep	59	SENT_6	[p1l1910t635r2041b668],
63	and	CC	O	and	_	0	SENT_6	[p1l2054t635r2108b661],
64	Women	NNP	O	Women	poss	66	SENT_6	[p1l49t685r180b710],
65	’s	POS	O	’s	_	0	SENT_6	[p1l49t685r180b710],
66	Hospital	NNP	O	Hospital	conj_and	54	SENT_6	[p1l192t684r315b717],
67	,	,	O	,	_	0	SENT_6	[p1l192t684r315b717],
68	Harvard	NNP	ORGANIZATION	Harvard	nn	70	SENT_6	[p1l332t684r446b710],
69	Medical	NNP	ORGANIZATION	Medical	nn	70	SENT_6	[p1l456t684r572b710],
70	School	NNP	ORGANIZATION	School	appos	54	SENT_6	[p1l583t684r684b714],
71	,	,	O	,	_	0	SENT_6	[p1l583t684r684b714],
72	Boston	NNP	LOCATION	Boston	nn	74	SENT_6	[p1l700t686r803b714],
73	,	,	O	,	_	0	SENT_6	[p1l700t686r803b714],
74	MA	NNP	LOCATION	MA	appos	70	SENT_6	[p1l818t686r879b714],
75	;	:	O	;	_	0	SENT_6	[p1l818t686r879b714],
76	and	CC	O	and	_	0	SENT_6	[p1l892t684r946b710],
77	1lUniversity	NN	O	1luniversity	conj_and	35	SENT_6	[p1l957t686r1120b717],
78	of	IN	O	of	_	0	SENT_6	[p1l1132t684r1163b710],
79	North	NNP	LOCATION	North	nn	80	SENT_6	[p1l1172t684r1252b710],
80	Carolina	NNP	LOCATION	Carolina	prep_of	19	SENT_6	[p1l1267t684r1385b710],
81	at	IN	O	at	_	0	SENT_6	[p1l1398t686r1426b710],
82	Chapel	NN	LOCATION	chapel	nn	83	SENT_6	[p1l1438t684r1537b717],
83	Hill	NNP	LOCATION	Hill	prep_at	80	SENT_6	[p1l1549t684r1605b714],
84	,	,	O	,	_	0	SENT_6	[p1l1549t684r1605b714],
85	NC	NNP	O	NC	appos	19	SENT_6	[p1l1621t685r1671b714],
86	,	,	O	,	_	0	SENT_6	[p1l1621t685r1671b714],
87	USA	NNP	LOCATION	USA	appos	1	SENT_6	[p1l1689t685r1747b710],

1	To	TO	O	to	aux	2	SENT_7	[p1l47t819r82b843],
2	cite	VB	O	cite	dep	7	SENT_7	[p1l93t819r143b843],
3	this	DT	O	this	det	4	SENT_7	[p1l153t817r205b843],
4	article	NN	O	article	dobj	2	SENT_7	[p1l216t817r311b843],
5	:	:	O	:	_	0	SENT_7	[p1l216t817r311b843],
6	Ferder	NN	O	ferder	nn	7	SENT_7	[p1l325t817r413b843],
7	NS	NN	O	n	_	0	SENT_7	[p1l424t818r469b847],
8	,	,	O	,	_	0	SENT_7	[p1l424t818r469b847],
9	Eby	NNP	ORGANIZATION	Eby	nn	10	SENT_7	[p1l483t817r531b850],
10	CS	NNP	ORGANIZATION	CS	appos	7	SENT_7	[p1l542t818r586b847],
11	,	,	O	,	_	0	SENT_7	[p1l542t818r586b847],
12	Deych	NNP	ORGANIZATION	Deych	nn	13	SENT_7	[p1l600t817r686b850],
13	E	NNP	ORGANIZATION	E	appos	7	SENT_7	[p1l699t819r720b847],
14	,	,	O	,	_	0	SENT_7	[p1l699t819r720b847],
15	Harris	NNP	ORGANIZATION	Harris	nn	16	SENT_7	[p1l735t819r814b843],
16	JK	NNP	ORGANIZATION	JK	appos	13	SENT_7	[p1l823t819r862b847],
17	,	,	O	,	_	0	SENT_7	[p1l823t819r862b847],
18	Ridker	NNP	PERSON	Ridker	nn	19	SENT_7	[p1l876t817r964b843],
19	PM	NNP	O	PM	appos	13	SENT_7	[p1l975t819r1029b847],
20	,	,	O	,	_	0	SENT_7	[p1l975t819r1029b847],
21	Milligan	NNP	ORGANIZATION	Milligan	nn	22	SENT_7	[p1l1042t817r1152b850],
22	PE	NNP	ORGANIZATION	PE	appos	13	SENT_7	[p1l1166t819r1205b847],
23	,	,	O	,	_	0	SENT_7	[p1l1166t819r1205b847],
24	Goldhaber	NNP	PERSON	Goldhaber	nn	25	SENT_7	[p1l1218t817r1366b843],
25	SZ	NNP	O	SZ	appos	13	SENT_7	[p1l1375t818r1416b847],
26	,	,	O	,	_	0	SENT_7	[p1l1375t818r1416b847],
27	King	NNP	O	King	nn	28	SENT_7	[p1l1430t819r1492b850],
28	CR	NN	O	cr	appos	13	SENT_7	[p1l1502t818r1550b847],
29	,	,	O	,	_	0	SENT_7	[p1l1502t818r1550b847],
30	Giri	NNP	PERSON	Giri	nn	31	SENT_7	[p1l1563t818r1609b843],
31	T	NN	PERSON	t	appos	13	SENT_7	[p1l1620t819r1645b847],
32	,	,	O	,	_	0	SENT_7	[p1l1620t819r1645b847],
33	McLeod	NNP	PERSON	McLeod	nn	34	SENT_7	[p1l1658t817r1770b843],
34	HL	NNS	O	hl	appos	13	SENT_7	[p1l1784t819r1829b847],
35	,	,	O	,	_	0	SENT_7	[p1l1784t819r1829b847],
36	Glynn	NNP	PERSON	Glynn	nn	37	SENT_7	[p1l1842t817r1922b850],
37	RJ	NN	PERSON	rj	appos	13	SENT_7	[p1l1936t819r1972b847],
38	,	,	O	,	_	0	SENT_7	[p1l1936t819r1972b847],
39	Gage	NNP	PERSON	Gage	nn	40	SENT_7	[p1l1985t818r2058b850],
40	BF	NNP	O	BF	appos	13	SENT_7	[p1l2070t819r2109b842],
41	.	.	O	.	_	0	SENT_7	[p1l2070t819r2109b842],

1	Ability	NN	O	ability	_	0	SENT_8	[p1l46t862r135b895],
2	of	IN	O	of	_	0	SENT_8	[p1l148t862r176b888],
3	VKORC1	NN	O	vkorc1	prep_of	1	SENT_8	[p1l187t864r312b888],
4	and	CC	O	and	_	0	SENT_8	[p1l330t862r380b888],
5	CYP2C9	NN	O	cyp2c9	prep_of	1	SENT_8	[p1l395t864r512b888],
6	to	TO	O	to	aux	7	SENT_8	[p1l524t864r552b888],
7	predict	VB	O	predict	infmod	1	SENT_8	[p1l566t862r662b896],
8	therapeutic	JJ	O	therapeutic	amod	10	SENT_8	[p1l673t862r832b896],
9	warfarin	NN	O	warfarin	nn	10	SENT_8	[p1l844t862r959b888],
10	dose	NN	O	dose	dobj	7	SENT_8	[p1l973t862r1037b888],
11	during	IN	O	during	_	0	SENT_8	[p1l1050t862r1141b895],
12	the	DT	DURATION	the	det	14	SENT_8	[p1l1152t862r1196b888],
13	initial	JJ	DURATION	initial	amod	14	SENT_8	[p1l1210t862r1281b888],
14	weeks	NNS	DURATION	week	prep_during	7	SENT_8	[p1l1295t862r1382b888],
15	of	IN	O	of	_	0	SENT_8	[p1l1395t862r1424b888],
16	therapy	NN	O	therapy	prep_of	14	SENT_8	[p1l1435t862r1549b896],
17	.	.	O	.	_	0	SENT_8	[p1l1435t862r1549b896],

1	J	NNP	O	J	nn	3	SENT_9	[p1l1562t864r1575b888],
2	Thromb	NNP	O	Thromb	nn	3	SENT_9	[p1l1589t862r1697b888],
3	Haemost	NNP	O	Haemost	_	0	SENT_9	[p1l1710t864r1837b888],
4	2010	CD	DATE	2010	num	3	SENT_9	[p1l1848t864r1928b892],
5	;	:	O	;	_	0	SENT_9	[p1l1848t864r1928b892],
6	8	CD	NUMBER	8	num	8	SENT_9	[p1l1942t864r1965b888],
7	:	:	O	:	_	0	SENT_9	[p1l1942t864r1965b888],
8	95-100	CD	NUMBER	95-100	dep	3	SENT_9	[p1l1980t864r2094b888],
9	.	.	O	.	_	0	SENT_9	[p1l1980t864r2094b888],

1	Summary	NN	O	summary	_	0	SENT_10	[p1l10t1140r369b1221],
2	.	.	O	.	_	0	SENT_10	[p1l10t1140r369b1221],

1	Background	NN	O	background	_	0	SENT_11	[p1l405t1139r824b1218],
2	:	:	O	:	_	0	SENT_11	[p1l405t1139r824b1218],
3	CYP2C9	NN	O	cyp2c9	nn	6	SENT_11	[p1l860t1140r1166b1202],
4	and	CC	O	and	_	0	SENT_11	[p1l1224t1139r1351b1201],
5	VKORC1	NN	O	vkorc1	conj_and	3	SENT_11	[p1l1404t1140r1748b1202],
6	genotypes	NNS	O	genotype	nsubj	7	SENT_11	[p1l1812t1148r2150b1218],
7	predict	VBP	O	predict	dep	1	SENT_11	[p1l8t1245r245b1324],
8	therapeutic	JJ	O	therapeutic	amod	10	SENT_11	[p1l296t1245r677b1324],
9	warfarin	NN	O	warfarin	nn	10	SENT_11	[p1l726t1245r1018b1308],
10	dose	NN	O	dose	dobj	7	SENT_11	[p1l1070t1245r1222b1308],
11	at	IN	O	at	_	0	SENT_11	[p1l1275t1254r1339b1308],
12	initiation	NN	O	initiation	prep_at	7	SENT_11	[p1l1389t1245r1698b1308],
13	of	IN	O	of	_	0	SENT_11	[p1l1751t1245r1827b1308],
14	therapy	NN	O	therapy	prep_of	12	SENT_11	[p1l1870t1245r2148b1324],
15	;	:	O	;	_	0	SENT_11	[p1l1870t1245r2148b1324],
16	however	RB	O	however	advmod	30	SENT_11	[p1l9t1352r315b1427],
17	,	,	O	,	_	0	SENT_11	[p1l9t1352r315b1427],
18	the	DT	O	the	det	20	SENT_11	[p1l352t1352r456b1414],
19	predictive	JJ	O	predictive	amod	20	SENT_11	[p1l489t1352r822b1431],
20	ability	NN	O	ability	nsubj	30	SENT_11	[p1l858t1352r1070b1431],
21	of	IN	O	of	_	0	SENT_11	[p1l1105t1352r1181b1414],
22	genetic	JJ	O	genetic	amod	23	SENT_11	[p1l1208t1352r1443b1431],
23	information	NN	O	information	prep_of	20	SENT_11	[p1l1477t1352r1887b1414],
24	after	IN	O	after	_	0	SENT_11	[p1l1923t1352r2079b1414],
25	a	DT	DURATION	a	det	26	SENT_11	[p1l2114t1372r2151b1414],
26	week	NN	DURATION	week	prep_after	23	SENT_11	[p1l8t1460r181b1522],
27	or	CC	O	or	_	0	SENT_11	[p1l219t1480r291b1522],
28	longer	JJR	O	longer	conj_or	26	SENT_11	[p1l326t1460r541b1539],
29	is	VBZ	O	be	cop	30	SENT_11	[p1l576t1460r625b1522],
30	unknown	JJ	O	unknown	parataxis	7	SENT_11	[p1l661t1460r1003b1522],
31	.	.	O	.	_	0	SENT_11	[p1l661t1460r1003b1522],

1	Experts	NNS	O	expert	nsubj	3	SENT_12	[p1l1045t1462r1303b1539],
2	have	VBP	O	have	aux	3	SENT_12	[p1l1340t1460r1498b1522],
3	hypothesized	VBN	O	hypothesize	_	0	SENT_12	[p1l1534t1460r1979b1539],
4	that	IN	O	that	complm	7	SENT_12	[p1l2015t1460r2151b1522],
5	genotype	NN	O	genotype	nsubj	7	SENT_12	[p1l10t1575r318b1645],
6	becomes	VBZ	O	become	cop	7	SENT_12	[p1l366t1566r656b1629],
7	irrelevant	JJ	O	irrelevant	ccomp	3	SENT_12	[p1l705t1566r1029b1629],
8	once	RB	DATE	once	advmod	10	SENT_12	[p1l1077t1587r1233b1629],
9	international	JJ	O	international	nsubj	10	SENT_12	[p1l1281t1566r1720b1629],
10	normalized	VBD	O	normalize	ccomp	7	SENT_12	[p1l1767t1566r2151b1629],
11	ratio	NN	O	ratio	dobj	10	SENT_12	[p1l9t1673r169b1735],
12	(	CD	NUMBER	(	num	15	SENT_12	[p1l196t1673r406b1752],
13	INR	NN	O	inr	nn	15	SENT_12	[p1l196t1673r406b1752],
14	)	NN	O	)	nn	15	SENT_12	[p1l196t1673r406b1752],
15	values	NNS	O	value	nsubj	17	SENT_12	[p1l431t1673r641b1735],
16	are	VBP	O	be	cop	17	SENT_12	[p1l668t1693r771b1735],
17	available	JJ	O	available	rcmod	11	SENT_12	[p1l797t1673r1097b1735],
18	because	IN	O	because	mark	21	SENT_12	[p1l1123t1673r1386b1735],
19	INR	NN	O	inr	nn	20	SENT_12	[p1l1412t1675r1573b1735],
20	response	NN	O	response	nsubj	21	SENT_12	[p1l1596t1693r1890b1752],
21	reﬂects	VBZ	O	reﬂects	ccomp	17	SENT_12	[p1l1915t1673r2150b1735],
22	warfarin	NN	O	warfarin	nn	23	SENT_12	[p1l8t1781r300b1843],
23	sensitivity	NN	O	sensitivity	dobj	21	SENT_12	[p1l331t1781r680b1860],
24	.	.	O	.	_	0	SENT_12	[p1l331t1781r680b1860],

1	Methods	NNS	O	method	_	0	SENT_13	[p1l714t1781r1024b1843],
2	:	:	O	:	_	0	SENT_13	[p1l714t1781r1024b1843],
3	We	PRP	O	we	nsubj	4	SENT_13	[p1l1084t1783r1200b1843],
4	genotyped	VBD	O	genotype	dep	1	SENT_13	[p1l1230t1781r1585b1860],
5	the	DT	O	the	det	6	SENT_13	[p1l1614t1781r1717b1843],
6	participants	NNS	O	participant	nsubj	17	SENT_13	[p1l1746t1781r2150b1860],
7	in	IN	O	in	_	0	SENT_13	[p1l9t1887r73b1948],
8	the	DT	O	the	det	9	SENT_13	[p1l119t1887r222b1949],
9	Prevention	NNP	O	Prevention	prep_in	6	SENT_13	[p1l268t1887r638b1949],
10	of	IN	O	of	_	0	SENT_13	[p1l684t1887r760b1949],
11	Recurrent	NNP	O	Recurrent	prep_of	9	SENT_13	[p1l799t1890r1141b1949],
12	Venous	JJ	O	venous	amod	17	SENT_13	[p1l1185t1890r1442b1949],
13	Thromboembolism	NN	O	thromboembolism	nn	17	SENT_13	[p1l1488t1887r2151b1949],
14	(	CD	NUMBER	(	num	17	SENT_13	[p1l11t1993r461b2072],
15	PREVENT	NNP	O	PREVENT	nn	17	SENT_13	[p1l11t1993r461b2072],
16	)	CD	NUMBER	)	num	17	SENT_13	[p1l11t1993r461b2072],
17	trial	NN	O	trial	xcomp	4	SENT_13	[p1l487t1993r641b2068],
18	,	,	O	,	_	0	SENT_13	[p1l487t1993r641b2068],
19	who	WP	O	who	nsubj	20	SENT_13	[p1l667t1993r813b2056],
20	had	VBD	O	have	ccomp	4	SENT_13	[p1l837t1993r966b2056],
21	idiopathic	JJ	O	idiopathic	amod	23	SENT_13	[p1l989t1993r1331b2072],
22	venous	JJ	O	venous	amod	23	SENT_13	[p1l1353t2013r1591b2056],
23	thromboemboli	NN	O	thromboembolus	dobj	20	SENT_13	[p1l1616t1993r2151b2056],
24	and	CC	O	and	_	0	SENT_13	[p1l10t2100r137b2163],
25	began	VBD	O	begin	conj_and	20	SENT_13	[p1l178t2100r382b2179],
26	low-intensity	JJ	O	low-intensity	amod	31	SENT_13	[p1l423t2100r861b2179],
27	warfarin	NN	O	warfarin	nn	31	SENT_13	[p1l901t2100r1193b2163],
28	(	CD	NUMBER	(	num	31	SENT_13	[p1l1235t2100r1642b2180],
29	therapeutic	JJ	O	therapeutic	amod	31	SENT_13	[p1l1235t2100r1642b2180],
30	INR	NN	O	inr	nn	31	SENT_13	[p1l1683t2103r1843b2162],
31	l.	NN	O	l.	nsubj	33	SENT_13	[p1l1891t2101r2149b2179],
32	5	CD	NUMBER	5	num	33	SENT_13	[p1l1891t2101r2149b2179],
33	—	NN	O	—	xcomp	25	SENT_13	[p1l1891t2101r2149b2179],
34	2.0	CD	NUMBER	2.0	num	35	SENT_13	[p1l1891t2101r2149b2179],
35	)	NN	O	)	dobj	20	SENT_13	[p1l1891t2101r2149b2179],
36	using	VBG	O	use	partmod	35	SENT_13	[p1l8t2207r189b2286],
37	a	DT	O	a	det	40	SENT_13	[p1l210t2227r248b2269],
38	standard	JJ	O	standard	amod	40	SENT_13	[p1l270t2207r568b2269],
39	dosing	NN	O	dosing	nn	40	SENT_13	[p1l589t2207r814b2286],
40	protocol	NN	O	protocol	dobj	36	SENT_13	[p1l833t2207r1140b2286],
41	.	.	O	.	_	0	SENT_13	[p1l833t2207r1140b2286],

1	To	TO	O	to	aux	2	SENT_14	[p1l1165t2209r1260b2269],
2	develop	VB	O	develop	purpcl	7	SENT_14	[p1l1283t2207r1546b2286],
3	pharmacogenetic	JJ	O	pharmacogenetic	amod	4	SENT_14	[p1l1566t2207r2151b2286],
4	models	NNS	O	model	dobj	2	SENT_14	[p1l8t2315r269b2390],
5	,	,	O	,	_	0	SENT_14	[p1l8t2315r269b2390],
6	we	PRP	O	we	nsubj	35	SENT_14	[p1l301t2335r394b2377],
7	quantiﬁed	VBD	O	quantiﬁed	_	0	SENT_14	[p1l425t2315r768b2394],
8	the	DT	O	the	det	9	SENT_14	[p1l799t2315r902b2377],
9	effect	NN	O	effect	dobj	7	SENT_14	[p1l933t2315r1112b2377],
10	of	IN	O	of	_	0	SENT_14	[p1l1143t2315r1219b2377],
11	genotypes	NNS	O	genotype	prep_of	9	SENT_14	[p1l1241t2324r1598b2394],
12	,	,	O	,	_	0	SENT_14	[p1l1241t2324r1598b2394],
13	clinical	JJ	O	clinical	amod	14	SENT_14	[p1l1631t2315r1868b2377],
14	factors	NNS	O	factor	prep_of	9	SENT_14	[p1l1898t2315r2148b2390],
15	,	,	O	,	_	0	SENT_14	[p1l1898t2315r2148b2390],
16	previous	JJ	O	previous	amod	17	SENT_14	[p1l8t2421r298b2500],
17	doses	NNS	O	dose	prep_of	9	SENT_14	[p1l317t2421r500b2484],
18	and	CC	O	and	_	0	SENT_14	[p1l520t2421r647b2484],
19	INR	NN	O	inr	prep_of	9	SENT_14	[p1l666t2424r826b2483],
20	on	IN	O	on	_	0	SENT_14	[p1l844t2442r930b2484],
21	therapeutic	JJ	O	therapeutic	amod	23	SENT_14	[p1l948t2421r1330b2500],
22	warfarin	NN	O	warfarin	nn	23	SENT_14	[p1l1345t2421r1638b2484],
23	dose	NN	O	dose	prep_on	7	SENT_14	[p1l1656t2421r1809b2484],
24	in	IN	O	in	_	0	SENT_14	[p1l1827t2421r1891b2483],
25	the	DT	O	the	det	28	SENT_14	[p1l1909t2421r2013b2484],
26	223	CD	NUMBER	223	num	28	SENT_14	[p1l2032t2423r2147b2484],
27	PREVENT	NN	O	prevent	nn	28	SENT_14	[p1l9t2530r410b2591],
28	participants	NNS	O	participant	prep_in	23	SENT_14	[p1l429t2528r832b2607],
29	who	WP	O	who	nsubjpass	31	SENT_14	[p1l851t2528r997b2591],
30	were	VBD	O	be	auxpass	31	SENT_14	[p1l1018t2548r1176b2591],
31	randomized	VBN	O	randomize	rcmod	28	SENT_14	[p1l1196t2528r1603b2591],
32	to	TO	O	to	_	0	SENT_14	[p1l1623t2537r1690b2591],
33	warfarin	NN	O	warfarin	prep_to	31	SENT_14	[p1l1711t2528r2003b2591],
34	and	CC	O	and	_	0	SENT_14	[p1l2024t2528r2150b2591],
35	achieved	VBD	O	achieve	conj_and	7	SENT_14	[p1l10t2636r304b2698],
36	stable	JJ	O	stable	amod	38	SENT_14	[p1l330t2636r524b2698],
37	therapeutic	JJ	O	therapeutic	amod	38	SENT_14	[p1l549t2636r931b2715],
38	INRs	NNS	MISC	inr	dobj	35	SENT_14	[p1l956t2638r1161b2698],
39	.	.	O	.	_	0	SENT_14	[p1l956t2638r1161b2698],

1	Results	NNS	O	result	nsubj	16	SENT_15	[p1l1190t2636r1447b2698],
2	:	:	O	:	_	0	SENT_15	[p1l1190t2636r1447b2698],
3	A	DT	O	a	det	5	SENT_15	[p1l1480t2636r1544b2697],
4	pharmacogenetic	JJ	O	pharmacogenetic	amod	5	SENT_15	[p1l1566t2636r2151b2715],
5	model	NN	O	model	dep	1	SENT_15	[p1l8t2742r220b2805],
6	using	VBG	O	use	partmod	5	SENT_15	[p1l274t2742r455b2821],
7	data	NNS	O	datum	dobj	6	SENT_15	[p1l509t2742r659b2805],
8	from	IN	O	from	_	0	SENT_15	[p1l713t2742r881b2805],
9	day	NN	DURATION	day	nn	11	SENT_15	[p1l935t2742r1059b2821],
10	o	NN	O	o	nn	11	SENT_15	[p1l1114t2744r1151b2805],
11	(	NN	O	(	prep_from	6	SENT_15	[p1l1208t2742r1446b2822],
12	before	IN	O	before	_	0	SENT_15	[p1l1208t2742r1446b2822],
13	therapy	NN	O	therapy	nn	14	SENT_15	[p1l1501t2742r1762b2821],
14	initiation	NN	O	initiation	prep_before	11	SENT_15	[p1l1815t2742r2149b2821],
15	)	CD	NUMBER	)	num	14	SENT_15	[p1l1815t2742r2149b2821],
16	explained	VBD	O	explain	_	0	SENT_15	[p1l9t2849r334b2928],
17	54	CD	PERCENT	54	num	18	SENT_15	[p1l364t2851r516b2913],
18	%	NN	PERCENT	%	dobj	16	SENT_15	[p1l364t2851r516b2913],
19	of	IN	O	of	_	0	SENT_15	[p1l551t2849r627b2912],
20	the	DT	O	the	det	21	SENT_15	[p1l646t2849r749b2911],
21	variability	NN	O	variability	prep_of	18	SENT_15	[p1l776t2849r1122b2928],
22	in	IN	O	in	_	0	SENT_15	[p1l1147t2849r1212b2911],
23	therapeutic	JJ	O	therapeutic	amod	27	SENT_15	[p1l1239t2849r1620b2928],
24	dose	NN	O	dose	nn	27	SENT_15	[p1l1647t2849r1800b2912],
25	(	NN	O	(	nn	27	SENT_15	[p1l1829t2833r1987b2928],
26	R2	NN	O	r2	nn	27	SENT_15	[p1l1829t2833r1987b2928],
27	)	NN	O	)	prep_in	16	SENT_15	[p1l1829t2833r1987b2928],
28	.	.	O	.	_	0	SENT_15	[p1l1829t2833r1987b2928],

1	The	DT	O	the	det	2	SENT_16	[p1l2018t2849r2150b2911],
2	R2	NN	O	r2	nsubj	3	SENT_16	[p1l12t2940r100b3018],
3	increased	VBD	O	increase	_	0	SENT_16	[p1l124t2956r439b3019],
4	to	TO	O	to	_	0	SENT_16	[p1l462t2965r530b3019],
5	68	CD	PERCENT	68	num	6	SENT_16	[p1l556t2958r710b3020],
6	%	NN	PERCENT	%	prep_to	3	SENT_16	[p1l556t2958r710b3020],
7	at	IN	O	at	_	0	SENT_16	[p1l741t2965r805b3019],
8	day	NN	DURATION	day	prep_at	6	SENT_16	[p1l829t2956r953b3035],
9	7	CD	NUMBER	7	num	8	SENT_16	[p1l977t2959r1031b3032],
10	,	,	O	,	_	0	SENT_16	[p1l977t2959r1031b3032],
11	75	CD	PERCENT	75	num	12	SENT_16	[p1l1060t2958r1213b3020],
12	%	NN	PERCENT	%	prep_to	3	SENT_16	[p1l1060t2958r1213b3020],
13	at	IN	O	at	_	0	SENT_16	[p1l1245t2965r1309b3019],
14	day	NN	DURATION	day	prep_at	12	SENT_16	[p1l1332t2956r1455b3035],
15	14	CD	NUMBER	14	num	14	SENT_16	[p1l1487t2958r1575b3032],
16	,	,	O	,	_	0	SENT_16	[p1l1487t2958r1575b3032],
17	and	CC	PERCENT	and	_	0	SENT_16	[p1l1604t2956r1730b3019],
18	77	CD	PERCENT	77	num	19	SENT_16	[p1l1755t2958r1909b3020],
19	%	NN	PERCENT	%	conj_and	6	SENT_16	[p1l1755t2958r1909b3020],
20	at	IN	O	at	_	0	SENT_16	[p1l1940t2966r2004b3019],
21	day	NN	DURATION	day	prep_at	19	SENT_16	[p1l2027t2956r2151b3035],
22	21	CD	NUMBER	21	num	21	SENT_16	[p1l10t3064r106b3138],
23	,	,	O	,	_	0	SENT_16	[p1l10t3064r106b3138],
24	because	IN	O	because	_	0	SENT_16	[p1l142t3063r405b3125],
25	of	IN	O	of	_	0	SENT_16	[p1l440t3063r516b3125],
26	increasing	VBG	O	increase	amod	27	SENT_16	[p1l539t3063r882b3142],
27	contributions	NNS	O	contribution	prep_because_of	3	SENT_16	[p1l913t3063r1370b3125],
28	from	IN	O	from	_	0	SENT_16	[p1l1404t3063r1572b3125],
29	prior	JJ	O	prior	amod	30	SENT_16	[p1l1603t3063r1774b3142],
30	doses	NNS	O	dose	prep_from	27	SENT_16	[p1l1806t3063r1989b3125],
31	and	CC	O	and	_	0	SENT_16	[p1l2024t3063r2151b3125],
32	INR	NN	O	inr	nn	33	SENT_16	[p1l10t3173r170b3233],
33	response	NN	O	response	prep_from	27	SENT_16	[p1l204t3191r514b3250],
34	.	.	O	.	_	0	SENT_16	[p1l204t3191r514b3250],

1	Although	IN	O	although	mark	9	SENT_17	[p1l554t3171r883b3250],
2	CYP2C9	NN	O	cyp2c9	nn	5	SENT_17	[p1l919t3172r1225b3233],
3	and	CC	O	and	_	0	SENT_17	[p1l1263t3171r1391b3233],
4	VKORC1	NN	O	vkorc1	conj_and	2	SENT_17	[p1l1424t3172r1768b3233],
5	genotypes	NNS	O	genotype	nsubj	9	SENT_17	[p1l1812t3179r2150b3250],
6	were	VBD	O	be	cop	9	SENT_17	[p1l8t3298r166b3340],
7	signiﬁcant	JJ	O	signiﬁcant	amod	9	SENT_17	[p1l199t3277r544b3356],
8	independent	JJ	O	independent	amod	9	SENT_17	[p1l572t3277r993b3356],
9	predictors	NNS	O	predictor	advcl	34	SENT_17	[p1l1020t3277r1362b3356],
10	of	IN	O	of	_	0	SENT_17	[p1l1395t3277r1470b3340],
11	therapeutic	JJ	O	therapeutic	amod	12	SENT_17	[p1l1492t3277r1874b3356],
12	dose	NN	O	dose	prep_of	9	SENT_17	[p1l1904t3277r2056b3340],
13	at	IN	O	at	_	0	SENT_17	[p1l2087t3286r2152b3340],
14	each	DT	SET	each	det	16	SENT_17	[p1l9t3384r163b3447],
15	weekly	JJ	SET	weekly	amod	16	SENT_17	[p1l192t3384r426b3463],
16	interval	NN	O	interval	prep_at	12	SENT_17	[p1l455t3384r731b3459],
17	,	,	O	,	_	0	SENT_17	[p1l455t3384r731b3459],
18	the	DT	O	the	det	19	SENT_17	[p1l764t3384r867b3446],
19	magnitude	NN	O	magnitude	nsubj	34	SENT_17	[p1l897t3384r1261b3463],
20	of	IN	O	of	_	0	SENT_17	[p1l1293t3384r1369b3447],
21	their	PRP$	O	they	poss	23	SENT_17	[p1l1391t3384r1547b3446],
22	predictive	JJ	O	predictive	amod	23	SENT_17	[p1l1576t3384r1908b3463],
23	ability	NN	O	ability	prep_of	19	SENT_17	[p1l1940t3384r2152b3463],
24	diminished	VBN	O	diminish	partmod	23	SENT_17	[p1l10t3492r382b3554],
25	over	IN	O	over	_	0	SENT_17	[p1l404t3512r552b3554],
26	time	NN	O	time	prep_over	24	SENT_17	[p1l572t3492r735b3554],
27	:	:	O	:	_	0	SENT_17	[p1l572t3492r735b3554],
28	partial	JJ	O	partial	amod	29	SENT_17	[p1l759t3492r983b3571],
29	R2	NN	O	r2	dep	23	SENT_17	[p1l1005t3476r1094b3553],
30	of	IN	O	of	_	0	SENT_17	[p1l1116t3492r1192b3554],
31	genotype	NN	O	genotype	prep_of	29	SENT_17	[p1l1203t3501r1512b3571],
32	was	VBD	O	be	cop	34	SENT_17	[p1l1531t3512r1660b3554],
33	43	CD	PERCENT	43	num	34	SENT_17	[p1l1680t3493r1836b3555],
34	%	NN	PERCENT	%	_	0	SENT_17	[p1l1680t3493r1836b3555],
35	at	IN	O	at	_	0	SENT_17	[p1l1864t3501r1928b3554],
36	day	NN	DURATION	day	nn	37	SENT_17	[p1l1948t3492r2071b3571],
37	o	NN	O	o	prep_at	34	SENT_17	[p1l2091t3494r2147b3567],
38	,	,	O	,	_	0	SENT_17	[p1l2091t3494r2147b3567],
39	12	CD	PERCENT	12	num	40	SENT_17	[p1l17t3600r164b3662],
40	%	NN	PERCENT	%	conj_and	34	SENT_17	[p1l17t3600r164b3662],
41	at	IN	O	at	_	0	SENT_17	[p1l212t3607r276b3661],
42	day	NN	DURATION	day	prep_at	40	SENT_17	[p1l317t3598r441b3677],
43	7	CD	NUMBER	7	num	42	SENT_17	[p1l482t3601r536b3674],
44	,	,	O	,	_	0	SENT_17	[p1l482t3601r536b3674],
45	4	CD	PERCENT	4	num	46	SENT_17	[p1l580t3600r695b3662],
46	%	NN	PERCENT	%	conj_and	34	SENT_17	[p1l580t3600r695b3662],
47	at	IN	O	at	_	0	SENT_17	[p1l743t3607r808b3661],
48	day	NN	DURATION	day	prep_at	46	SENT_17	[p1l848t3598r971b3677],
49	14	CD	NUMBER	14	num	48	SENT_17	[p1l1019t3600r1108b3673],
50	,	,	O	,	_	0	SENT_17	[p1l1019t3600r1108b3673],
51	and	CC	PERCENT	and	_	0	SENT_17	[p1l1153t3598r1279b3661],
52	1	CD	PERCENT	1	num	53	SENT_17	[p1l1328t3600r1435b3662],
53	%	NN	PERCENT	%	conj_and	34	SENT_17	[p1l1328t3600r1435b3662],
54	at	IN	O	at	_	0	SENT_17	[p1l1482t3607r1547b3661],
55	day	NN	DURATION	day	prep_at	53	SENT_17	[p1l1587t3598r1711b3677],
56	21	CD	NUMBER	21	num	55	SENT_17	[p1l1751t3600r1845b3660],
57	.	.	O	.	_	0	SENT_17	[p1l1751t3600r1845b3660],

1	Conclusion	NN	O	conclusion	_	0	SENT_18	[p1l1895t3599r2149b3661, p1l8t3710r156b3768],
2	:	:	O	:	_	0	SENT_18	[p1l1895t3599r2149b3661, p1l8t3710r156b3768],
3	Over	IN	O	over	_	0	SENT_18	[p1l191t3706r358b3768],
4	the	DT	O	the	det	6	SENT_18	[p1l387t3705r490b3767],
5	ﬁrst	NN	O	ﬁrst	nn	6	SENT_18	[p1l518t3705r650b3767],
6	weeks	NNS	DURATION	week	prep_over	26	SENT_18	[p1l677t3705r880b3768],
7	of	IN	O	of	_	0	SENT_18	[p1l911t3705r987b3768],
8	warfarin	NN	O	warfarin	nn	9	SENT_18	[p1l1006t3705r1298b3768],
9	therapy	NN	O	therapy	prep_of	6	SENT_18	[p1l1327t3705r1604b3784],
10	,	,	O	,	_	0	SENT_18	[p1l1327t3705r1604b3784],
11	INR	NN	O	inr	nsubj	26	SENT_18	[p1l1637t3708r1797b3767],
12	and	CC	O	and	_	0	SENT_18	[p1l1825t3705r1952b3768],
13	prior	RB	O	prior	advmod	14	SENT_18	[p1l1980t3705r2151b3784],
14	dose	NN	O	dose	conj_and	11	SENT_18	[p2l10t21r162b84],
15	become	VBN	O	become	cop	17	SENT_18	[p2l197t21r457b84],
16	increasingly	RB	O	increasingly	advmod	17	SENT_18	[p2l491t21r895b100],
17	predictive	JJ	O	predictive	partmod	14	SENT_18	[p2l927t21r1259b100],
18	of	IN	O	of	_	0	SENT_18	[p2l1296t21r1372b84],
19	therapeutic	JJ	O	therapeutic	amod	20	SENT_18	[p2l1398t21r1780b100],
20	dose	NN	O	dose	prep_of	17	SENT_18	[p2l1814t21r1984b97],
21	,	,	O	,	_	0	SENT_18	[p2l1814t21r1984b97],
22	and	CC	O	and	_	0	SENT_18	[p2l2023t21r2150b84],
23	genotype	NN	O	genotype	conj_and	14	SENT_18	[p2l10t137r318b207],
24	becomes	VBZ	O	become	cop	26	SENT_18	[p2l349t128r639b190],
25	less	JJR	O	less	dep	26	SENT_18	[p2l670t128r785b190],
26	relevant	JJ	O	relevant	dep	1	SENT_18	[p2l817t128r1104b190],
27	.	.	O	.	_	0	SENT_18	[p2l817t128r1104b190],

1	However	RB	O	however	advmod	10	SENT_19	[p2l1140t130r1467b203],
2	,	,	O	,	_	0	SENT_19	[p2l1140t130r1467b203],
3	at	IN	O	at	_	0	SENT_19	[p2l1502t137r1566b190],
4	day	NN	DURATION	day	prep_at	10	SENT_19	[p2l1597t128r1721b207],
5	7	CD	DATE	7	num	4	SENT_19	[p2l1752t130r1807b203],
6	,	,	O	,	_	0	SENT_19	[p2l1752t130r1807b203],
7	genotype	NN	O	genotype	nsubj	10	SENT_19	[p2l1841t137r2149b207],
8	remains	VBZ	O	remain	cop	10	SENT_19	[p2l9t236r276b298],
9	clinically	RB	O	clinically	advmod	10	SENT_19	[p2l305t236r604b315],
10	relevant	JJ	O	relevant	_	0	SENT_19	[p2l631t236r920b311],
11	,	,	O	,	_	0	SENT_19	[p2l631t236r920b311],
12	accounting	VBG	O	account	prep	10	SENT_19	[p2l952t236r1327b315],
13	for	IN	O	for	pcomp	12	SENT_19	[p2l1354t236r1454b298],
14	12	CD	PERCENT	12	num	15	SENT_19	[p2l1490t237r1637b299],
15	%	NN	PERCENT	%	pobj	13	SENT_19	[p2l1490t237r1637b299],
16	of	IN	O	of	_	0	SENT_19	[p2l1674t236r1749b298],
17	therapeutic	JJ	O	therapeutic	amod	19	SENT_19	[p2l1769t236r2151b315],
18	dose	NN	O	dose	nn	19	SENT_19	[p2l10t342r162b405],
19	variability	NN	O	variability	prep_of	15	SENT_19	[p2l187t342r549b421],
20	.	.	O	.	_	0	SENT_19	[p2l187t342r549b421],

1	Keywords	NNPS	O	Keywords	_	0	SENT_20	[p2l8t559r354b636],
2	:	:	O	:	_	0	SENT_20	[p2l8t559r354b636],
3	cytochrome	NN	O	cytochrome	nn	6	SENT_20	[p2l413t556r816b635],
4	P450	NN	O	p450	nn	6	SENT_20	[p2l871t558r1039b619],
5	2C9	NN	O	2c9	nn	6	SENT_20	[p2l1094t557r1230b619],
6	gene	NN	O	gene	dep	1	SENT_20	[p2l1287t577r1458b635],
7	,	,	O	,	_	0	SENT_20	[p2l1287t577r1458b635],
8	pharmacogenetics	NNS	O	pharmacogenetic	appos	6	SENT_20	[p2l1514t556r2148b635],
9	,	,	O	,	_	0	SENT_20	[p2l1514t556r2148b635],
10	vitamin	NN	O	vitamin	nn	14	SENT_20	[p2l8t664r269b726],
11	K	NN	O	k	nn	14	SENT_20	[p2l293t666r360b725],
12	epoxide	NN	O	epoxide	nn	14	SENT_20	[p2l384t664r647b743],
13	reductase	NN	O	reductase	nn	14	SENT_20	[p2l672t664r991b726],
14	complex	NN	O	complex	appos	6	SENT_20	[p2l1017t664r1304b743],
15	1	CD	NUMBER	1	dep	14	SENT_20	[p2l1337t666r1385b739],
16	,	,	O	,	_	0	SENT_20	[p2l1337t666r1385b739],
17	warfarin	NN	O	warfarin	appos	6	SENT_20	[p2l1412t664r1720b726],
18	.	.	O	.	_	0	SENT_20	[p2l1412t664r1720b726],

1	Correspondence	NN	O	correspondence	_	0	SENT_21	[p2l10t925r516b992],
2	:	:	O	:	_	0	SENT_21	[p2l10t925r516b992],
3	Brian	NNP	PERSON	Brian	nn	4	SENT_21	[p2l561t925r726b978],
4	Gage	NNP	PERSON	Gage	dep	1	SENT_21	[p2l767t926r941b992],
5	,	,	O	,	_	0	SENT_21	[p2l767t926r941b992],
6	660	CD	NUMBER	660	num	9	SENT_21	[p2l985t927r1086b978],
7	S.	NNP	O	S.	nn	9	SENT_21	[p2l1129t926r1179b978],
8	Euclid	NNP	O	Euclid	nn	9	SENT_21	[p2l1223t925r1415b978],
9	Avenue	NNP	O	Avenue	appos	4	SENT_21	[p2l1454t925r1701b988],
10	,	,	O	,	_	0	SENT_21	[p2l1454t925r1701b988],
11	Campus	NNP	O	Campus	nn	12	SENT_21	[p2l1744t926r1992b992],
12	Box	NNP	O	Box	appos	4	SENT_21	[p2l2033t927r2152b978],
13	6005	CD	NUMBER	6005	num	12	SENT_21	[p2l10t1025r165b1087],
14	,	,	O	,	_	0	SENT_21	[p2l10t1025r165b1087],
15	St	NNP	LOCATION	St	nn	16	SENT_21	[p2l197t1024r255b1076],
16	Louis	NNP	LOCATION	Louis	appos	4	SENT_21	[p2l283t1024r469b1087],
17	,	,	O	,	_	0	SENT_21	[p2l283t1024r469b1087],
18	MO	NNP	DURATION	MO	appos	4	SENT_21	[p2l498t1024r620b1076],
19	63110	CD	NUMBER	63110	num	18	SENT_21	[p2l649t1025r840b1087],
20	,	,	O	,	_	0	SENT_21	[p2l649t1025r840b1087],
21	USA	NNP	LOCATION	USA	appos	4	SENT_21	[p2l869t1024r1034b1076],
22	.	.	O	.	_	0	SENT_21	[p2l869t1024r1034b1076],

1	Te1.	NNP	O	Te1.	_	0	SENT_22	[p2l9t1122r138b1175],
2	:	:	O	:	_	0	SENT_22	[p2l9t1122r138b1175],
3	+1	CD	NUMBER	+1	number	4	SENT_22	[p2l181t1123r266b1174],
4	314 454 8369	CD	NUMBER	314 454 8369	dep	1	SENT_22	[p2l564t1123r718b1186],[p2l302t1123r404b1175],
5	;	:	O	;	_	0	SENT_22	[p2l564t1123r718b1186],
6	fax	NN	O	fax	dep	4	SENT_22	[p2l748t1122r855b1175],
7	:	:	O	:	_	0	SENT_22	[p2l748t1122r855b1175],
8	+1	CD	NUMBER	+1	number	9	SENT_22	[p2l897t1123r983b1174],
9	314 454 5554	CD	NUMBER	314 454 5554	dep	6	SENT_22	[p2l1281t1123r1433b1175],[p2l1018t1123r1121b1175],
10	.	.	O	.	_	0	SENT_22	[p2l1281t1123r1433b1175],

1	E-mail	NN	O	e-mail	_	0	SENT_23	[p2l10t1219r226b1272],
2	:	:	O	:	_	0	SENT_23	[p2l10t1219r226b1272],
3	bgage@dom.wustl.edu	NN	O	bgage@dom.wustl.edu	dep	1	SENT_23	[p2l256t1219r950b1286],

1	Received	VBN	O	receive	_	0	SENT_24	[p2l11t1416r270b1468],
2	1	CD	DATE	1	dobj	1	SENT_24	[p2l300t1417r319b1467],
3	February	NNP	DATE	February	tmod	1	SENT_24	[p2l350t1416r620b1482],
4	2009	CD	DATE	2009	num	3	SENT_24	[p2l643t1417r793b1479],
5	,	,	O	,	_	0	SENT_24	[p2l643t1417r793b1479],
6	accepted	VBN	O	accept	partmod	1	SENT_24	[p2l820t1416r1069b1482],
7	18	CD	DATE	18	dobj	6	SENT_24	[p2l1099t1417r1156b1468],
8	September	NNP	DATE	September	tmod	6	SENT_24	[p2l1184t1416r1489b1482],
9	2009	CD	DATE	2009	num	8	SENT_24	[p2l1512t1417r1645b1468],

1	©	RB	O	©	dep	2	SENT_25	[p2l10t1633r61b1683],
2	2009	CD	DATE	2009	dep	4	SENT_25	[p2l90t1632r228b1683],
3	International	NNP	ORGANIZATION	International	nn	4	SENT_25	[p2l256t1631r653b1683],
4	Society	NNP	ORGANIZATION	Society	dep	9	SENT_25	[p2l683t1631r898b1696],
5	on	IN	O	on	_	0	SENT_25	[p2l925t1648r1000b1683],
6	Thrombosis	NNP	O	Thrombosis	prep_on	4	SENT_25	[p2l1027t1630r1388b1683],
7	and	CC	O	and	_	0	SENT_25	[p2l1417t1630r1527b1683],
8	Haemostasis	NNP	O	Haemostasis	prep_on	4	SENT_25	[p2l1555t1631r1935b1683],
9	Introduction	NN	O	introduction	_	0	SENT_25	[p2l11t1732r451b1797],

1	Prevention	NNP	O	Prevention	nsubjpass	15	SENT_26	[p2l7t1895r377b1957],
2	and	CC	O	and	_	0	SENT_26	[p2l403t1895r530b1957],
3	treatment	NN	O	treatment	conj_and	1	SENT_26	[p2l556t1904r886b1957],
4	of	IN	O	of	_	0	SENT_26	[p2l912t1895r988b1957],
5	venous	JJ	O	venous	amod	8	SENT_26	[p2l1005t1915r1242b1957],
6	thromboembolism	NN	O	thromboembolism	nn	8	SENT_26	[p2l1269t1895r1902b1957],
7	o/TE	NN	O	o/te	nn	8	SENT_26	[p2l1929t1895r2143b1973],
8	)	NN	O	)	prep_of	3	SENT_26	[p2l1929t1895r2143b1973],
9	with	IN	O	with	_	0	SENT_26	[p2l6t2002r157b2063],
10	the	DT	O	the	det	13	SENT_26	[p2l194t2002r297b2063],
11	oral	JJ	O	oral	amod	13	SENT_26	[p2l337t2002r470b2063],
12	anticoagulant	JJ	O	anticoagulant	amod	13	SENT_26	[p2l508t2002r974b2080],
13	warfarin	NN	O	warfarin	prep_with	8	SENT_26	[p2l1010t2002r1302b2063],
14	is	VBZ	O	be	auxpass	15	SENT_26	[p2l1338t2002r1388b2063],
15	indicated	VBN	O	indicate	_	0	SENT_26	[p2l1426t2002r1737b2063],
16	for	IN	O	for	_	0	SENT_26	[p2l1774t2002r1874b2063],
17	a	DT	O	a	det	19	SENT_26	[p2l1913t2022r1950b2063],
18	wide	JJ	O	wide	amod	19	SENT_26	[p2l1986t2002r2144b2063],
19	variety	NN	O	variety	prep_for	15	SENT_26	[p2l6t2108r239b2186],
20	of	IN	O	of	_	0	SENT_26	[p2l263t2108r339b2170],
21	patients	NNS	O	patient	prep_of	19	SENT_26	[p2l353t2108r637b2187],
22	.	.	O	.	_	0	SENT_26	[p2l353t2108r637b2187],

1	Warfarin	NNP	O	Warfarin	nsubj	2	SENT_27	[p2l663t2108r978b2170],
2	has	VBZ	O	have	_	0	SENT_27	[p2l1001t2108r1114b2170],
3	a	DT	O	a	det	6	SENT_27	[p2l1139t2128r1177b2170],
4	narrow	JJ	O	narrow	amod	6	SENT_27	[p2l1199t2128r1448b2170],
5	therapeutic	JJ	O	therapeutic	amod	6	SENT_27	[p2l1471t2107r1852b2187],
6	window	NN	O	window	dobj	2	SENT_27	[p2l1874t2107r2147b2170],
7	requiring	VBG	O	require	partmod	6	SENT_27	[p2l7t2215r318b2293],
8	frequent	JJ	O	frequent	amod	9	SENT_27	[p2l345t2215r631b2293],
9	monitoring	NN	O	monitoring	nsubj	13	SENT_27	[p2l657t2215r1042b2293],
10	of	IN	O	of	_	0	SENT_27	[p2l1071t2215r1147b2276],
11	the	DT	O	the	det	12	SENT_27	[p2l1166t2215r1270b2276],
12	international	JJ	O	international	prep_of	9	SENT_27	[p2l1297t2215r1736b2276],
13	normalized	VBD	O	normalize	ccomp	7	SENT_27	[p2l1763t2215r2145b2276],
14	ratio	NN	O	ratio	nn	17	SENT_27	[p2l7t2320r166b2383],
15	(	CD	NUMBER	(	num	17	SENT_27	[p2l222t2321r431b2400],
16	INR	NN	O	inr	nn	17	SENT_27	[p2l222t2321r431b2400],
17	)	NN	O	)	dobj	13	SENT_27	[p2l222t2321r431b2400],
18	until	IN	O	until	mark	23	SENT_27	[p2l484t2320r640b2383],
19	a	DT	O	a	det	21	SENT_27	[p2l694t2341r731b2383],
20	stable	JJ	O	stable	amod	21	SENT_27	[p2l785t2320r979b2383],
21	dose	NN	O	dose	nsubjpass	23	SENT_27	[p2l1031t2320r1184b2383],
22	is	VBZ	O	be	auxpass	23	SENT_27	[p2l1237t2320r1286b2383],
23	achieved	VBN	O	achieve	dep	17	SENT_27	[p2l1340t2320r1649b2383],
24	.	.	O	.	_	0	SENT_27	[p2l1340t2320r1649b2383],

1	Initiation	NN	O	initiation	nsubj	4	SENT_28	[p2l1707t2320r2024b2383],
2	of	IN	O	of	_	0	SENT_28	[p2l2078t2320r2154b2383],
3	warfarin	NN	O	warfarin	prep_of	1	SENT_28	[p2l6t2427r298b2488],
4	poses	VBZ	O	pose	_	0	SENT_28	[p2l326t2447r509b2505],
5	challenges	NNS	O	challenge	dobj	4	SENT_28	[p2l538t2427r883b2505],
6	for	IN	O	for	_	0	SENT_28	[p2l913t2427r1014b2488],
7	both	DT	O	both	preconj	8	SENT_28	[p2l1042t2427r1201b2488],
8	clinicians	NNS	O	clinician	prep_for	5	SENT_28	[p2l1229t2427r1540b2488],
9	and	CC	O	and	_	0	SENT_28	[p2l1571t2427r1698b2488],
10	patients	NNS	O	patient	prep_for	5	SENT_28	[p2l1726t2427r1993b2505],
11	due	JJ	O	due	_	0	SENT_28	[p2l2023t2427r2145b2488],
12	to	TO	O	to	_	0	SENT_28	[p2l7t2542r74b2595],
13	complex	JJ	O	complex	amod	14	SENT_28	[p2l105t2534r392b2612],
14	pharmacology	NN	O	pharmacology	prep_due_to	8	SENT_28	[p2l419t2534r929b2612],
15	,	,	O	,	_	0	SENT_28	[p2l419t2534r929b2612],
16	risks	NNS	O	risk	conj_and	5	SENT_28	[p2l961t2534r1116b2595],
17	of	IN	O	of	_	0	SENT_28	[p2l1147t2534r1222b2595],
18	bleeding	NN	O	bleeding	prep_of	16	SENT_28	[p2l1243t2534r1527b2612],
19	and	CC	O	and	_	0	SENT_28	[p2l1556t2534r1683b2595],
20	clotting	NN	O	clotting	conj_and	18	SENT_28	[p2l1711t2534r1986b2612],
21	,	,	O	,	_	0	SENT_28	[p2l1711t2534r1986b2612],
22	and	CC	O	and	_	0	SENT_28	[p2l2019t2534r2145b2595],
23	great	JJ	O	great	amod	26	SENT_28	[p2l8t2648r178b2717],
24	inter-subject	JJ	O	inter-subject	amod	26	SENT_28	[p2l216t2639r635b2717],
25	dose	NN	O	dose	nn	26	SENT_28	[p2l673t2639r825b2701],
26	variability	NN	O	variability	dobj	4	SENT_28	[p2l863t2639r1224b2717],
27	.	.	O	.	_	0	SENT_28	[p2l863t2639r1224b2717],

1	Typically	RB	O	typically	advmod	16	SENT_29	[p2l1267t2639r1600b2717],
2	,	,	O	,	_	0	SENT_29	[p2l1267t2639r1600b2717],
3	clinicians	NNS	O	clinician	nn	5	SENT_29	[p2l1641t2639r1952b2701],
4	dose	NN	O	dose	nn	5	SENT_29	[p2l1992t2639r2144b2701],
5	warfarin	NN	O	warfarin	nsubj	16	SENT_29	[p2l6t2745r298b2807],
6	on	IN	O	on	_	0	SENT_29	[p2l330t2765r416b2807],
7	an	DT	O	a	det	9	SENT_29	[p2l448t2765r531b2807],
8	empiric	JJ	O	empiric	amod	9	SENT_29	[p2l561t2745r815b2823],
9	basis	NN	O	basis	prep_on	5	SENT_29	[p2l845t2745r1028b2819],
10	,	,	O	,	_	0	SENT_29	[p2l845t2745r1028b2819],
11	using	VBG	O	use	partmod	9	SENT_29	[p2l1061t2745r1242b2823],
12	clinical	JJ	O	clinical	amod	15	SENT_29	[p2l1272t2745r1508b2807],
13	and	CC	O	and	_	0	SENT_29	[p2l1541t2745r1667b2807],
14	demographic	JJ	O	demographic	conj_and	12	SENT_29	[p2l1699t2745r2146b2823],
15	factors	NNS	O	factor	dobj	11	SENT_29	[p2l7t2852r238b2913],
16	(	VBP	O	(	_	0	SENT_29	[p2l265t2852r338b2930],
17	e.	NN	O	e.	nn	18	SENT_29	[p2l265t2852r338b2930],
18	g.	NN	O	g.	dobj	16	SENT_29	[p2l345t2872r399b2930],
19	age	NN	O	age	nsubj	22	SENT_29	[p2l430t2852r567b2930],
20	)	CD	NUMBER	)	num	19	SENT_29	[p2l430t2852r567b2930],
21	to	TO	O	to	aux	22	SENT_29	[p2l594t2860r660b2913],
22	estimate	VB	O	estimate	infmod	18	SENT_29	[p2l687t2852r966b2913],
23	a	DT	O	a	det	25	SENT_29	[p2l993t2872r1031b2913],
24	starting	VBG	O	start	amod	25	SENT_29	[p2l1057t2852r1313b2930],
25	dose	NN	O	dose	dobj	22	SENT_29	[p2l1337t2852r1490b2913],
26	and	CC	O	and	_	0	SENT_29	[p2l1516t2852r1642b2913],
27	INR	NN	O	inr	nn	28	SENT_29	[p2l1668t2854r1828b2913],
28	response	NN	O	response	conj_and	25	SENT_29	[p2l1852t2872r2145b2930],
29	to	TO	O	to	aux	30	SENT_29	[p2l7t2966r74b3019],
30	make	VB	O	make	xcomp	16	SENT_29	[p2l106t2957r292b3019],
31	subsequent	JJ	O	subsequent	amod	32	SENT_29	[p2l325t2957r703b3035],
32	reﬁnements	NNS	O	reﬁnements	dobj	30	SENT_29	[p2l733t2958r1141b3019],
33	.	.	O	.	_	0	SENT_29	[p2l733t2958r1141b3019],

1	Traditionally	RB	O	traditionally	advmod	8	SENT_30	[p2l1176t2957r1641b3035],
2	,	,	O	,	_	0	SENT_30	[p2l1176t2957r1641b3035],
3	this	DT	O	this	det	5	SENT_30	[p2l1675t2958r1795b3019],
4	trialanderror	NN	O	trialanderror	nn	5	SENT_30	[p2l1827t2957r2144b3019, p2l7t3084r177b3125],
5	process	NN	O	process	nsubj	8	SENT_30	[p2l203t3084r452b3142],
6	does	VBZ	O	do	aux	8	SENT_30	[p2l480t3064r632b3125],
7	not	RB	O	not	neg	8	SENT_30	[p2l660t3072r775b3125],
8	take	VB	O	take	_	0	SENT_30	[p2l801t3064r945b3125],
9	genotype	NN	O	genotype	dobj	8	SENT_30	[p2l973t3072r1281b3142],
10	into	IN	O	into	_	0	SENT_30	[p2l1308t3064r1441b3125],
11	account	NN	O	account	prep_into	8	SENT_30	[p2l1471t3072r1755b3125],
12	.	.	O	.	_	0	SENT_30	[p2l1471t3072r1755b3125],

1	In	IN	O	in	_	0	SENT_31	[p2l93t3172r166b3230],
2	addition	NN	O	addition	_	0	SENT_31	[p2l213t3169r497b3231],
3	to	TO	O	to	_	0	SENT_31	[p2l545t3178r611b3231],
4	clinical	JJ	O	clinical	amod	7	SENT_31	[p2l660t3169r896b3231],
5	and	CC	O	and	_	0	SENT_31	[p2l944t3169r1071b3231],
6	demographic	JJ	O	demographic	amod	7	SENT_31	[p2l1118t3169r1565b3247],
7	factors	NNS	O	factor	prep_in_addition_to	14	SENT_31	[p2l1611t3169r1860b3244],
8	,	,	O	,	_	0	SENT_31	[p2l1611t3169r1860b3244],
9	genetic	JJ	O	genetic	amod	10	SENT_31	[p2l1911t3169r2145b3247],
10	variations	NNS	O	variation	nsubj	14	SENT_31	[p2l6t3275r344b3337],
11	in	IN	O	in	_	0	SENT_31	[p2l385t3275r450b3336],
12	two	CD	NUMBER	two	num	13	SENT_31	[p2l490t3284r616b3337],
13	genes	NNS	O	gene	prep_in	10	SENT_31	[p2l658t3295r840b3353],
14	affect	VBP	O	affect	_	0	SENT_31	[p2l883t3275r1070b3337],
15	patients	NNS	O	patient	dobj	14	SENT_31	[p2l1109t3275r1392b3353],
16	’	JJ	O	’	amod	19	SENT_31	[p2l1109t3275r1392b3353],
17	therapeutic	JJ	O	therapeutic	amod	19	SENT_31	[p2l1434t3275r1815b3353],
18	warfarin	NN	O	warfarin	nn	19	SENT_31	[p2l1854t3275r2146b3337],
19	dose	NN	O	dose	dep	15	SENT_31	[p2l8t3382r176b3443],
20	.	.	O	.	_	0	SENT_31	[p2l8t3382r176b3443],

1	Single	JJ	O	single	amod	3	SENT_32	[p2l226t3382r428b3460],
2	nucleotide	NN	O	nucleotide	nn	3	SENT_32	[p2l470t3382r820b3443],
3	polymorphisms	NNS	O	polymorphism	nsubj	4	SENT_32	[p2l862t3382r1392b3460],
4	(	VBP	O	(	dep	16	SENT_32	[p2l1438t3382r1677b3460],
5	SNPS	NN	O	snp	nn	6	SENT_32	[p2l1438t3382r1677b3460],
6	)	NN	O	)	dobj	4	SENT_32	[p2l1438t3382r1677b3460],
7	in	IN	O	in	_	0	SENT_32	[p2l1721t3382r1786b3442],
8	the	DT	O	the	det	14	SENT_32	[p2l1828t3382r1932b3443],
9	cytochrome	NN	O	cytochrome	nn	14	SENT_32	[p2l1974t3391r2143b3460, p2l7t3487r263b3550],
10	P450	NN	O	p450	nn	14	SENT_32	[p2l304t3489r472b3550],
11	2C9	NN	O	2c9	nn	14	SENT_32	[p2l515t3488r650b3550],
12	gene	NN	O	gene	nn	14	SENT_32	[p2l694t3508r846b3566],
13	(	CD	NUMBER	(	num	14	SENT_32	[p2l890t3488r1248b3566],
14	CYPZC9	NN	O	cypzc9	prep_in	6	SENT_32	[p2l890t3488r1248b3566],
15	)	CD	NUMBER	)	nsubj	16	SENT_32	[p2l890t3488r1248b3566],
16	affect	VBP	O	affect	_	0	SENT_32	[p2l1292t3487r1479b3550],
17	the	DT	O	the	det	18	SENT_32	[p2l1520t3487r1623b3550],
18	rate	NN	O	rate	dobj	16	SENT_32	[p2l1665t3496r1795b3550],
19	at	IN	O	at	_	0	SENT_32	[p2l1838t3496r1903b3550],
20	which	WDT	O	which	rel	22	SENT_32	[p2l1942t3487r2146b3550],
21	patients	NNS	O	patient	nsubj	22	SENT_32	[p2l6t3594r273b3672],
22	metabolize	VBZ	O	metabolize	rcmod	18	SENT_32	[p2l299t3594r668b3656],
23	S-warfarin	NN	O	s-warfarin	dobj	22	SENT_32	[p2l699t3594r1075b3668],
24	,	,	O	,	_	0	SENT_32	[p2l699t3594r1075b3668],
25	the	DT	O	the	det	28	SENT_32	[p2l1106t3594r1209b3656],
26	more	RBR	O	more	advmod	27	SENT_32	[p2l1235t3614r1412b3656],
27	active	JJ	O	active	amod	28	SENT_32	[p2l1441t3594r1635b3656],
28	enantiomer	NN	O	enantiomer	appos	23	SENT_32	[p2l1662t3594r2051b3656],
29	of	IN	O	of	_	0	SENT_32	[p2l2079t3594r2154b3656],
30	the	DT	O	the	det	31	SENT_32	[p2l7t3701r111b3762],
31	drug	NN	O	drug	prep_of	28	SENT_32	[p2l140t3701r314b3779],
32	.	.	O	.	_	0	SENT_32	[p2l140t3701r314b3779],

1	Patients	NNS	O	patient	_	0	SENT_33	[p2l347t3701r618b3762],
2	with	IN	O	with	_	0	SENT_33	[p2l646t3701r796b3762],
3	a	DT	O	a	det	5	SENT_33	[p2l825t3721r863b3762],
4	CYP2C9	NN	O	cyp2c9	nn	5	SENT_33	[p2l893t3701r1279b3762],
5	*	NN	O	*	prep_with	1	SENT_33	[p2l893t3701r1279b3762],
6	2	CD	NUMBER	2	num	8	SENT_33	[p2l893t3701r1279b3762],
7	and/or	NN	O	and/or	nn	8	SENT_33	[p2l1310t3701r1538b3779],
8	CYP2C9	NN	O	cyp2c9	dep	1	SENT_33	[p2l1568t3701r1953b3762],
9	*	CD	NUMBER	*	number	10	SENT_33	[p2l1568t3701r1953b3762],
10	3	CD	NUMBER	3	num	11	SENT_33	[p2l1568t3701r1953b3762],
11	SNP	NN	ORGANIZATION	snp	dep	8	SENT_33	[p2l1988t3702r2144b3762],

1	metabolize	VBZ	O	metabolize	dep	15	SENT_34	[p3l6t20r375b83],
2	warfarin	NN	O	warfarin	dobj	1	SENT_34	[p3l424t21r716b83],
3	more	RBR	O	more	advmod	4	SENT_34	[p3l764t41r940b83],
4	slowly	RB	O	slowly	advmod	1	SENT_34	[p3l992t21r1204b99],
5	than	IN	O	than	_	0	SENT_34	[p3l1254t20r1408b83],
6	a	DT	O	a	det	11	SENT_34	[p3l1458t41r1496b83],
7	wild-type	JJ	O	wild-type	amod	11	SENT_34	[p3l1544t20r1860b100],
8	patient	NN	O	patient	nn	11	SENT_34	[p3l1909t21r2146b100],
9	(	CD	NUMBER	(	num	11	SENT_34	[p3l9t128r448b206],
10	CYPC29	NN	O	cypc29	nn	11	SENT_34	[p3l9t128r448b206],
11	*	NN	O	*	prep_than	1	SENT_34	[p3l9t128r448b206],
12	l	NN	O	l	tmod	11	SENT_34	[p3l9t128r448b206],
13	/	:	O	/	punct	15	SENT_34	[p3l9t128r448b206],
14	*	CD	NUMBER	*	number	15	SENT_34	[p3l454t128r573b206],
15	1	CD	NUMBER	1	_	0	SENT_34	[p3l454t128r573b206],
16	)	NN	O	)	dep	15	SENT_34	[p3l454t128r573b206],
17	,	,	O	,	_	0	SENT_34	[p3l454t128r573b206],
18	resulting	VBG	O	result	appos	15	SENT_34	[p3l605t128r896b206],
19	in	IN	O	in	_	0	SENT_34	[p3l924t128r989b188],
20	lower	JJR	O	lower	amod	23	SENT_34	[p3l1016t128r1206b189],
21	therapeutic	JJ	O	therapeutic	amod	23	SENT_34	[p3l1234t128r1615b206],
22	warfarin	NN	O	warfarin	nn	23	SENT_34	[p3l1642t128r1934b189],
23	doses	NNS	O	dose	prep_in	18	SENT_34	[p3l1962t128r2144b189],
24	[	VBP	O	[	rcmod	23	SENT_34	[p3l10t235r104b311],
25	1	CD	NUMBER	1	number	26	SENT_34	[p3l10t235r104b311],
26	]	CD	NUMBER	]	dobj	24	SENT_34	[p3l10t235r104b311],
27	.	.	O	.	_	0	SENT_34	[p3l10t235r104b311],

1	Patients	NNS	O	patient	nsubj	17	SENT_35	[p3l158t233r429b295],
2	with	IN	O	with	_	0	SENT_35	[p3l479t233r629b295],
3	haplotype	NN	O	haplotype	nn	4	SENT_35	[p3l679t233r1018b311],
4	A	NN	O	a	prep_with	1	SENT_35	[p3l1068t233r1132b294],
5	of	IN	O	of	_	0	SENT_35	[p3l1183t233r1259b295],
6	the	DT	O	the	det	8	SENT_35	[p3l1301t233r1405b295],
7	vitamin	NN	O	vitamin	nn	8	SENT_35	[p3l1455t233r1715b295],
8	K	NN	O	k	prep_of	4	SENT_35	[p3l1766t236r1833b294],
9	epoxide	NN	O	epoxide	nn	15	SENT_35	[p3l1882t233r2145b311],
10	reductase	NN	O	reductase	nn	15	SENT_35	[p3l7t339r327b401],
11	complex	NN	O	complex	nn	15	SENT_35	[p3l349t339r636b417],
12	1	CD	NUMBER	1	num	15	SENT_35	[p3l666t341r689b400],
13	WKORCI	NN	O	wkorcus	nn	15	SENT_35	[p3l721t339r1120b417],
14	)	NN	O	)	nn	15	SENT_35	[p3l721t339r1120b417],
15	gene	NN	O	gene	dep	8	SENT_35	[p3l1144t359r1296b417],
16	have	VBP	O	have	aux	17	SENT_35	[p3l1319t339r1477b401],
17	reduced	VBN	O	reduce	_	0	SENT_35	[p3l1500t339r1768b401],
18	expression	NN	O	expression	dobj	17	SENT_35	[p3l1790t339r2145b417],
19	of	IN	O	of	_	0	SENT_35	[p3l9t446r85b507],
20	the	DT	O	the	det	22	SENT_35	[p3l121t446r224b507],
21	VKOR	NN	O	vkor	nn	22	SENT_35	[p3l267t447r521b507],
22	protein	NN	O	protein	prep_of	18	SENT_35	[p3l562t446r808b524],
23	and	CC	O	and	_	0	SENT_35	[p3l853t446r980b507],
24	concomitant	JJ	O	concomitant	amod	27	SENT_35	[p3l1024t446r1453b507],
25	increased	VBN	O	increase	amod	27	SENT_35	[p3l1496t446r1811b507],
26	warfarin	NN	O	warfarin	nn	27	SENT_35	[p3l1854t446r2146b507],
27	sensitivity	NN	O	sensitivity	prep_of	18	SENT_35	[p3l9t551r342b629],
28	[	CD	NUMBER	[	num	30	SENT_35	[p3l392t553r547b629],
29	2,3	CD	NUMBER	2,3	num	30	SENT_35	[p3l392t553r547b629],
30	]	NN	O	]	dep	18	SENT_35	[p3l392t553r547b629],
31	.	.	O	.	_	0	SENT_35	[p3l392t553r547b629],

1	Thus	RB	O	thus	advmod	8	SENT_36	[p3l599t551r789b626],
2	,	,	O	,	_	0	SENT_36	[p3l599t551r789b626],
3	these	DT	O	these	det	6	SENT_36	[p3l841t551r1009b613],
4	common	JJ	O	common	amod	6	SENT_36	[p3l1057t571r1361b613],
5	genetic	JJ	O	genetic	amod	6	SENT_36	[p3l1409t551r1644b629],
6	factors	NNS	O	factor	nsubj	8	SENT_36	[p3l1691t551r1922b613],
7	often	RB	O	often	advmod	8	SENT_36	[p3l1972t551r2145b613],
8	result	VBP	O	result	_	0	SENT_36	[p3l7t657r193b719],
9	in	IN	O	in	_	0	SENT_36	[p3l239t657r304b718],
10	a	DT	O	a	det	11	SENT_36	[p3l352t677r389b719],
11	patient	NN	O	patient	prep_in	8	SENT_36	[p3l435t657r672b735],
12	requiring	VBG	O	require	partmod	11	SENT_36	[p3l719t657r1029b735],
13	a	DT	O	a	det	17	SENT_36	[p3l1077t677r1114b719],
14	greater	JJR	O	greater	amod	17	SENT_36	[p3l1161t666r1398b735],
15	or	CC	O	or	_	0	SENT_36	[p3l1446t677r1518b719],
16	lesser	JJR	O	lesser	conj_or	14	SENT_36	[p3l1565t657r1746b719],
17	dose	NN	O	dose	dobj	12	SENT_36	[p3l1793t657r1944b719],
18	than	IN	O	than	prep	17	SENT_36	[p3l1992t657r2146b719],
19	clinically	RB	O	clinically	advmod	20	SENT_36	[p3l7t764r305b842],
20	anticipated	VBN	O	anticipate	dep	18	SENT_36	[p3l333t764r724b842],
21	.	.	O	.	_	0	SENT_36	[p3l333t764r724b842],

1	Clinical	JJ	O	clinical	amod	3	SENT_37	[p3l93t870r352b932],
2	dosing	NN	O	dosing	nn	3	SENT_37	[p3l390t869r614b949],
3	algorithms	NNS	O	algorithm	nsubjpass	10	SENT_37	[p3l652t870r1015b949],
4	and	CC	O	and	_	0	SENT_37	[p3l1055t869r1181b932],
5	genetic-based	JJ	O	genetic-based	amod	7	SENT_37	[p3l1220t869r1676b949],
6	dosing	NN	O	dosing	nn	7	SENT_37	[p3l1714t869r1938b949],
7	algorithms	NNS	O	algorithm	conj_and	3	SENT_37	[p3l1977t870r2144b949, p3l7t977r225b1038],
8	have	VBP	O	have	aux	10	SENT_37	[p3l272t977r431b1038],
9	been	VBN	O	be	auxpass	10	SENT_37	[p3l478t977r635b1038],
10	developed	VBN	O	develop	_	0	SENT_37	[p3l682t977r1024b1055],
11	to	TO	O	to	aux	12	SENT_37	[p3l1071t985r1138b1038],
12	assist	VB	O	assist	xcomp	10	SENT_37	[p3l1188t977r1364b1038],
13	clinicians	NNS	O	clinician	nsubj	15	SENT_37	[p3l1410t977r1721b1038],
14	a	DT	O	a	det	15	SENT_37	[p3l1769t998r1807b1038],
15	priori	FW	O	priori	xcomp	12	SENT_37	[p3l1844t981r2039b1055],
16	in	IN	O	in	_	0	SENT_37	[p3l2081t977r2146b1037],
17	estimating	VBG	O	estimate	prepc_in	12	SENT_37	[p3l7t1082r358b1160],
18	a	DT	O	a	det	21	SENT_37	[p3l387t1102r424b1144],
19	stable	JJ	O	stable	amod	21	SENT_37	[p3l454t1082r647b1144],
20	warfarin	NN	O	warfarin	nn	21	SENT_37	[p3l674t1082r966b1144],
21	dose	NN	O	dose	dobj	17	SENT_37	[p3l994t1082r1163b1144],
22	.	.	O	.	_	0	SENT_37	[p3l994t1082r1163b1144],

1	Clinical	JJ	O	clinical	amod	2	SENT_38	[p3l1197t1082r1455b1144],
2	algorithms	NNS	O	algorithm	nsubj	3	SENT_38	[p3l1485t1082r1848b1160],
3	account	VBP	O	account	_	0	SENT_38	[p3l1878t1091r2146b1144],
4	for	IN	O	for	_	0	SENT_38	[p3l7t1188r107b1251],
5	about	IN	O	about	advmod	8	SENT_38	[p3l135t1188r333b1251],
6	17-22	CD	PERCENT	17-22	num	7	SENT_38	[p3l366t1189r634b1252],
7	%	NN	PERCENT	%	pobj	5	SENT_38	[p3l366t1189r634b1252],
8	(	CD	NUMBER	(	prep_for	3	SENT_38	[p3l668t1172r808b1267],
9	R2	NN	O	r2	nn	11	SENT_38	[p3l668t1172r808b1267],
10	)	CD	NUMBER	)	num	11	SENT_38	[p3l668t1172r808b1267],
11	[	NN	O	[	dobj	3	SENT_38	[p3l840t1189r914b1266],
12	4	CD	NUMBER	4	num	13	SENT_38	[p3l840t1189r914b1266],
13	]	NN	O	]	nsubj	17	SENT_38	[p3l840t1189r914b1266],
14	and	CC	O	and	_	0	SENT_38	[p3l945t1188r1072b1251],
15	genetic	JJ	O	genetic	amod	16	SENT_38	[p3l1099t1188r1334b1267],
16	algorithms	NNS	O	algorithm	conj_and	13	SENT_38	[p3l1361t1188r1723b1267],
17	account	VBP	O	account	rcmod	11	SENT_38	[p3l1752t1197r2020b1251],
18	for	IN	O	for	dep	17	SENT_38	[p3l2046t1188r2146b1251],
19	about	IN	O	about	_	0	SENT_38	[p3l8t1296r206b1358],
20	half	NN	O	half	nn	23	SENT_38	[p3l239t1296r377b1358],
21	(	CD	NUMBER	(	num	23	SENT_38	[p3l404t1280r520b1375],
22	R2	NN	O	r2	nn	23	SENT_38	[p3l404t1280r520b1375],
23	~	NN	O	~	prep_about	17	SENT_38	[p3l555t1296r804b1375],
24	50	CD	PERCENT	50	number	25	SENT_38	[p3l555t1296r804b1375],
25	%	NN	PERCENT	%	amod	23	SENT_38	[p3l555t1296r804b1375],
26	)	CD	NUMBER	)	dobj	17	SENT_38	[p3l555t1296r804b1375],
27	of	IN	O	of	_	0	SENT_38	[p3l841t1296r917b1358],
28	the	DT	O	the	det	30	SENT_38	[p3l942t1296r1045b1358],
29	dose	NN	O	dose	nn	30	SENT_38	[p3l1079t1296r1232b1358],
30	variability	NN	O	variability	prep_of	26	SENT_38	[p3l1264t1296r1610b1375],
31	[	CD	NUMBER	[	num	33	SENT_38	[p3l1645t1297r1820b1374],
32	S-8	NN	O	s-8	nn	33	SENT_38	[p3l1645t1297r1820b1374],
33	]	NN	O	]	dep	30	SENT_38	[p3l1645t1297r1820b1374],
34	.	.	O	.	_	0	SENT_38	[p3l1645t1297r1820b1374],

1	Geneticbased	JJ	MISC	geneticbased	amod	2	SENT_39	[p3l1859t1296r2144b1358, p3l7t1402r201b1464],
2	algorithms	NNS	O	algorithm	dep	16	SENT_39	[p3l223t1402r586b1480],
3	that	WDT	O	that	nsubj	4	SENT_39	[p3l608t1402r743b1464],
4	incorporate	VBP	O	incorporate	rcmod	2	SENT_39	[p3l763t1402r1159b1480],
5	an	DT	O	a	det	6	SENT_39	[p3l1181t1422r1263b1464],
6	INR	NN	O	inr	dobj	4	SENT_39	[p3l1284t1405r1445b1463],
7	after	IN	O	after	_	0	SENT_39	[p3l1466t1402r1622b1464],
8	3	CD	NUMBER	3	num	12	SENT_39	[p3l1644t1404r1677b1464],
9	or	CC	O	or	_	0	SENT_39	[p3l1703t1422r1776b1464],
10	4	CD	NUMBER	4	num	12	SENT_39	[p3l1795t1404r1834b1463],
11	warfarin	NN	O	warfarin	nn	12	SENT_39	[p3l1854t1402r2146b1464],
12	doses	NNS	O	dose	prep_after	4	SENT_39	[p3l8t1508r190b1570],
13	are	VBP	O	be	cop	16	SENT_39	[p3l259t1528r361b1570],
14	even	RB	O	even	advmod	16	SENT_39	[p3l428t1528r581b1570],
15	more	RBR	O	more	advmod	16	SENT_39	[p3l646t1528r823b1570],
16	accurate	JJ	O	accurate	_	0	SENT_39	[p3l891t1517r1175b1570],
17	[	NN	O	[	nsubj	16	SENT_39	[p3l1244t1509r1439b1585],
18	9	CD	NUMBER	9	num	17	SENT_39	[p3l1244t1509r1439b1585],
19	,	,	O	,	_	0	SENT_39	[p3l1244t1509r1439b1585],
20	l0	NN	O	l0	nn	21	SENT_39	[p3l1244t1509r1439b1585],
21	]	NN	O	]	appos	17	SENT_39	[p3l1244t1509r1439b1585],
22	.	.	O	.	_	0	SENT_39	[p3l1244t1509r1439b1585],

1	However	RB	O	however	advmod	8	SENT_40	[p3l1511t1511r1839b1582],
2	,	,	O	,	_	0	SENT_40	[p3l1511t1511r1839b1582],
3	clinical	JJ	O	clinical	amod	4	SENT_40	[p3l1908t1508r2145b1570],
4	algorithms	NNS	O	algorithm	nsubj	8	SENT_40	[p3l8t1615r371b1693],
5	also	RB	O	also	advmod	8	SENT_40	[p3l411t1615r543b1676],
6	become	VBP	O	become	cop	8	SENT_40	[p3l583t1615r843b1676],
7	more	RBR	O	more	advmod	8	SENT_40	[p3l880t1635r1057b1676],
8	accurate	JJ	O	accurate	_	0	SENT_40	[p3l1097t1623r1381b1676],
9	after	IN	O	after	_	0	SENT_40	[p3l1421t1615r1577b1676],
10	several	JJ	DURATION	several	amod	11	SENT_40	[p3l1616t1615r1845b1676],
11	days	NNS	DURATION	day	prep_after	8	SENT_40	[p3l1884t1615r2037b1693],
12	of	IN	O	of	_	0	SENT_40	[p3l2078t1615r2154b1676],
13	therapy	NN	O	therapy	nn	14	SENT_40	[p3l7t1720r267b1800],
14	[	NN	O	[	prep_of	11	SENT_40	[p3l298t1722r347b1799],
15	1	CD	NUMBER	1	number	16	SENT_40	[p3l298t1722r347b1799],
16	1,12	CD	NUMBER	1,12	num	17	SENT_40	[p3l365t1722r535b1799],
17	]	NN	O	]	attr	8	SENT_40	[p3l365t1722r535b1799],
18	,	,	O	,	_	0	SENT_40	[p3l365t1722r535b1799],
19	prompting	VBG	O	prompt	partmod	17	SENT_40	[p3l565t1721r930b1800],
20	some	DT	O	some	det	21	SENT_40	[p3l959t1741r1133b1783],
21	experts	NNS	O	expert	dobj	19	SENT_40	[p3l1162t1730r1402b1800],
22	to	TO	O	to	aux	23	SENT_40	[p3l1431t1730r1498b1783],
23	argue	VB	O	argue	xcomp	19	SENT_40	[p3l1530t1741r1718b1800],
24	that	IN	O	that	complm	28	SENT_40	[p3l1747t1720r1883b1783],
25	genetic	JJ	O	genetic	amod	26	SENT_40	[p3l1911t1721r2146b1800],
26	information	NN	O	information	nsubj	28	SENT_40	[p3l6t1828r417b1889],
27	becomes	VBZ	O	become	cop	28	SENT_40	[p3l448t1828r737b1889],
28	irrelevant	JJ	O	irrelevant	ccomp	23	SENT_40	[p3l768t1828r1092b1889],
29	once	RB	DATE	once	advmod	33	SENT_40	[p3l1125t1848r1280b1889],
30	INR	NN	O	inr	nn	31	SENT_40	[p3l1313t1830r1474b1889],
31	response	NN	O	response	nsubjpass	33	SENT_40	[p3l1503t1848r1797b1906],
32	is	VBZ	O	be	auxpass	33	SENT_40	[p3l1828t1828r1878b1889],
33	known	VBN	O	know	ccomp	28	SENT_40	[p3l1910t1828r2146b1889],
34	[	CD	NUMBER	[	num	36	SENT_40	[p3l10t1935r144b2011],
35	13	CD	NUMBER	13	num	36	SENT_40	[p3l10t1935r144b2011],
36	]	NN	O	]	dobj	33	SENT_40	[p3l10t1935r144b2011],
37	.	.	O	.	_	0	SENT_40	[p3l10t1935r144b2011],

1	This	DT	O	this	det	2	SENT_41	[p3l175t1933r323b1995],
2	uncertainty	NN	O	uncertainty	nsubj	4	SENT_41	[p3l350t1933r737b2011],
3	is	VBZ	O	be	cop	4	SENT_41	[p3l763t1933r812b1995],
4	important	JJ	O	important	_	0	SENT_41	[p3l839t1933r1184b2011],
5	because	IN	O	because	mark	9	SENT_41	[p3l1211t1933r1474b1995],
6	currently	RB	DATE	currently	advmod	9	SENT_41	[p3l1500t1933r1807b2011],
7	clinicians	NNS	O	clinician	nsubj	9	SENT_41	[p3l1833t1933r2144b1995],
8	are	VBP	O	be	cop	9	SENT_41	[p3l8t2059r111b2101],
9	reluctant	JJ	O	reluctant	advcl	4	SENT_41	[p3l153t2039r455b2101],
10	to	TO	O	to	aux	11	SENT_41	[p3l496t2048r563b2101],
11	consider	VB	O	consider	xcomp	9	SENT_41	[p3l607t2039r891b2101],
12	obtaining	VBG	O	obtain	xcomp	11	SENT_41	[p3l934t2039r1258b2117],
13	genotype	NN	O	genotype	nn	14	SENT_41	[p3l1300t2048r1607b2117],
14	information	NN	O	information	dobj	12	SENT_41	[p3l1649t2039r2059b2101],
15	if	IN	O	if	mark	25	SENT_41	[p3l2100t2039r2154b2100],
16	96	CD	NUMBER	96	num	18	SENT_41	[p3l8t2161r92b2218],
17	N.	NNP	PERSON	N.	nn	18	SENT_41	[p3l136t2163r212b2218],
18	Ferder	NNP	PERSON	Ferder	nsubj	25	SENT_41	[p3l246t2160r465b2218],
19	et	FW	O	et	nn	21	SENT_41	[p3l494t2168r553b2218],
20	al	FW	O	al	nn	21	SENT_41	[p3l583t2160r641b2218],
21	results	NNS	O	result	dep	18	SENT_41	[p3l8t2369r223b2431],
22	will	MD	O	will	aux	25	SENT_41	[p3l244t2369r365b2431],
23	not	RB	O	not	neg	25	SENT_41	[p3l385t2378r500b2431],
24	be	VB	O	be	cop	25	SENT_41	[p3l520t2369r597b2431],
25	available	JJ	O	available	advcl	11	SENT_41	[p3l620t2369r920b2431],
26	within	IN	O	within	_	0	SENT_41	[p3l940t2369r1155b2431],
27	the	DT	O	the	det	30	SENT_41	[p3l1176t2369r1280b2431],
28	ﬁrst	JJ	O	ﬁrst	amod	30	SENT_41	[p3l1300t2369r1431b2431],
29	few	JJ	DURATION	few	amod	30	SENT_41	[p3l1452t2369r1570b2431],
30	days	NNS	DURATION	day	prep_within	25	SENT_41	[p3l1591t2369r1743b2447],
31	of	IN	O	of	_	0	SENT_41	[p3l1767t2369r1843b2431],
32	warfarin	NN	O	warfarin	nn	33	SENT_41	[p3l1854t2369r2146b2431],
33	therapy	NN	O	therapy	prep_of	30	SENT_41	[p3l8t2475r284b2553],
34	.	.	O	.	_	0	SENT_41	[p3l8t2475r284b2553],

1	If	IN	O	if	mark	3	SENT_42	[p3l321t2475r384b2536],
2	genotype	NN	O	genotype	nsubj	3	SENT_42	[p3l408t2484r715b2553],
3	proves	VBZ	O	prove	advcl	18	SENT_42	[p3l747t2495r971b2553],
4	to	TO	O	to	aux	6	SENT_42	[p3l1004t2484r1070b2536],
5	be	VB	O	be	cop	6	SENT_42	[p3l1105t2475r1182b2536],
6	useful	JJ	O	useful	xcomp	3	SENT_42	[p3l1213t2475r1414b2536],
7	beyond	IN	O	beyond	_	0	SENT_42	[p3l1446t2475r1698b2553],
8	the	DT	O	the	det	11	SENT_42	[p3l1730t2475r1834b2536],
9	ﬁrst	JJ	O	ﬁrst	amod	11	SENT_42	[p3l1865t2475r1996b2536],
10	few	JJ	DURATION	few	amod	11	SENT_42	[p3l2028t2475r2146b2536],
11	days	NNS	DURATION	day	prep_beyond	6	SENT_42	[p3l8t2582r161b2660],
12	of	IN	O	of	_	0	SENT_42	[p3l217t2582r292b2643],
13	therapy	NN	O	therapy	prep_of	11	SENT_42	[p3l337t2582r614b2660],
14	,	,	O	,	_	0	SENT_42	[p3l337t2582r614b2660],
15	it	PRP	O	it	nsubjpass	18	SENT_42	[p3l669t2582r716b2643],
16	could	MD	O	could	aux	18	SENT_42	[p3l767t2582r956b2643],
17	be	VB	O	be	auxpass	18	SENT_42	[p3l1009t2582r1086b2643],
18	combined	VBN	O	combine	_	0	SENT_42	[p3l1139t2582r1474b2643],
19	with	IN	O	with	_	0	SENT_42	[p3l1526t2582r1677b2643],
20	clinical	JJ	O	clinical	amod	23	SENT_42	[p3l1728t2582r1965b2643],
21	and	CC	O	and	_	0	SENT_42	[p3l2019t2582r2146b2643],
22	demographic	JJ	O	demographic	conj_and	20	SENT_42	[p3l8t2687r455b2765],
23	factors	NNS	O	factor	prep_with	18	SENT_42	[p3l502t2687r732b2749],
24	to	TO	O	to	aux	25	SENT_42	[p3l780t2696r847b2749],
25	create	VB	O	create	xcomp	18	SENT_42	[p3l895t2696r1095b2749],
26	a	DT	O	a	det	27	SENT_42	[p3l1143t2707r1180b2749],
27	family	NN	O	family	dobj	25	SENT_42	[p3l1227t2687r1441b2765],
28	of	IN	O	of	_	0	SENT_42	[p3l1489t2687r1565b2749],
29	dose-reﬁnement	NN	O	dose-reﬁnement	nn	30	SENT_42	[p3l1604t2687r2147b2749],
30	algorithms	NNS	O	algorithm	prep_of	27	SENT_42	[p3l9t2793r388b2871],
31	.	.	O	.	_	0	SENT_42	[p3l9t2793r388b2871],

1	To	TO	O	to	aux	2	SENT_43	[p3l93t2902r188b2961],
2	address	VB	O	address	purpcl	7	SENT_43	[p3l253t2900r506b2961],
3	these	DT	O	these	det	4	SENT_43	[p3l569t2900r738b2961],
4	issues	NNS	O	issue	dobj	2	SENT_43	[p3l800t2900r1009b2974],
5	,	,	O	,	_	0	SENT_43	[p3l800t2900r1009b2974],
6	we	PRP	O	we	nsubj	7	SENT_43	[p3l1074t2920r1167b2961],
7	quantiﬁed	VBD	O	quantiﬁed	_	0	SENT_43	[p3l1230t2900r1574b2978],
8	the	DT	O	the	det	9	SENT_43	[p3l1636t2900r1739b2961],
9	ability	NN	O	ability	dobj	7	SENT_43	[p3l1803t2900r2015b2978],
10	of	IN	O	of	_	0	SENT_43	[p3l2079t2900r2154b2961],
11	CYP2C9	NN	O	cyp2c9	nn	12	SENT_43	[p3l9t3006r414b3081],
12	*	NN	O	*	prep_of	9	SENT_43	[p3l9t3006r414b3081],
13	2	CD	NUMBER	2	num	12	SENT_43	[p3l9t3006r414b3081],
14	,	,	O	,	_	0	SENT_43	[p3l9t3006r414b3081],
15	CYP2C9	NN	O	cyp2c9	dobj	7	SENT_43	[p3l445t3006r829b3068],
16	*	CD	NUMBER	*	number	17	SENT_43	[p3l445t3006r829b3068],
17	3	CD	NUMBER	3	dep	15	SENT_43	[p3l445t3006r829b3068],
18	and	CC	O	and	_	0	SENT_43	[p3l859t3005r986b3068],
19	VKORCI	NNP	O	VKORCI	dobj	7	SENT_43	[p3l1011t3007r1354b3068],
20	-1639	CD	NUMBER	-1639	num	21	SENT_43	[p3l1389t3007r1573b3068],
21	SNPs	NNS	O	snp	dep	19	SENT_43	[p3l1602t3007r1789b3068],
22	to	TO	O	to	aux	23	SENT_43	[p3l1816t3014r1883b3068],
23	predict	VB	O	predict	xcomp	7	SENT_43	[p3l1910t3005r2147b3085],
24	therapeutic	JJ	O	therapeutic	amod	25	SENT_43	[p3l8t3113r389b3191],
25	dose	NN	O	dose	dobj	23	SENT_43	[p3l405t3113r558b3174],
26	at	IN	O	at	_	0	SENT_43	[p3l576t3121r640b3174],
27	the	DT	O	the	det	28	SENT_43	[p3l656t3113r759b3174],
28	time	NN	O	time	prep_at	25	SENT_43	[p3l776t3113r923b3174],
29	of	IN	O	of	_	0	SENT_43	[p3l941t3113r1017b3174],
30	initiation	NN	O	initiation	prep_of	28	SENT_43	[p3l1025t3113r1334b3174],
31	of	IN	O	of	_	0	SENT_43	[p3l1351t3113r1427b3174],
32	warfarin	NN	O	warfarin	nn	33	SENT_43	[p3l1434t3113r1726b3174],
33	therapy	NN	O	therapy	prep_of	30	SENT_43	[p3l1742t3113r2002b3191],
34	and	CC	O	and	_	0	SENT_43	[p3l2019t3113r2145b3174],
35	after	IN	O	after	_	0	SENT_43	[p3l9t3218r165b3280],
36	days	NNS	DURATION	day	prep_after	25	SENT_43	[p3l212t3218r364b3296],
37	7	CD	NUMBER	7	dep	25	SENT_43	[p3l414t3221r468b3292],
38	,	,	O	,	_	0	SENT_43	[p3l414t3221r468b3292],
39	14	CD	NUMBER	14	num	37	SENT_43	[p3l527t3220r598b3279],
40	and	CC	O	and	_	0	SENT_43	[p3l646t3218r773b3280],
41	21	CD	NUMBER	21	conj_and	37	SENT_43	[p3l821t3220r891b3279],
42	of	IN	O	of	_	0	SENT_43	[p3l948t3218r1024b3280],
43	therapy	NN	O	therapy	prep_of	25	SENT_43	[p3l1063t3218r1323b3296],
44	in	IN	O	in	_	0	SENT_43	[p3l1369t3218r1434b3279],
45	participants	NNS	O	participant	prep_in	23	SENT_43	[p3l1480t3218r1882b3296],
46	in	IN	O	in	_	0	SENT_43	[p3l1930t3218r1995b3279],
47	the	DT	O	the	det	52	SENT_43	[p3l2042t3218r2145b3280],
48	PREVENT	JJ	O	prevent	amod	52	SENT_43	[p3l7t3326r408b3385],
49	trial	NN	O	trial	nn	52	SENT_43	[p3l438t3324r575b3385],
50	[	NN	O	[	nn	52	SENT_43	[p3l607t3325r740b3401],
51	14	CD	NUMBER	14	num	52	SENT_43	[p3l607t3325r740b3401],
52	]	NN	O	]	prep_in	45	SENT_43	[p3l607t3325r740b3401],
53	.	.	O	.	_	0	SENT_43	[p3l607t3325r740b3401],

1	PREVENT	VB	O	prevent	_	0	SENT_44	[p3l774t3326r1175b3385],
2	was	VBD	O	be	auxpass	4	SENT_44	[p3l1204t3344r1332b3385],
3	a	DT	O	a	advmod	4	SENT_44	[p3l1364t3344r1402b3385],
4	randomized	VBN	O	randomize	dep	1	SENT_44	[p3l1431t3324r1854b3398],
5	,	,	O	,	_	0	SENT_44	[p3l1431t3324r1854b3398],
6	doubleblind	NN	O	doubleblind	nn	9	SENT_44	[p3l1887t3324r2144b3385, p3l8t3431r199b3505],
7	,	,	O	,	_	0	SENT_44	[p3l1887t3324r2144b3385, p3l8t3431r199b3505],
8	placebo-controlled	JJ	O	placebo-controlled	amod	9	SENT_44	[p3l225t3431r863b3509],
9	trial	NN	O	trial	dobj	4	SENT_44	[p3l887t3431r1024b3492],
10	of	IN	O	of	_	0	SENT_44	[p3l1050t3431r1126b3492],
11	low-intensity	JJ	O	low-intensity	amod	12	SENT_44	[p3l1141t3431r1580b3509],
12	warfarin	NN	O	warfarin	prep_of	9	SENT_44	[p3l1603t3431r1895b3492],
13	(	CD	NUMBER	(	num	15	SENT_44	[p3l1921t3431r2144b3509, p3l7t3536r213b3614],
14	therapeutic	JJ	O	therapeutic	amod	15	SENT_44	[p3l1921t3431r2144b3509, p3l7t3536r213b3614],
15	INR	NN	O	inr	nsubjpass	4	SENT_44	[p3l241t3539r402b3597],
16	1.5-2	CD	NUMBER	1.5-2	num	15	SENT_44	[p3l438t3537r695b3614],
17	.0	CD	NUMBER	.0	num	18	SENT_44	[p3l438t3537r695b3614],
18	)	NN	O	)	nsubj	1	SENT_44	[p3l438t3537r695b3614],
19	for	IN	O	for	_	0	SENT_44	[p3l725t3536r826b3598],
20	the	DT	O	the	det	21	SENT_44	[p3l854t3536r957b3598],
21	prevention	NN	O	prevention	prep_for	18	SENT_44	[p3l985t3536r1351b3614],
22	of	IN	O	of	_	0	SENT_44	[p3l1381t3536r1457b3598],
23	recurrent	JJ	O	recurrent	amod	24	SENT_44	[p3l1478t3545r1789b3598],
24	VTE	NN	O	vte	prep_of	21	SENT_44	[p3l1815t3539r1982b3598],
25	that	WDT	O	that	nsubjpass	27	SENT_44	[p3l2011t3536r2147b3598],
26	was	VBD	O	be	auxpass	27	SENT_44	[p3l7t3662r135b3704],
27	terminated	VBN	O	terminate	rcmod	18	SENT_44	[p3l175t3642r544b3704],
28	early	RB	O	early	advmod	27	SENT_44	[p3l583t3642r749b3720],
29	after	IN	O	after	_	0	SENT_44	[p3l789t3642r945b3704],
30	its	PRP$	O	its	poss	32	SENT_44	[p3l983t3642r1058b3704],
31	independent	JJ	O	independent	amod	32	SENT_44	[p3l1098t3642r1517b3720],
32	Data	NNS	O	datum	prep_after	27	SENT_44	[p3l1556t3645r1728b3704],
33	and	CC	O	and	_	0	SENT_44	[p3l1769t3642r1896b3704],
34	Safety	NN	O	safety	prep_after	27	SENT_44	[p3l1938t3642r2146b3720],

1	Monitoring	VBG	O	monitor	csubj	3	SENT_45	[p4l9t21r405b99],
2	Board	NNP	O	Board	dobj	1	SENT_45	[p4l444t21r655b82],
3	found	VBD	O	find	_	0	SENT_45	[p4l693t21r896b82],
4	a	DT	O	a	det	8	SENT_45	[p4l935t41r973b82],
5	64	CD	PERCENT	64	num	8	SENT_45	[p4l1012t22r1165b83],
6	%	NN	PERCENT	%	nn	8	SENT_45	[p4l1012t22r1165b83],
7	risk	NN	O	risk	nn	8	SENT_45	[p4l1210t21r1335b82],
8	reduction	NN	O	reduction	dobj	3	SENT_45	[p4l1372t21r1697b82],
9	in	IN	O	in	_	0	SENT_45	[p4l1733t21r1798b81],
10	recurrent	JJ	O	recurrent	amod	11	SENT_45	[p4l1836t29r2147b82],
11	VTE	NN	O	vte	prep_in	8	SENT_45	[p4l6t129r190b189],
12	.	.	O	.	_	0	SENT_45	[p4l6t129r190b189],

1	PREVENT	JJ	O	prevent	amod	2	SENT_46	[p4l222t129r623b189],
2	participants	NNS	O	participant	nsubj	3	SENT_46	[p4l650t127r1053b206],
3	had	VBD	O	have	_	0	SENT_46	[p4l1082t126r1210b189],
4	an	DT	O	a	det	5	SENT_46	[p4l1239t147r1321b189],
5	INR	NN	O	inr	dobj	3	SENT_46	[p4l1350t129r1510b189],
6	drawn	VBN	O	draw	partmod	5	SENT_46	[p4l1538t126r1755b189],
7	at	IN	O	at	_	0	SENT_46	[p4l1784t136r1848b189],
8	baseline	NN	O	baseline	prep_at	6	SENT_46	[p4l1876t126r2146b189],
9	and	CC	O	and	_	0	SENT_46	[p4l9t234r135b295],
10	then	RB	O	then	advmod	11	SENT_46	[p4l183t234r331b295],
11	weekly	JJ	SET	weekly	prep_at	6	SENT_46	[p4l377t234r611b312],
12	for	IN	O	for	_	0	SENT_46	[p4l657t234r758b295],
13	4	CD	DURATION	4	num	14	SENT_46	[p4l803t235r842b294],
14	weeks	NNS	NUMBER	week	prep_for	6	SENT_46	[p4l871t234r1092b308],
15	,	,	O	,	_	0	SENT_46	[p4l871t234r1092b308],
16	allowing	VBG	O	allow	xcomp	6	SENT_46	[p4l1143t234r1432b312],
17	us	PRP	O	we	nsubj	19	SENT_46	[p4l1478t254r1551b295],
18	to	TO	O	to	aux	19	SENT_46	[p4l1599t242r1666b295],
19	evaluate	VB	O	evaluate	xcomp	16	SENT_46	[p4l1714t234r1994b295],
20	the	DT	O	the	det	21	SENT_46	[p4l2042t234r2145b295],
21	relevance	NN	O	relevance	dobj	19	SENT_46	[p4l8t339r322b401],
22	of	IN	O	of	_	0	SENT_46	[p4l338t339r414b401],
23	genotype	NN	O	genotype	prep_of	21	SENT_46	[p4l420t348r728b417],
24	to	TO	O	to	_	0	SENT_46	[p4l743t348r810b401],
25	INR	NN	O	inr	nn	26	SENT_46	[p4l826t342r987b400],
26	control	NN	O	control	prep_to	19	SENT_46	[p4l1000t339r1245b401],
27	and	CC	O	and	_	0	SENT_46	[p4l1260t339r1387b401],
28	therapeutic	JJ	O	therapeutic	amod	29	SENT_46	[p4l1401t339r1783b417],
29	dose	NN	O	dose	conj_and	26	SENT_46	[p4l1797t339r1949b401],
30	in	IN	O	in	_	0	SENT_46	[p4l1963t339r2028b400],
31	the	DT	O	the	det	32	SENT_46	[p4l2042t339r2145b401],
32	setting	NN	O	setting	prep_in	19	SENT_46	[p4l10t445r230b523],
33	of	IN	O	of	_	0	SENT_46	[p4l253t445r329b507],
34	protocol-driven	JJ	O	protocol-driven	amod	35	SENT_46	[p4l341t445r874b523],
35	monitoring	NN	O	monitoring	prep_of	32	SENT_46	[p4l894t445r1279b523],
36	and	CC	O	and	_	0	SENT_46	[p4l1301t445r1428b507],
37	dose	NN	O	dose	nn	38	SENT_46	[p4l1451t445r1603b507],
38	adjustments	NNS	O	adjustment	prep_of	32	SENT_46	[p4l1627t445r2052b523],
39	.	.	O	.	_	0	SENT_46	[p4l1627t445r2052b523],

1	Methods	NNS	O	method	_	0	SENT_47	[p4l9t684r332b749],

1	We	PRP	O	we	nsubj	2	SENT_48	[p4l6t849r122b908],
2	collected	VBD	O	collect	_	0	SENT_48	[p4l198t846r493b908],
3	blood	NN	O	blood	dobj	2	SENT_48	[p4l569t846r785b920],
4	,	,	O	,	_	0	SENT_48	[p4l569t846r785b920],
5	demographic	JJ	O	demographic	amod	6	SENT_48	[p4l864t846r1311b924],
6	variables	NNS	O	variable	conj_and	3	SENT_48	[p4l1385t846r1705b921],
7	,	,	O	,	_	0	SENT_48	[p4l1385t846r1705b921],
8	laboratory	NN	O	laboratory	nn	9	SENT_48	[p4l1784t846r2146b924],
9	data	NNS	O	datum	conj_and	3	SENT_48	[p4l8t952r175b1026],
10	,	,	O	,	_	0	SENT_48	[p4l8t952r175b1026],
11	smoking	NN	O	smoking	nn	12	SENT_48	[p4l205t952r495b1030],
12	status	NN	O	status	dobj	2	SENT_48	[p4l522t961r716b1014],
13	and	CC	O	and	_	0	SENT_48	[p4l742t952r869b1014],
14	medication	NN	O	medication	nn	15	SENT_48	[p4l893t952r1273b1014],
15	information	NN	O	information	conj_and	3	SENT_48	[p4l1297t952r1707b1014],
16	from	IN	O	from	_	0	SENT_48	[p4l1732t952r1900b1014],
17	participants	NNS	O	participant	prep_from	2	SENT_48	[p4l1923t952r2144b1030, p4l7t1058r230b1136],
18	.	.	O	.	_	0	SENT_48	[p4l1923t952r2144b1030, p4l7t1058r230b1136],

1	The	DT	O	the	det	3	SENT_49	[p4l253t1058r385b1119],
2	Human	JJ	O	human	amod	3	SENT_49	[p4l405t1060r668b1119],
3	Subjects	NNS	O	subject	nsubj	4	SENT_49	[p4l690t1058r982b1136],
4	’	VBP	O	’	_	0	SENT_49	[p4l690t1058r982b1136],
5	Committee	NNP	O	Committee	nsubj	6	SENT_49	[p4l1003t1058r1381b1119],
6	approved	VBD	O	approve	ccomp	4	SENT_49	[p4l1402t1058r1724b1136],
7	the	DT	O	the	det	9	SENT_49	[p4l1743t1058r1847b1119],
8	research	NN	O	research	nn	9	SENT_49	[p4l1867t1058r2147b1119],
9	protocol	NN	O	protocol	dobj	6	SENT_49	[p4l7t1164r313b1243],
10	.	.	O	.	_	0	SENT_49	[p4l7t1164r313b1243],

1	All	DT	O	all	det	2	SENT_50	[p4l344t1164r448b1225],
2	subjects	NNS	O	subject	nsubj	3	SENT_50	[p4l478t1163r740b1243],
3	gave	VBD	O	give	_	0	SENT_50	[p4l768t1184r922b1243],
4	written	VBN	O	write	dep	3	SENT_50	[p4l948t1164r1208b1239],
5	,	,	O	,	_	0	SENT_50	[p4l948t1164r1208b1239],
6	informed	VBN	O	inform	dep	4	SENT_50	[p4l1237t1163r1550b1226],
7	consent	NN	O	consent	dobj	4	SENT_50	[p4l1577t1172r1852b1226],
8	.	.	O	.	_	0	SENT_50	[p4l1577t1172r1852b1226],

1	Study	NNP	O	Study	nn	2	SENT_51	[p4l6t1404r201b1484],
2	subjects	NNS	O	subject	_	0	SENT_51	[p4l227t1404r504b1483],

1	The	DT	O	the	det	3	SENT_52	[p4l8t1564r140b1625],
2	study	NN	O	study	nn	3	SENT_52	[p4l172t1564r356b1642],
3	population	NN	O	population	nsubj	4	SENT_52	[p4l384t1564r760b1642],
4	consisted	VBD	O	consist	_	0	SENT_52	[p4l790t1564r1100b1625],
5	of	IN	O	of	_	0	SENT_52	[p4l1132t1564r1208b1625],
6	the	DT	O	the	det	8	SENT_52	[p4l1231t1564r1334b1625],
7	508	CD	NUMBER	508	num	8	SENT_52	[p4l1368t1566r1481b1626],
8	participants	NNS	O	participant	prep_of	4	SENT_52	[p4l1513t1564r1916b1642],
9	in	IN	O	in	_	0	SENT_52	[p4l1946t1564r2011b1624],
10	the	DT	O	the	det	12	SENT_52	[p4l2042t1564r2145b1625],
11	PREVENT	JJ	O	prevent	amod	12	SENT_52	[p4l7t1672r408b1731],
12	trial	NN	O	trial	prep_in	4	SENT_52	[p4l450t1669r603b1731],
13	.	.	O	.	_	0	SENT_52	[p4l450t1669r603b1731],

1	Eligible	JJ	O	eligible	amod	2	SENT_53	[p4l651t1669r906b1747],
2	subjects	NNS	O	subject	dep	4	SENT_53	[p4l950t1669r1212b1747],
3	had	VBD	O	have	aux	4	SENT_53	[p4l1255t1669r1383b1731],
4	experienced	VBN	O	experience	_	0	SENT_53	[p4l1426t1669r1824b1747],
5	an	DT	O	a	det	9	SENT_53	[p4l1867t1689r1949b1731],
6	idiopathic	JJ	O	idiopathic	amod	9	SENT_53	[p4l1990t1669r2145b1731, p4l7t1775r218b1853],
7	venous	JJ	O	venous	amod	9	SENT_53	[p4l276t1795r514b1837],
8	thromboembolic	NN	O	thromboembolic	nn	9	SENT_53	[p4l574t1775r1144b1837],
9	event	NN	O	event	dobj	4	SENT_53	[p4l1201t1784r1398b1849],
10	,	,	O	,	_	0	SENT_53	[p4l1201t1784r1398b1849],
11	completed	VBN	O	complete	partmod	9	SENT_53	[p4l1460t1775r1812b1853],
12	at	IN	DURATION	at	quantmod	14	SENT_53	[p4l1872t1784r1936b1837],
13	least	JJS	DURATION	least	mwe	12	SENT_53	[p4l1995t1775r2146b1837],
14	3	CD	DURATION	3	num	15	SENT_53	[p4l10t1884r43b1943],
15	months	NNS	NUMBER	month	dobj	11	SENT_53	[p4l75t1882r332b1943],
16	of	IN	O	of	_	0	SENT_53	[p4l384t1882r460b1943],
17	standard	JJ	O	standard	amod	19	SENT_53	[p4l504t1882r802b1943],
18	anticoagulation	NN	O	anticoagulation	nn	19	SENT_53	[p4l853t1882r1385b1960],
19	therapy	NN	O	therapy	prep_of	15	SENT_53	[p4l1435t1882r1694b1960],
20	(	CD	NUMBER	(	num	23	SENT_53	[p4l1746t1882r1931b1960],
21	INR	NN	O	inr	nn	23	SENT_53	[p4l1746t1882r1931b1960],
22	2-3	CD	NUMBER	2-3	num	23	SENT_53	[p4l1981t1882r2143b1960],
23	)	NN	O	)	nsubj	4	SENT_53	[p4l1981t1882r2143b1960],
24	,	,	O	,	_	0	SENT_53	[p4l1981t1882r2143b1960],
25	and	CC	O	and	_	0	SENT_53	[p4l9t1987r136b2050],
26	returned	VBD	O	return	conj_and	4	SENT_53	[p4l169t1987r459b2050],
27	to	TO	O	to	_	0	SENT_53	[p4l494t1996r561b2050],
28	a	DT	O	a	det	30	SENT_53	[p4l597t2008r635b2050],
29	baseline	NN	O	baseline	nn	30	SENT_53	[p4l669t1987r938b2050],
30	INR	NN	O	inr	prep_to	26	SENT_53	[p4l974t1990r1134b2049],
31	<	JJR	O	<	nsubj	26	SENT_53	[p4l1184t1999r1231b2040],
32	1.2	CD	NUMBER	1.2	num	34	SENT_53	[p4l1286t1989r1377b2050],
33	following	VBG	O	follow	amod	34	SENT_53	[p4l1411t1988r1732b2067],
34	discontinuation	NN	O	discontinuation	dep	31	SENT_53	[p4l1765t1987r2144b2050, p4l9t2094r183b2156],
35	of	IN	O	of	_	0	SENT_53	[p4l207t2094r283b2156],
36	standard	JJ	O	standard	amod	38	SENT_53	[p4l298t2094r597b2156],
37	warfarin	NN	O	warfarin	nn	38	SENT_53	[p4l618t2094r910b2156],
38	therapy	NN	O	therapy	prep_of	34	SENT_53	[p4l933t2094r1208b2172],
39	.	.	O	.	_	0	SENT_53	[p4l933t2094r1208b2172],

1	Potential	JJ	O	potential	amod	2	SENT_54	[p4l1236t2094r1541b2156],
2	participants	NNS	O	participant	nsubjpass	4	SENT_54	[p4l1562t2094r1965b2172],
3	were	VBD	O	be	auxpass	4	SENT_54	[p4l1987t2114r2145b2156],
4	excluded	VBN	O	exclude	_	0	SENT_54	[p4l8t2200r306b2262],
5	if	IN	O	if	mark	8	SENT_54	[p4l339t2200r393b2261],
6	they	PRP	O	they	nsubj	8	SENT_54	[p4l420t2200r564b2278],
7	were	VBD	O	be	aux	8	SENT_54	[p4l596t2220r754b2262],
8	taking	VBG	O	take	advcl	4	SENT_54	[p4l789t2200r1004b2278],
9	dipyridamole	NN	O	dipyridamole	dobj	8	SENT_54	[p4l1038t2200r1508b2278],
10	,	,	O	,	_	0	SENT_54	[p4l1038t2200r1508b2278],
11	ticlopidine	NN	O	ticlopidine	dobj	8	SENT_54	[p4l1545t2200r1919b2278],
12	,	,	O	,	_	0	SENT_54	[p4l1545t2200r1919b2278],
13	clopidogrel	NN	O	clopidogrel	conj_or	9	SENT_54	[p4l1955t2200r2144b2278, p4l8t2306r239b2384],
14	,	,	O	,	_	0	SENT_54	[p4l1955t2200r2144b2278, p4l8t2306r239b2384],
15	heparin	NN	O	heparin	conj_or	9	SENT_54	[p4l261t2306r537b2384],
16	,	,	O	,	_	0	SENT_54	[p4l261t2306r537b2384],
17	>	JJR	O	>	conj_or	9	SENT_54	[p4l577t2317r624b2358],
18	325	CD	NUMBER	325	num	19	SENT_54	[p4l673t2308r788b2368],
19	mg	NN	O	mg	dep	17	SENT_54	[p4l819t2326r927b2384],
20	of	IN	O	of	_	0	SENT_54	[p4l947t2306r1022b2368],
21	aspirin	NN	O	aspirin	prep_of	19	SENT_54	[p4l1034t2306r1280b2384],
22	,	,	O	,	_	0	SENT_54	[p4l1034t2306r1280b2384],
23	or	CC	O	or	_	0	SENT_54	[p4l1303t2326r1376b2368],
24	drugs	NNS	O	drug	conj_or	9	SENT_54	[p4l1395t2306r1582b2384],
25	that	WDT	O	that	nsubj	26	SENT_54	[p4l1603t2306r1738b2368],
26	affected	VBD	O	affect	rcmod	24	SENT_54	[p4l1757t2306r2023b2368],
27	the	DT	O	the	det	29	SENT_54	[p4l2042t2306r2145b2368],
28	prothrombin	NN	O	prothrombin	nn	29	SENT_54	[p4l7t2413r450b2491],
29	time	NN	O	time	dobj	26	SENT_54	[p4l481t2413r645b2474],
30	.	.	O	.	_	0	SENT_54	[p4l481t2413r645b2474],

1	After	IN	O	after	mark	5	SENT_55	[p4l678t2413r860b2474],
2	their	PRP$	O	they	poss	3	SENT_55	[p4l889t2413r1045b2474],
3	INR	NN	O	inr	nsubj	5	SENT_55	[p4l1075t2415r1236b2474],
4	had	VBD	O	have	aux	5	SENT_55	[p4l1265t2413r1392b2474],
5	drifted	VBN	O	drift	advcl	23	SENT_55	[p4l1423t2413r1649b2474],
6	to	TO	O	to	_	0	SENT_55	[p4l1680t2421r1746b2474],
7	<	JJR	O	<	prep_to	5	SENT_55	[p4l1795t2424r1842b2464],
8	1.2	CD	NUMBER	1.2	dep	7	SENT_55	[p4l1897t2414r1988b2474],
9	and	CC	O	and	cc	5	SENT_55	[p4l2020t2413r2146b2474],
10	prior	RB	O	prior	advmod	5	SENT_55	[p4l7t2518r178b2596],
11	to	TO	O	to	dep	5	SENT_55	[p4l197t2527r263b2580],
12	randomization	NN	O	randomization	pobj	11	SENT_55	[p4l284t2518r787b2580],
13	to	TO	O	to	_	0	SENT_55	[p4l807t2527r873b2580],
14	long-terrn	JJ	O	long-terrn	amod	15	SENT_55	[p4l894t2518r1229b2596],
15	treatment	NN	O	treatment	prep_to	5	SENT_55	[p4l1248t2527r1577b2580],
16	with	IN	O	with	_	0	SENT_55	[p4l1594t2518r1744b2580],
17	warfarin	NN	O	warfarin	prep_with	5	SENT_55	[p4l1762t2518r2053b2580],
18	or	CC	O	or	_	0	SENT_55	[p4l2074t2538r2147b2580],
19	placebo	NN	O	placebo	conj_or	17	SENT_55	[p4l7t2624r289b2702],
20	,	,	O	,	_	0	SENT_55	[p4l7t2624r289b2702],
21	all	DT	O	all	det	22	SENT_55	[p4l315t2624r394b2686],
22	participants	NNS	O	participant	nsubj	23	SENT_55	[p4l415t2624r819b2702],
23	took	VBD	O	take	_	0	SENT_55	[p4l842t2624r1001b2686],
24	part	NN	O	part	dobj	23	SENT_55	[p4l1022t2633r1163b2702],
25	in	IN	O	in	_	0	SENT_55	[p4l1184t2624r1249b2685],
26	an	DT	O	a	det	31	SENT_55	[p4l1272t2644r1355b2686],
27	open	JJ	O	open	amod	31	SENT_55	[p4l1379t2644r1545b2702],
28	label	NN	O	label	nn	31	SENT_55	[p4l1567t2624r1727b2686],
29	28-day	JJ	DURATION	28-day	amod	31	SENT_55	[p4l1750t2624r1980b2702],
30	runin	NN	O	runin	nn	31	SENT_55	[p4l2002t2644r2145b2686, p4l7t2731r72b2791],
31	phase	NN	O	phase	prep_in	23	SENT_55	[p4l107t2731r301b2809],
32	to	TO	O	to	aux	33	SENT_55	[p4l338t2739r405b2792],
33	ensure	VB	O	ensure	dep	23	SENT_55	[p4l443t2751r661b2792],
34	compliance	NN	O	compliance	dobj	33	SENT_55	[p4l698t2731r1084b2809],
35	and	CC	O	and	_	0	SENT_55	[p4l1123t2731r1249b2792],
36	to	TO	O	to	aux	37	SENT_55	[p4l1286t2739r1352b2792],
37	determine	VB	O	determine	dep	23	SENT_55	[p4l1391t2731r1728b2792],
38	therapeutic	JJ	O	therapeutic	amod	40	SENT_55	[p4l1765t2731r2147b2809],
39	warfarin	NN	O	warfarin	nn	40	SENT_55	[p4l7t2837r299b2899],
40	dose	NN	O	dose	dobj	37	SENT_55	[p4l331t2836r483b2899],
41	for	IN	O	for	_	0	SENT_55	[p4l515t2837r616b2899],
42	an	DT	O	a	det	44	SENT_55	[p4l648t2857r730b2899],
43	INR	NN	O	inr	nn	44	SENT_55	[p4l763t2839r923b2899],
44	target	NN	O	target	prep_for	37	SENT_55	[p4l954t2845r1151b2916],
45	of	IN	O	of	_	0	SENT_55	[p4l1184t2837r1260b2899],
46	1.5-2	CD	NUMBER	1.5-2	num	47	SENT_55	[p4l1292t2838r1541b2899],
47	.0	CD	NUMBER	.0	prep_of	44	SENT_55	[p4l1292t2838r1541b2899],
48	.	.	O	.	_	0	SENT_55	[p4l1292t2838r1541b2899],

1	Starting	VBG	O	start	prep	13	SENT_56	[p4l1581t2837r1851b2916],
2	with	IN	O	with	pcomp	1	SENT_56	[p4l1881t2836r2032b2899],
3	an	DT	O	a	det	5	SENT_56	[p4l2064t2857r2146b2899],
4	initial	JJ	O	initial	amod	5	SENT_56	[p4l7t2943r200b3005],
5	dose	NN	O	dose	pobj	2	SENT_56	[p4l232t2943r384b3005],
6	of	IN	O	of	_	0	SENT_56	[p4l418t2943r493b3005],
7	3.0	CD	NUMBER	3.0	num	8	SENT_56	[p4l519t2945r615b3005],
8	mg	NN	O	mg	prep_of	5	SENT_56	[p4l645t2963r770b3021],
9	,	,	O	,	_	0	SENT_56	[p4l645t2963r770b3021],
10	dose	NN	O	dose	nn	11	SENT_56	[p4l805t2943r957b3005],
11	adjustments	NNS	O	adjustment	nsubjpass	13	SENT_56	[p4l990t2943r1396b3021],
12	were	VBD	O	be	auxpass	13	SENT_56	[p4l1427t2963r1585b3005],
13	made	VBN	O	make	_	0	SENT_56	[p4l1616t2943r1802b3005],
14	based	VBN	O	base	_	0	SENT_56	[p4l1834t2943r2027b3005],
15	on	IN	O	on	prepc_based_on	13	SENT_56	[p4l2060t2963r2147b3005],
16	approximately	RB	O	approximately	advmod	19	SENT_56	[p4l9t3049r503b3127],
17	weekly	JJ	SET	weekly	amod	19	SENT_56	[p4l553t3049r787b3127],
18	INR	NN	O	inr	nn	19	SENT_56	[p4l840t3052r1000b3110],
19	determinations	NNS	O	determination	nsubj	20	SENT_56	[p4l1052t3049r1560b3111],
20	using	VBG	O	use	pcomp	13	SENT_56	[p4l1612t3049r1793b3127],
21	a	DT	O	a	det	22	SENT_56	[p4l1845t3069r1883b3111],
22	studyspeciﬁc	NN	O	studyspeciﬁc	nsubj	25	SENT_56	[p4l1937t3049r2144b3127, p4l10t3155r252b3233],
23	clinical	JJ	O	clinical	amod	25	SENT_56	[p4l293t3155r529b3217],
24	nomogram	NN	O	nomogram	nn	25	SENT_56	[p4l570t3175r949b3233],
25	[	NN	O	[	xcomp	20	SENT_56	[p4l992t3156r1126b3232],
26	14	CD	NUMBER	14	num	27	SENT_56	[p4l992t3156r1126b3232],
27	]	NN	O	]	dep	25	SENT_56	[p4l992t3156r1126b3232],
28	.	.	O	.	_	0	SENT_56	[p4l992t3156r1126b3232],

1	Genotyping	VBG	O	genotype	nsubjpass	3	SENT_57	[p4l1173t3155r1579b3233],
2	was	VBD	O	be	auxpass	3	SENT_57	[p4l1618t3175r1747b3217],
3	perfonned	VBN	O	perfonn	_	0	SENT_57	[p4l1788t3155r2146b3233],
4	after	IN	O	after	_	0	SENT_57	[p4l9t3262r165b3323],
5	the	DT	O	the	det	6	SENT_57	[p4l197t3262r300b3323],
6	completion	NN	O	completion	prep_after	3	SENT_57	[p4l333t3262r716b3340],
7	of	IN	O	of	_	0	SENT_57	[p4l749t3262r825b3323],
8	PREVENT	NNP	O	PREVENT	prep_of	6	SENT_57	[p4l848t3264r1265b3323],
9	.	.	O	.	_	0	SENT_57	[p4l848t3264r1265b3323],

1	Our	PRP$	O	we	poss	3	SENT_58	[p4l1303t3263r1440b3323],
2	primary	JJ	O	primary	amod	3	SENT_58	[p4l1470t3262r1745b3340],
3	analysis	NN	O	analysis	nsubj	24	SENT_58	[p4l1778t3262r2043b3340],
4	of	IN	O	of	_	0	SENT_58	[p4l2078t3262r2154b3323],
5	the	DT	O	the	det	6	SENT_58	[p4l8t3367r111b3430],
6	importance	NN	O	importance	prep_of	3	SENT_58	[p4l135t3368r522b3447],
7	of	IN	O	of	_	0	SENT_58	[p4l547t3368r623b3430],
8	genetic	JJ	O	genetic	amod	9	SENT_58	[p4l638t3368r873b3447],
9	factors	NNS	O	factor	prep_of	6	SENT_58	[p4l895t3368r1125b3430],
10	in	IN	O	in	_	0	SENT_58	[p4l1149t3368r1213b3429],
11	dose	NN	O	dose	nn	12	SENT_58	[p4l1237t3367r1389b3430],
12	prediction	NN	O	prediction	prep_in	9	SENT_58	[p4l1411t3367r1757b3447],
13	on	IN	O	on	_	0	SENT_58	[p4l1782t3388r1868b3430],
14	days	NNS	DURATION	day	prep_on	12	SENT_58	[p4l1891t3367r2043b3446],
15	021	CD	NUMBER	021	nsubjpass	17	SENT_58	[p4l2068t3370r2149b3430, p4l8t3476r78b3535],
16	was	VBD	O	be	auxpass	17	SENT_58	[p4l122t3494r250b3536],
17	performed	VBN	O	perform	rcmod	14	SENT_58	[p4l287t3474r645b3552],
18	using	VBG	O	use	xcomp	17	SENT_58	[p4l681t3474r862b3552],
19	therapeutic	JJ	O	therapeutic	amod	20	SENT_58	[p4l898t3474r1279b3552],
20	doses	NNS	O	dose	dobj	18	SENT_58	[p4l1315t3474r1498b3536],
21	from	IN	O	from	_	0	SENT_58	[p4l1535t3474r1703b3536],
22	the	DT	O	the	det	23	SENT_58	[p4l1740t3474r1843b3536],
23	patients	NNS	O	patient	prep_from	18	SENT_58	[p4l1879t3474r2145b3552],
24	randomized	VBD	O	randomize	_	0	SENT_58	[p4l8t3581r414b3642],
25	to	TO	O	to	_	0	SENT_58	[p4l445t3589r512b3642],
26	long-terrn	JJ	O	long-terrn	amod	29	SENT_58	[p4l545t3581r880b3659],
27	warfarin	NN	O	warfarin	nn	29	SENT_58	[p4l909t3581r1201b3642],
28	(	NN	O	(	nn	29	SENT_58	[p4l1234t3581r1296b3659],
29	n	NN	O	n	prep_to	24	SENT_58	[p4l1234t3581r1296b3659],
30	=	JJ	O	=	advmod	24	SENT_58	[p4l1341t3604r1392b3621],
31	223	CD	NUMBER	223	num	32	SENT_58	[p4l1437t3581r1599b3659],
32	)	NN	O	)	dep	30	SENT_58	[p4l1437t3581r1599b3659],
33	.	.	O	.	_	0	SENT_58	[p4l1437t3581r1599b3659],

1	Our	PRP$	O	we	poss	3	SENT_59	[p4l1635t3582r1772b3642],
2	secondary	JJ	O	secondary	amod	3	SENT_59	[p4l1804t3581r2147b3659],
3	analysis	NN	O	analysis	nsubjpass	13	SENT_59	[p4l9t3687r274b3765],
4	of	IN	O	of	_	0	SENT_59	[p4l304t3687r379b3749],
5	importance	NN	O	importance	prep_of	3	SENT_59	[p4l398t3687r785b3766],
6	of	IN	O	of	_	0	SENT_59	[p4l815t3687r891b3749],
7	genetic	JJ	O	genetic	amod	8	SENT_59	[p4l910t3687r1145b3766],
8	factors	NNS	O	factor	prep_of	5	SENT_59	[p4l1172t3687r1403b3749],
9	for	IN	O	for	_	0	SENT_59	[p4l1431t3686r1532b3749],
10	INR	NN	O	inr	nn	11	SENT_59	[p4l1559t3689r1720b3748],
11	control	NN	O	control	prep_for	8	SENT_59	[p4l1745t3687r1990b3749],
12	was	VBD	O	be	auxpass	13	SENT_59	[p4l2017t3707r2145b3749],
13	performed	VBN	O	perform	_	0	SENT_59	[p5l7t20r364b98],
14	based	VBN	O	base	_	0	SENT_59	[p5l395t20r589b82],
15	on	IN	O	on	prepc_based_on	13	SENT_59	[p5l621t40r707b82],
16	all	DT	O	all	det	22	SENT_59	[p5l739t20r818b82],
17	patients	NNS	O	patient	dep	22	SENT_59	[p5l847t20r1114b98],
18	(	IN	O	(	_	0	SENT_59	[p5l1147t21r1209b98],
19	n	NN	O	n	prep_(	17	SENT_59	[p5l1147t21r1209b98],
20	=	JJ	O	=	amod	22	SENT_59	[p5l1255t43r1306b61],
21	508	CD	NUMBER	508	num	22	SENT_59	[p5l1354t20r1494b98],
22	)	NN	O	)	pobj	13	SENT_59	[p5l1354t20r1494b98],
23	during	IN	O	during	_	0	SENT_59	[p5l1527t20r1751b98],
24	the	DT	O	the	det	27	SENT_59	[p5l1782t20r1884b82],
25	28-day	JJ	DURATION	28-day	amod	27	SENT_59	[p5l1916t20r2146b98],
26	run-in	NN	O	run-in	nn	27	SENT_59	[p5l8t126r218b188],
27	phase	NN	O	phase	prep_during	22	SENT_59	[p5l243t126r454b204],
28	.	.	O	.	_	0	SENT_59	[p5l243t126r454b204],

1	Genotyping	VBG	O	genotype	_	0	SENT_60	[p5l10t365r412b441],

1	We	PRP	O	we	nsubj	2	SENT_61	[p5l6t523r122b582],
2	extracted	VBD	O	extract	dep	9	SENT_61	[p5l177t521r488b582],
3	DNA	NN	O	dna	dobj	2	SENT_61	[p5l542t521r739b582],
4	from	IN	O	from	_	0	SENT_61	[p5l792t521r960b582],
5	white	JJ	O	white	amod	6	SENT_61	[p5l1012t521r1196b582],
6	cell	NN	O	cell	prep_from	2	SENT_61	[p5l1251t521r1361b582],
7	buffy	JJ	O	buffy	amod	8	SENT_61	[p5l1415t521r1595b599],
8	coats	NNS	O	coat	nsubj	9	SENT_61	[p5l1649t529r1823b582],
9	(	VBP	O	(	_	0	SENT_61	[p5l1880t521r2146b599],
10	Gentra	NNP	ORGANIZATION	Gentra	nn	13	SENT_61	[p5l1880t521r2146b599],
11	Systems	NNPS	ORGANIZATION	Systems	nn	13	SENT_61	[p5l10t627r280b704],
12	Puregene	NNP	ORGANIZATION	Puregene	nn	13	SENT_61	[p5l325t629r637b704],
13	kit	NN	O	kit	dobj	9	SENT_61	[p5l682t626r790b701],
14	,	,	O	,	_	0	SENT_61	[p5l682t626r790b701],
15	Minneapolis	NNP	LOCATION	Minneapolis	appos	13	SENT_61	[p5l838t626r1281b704],
16	,	,	O	,	_	0	SENT_61	[p5l838t626r1281b704],
17	MN	NN	O	mn	nn	18	SENT_61	[p5l1330t627r1501b704],
18	)	NN	O	)	appos	13	SENT_61	[p5l1330t627r1501b704],
19	prepared	VBN	O	prepare	partmod	18	SENT_61	[p5l1546t626r1851b704],
20	from	IN	O	from	_	0	SENT_61	[p5l1895t626r2064b688],
21	a	DT	O	a	det	23	SENT_61	[p5l2108t646r2146b688],
22	10-ml	JJ	O	10-ml	amod	23	SENT_61	[p5l16t732r202b794],
23	EDTA	NN	O	edta	prep_from	19	SENT_61	[p5l253t732r491b793],
24	anticoagulated	VBN	O	anticoagulate	partmod	23	SENT_61	[p5l543t732r1043b810],
25	blood	NN	O	blood	nn	26	SENT_61	[p5l1095t732r1292b794],
26	sample	NN	O	sample	dobj	24	SENT_61	[p5l1346t732r1581b810],
27	collected	VBN	O	collect	partmod	26	SENT_61	[p5l1632t732r1927b794],
28	from	IN	O	from	_	0	SENT_61	[p5l1979t732r2147b794],
29	each	DT	O	each	det	30	SENT_61	[p5l8t838r161b899],
30	participant	NN	O	participant	prep_from	27	SENT_61	[p5l179t838r552b916],
31	during	IN	O	during	_	0	SENT_61	[p5l571t838r795b916],
32	the	DT	O	the	det	35	SENT_61	[p5l813t838r917b899],
33	original	JJ	O	original	amod	35	SENT_61	[p5l937t838r1197b916],
34	PREVENT	NNP	O	PREVENT	nn	35	SENT_61	[p5l1215t840r1616b899],
35	study	NN	O	study	prep_during	27	SENT_61	[p5l1636t838r1835b916],
36	.	.	O	.	_	0	SENT_61	[p5l1636t838r1835b916],

1	We	PRP	O	we	nsubj	2	SENT_62	[p5l1857t840r1974b899],
2	used	VBD	O	use	_	0	SENT_62	[p5l1992t838r2146b899],
3	PyrosequencingTM	NN	O	pyrosequencingtm	dobj	2	SENT_62	[p5l7t932r637b1023],
4	[	CD	NUMBER	[	number	5	SENT_62	[p5l717t946r933b1022],
5	15,16	CD	NUMBER	15,16	num	6	SENT_62	[p5l717t946r933b1022],
6	]	NN	O	]	nsubj	38	SENT_62	[p5l717t946r933b1022],
7	to	TO	O	to	_	0	SENT_62	[p5l1011t953r1078b1006],
8	genotype	NN	O	genotype	prep_to	6	SENT_62	[p5l1156t953r1464b1023],
9	for	IN	O	for	_	0	SENT_62	[p5l1540t945r1640b1006],
10	four	CD	NUMBER	four	num	11	SENT_62	[p5l1715t945r1860b1006],
11	SNPS	NNS	O	snp	prep_for	8	SENT_62	[p5l1938t946r2141b1006],
12	:	:	O	:	_	0	SENT_62	[p5l1938t946r2141b1006],
13	CYP2C9	NN	O	cyp2c9	nn	14	SENT_62	[p5l9t1050r397b1112],
14	*	NN	O	*	conj_and	6	SENT_62	[p5l9t1050r397b1112],
15	2	CD	NUMBER	2	number	16	SENT_62	[p5l9t1050r397b1112],
16	[	CD	NUMBER	[	num	18	SENT_62	[p5l451t1052r849b1128],
17	rsl799853	NN	O	rsl799853	nn	18	SENT_62	[p5l451t1052r849b1128],
18	]	NN	O	]	dep	14	SENT_62	[p5l451t1052r849b1128],
19	,	,	O	,	_	0	SENT_62	[p5l451t1052r849b1128],
20	CYP2C9	NN	O	cyp2c9	conj_and	6	SENT_62	[p5l904t1050r1287b1112],
21	*	CD	NUMBER	*	num	20	SENT_62	[p5l904t1050r1287b1112],
22	3	CD	NUMBER	3	num	25	SENT_62	[p5l904t1050r1287b1112],
23	[	NN	O	[	nn	25	SENT_62	[p5l1344t1052r1741b1128],
24	rsl057910	NN	O	rsl057910	nn	25	SENT_62	[p5l1344t1052r1741b1128],
25	]	NN	O	]	dep	20	SENT_62	[p5l1344t1052r1741b1128],
26	,	,	O	,	_	0	SENT_62	[p5l1344t1052r1741b1128],
27	VKORC1	NN	O	vkorc1	nsubj	38	SENT_62	[p5l1794t1051r2137b1112],
28	6853	CD	NUMBER	6853	number	29	SENT_62	[p5l10t1158r163b1218],
29	[	CD	NUMBER	[	num	31	SENT_62	[p5l209t1157r586b1233],
30	rs8050894	NN	O	rs8050894	nn	31	SENT_62	[p5l209t1157r586b1233],
31	]	NN	O	]	dep	27	SENT_62	[p5l209t1157r586b1233],
32	and	CC	O	and	_	0	SENT_62	[p5l629t1156r756b1218],
33	-1639	CD	NUMBER	-1639	num	35	SENT_62	[p5l798t1158r1005b1218],
34	[	CD	NUMBER	[	num	35	SENT_62	[p5l1048t1157r1425b1233],
35	rs9923231	NN	O	rs9923231	conj_and	6	SENT_62	[p5l1048t1157r1425b1233],
36	]	CD	NUMBER	]	num	37	SENT_62	[p5l1048t1157r1425b1233],
37	(	NN	O	(	dep	35	SENT_62	[p5l1469t1156r1670b1234],
38	listed	VBN	O	list	rcmod	3	SENT_62	[p5l1469t1156r1670b1234],
39	with	IN	O	with	_	0	SENT_62	[p5l1708t1156r1858b1218],
40	dbSNP	NN	O	dbsnp	nn	43	SENT_62	[p5l1897t1156r2146b1218],
41	reference	NN	O	reference	nn	43	SENT_62	[p5l8t1263r312b1324],
42	SNP	NN	O	snp	nn	43	SENT_62	[p5l334t1264r491b1324],
43	identiﬁers	NNS	O	identiﬁers	prep_with	38	SENT_62	[p5l510t1263r883b1341],
44	)	CD	NUMBER	)	tmod	38	SENT_62	[p5l510t1263r883b1341],
45	.	.	O	.	_	0	SENT_62	[p5l510t1263r883b1341],

1	VKORC1	NN	O	vkorc1	nn	2	SENT_63	[p5l906t1264r1250b1324],
2	SNPs	NNS	O	snp	nsubj	6	SENT_63	[p5l1280t1264r1466b1324],
3	-1639	CD	NUMBER	-1639	dep	2	SENT_63	[p5l1489t1264r1695b1324],
4	and	CC	O	and	_	0	SENT_63	[p5l1717t1263r1844b1324],
5	6853	CD	DATE	6853	dep	2	SENT_63	[p5l1865t1264r2019b1324],
6	are	VBP	O	be	_	0	SENT_63	[p5l2043t1283r2145b1324],
7	in	IN	O	in	_	0	SENT_63	[p5l7t1369r72b1430],
8	high	JJ	O	high	amod	10	SENT_63	[p5l118t1368r267b1448],
9	linkage	NN	O	linkage	nn	10	SENT_63	[p5l314t1368r558b1448],
10	disequilibrium	NN	O	disequilibrium	prep_in	6	SENT_63	[p5l605t1368r1094b1447],
11	and	CC	O	and	_	0	SENT_63	[p5l1142t1368r1269b1431],
12	designate	VB	O	designate	conj_and	6	SENT_63	[p5l1315t1368r1630b1448],
13	haplotype	NN	O	haplotype	nn	14	SENT_63	[p5l1677t1369r2016b1448],
14	A	NN	O	a	dobj	12	SENT_63	[p5l2062t1369r2142b1444],
15	,	,	O	,	_	0	SENT_63	[p5l2062t1369r2142b1444],
16	which	WDT	O	which	nsubjpass	18	SENT_63	[p5l7t1476r211b1537],
17	is	VBZ	O	be	auxpass	18	SENT_63	[p5l232t1476r281b1537],
18	associated	VBN	O	associate	rcmod	14	SENT_63	[p5l307t1476r651b1537],
19	with	IN	O	with	_	0	SENT_63	[p5l673t1476r823b1537],
20	increased	VBN	O	increase	amod	23	SENT_63	[p5l845t1476r1161b1537],
21	warfarin	NN	O	warfarin	nn	23	SENT_63	[p5l1182t1476r1475b1537],
22	sensitivity	NN	O	sensitivity	nn	23	SENT_63	[p5l1499t1476r1832b1554],
23	[	NN	O	[	prep_with	18	SENT_63	[p5l1856t1477r1950b1553],
24	2	CD	NUMBER	2	num	25	SENT_63	[p5l1856t1477r1950b1553],
25	]	NN	O	]	nsubj	12	SENT_63	[p5l1856t1477r1950b1553],
26	.	.	O	.	_	0	SENT_63	[p5l1856t1477r1950b1553],

1	PCR	NN	O	pcr	nn	2	SENT_64	[p5l1976t1477r2148b1537],
2	reactions	NNS	O	reaction	nsubjpass	6	SENT_64	[p5l8t1581r312b1643],
3	and	CC	O	and	_	0	SENT_64	[p5l353t1581r480b1643],
4	Pyrosequencing	NN	O	pyrosequencing	nsubjpass	6	SENT_64	[p5l519t1581r1057b1659],
5	were	VBD	O	be	auxpass	6	SENT_64	[p5l1095t1601r1252b1643],
6	performed	VBN	O	perform	_	0	SENT_64	[p5l1290t1581r1649b1659],
7	as	IN	O	as	mark	9	SENT_64	[p5l1689t1601r1756b1643],
8	previously	RB	DATE	previously	advmod	9	SENT_64	[p5l1794t1581r2146b1659],
9	prescribed	VBN	O	prescribe	advcl	6	SENT_64	[p5l7t1687r358b1765],
10	[	NN	O	[	nn	12	SENT_64	[p5l409t1688r502b1764],
11	4	CD	NUMBER	4	num	12	SENT_64	[p5l409t1688r502b1764],
12	]	NN	O	]	dobj	9	SENT_64	[p5l409t1688r502b1764],
13	.	.	O	.	_	0	SENT_64	[p5l409t1688r502b1764],

1	The	DT	O	the	det	3	SENT_65	[p5l554t1687r686b1748],
2	genotyping	NN	O	genotyping	nn	3	SENT_65	[p5l735t1687r1114b1765],
3	platforms	NNS	O	platform	nsubj	17	SENT_65	[p5l1160t1687r1490b1765],
4	for	IN	O	for	_	0	SENT_65	[p5l1538t1687r1638b1748],
5	the	DT	O	the	det	6	SENT_65	[p5l1686t1687r1789b1748],
6	SNPs	NNS	O	snp	prep_for	3	SENT_65	[p5l1840t1688r2026b1749],
7	of	IN	O	of	_	0	SENT_65	[p5l2078t1687r2153b1748],
8	interest	NN	O	interest	prep_of	6	SENT_65	[p5l7t1794r255b1855],
9	are	VBP	O	be	cop	17	SENT_65	[p5l282t1814r385b1855],
10	99	CD	PERCENT	99	number	11	SENT_65	[p5l414t1795r729b1856],
11	—	CD	PERCENT	—	nn	17	SENT_65	[p5l414t1795r729b1856],
12	100	CD	PERCENT	100	num	13	SENT_65	[p5l414t1795r729b1856],
13	%	NN	PERCENT	%	dep	11	SENT_65	[p5l414t1795r729b1856],
14	accurate	JJ	O	accurate	amod	17	SENT_65	[p5l764t1802r1048b1855],
15	[	NN	O	[	dep	14	SENT_65	[p5l1078t1795r1211b1871],
16	17	CD	NUMBER	17	num	15	SENT_65	[p5l1078t1795r1211b1871],
17	]	NN	O	]	_	0	SENT_65	[p5l1078t1795r1211b1871],
18	.	.	O	.	_	0	SENT_65	[p5l1078t1795r1211b1871],

1	Clinical	JJ	O	clinical	_	0	SENT_66	[p5l10t2033r269b2094],
2	and	CC	O	and	_	0	SENT_66	[p5l297t2032r428b2094],
3	genetic	JJ	O	genetic	amod	4	SENT_66	[p5l451t2036r703b2112],
4	variables	NNS	O	variable	conj_and	1	SENT_66	[p5l733t2033r1036b2094],

1	We	PRP	O	we	nsubj	2	SENT_67	[p5l6t2194r122b2254],
2	used	VBD	O	use	_	0	SENT_67	[p5l141t2192r294b2253],
3	height	NN	O	height	dobj	2	SENT_67	[p5l313t2192r524b2270],
4	and	CC	O	and	_	0	SENT_67	[p5l544t2192r670b2253],
5	weight	NN	O	weight	conj_and	3	SENT_67	[p5l688t2192r914b2270],
6	to	TO	O	to	aux	7	SENT_67	[p5l932t2201r999b2253],
7	estimate	VB	O	estimate	xcomp	2	SENT_67	[p5l1020t2192r1299b2253],
8	body	NN	O	body	nn	10	SENT_67	[p5l1318t2192r1491b2270],
9	surface	NN	O	surface	nn	10	SENT_67	[p5l1512t2192r1750b2253],
10	area	NN	O	area	dobj	7	SENT_67	[p5l1770t2212r1914b2253],
11	(	CD	NUMBER	(	num	12	SENT_67	[p5l1935t2192r2144b2270],
12	BSA	NN	ORGANIZATION	bsa	dep	10	SENT_67	[p5l1935t2192r2144b2270],
13	)	CD	NUMBER	)	number	14	SENT_67	[p5l1935t2192r2144b2270],
14	[	CD	NUMBER	[	dep	12	SENT_67	[p5l10t2300r144b2376],
15	18	CD	NUMBER	18	num	16	SENT_67	[p5l10t2300r144b2376],
16	]	NN	O	]	dep	14	SENT_67	[p5l10t2300r144b2376],
17	.	.	O	.	_	0	SENT_67	[p5l10t2300r144b2376],

1	For	IN	O	for	_	0	SENT_68	[p5l192t2301r319b2360],
2	CYP2C9	NN	O	cyp2c9	nn	3	SENT_68	[p5l362t2299r767b2373],
3	*	NN	O	*	prep_for	20	SENT_68	[p5l362t2299r767b2373],
4	2	CD	NUMBER	2	num	3	SENT_68	[p5l362t2299r767b2373],
5	,	,	O	,	_	0	SENT_68	[p5l362t2299r767b2373],
6	CYP2C9	NN	O	cyp2c9	dep	14	SENT_68	[p5l814t2299r1198b2360],
7	*	CD	NUMBER	*	num	8	SENT_68	[p5l814t2299r1198b2360],
8	3	CD	NUMBER	3	dep	6	SENT_68	[p5l814t2299r1198b2360],
9	and	CC	O	and	_	0	SENT_68	[p5l1244t2299r1371b2360],
10	VKORC1	NN	O	vkorc1	dep	6	SENT_68	[p5l1412t2300r1755b2360],
11	-1639	CD	NUMBER	-1639	num	12	SENT_68	[p5l1808t2300r2014b2360],
12	(	NN	O	(	dep	14	SENT_68	[p5l2060t2299r2146b2377],
13	A	DT	O	a	det	14	SENT_68	[p5l2060t2299r2146b2377],
14	genotype	NN	O	genotype	dep	20	SENT_68	[p5l8t2413r317b2482],
15	and	CC	O	and	_	0	SENT_68	[p5l348t2404r475b2466],
16	A	DT	O	a	det	18	SENT_68	[p5l503t2404r566b2465],
17	haplotype	NN	O	haplotype	nn	18	SENT_68	[p5l594t2404r958b2482],
18	)	NN	O	)	conj_and	14	SENT_68	[p5l594t2404r958b2482],
19	we	PRP	O	we	nsubj	20	SENT_68	[p5l988t2424r1081b2466],
20	coded	VBD	O	code	_	0	SENT_68	[p5l1110t2404r1313b2466],
21	each	DT	O	each	dobj	20	SENT_68	[p5l1342t2404r1496b2466],
22	of	IN	O	of	_	0	SENT_68	[p5l1527t2404r1603b2466],
23	the	DT	O	the	det	25	SENT_68	[p5l1624t2404r1727b2466],
24	three	CD	NUMBER	three	num	25	SENT_68	[p5l1757t2404r1926b2466],
25	SNPs	NNS	MISC	snp	prep_of	21	SENT_68	[p5l1959t2406r2145b2466],
26	using	VBG	O	use	xcomp	20	SENT_68	[p5l7t2510r188b2588],
27	its	PRP$	O	its	poss	29	SENT_68	[p5l207t2510r282b2572],
28	own	JJ	O	own	amod	29	SENT_68	[p5l305t2530r449b2572],
29	dummy	NN	O	dummy	nsubj	31	SENT_68	[p5l470t2510r733b2588],
30	Variable	JJ	O	variable	dep	31	SENT_68	[p5l752t2510r1023b2572],
31	coded	VBN	O	code	xcomp	26	SENT_68	[p5l1044t2510r1247b2572],
32	as	IN	O	as	_	0	SENT_68	[p5l1268t2530r1335b2572],
33	o	NN	O	o	prep_as	31	SENT_68	[p5l1357t2512r1412b2584],
34	,	,	O	,	_	0	SENT_68	[p5l1357t2512r1412b2584],
35	1	CD	NUMBER	1	conj_or	33	SENT_68	[p5l1444t2512r1466b2571],
36	or	CC	O	or	_	0	SENT_68	[p5l1496t2530r1568b2572],
37	2	CD	NUMBER	2	conj_or	33	SENT_68	[p5l1589t2512r1626b2571],
38	to	TO	O	to	aux	39	SENT_68	[p5l1647t2519r1714b2572],
39	quantify	VB	O	quantify	xcomp	31	SENT_68	[p5l1737t2510r2023b2588],
40	the	DT	O	the	det	41	SENT_68	[p5l2043t2510r2146b2572],
41	number	NN	O	number	dobj	39	SENT_68	[p5l7t2617r274b2678],
42	of	IN	O	of	_	0	SENT_68	[p5l293t2617r369b2678],
43	Variant	JJ	O	variant	amod	44	SENT_68	[p5l378t2617r620b2678],
44	alleles	NNS	O	allele	prep_of	41	SENT_68	[p5l639t2617r855b2678],
45	.	.	O	.	_	0	SENT_68	[p5l639t2617r855b2678],

1	We	PRP	O	we	nsubj	2	SENT_69	[p5l877t2619r993b2678],
2	used	VBD	O	use	ccomp	21	SENT_69	[p5l1011t2617r1164b2678],
3	dummy	NN	O	dummy	nn	4	SENT_69	[p5l1183t2617r1446b2695],
4	Variables	NNS	O	variable	dobj	2	SENT_69	[p5l1463t2617r1764b2678],
5	to	TO	O	to	aux	6	SENT_69	[p5l1783t2625r1850b2678],
6	code	VB	O	code	xcomp	2	SENT_69	[p5l1870t2617r2027b2678],
7	for	IN	O	for	mark	10	SENT_69	[p5l2046t2617r2146b2678],
8	demographic	JJ	O	demographic	amod	9	SENT_69	[p5l8t2722r455b2801],
9	factors	NNS	O	factor	nsubj	10	SENT_69	[p5l490t2722r720b2785],
10	(	VBP	O	(	advcl	6	SENT_69	[p5l758t2723r887b2802],
11	sex	NN	O	sex	dobj	10	SENT_69	[p5l758t2723r887b2802],
12	and	CC	O	and	_	0	SENT_69	[p5l923t2722r1049b2785],
13	race	NN	O	race	conj_and	11	SENT_69	[p5l1085t2723r1267b2801],
14	)	RB	O	)	advmod	10	SENT_69	[p5l1085t2723r1267b2801],
15	,	,	O	,	_	0	SENT_69	[p5l1085t2723r1267b2801],
16	smoking	NN	O	smoking	nn	17	SENT_69	[p5l1308t2722r1598b2801],
17	status	NN	O	status	nsubj	21	SENT_69	[p5l1634t2731r1828b2785],
18	and	CC	O	and	_	0	SENT_69	[p5l1866t2722r1993b2785],
19	key	JJ	O	key	amod	20	SENT_69	[p5l2028t2722r2147b2801],
20	medications	NNS	O	medication	conj_and	17	SENT_69	[p5l6t2829r415b2892],
21	(	VBP	O	(	_	0	SENT_69	[p5l450t2829r903b2909],
22	amiodarone	NN	O	amiodarone	nn	27	SENT_69	[p5l450t2829r903b2909],
23	,	,	O	,	_	0	SENT_69	[p5l450t2829r903b2909],
24	statins	NNS	O	statin	dep	27	SENT_69	[p5l941t2830r1174b2905],
25	,	,	O	,	_	0	SENT_69	[p5l941t2830r1174b2905],
26	aspirin	NN	O	aspirin	dep	27	SENT_69	[p5l1210t2830r1482b2909],
27	)	NN	O	)	dobj	21	SENT_69	[p5l1210t2830r1482b2909],
28	.	.	O	.	_	0	SENT_69	[p5l1210t2830r1482b2909],

1	We	PRP	O	we	nsubj	2	SENT_70	[p5l1517t2832r1634b2892],
2	deﬁned	VBD	O	deﬁned	_	0	SENT_70	[p5l1667t2829r1912b2892],
3	therapeutic	JJ	O	therapeutic	amod	4	SENT_70	[p5l1945t2829r2144b2892, p5l7t2936r213b3014],
4	dose	NN	O	dose	dobj	2	SENT_70	[p5l245t2936r397b2998],
5	as	IN	O	as	_	0	SENT_70	[p5l431t2956r498b2998],
6	the	DT	O	the	det	7	SENT_70	[p5l531t2936r635b2998],
7	dose	NN	O	dose	prep_as	2	SENT_70	[p5l667t2936r820b2998],
8	resulting	VBG	O	result	partmod	7	SENT_70	[p5l853t2936r1144b3014],
9	in	IN	O	in	_	0	SENT_70	[p5l1176t2936r1240b2997],
10	two	CD	NUMBER	two	num	13	SENT_70	[p5l1272t2945r1398b2998],
11	in-range	JJ	O	in-range	amod	13	SENT_70	[p5l1431t2936r1711b3014],
12	INR	NNP	ORGANIZATION	INR	nn	13	SENT_70	[p5l1745t2939r1905b2997],
13	Values	NNS	ORGANIZATION	value	prep_in	8	SENT_70	[p5l1935t2936r2145b2998],
14	following	VBG	DATE	follow	_	0	SENT_70	[p5l8t3042r328b3120],
15	a	DT	DATE	a	det	16	SENT_70	[p5l345t3062r382b3103],
16	week	NN	DATE	week	prep_following	13	SENT_70	[p5l397t3042r571b3103],
17	of	IN	O	of	_	0	SENT_70	[p5l589t3042r664b3103],
18	steady	JJ	O	steady	amod	20	SENT_70	[p5l674t3042r888b3120],
19	dose	NN	O	dose	nn	20	SENT_70	[p5l904t3042r1056b3103],
20	regimen	NN	O	regimen	prep_of	16	SENT_70	[p5l1073t3042r1361b3120],
21	.	.	O	.	_	0	SENT_70	[p5l1073t3042r1361b3120],

1	To	TO	O	to	aux	2	SENT_71	[p5l1382t3044r1478b3103],
2	get	VB	O	get	purpcl	17	SENT_71	[p5l1497t3051r1597b3120],
3	a	DT	O	a	det	6	SENT_71	[p5l1614t3062r1652b3103],
4	more	RBR	O	more	advmod	5	SENT_71	[p5l1666t3062r1844b3103],
5	accurate	JJ	O	accurate	amod	6	SENT_71	[p5l1861t3050r2145b3103],
6	estimate	NN	O	estimate	dobj	2	SENT_71	[p5l8t3149r287b3210],
7	of	IN	O	of	_	0	SENT_71	[p5l334t3149r410b3210],
8	the	DT	O	the	det	11	SENT_71	[p5l446t3149r550b3210],
9	ﬁnal	JJ	O	ﬁnal	amod	11	SENT_71	[p5l594t3149r744b3210],
10	therapeutic	JJ	O	therapeutic	amod	11	SENT_71	[p5l788t3149r1169b3227],
11	dose	NN	O	dose	prep_of	6	SENT_71	[p5l1214t3149r1366b3210],
12	for	IN	O	for	_	0	SENT_71	[p5l1411t3149r1511b3210],
13	each	DT	O	each	det	14	SENT_71	[p5l1555t3149r1709b3210],
14	patient	NN	O	patient	prep_for	11	SENT_71	[p5l1752t3149r2006b3227],
15	,	,	O	,	_	0	SENT_71	[p5l1752t3149r2006b3227],
16	we	PRP	O	we	nsubj	31	SENT_71	[p5l2053t3169r2145b3210],
17	excluded	VBD	O	exclude	_	0	SENT_71	[p5l8t3254r306b3316],
18	285	CD	NUMBER	285	num	19	SENT_71	[p5l334t3256r451b3316],
19	patients	NNS	O	patient	dobj	17	SENT_71	[p5l479t3254r746b3332],
20	from	IN	O	from	_	0	SENT_71	[p5l775t3254r942b3316],
21	our	PRP$	O	we	poss	23	SENT_71	[p5l971t3274r1089b3316],
22	primary	JJ	O	primary	amod	23	SENT_71	[p5l1114t3254r1389b3332],
23	analysis	NN	O	analysis	prep_from	17	SENT_71	[p5l1417t3254r1681b3332],
24	because	IN	O	because	mark	27	SENT_71	[p5l1710t3254r1973b3316],
25	they	PRP	O	they	nsubjpass	27	SENT_71	[p5l2001t3254r2146b3332],
26	were	VBD	O	be	auxpass	27	SENT_71	[p5l7t3380r165b3422],
27	randomized	VBN	O	randomize	advcl	17	SENT_71	[p5l190t3360r595b3422],
28	to	TO	O	to	_	0	SENT_71	[p5l620t3369r686b3422],
29	placebo	NN	O	placebo	prep_to	27	SENT_71	[p5l711t3360r974b3438],
30	or	CC	O	or	_	0	SENT_71	[p5l1000t3380r1073b3422],
31	failed	VBD	O	fail	conj_or	17	SENT_71	[p5l1096t3360r1282b3422],
32	to	TO	O	to	aux	34	SENT_71	[p5l1306t3369r1373b3422],
33	become	VB	O	become	cop	34	SENT_71	[p5l1398t3360r1658b3422],
34	therapeutic	JJ	O	therapeutic	xcomp	31	SENT_71	[p5l1682t3360r2079b3438],
35	.	.	O	.	_	0	SENT_71	[p5l1682t3360r2079b3438],

1	Statistical	JJ	O	statistical	amod	2	SENT_72	[p5l6t3599r341b3660],
2	analyses	NNS	O	analysis	_	0	SENT_72	[p5l368t3599r657b3677],

1	In	IN	O	in	_	0	SENT_73	[p6l8t50r81b108],
2	the	DT	O	the	det	4	SENT_73	[p6l112t47r216b109],
3	primary	JJ	O	primary	amod	4	SENT_73	[p6l246t47r520b125],
4	analysis	NN	O	analysis	prep_in	7	SENT_73	[p6l552t47r834b125],
5	,	,	O	,	_	0	SENT_73	[p6l552t47r834b125],
6	we	PRP	O	we	nsubj	7	SENT_73	[p6l867t67r960b109],
7	used	VBD	O	use	_	0	SENT_73	[p6l991t47r1144b109],
8	multiple	JJ	O	multiple	amod	10	SENT_73	[p6l1173t47r1453b125],
9	linear	JJ	O	linear	amod	10	SENT_73	[p6l1484t47r1676b109],
10	regression	NN	O	regression	dobj	7	SENT_73	[p6l1706t47r2047b125],
11	to	TO	O	to	aux	12	SENT_73	[p6l2077t56r2144b109],
12	test	VB	O	test	xcomp	7	SENT_73	[p6l8t161r124b214],
13	the	DT	O	the	det	14	SENT_73	[p6l144t153r247b214],
14	effect	NN	O	effect	dobj	12	SENT_73	[p6l267t153r448b214],
15	of	IN	O	of	_	0	SENT_73	[p6l469t153r545b214],
16	the	DT	O	the	det	20	SENT_73	[p6l556t153r659b214],
17	genetic	JJ	O	genetic	amod	20	SENT_73	[p6l679t153r914b231],
18	and	CC	O	and	_	0	SENT_73	[p6l934t153r1061b214],
19	clinical	JJ	O	clinical	amod	20	SENT_73	[p6l1079t153r1316b214],
20	factors	NNS	O	factor	prep_of	14	SENT_73	[p6l1336t153r1566b214],
21	on	IN	O	on	_	0	SENT_73	[p6l1587t173r1674b214],
22	percentage	NN	O	percentage	prep_on	12	SENT_73	[p6l1692t161r2057b231],
23	of	IN	O	of	_	0	SENT_73	[p6l2079t153r2154b214],
24	variability	NN	O	variability	prep_of	22	SENT_73	[p6l7t260r352b338],
25	in	IN	O	in	_	0	SENT_73	[p6l383t260r448b320],
26	log-transformed	JJ	O	log-transformed	amod	29	SENT_73	[p6l480t260r1031b338],
27	therapeutic	JJ	O	therapeutic	amod	29	SENT_73	[p6l1064t260r1445b338],
28	dose	NN	O	dose	nn	29	SENT_73	[p6l1477t260r1629b321],
29	values	NNS	O	value	prep_in	12	SENT_73	[p6l1662t260r1871b321],
30	at	IN	O	at	_	0	SENT_73	[p6l1905t268r1970b321],
31	four	CD	NUMBER	four	num	32	SENT_73	[p6l2001t260r2147b321],
32	times	NNS	O	time	prep_at	29	SENT_73	[p6l8t365r202b426],
33	:	:	O	:	_	0	SENT_73	[p6l8t365r202b426],
34	days	NNS	DURATION	day	dep	29	SENT_73	[p6l246t365r398b443],
35	o	NN	O	o	dep	34	SENT_73	[p6l438t367r494b439],
36	,	,	O	,	_	0	SENT_73	[p6l438t367r494b439],
37	7	CD	NUMBER	7	tmod	12	SENT_73	[p6l538t367r593b439],
38	,	,	O	,	_	0	SENT_73	[p6l538t367r593b439],
39	14	CD	NUMBER	14	num	37	SENT_73	[p6l643t366r714b426],
40	and	CC	O	and	_	0	SENT_73	[p6l753t365r880b426],
41	21	CD	NUMBER	21	conj_and	37	SENT_73	[p6l919t366r990b426],
42	of	IN	O	of	_	0	SENT_73	[p6l1038t365r1114b426],
43	therapy	NN	O	therapy	prep_of	7	SENT_73	[p6l1145t365r1420b443],
44	.	.	O	.	_	0	SENT_73	[p6l1145t365r1420b443],

1	We	PRP	O	we	nsubj	2	SENT_74	[p6l1462t367r1578b426],
2	used	VBD	O	use	_	0	SENT_74	[p6l1616t365r1770b426],
3	backward	RB	O	backward	advmod	4	SENT_74	[p6l1809t365r2145b426],
4	selection	NN	O	selection	dobj	2	SENT_74	[p6l10t472r299b534],
5	to	TO	O	to	aux	6	SENT_74	[p6l332t481r398b534],
6	select	VB	O	select	dep	4	SENT_74	[p6l435t472r614b534],
7	the	DT	O	the	det	9	SENT_74	[p6l647t472r750b534],
8	predictor	NN	O	predictor	nn	9	SENT_74	[p6l782t471r1094b551],
9	variables	NNS	O	variable	dobj	6	SENT_74	[p6l1125t471r1426b534],
10	and	CC	O	and	_	0	SENT_74	[p6l1461t471r1588b534],
11	to	TO	O	to	aux	12	SENT_74	[p6l1622t481r1688b534],
12	quantify	VB	O	quantify	dep	4	SENT_74	[p6l1724t472r2009b550],
13	the	DT	O	the	det	16	SENT_74	[p6l2042t471r2145b534],
14	corresponding	JJ	O	corresponding	amod	16	SENT_74	[p6l7t578r497b657],
15	partial	JJ	O	partial	amod	16	SENT_74	[p6l527t579r749b657],
16	R2	NN	O	r2	dobj	12	SENT_74	[p6l783t562r888b641],
17	.	.	O	.	_	0	SENT_74	[p6l783t562r888b641],

1	For	IN	O	for	_	0	SENT_75	[p6l926t581r1053b641],
2	this	DT	O	this	det	3	SENT_75	[p6l1084t578r1203b641],
3	analysis	NN	O	analysis	prep_for	6	SENT_75	[p6l1237t579r1520b657],
4	,	,	O	,	_	0	SENT_75	[p6l1237t579r1520b657],
5	we	PRP	O	we	nsubj	6	SENT_75	[p6l1553t599r1646b641],
6	included	VBD	O	include	dep	61	SENT_75	[p6l1677t578r1966b641],
7	only	RB	O	only	advmod	9	SENT_75	[p6l1999t579r2147b657],
8	those	DT	O	those	det	9	SENT_75	[p6l8t685r187b746],
9	participants	NNS	O	participant	dobj	6	SENT_75	[p6l237t685r640b763],
10	who	WP	O	who	nsubjpass	12	SENT_75	[p6l691t685r837b746],
11	were	VBD	O	be	auxpass	12	SENT_75	[p6l889t705r1047b746],
12	randomized	VBN	O	randomize	rcmod	9	SENT_75	[p6l1099t685r1505b746],
13	to	TO	O	to	_	0	SENT_75	[p6l1557t693r1624b746],
14	warfarin	NN	O	warfarin	prep_to	12	SENT_75	[p6l1675t685r1967b746],
15	and	CC	O	and	_	0	SENT_75	[p6l2019t685r2146b746],
16	achieved	VBD	O	achieve	conj_and	6	SENT_75	[p6l9t791r302b854],
17	a	DT	O	a	det	22	SENT_75	[p6l350t812r388b854],
18	stable	JJ	O	stable	amod	22	SENT_75	[p6l436t791r630b854],
19	therapeutic	JJ	O	therapeutic	amod	22	SENT_75	[p6l678t792r1059b871],
20	INR	NN	O	inr	nn	22	SENT_75	[p6l1106t794r1266b853],
21	(	NN	O	(	nn	22	SENT_75	[p6l1314t792r1377b871],
22	n	NN	O	n	nsubj	43	SENT_75	[p6l1314t792r1377b871],
23	=	JJ	O	=	dep	43	SENT_75	[p6l1422t815r1473b832],
24	223	CD	NUMBER	223	num	25	SENT_75	[p6l1518t792r1681b871],
25	)	NN	O	)	dep	29	SENT_75	[p6l1518t792r1681b871],
26	;	:	O	;	_	0	SENT_75	[p6l1518t792r1681b871],
27	others	NNS	O	other	nsubjpass	29	SENT_75	[p6l1733t791r1940b854],
28	were	VBD	O	be	auxpass	29	SENT_75	[p6l1987t812r2145b854],
29	excluded	VBN	O	exclude	ccomp	43	SENT_75	[p6l8t898r306b961],
30	because	IN	O	because	mark	32	SENT_75	[p6l336t898r598b961],
31	they	PRP	O	they	nsubj	32	SENT_75	[p6l629t898r774b977],
32	lacked	VBD	O	lack	advcl	29	SENT_75	[p6l803t898r1021b961],
33	long-term	JJ	O	long-term	amod	34	SENT_75	[p6l1051t898r1385b977],
34	follow-up	NN	O	follow-up	nn	39	SENT_75	[p6l1415t898r1743b977],
35	(	CD	NUMBER	(	num	36	SENT_75	[p6l1776t899r1838b978],
36	rt	NN	O	rt	dep	34	SENT_75	[p6l1776t899r1838b978],
37	=	JJ	O	=	amod	39	SENT_75	[p6l1884t922r1935b939],
38	261	CD	NUMBER	261	tmod	37	SENT_75	[p6l1981t899r2143b977],
39	)	NN	O	)	dobj	32	SENT_75	[p6l1981t899r2143b977],
40	,	,	O	,	_	0	SENT_75	[p6l1981t899r2143b977],
41	did	VBD	O	do	aux	43	SENT_75	[p6l8t1005r116b1066],
42	not	RB	O	not	neg	43	SENT_75	[p6l153t1014r268b1066],
43	achieve	VB	O	achieve	xcomp	16	SENT_75	[p6l306t1005r553b1066],
44	a	DT	O	a	det	49	SENT_75	[p6l592t1025r630b1066],
45	stable	JJ	O	stable	amod	49	SENT_75	[p6l669t1005r863b1066],
46	therapeutic	JJ	O	therapeutic	amod	49	SENT_75	[p6l900t1005r1282b1083],
47	dose	NN	O	dose	nn	49	SENT_75	[p6l1319t1005r1471b1066],
48	(	NN	O	(	nn	49	SENT_75	[p6l1511t1005r1573b1083],
49	n	NN	O	n	nsubj	50	SENT_75	[p6l1511t1005r1573b1083],
50	=	JJ	O	=	xcomp	43	SENT_75	[p6l1619t1028r1669b1046],
51	11	CD	NUMBER	11	num	52	SENT_75	[p6l1723t1005r1837b1083],
52	)	NN	O	)	nsubj	43	SENT_75	[p6l1723t1005r1837b1083],
53	,	,	O	,	_	0	SENT_75	[p6l1723t1005r1837b1083],
54	or	CC	O	or	_	0	SENT_75	[p6l1880t1025r1952b1066],
55	were	VBD	O	be	aux	56	SENT_75	[p6l1987t1025r2145b1066],
56	missing	VBG	O	miss	dep	61	SENT_75	[p6l7t1112r262b1190],
57	clinical	JJ	O	clinical	amod	60	SENT_75	[p6l321t1112r558b1173],
58	or	CC	O	or	_	0	SENT_75	[p6l619t1132r692b1173],
59	genetic	JJ	O	genetic	conj_or	57	SENT_75	[p6l751t1112r986b1190],
60	factors	NNS	O	factor	dobj	56	SENT_75	[p6l1045t1112r1277b1173],
61	(	VBP	O	(	_	0	SENT_75	[p6l1339t1112r1401b1190],
62	n	NN	O	n	nsubj	63	SENT_75	[p6l1339t1112r1401b1190],
63	=	JJ	O	=	xcomp	61	SENT_75	[p6l1447t1135r1497b1152],
64	13	CD	NUMBER	13	num	65	SENT_75	[p6l1551t1112r1664b1190],
65	)	NN	O	)	nsubj	61	SENT_75	[p6l1551t1112r1664b1190],
66	.	.	O	.	_	0	SENT_75	[p6l1551t1112r1664b1190],

1	In	IN	O	in	_	0	SENT_76	[p6l1729t1114r1802b1172],
2	all	DT	O	all	det	5	SENT_76	[p6l1863t1112r1942b1173],
3	four	CD	NUMBER	four	num	5	SENT_76	[p6l2001t1112r2147b1173],
4	regression	NN	O	regression	nn	5	SENT_76	[p6l8t1217r349b1295],
5	models	NNS	O	model	prep_in	8	SENT_76	[p6l370t1217r631b1291],
6	,	,	O	,	_	0	SENT_76	[p6l370t1217r631b1291],
7	we	PRP	O	we	nsubj	8	SENT_76	[p6l656t1237r749b1278],
8	adjusted	VBD	O	adjust	_	0	SENT_76	[p6l773t1217r1057b1295],
9	for	IN	O	for	_	0	SENT_76	[p6l1080t1217r1180b1278],
10	clinical	JJ	O	clinical	amod	11	SENT_76	[p6l1202t1217r1439b1278],
11	factors	NNS	O	factor	prep_for	8	SENT_76	[p6l1462t1217r1711b1291],
12	,	,	O	,	_	0	SENT_76	[p6l1462t1217r1711b1291],
13	and	CC	O	and	_	0	SENT_76	[p6l1739t1217r1865b1278],
14	starting	VBG	O	start	csubj	21	SENT_76	[p6l1890t1217r2147b1295],
15	at	IN	O	at	_	0	SENT_76	[p6l9t1333r73b1386],
16	day	NN	DURATION	day	prep_at	14	SENT_76	[p6l93t1323r217b1402],
17	7	CD	NUMBER	7	num	16	SENT_76	[p6l238t1326r292b1399],
18	,	,	O	,	_	0	SENT_76	[p6l238t1326r292b1399],
19	we	PRP	O	we	appos	16	SENT_76	[p6l315t1344r408b1386],
20	also	RB	O	also	advmod	21	SENT_76	[p6l430t1324r562b1386],
21	adjusted	VBN	O	adjust	conj_and	8	SENT_76	[p6l585t1323r869b1403],
22	for	IN	O	for	_	0	SENT_76	[p6l890t1324r990b1386],
23	the	DT	DATE	the	det	25	SENT_76	[p6l1010t1323r1113b1386],
24	prior	JJ	DATE	prior	amod	25	SENT_76	[p6l1133t1324r1305b1403],
25	week	NN	DATE	week	poss	28	SENT_76	[p6l1323t1323r1543b1386],
26	’s	POS	O	’s	_	0	SENT_76	[p6l1323t1323r1543b1386],
27	average	NN	O	average	nn	28	SENT_76	[p6l1565t1344r1824b1403],
28	dose	NN	O	dose	prep_for	21	SENT_76	[p6l1845t1323r1997b1386],
29	and	CC	O	and	_	0	SENT_76	[p6l2019t1323r2146b1386],
30	most	RBS	O	most	advmod	31	SENT_76	[p6l7t1439r176b1492],
31	recent	JJ	O	recent	amod	33	SENT_76	[p6l205t1439r410b1492],
32	INR	NN	O	inr	nn	33	SENT_76	[p6l440t1433r600b1491],
33	value	NN	O	value	conj_and	28	SENT_76	[p6l628t1430r825b1492],
34	.	.	O	.	_	0	SENT_76	[p6l628t1430r825b1492],

1	We	PRP	O	we	nsubj	3	SENT_77	[p6l857t1433r974b1492],
2	then	RB	O	then	advmod	3	SENT_77	[p6l1005t1430r1153b1492],
3	repeated	VBD	O	repeat	_	0	SENT_77	[p6l1183t1430r1472b1508],
4	the	DT	O	the	det	5	SENT_77	[p6l1503t1430r1607b1492],
5	analysis	NN	O	analysis	nsubj	8	SENT_77	[p6l1638t1430r1903b1508],
6	in	IN	O	in	_	0	SENT_77	[p6l1933t1430r1997b1491],
7	250	CD	NUMBER	250	prep_in	5	SENT_77	[p6l2028t1432r2145b1492],
8	bootstrapped	VBD	O	bootstrapp	ccomp	3	SENT_77	[p6l8t1536r462b1614],
9	samples	NNS	O	sample	dobj	8	SENT_77	[p6l486t1536r751b1614],
10	to	TO	O	to	aux	11	SENT_77	[p6l774t1545r841b1597],
11	obtain	VB	O	obtain	xcomp	8	SENT_77	[p6l866t1536r1084b1597],
12	the	DT	O	the	det	14	SENT_77	[p6l1106t1536r1209b1597],
13	standard	JJ	O	standard	amod	14	SENT_77	[p6l1233t1536r1532b1597],
14	deviations	NNS	O	deviation	dobj	11	SENT_77	[p6l1554t1536r1898b1597],
15	for	IN	O	for	_	0	SENT_77	[p6l1920t1536r2021b1597],
16	the	DT	O	the	det	18	SENT_77	[p6l2042t1536r2146b1597],
17	R2	NN	O	r2	nn	18	SENT_77	[p6l10t1627r99b1703],
18	values	NNS	O	value	prep_for	14	SENT_77	[p6l125t1643r352b1704],
19	.	.	O	.	_	0	SENT_77	[p6l125t1643r352b1704],

1	In	IN	O	in	_	0	SENT_78	[p6l93t1751r166b1809],
2	the	DT	O	the	det	4	SENT_78	[p6l220t1748r323b1810],
3	secondary	JJ	O	secondary	amod	4	SENT_78	[p6l380t1748r722b1826],
4	analyses	NNS	O	analysis	prep_in	7	SENT_78	[p6l776t1748r1073b1826],
5	,	,	O	,	_	0	SENT_78	[p6l776t1748r1073b1826],
6	we	PRP	O	we	nsubj	7	SENT_78	[p6l1129t1768r1222b1810],
7	used	VBD	O	use	_	0	SENT_78	[p6l1276t1748r1429b1810],
8	logistic	JJ	O	logistic	amod	11	SENT_78	[p6l1483t1748r1721b1826],
9	and	CC	O	and	_	0	SENT_78	[p6l1775t1748r1902b1810],
10	linear	JJ	O	linear	amod	11	SENT_78	[p6l1956t1748r2147b1810],
11	regression	NN	O	regression	dobj	7	SENT_78	[p6l8t1854r349b1932],
12	to	TO	O	to	aux	13	SENT_78	[p6l380t1862r447b1915],
13	determine	VB	O	determine	xcomp	7	SENT_78	[p6l481t1854r818b1915],
14	the	DT	O	the	det	15	SENT_78	[p6l851t1854r953b1915],
15	association	NN	O	association	dobj	13	SENT_78	[p6l987t1854r1362b1915],
16	between	IN	O	between	_	0	SENT_78	[p6l1394t1854r1671b1916],
17	VKORCI	NNP	O	VKORCI	nn	19	SENT_78	[p6l1701t1855r2044b1916],
18	A	NNP	O	A	nn	19	SENT_78	[p6l2083t1854r2146b1914],
19	haplotype	NN	O	haplotype	prep_between	15	SENT_78	[p6l8t1961r347b2039],
20	(	CD	NUMBER	(	num	21	SENT_78	[p6l372t1961r606b2039],
21	-1639	CD	NUMBER	-1639	xcomp	13	SENT_78	[p6l372t1961r606b2039],
22	A	DT	O	a	det	24	SENT_78	[p6l630t1961r693b2021],
23	genotype	NN	O	genotype	nn	24	SENT_78	[p6l716t1961r1068b2039],
24	)	NN	O	)	npadvmod	21	SENT_78	[p6l716t1961r1068b2039],
25	,	,	O	,	_	0	SENT_78	[p6l716t1961r1068b2039],
26	CYPC29	NN	O	cypc29	nn	27	SENT_78	[p6l1096t1962r1402b2022],
27	genotype	NN	O	genotype	npadvmod	21	SENT_78	[p6l1427t1969r1735b2039],
28	and	CC	O	and	_	0	SENT_78	[p6l1760t1961r1886b2022],
29	clinical	JJ	O	clinical	amod	30	SENT_78	[p6l1910t1961r2146b2022],
30	variables	NNS	O	variable	npadvmod	21	SENT_78	[p6l7t2066r308b2127],
31	with	IN	O	with	_	0	SENT_78	[p6l334t2066r485b2127],
32	time	NN	O	time	prep_with	21	SENT_78	[p6l510t2066r658b2127],
33	above	IN	O	above	advmod	32	SENT_78	[p6l685t2066r887b2127],
34	and	CC	O	and	cc	21	SENT_78	[p6l914t2066r1041b2127],
35	then	RB	O	then	advmod	21	SENT_78	[p6l1068t2066r1217b2127],
36	with	IN	O	with	dep	21	SENT_78	[p6l1241t2066r1391b2128],
37	time	NN	O	time	pobj	36	SENT_78	[p6l1417t2066r1564b2127],
38	below	IN	O	below	_	0	SENT_78	[p6l1591t2066r1794b2127],
39	the	DT	O	the	det	42	SENT_78	[p6l1820t2066r1923b2127],
40	target	NN	O	target	nn	42	SENT_78	[p6l1950t2075r2147b2144],
41	INR	NN	O	inr	nn	42	SENT_78	[p6l9t2175r168b2234],
42	range	NN	O	range	prep_below	13	SENT_78	[p6l203t2193r392b2252],
43	(	CD	NUMBER	(	num	45	SENT_78	[p6l429t2173r737b2252],
44	15-20	CD	NUMBER	15-20	num	45	SENT_78	[p6l429t2173r737b2252],
45	)	NN	O	)	dobj	13	SENT_78	[p6l429t2173r737b2252],
46	.	.	O	.	_	0	SENT_78	[p6l429t2173r737b2252],

1	For	IN	O	for	_	0	SENT_79	[p6l779t2175r906b2235],
2	these	DT	O	these	det	3	SENT_79	[p6l942t2172r1110b2235],
3	analyses	NNS	O	analysis	prep_for	6	SENT_79	[p6l1148t2173r1445b2251],
4	,	,	O	,	_	0	SENT_79	[p6l1148t2173r1445b2251],
5	we	PRP	O	we	nsubj	6	SENT_79	[p6l1483t2193r1576b2235],
6	used	VBD	O	use	_	0	SENT_79	[p6l1611t2172r1765b2235],
7	INR	NNP	O	INR	nn	8	SENT_79	[p6l1801t2175r1961b2234],
8	data	NNS	O	datum	dobj	6	SENT_79	[p6l1997t2172r2146b2235],
9	from	IN	O	from	_	0	SENT_79	[p6l8t2279r176b2341],
10	all	DT	O	all	det	11	SENT_79	[p6l225t2279r304b2341],
11	participants	NNS	O	participant	prep_from	6	SENT_79	[p6l352t2279r755b2357],
12	during	IN	O	during	_	0	SENT_79	[p6l805t2279r1029b2357],
13	the	DT	O	the	det	16	SENT_79	[p6l1078t2279r1181b2341],
14	28-day	JJ	DURATION	28-day	amod	16	SENT_79	[p6l1231t2279r1461b2357],
15	run-in	NN	O	run-in	nn	16	SENT_79	[p6l1510t2279r1719b2341],
16	phase	NN	O	phase	prep_during	6	SENT_79	[p6l1767t2279r1977b2357],
17	.	.	O	.	_	0	SENT_79	[p6l1767t2279r1977b2357],

1	We	PRP	O	we	nsubj	2	SENT_80	[p6l2029t2282r2146b2341],
2	calculated	VBD	O	calculate	_	0	SENT_80	[p6l8t2385r348b2446],
3	percentage	NN	O	percentage	nn	4	SENT_80	[p6l370t2393r735b2463],
4	time	NN	O	time	dobj	2	SENT_80	[p6l759t2385r906b2446],
5	each	DT	O	each	det	6	SENT_80	[p6l930t2385r1084b2446],
6	patient	NN	O	patient	nsubj	7	SENT_80	[p6l1105t2385r1342b2463],
7	spent	VBD	O	spend	rcmod	4	SENT_80	[p6l1367t2394r1545b2463],
8	above	IN	O	above	prep	7	SENT_80	[p6l1568t2385r1769b2446],
9	and	CC	O	and	_	0	SENT_80	[p6l1794t2385r1921b2446],
10	below	IN	O	below	conj_and	8	SENT_80	[p6l1944t2385r2147b2446],
11	therapeutic	JJ	O	therapeutic	amod	13	SENT_80	[p6l8t2492r389b2570],
12	INR	NN	O	inr	nn	13	SENT_80	[p6l430t2494r590b2553],
13	range	NN	O	range	nsubj	19	SENT_80	[p6l629t2512r818b2570],
14	between	IN	O	between	_	0	SENT_80	[p6l859t2492r1136b2553],
15	days	NNS	DURATION	day	prep_between	13	SENT_80	[p6l1176t2492r1329b2570],
16	7	CD	NUMBER	7	num	15	SENT_80	[p6l1372t2494r1407b2553],
17	and	CC	O	and	_	0	SENT_80	[p6l1450t2492r1577b2553],
18	28	CD	NUMBER	28	prep_between	13	SENT_80	[p6l1617t2493r1693b2553],
19	using	VBG	O	use	pcomp	10	SENT_80	[p6l1736t2492r1916b2570],
20	linear	JJ	O	linear	amod	21	SENT_80	[p6l1956t2492r2147b2553],
21	interpolation	NN	O	interpolation	dobj	19	SENT_80	[p6l7t2597r450b2675],
22	[	CD	NUMBER	[	number	23	SENT_80	[p6l483t2599r617b2675],
23	19	CD	NUMBER	19	num	24	SENT_80	[p6l483t2599r617b2675],
24	]	NN	O	]	dobj	7	SENT_80	[p6l483t2599r617b2675],
25	.	.	O	.	_	0	SENT_80	[p6l483t2599r617b2675],

1	The	DT	O	the	det	2	SENT_81	[p6l652t2597r784b2659],
2	percentage	NN	O	percentage	nsubjpass	11	SENT_81	[p6l813t2606r1179b2675],
3	of	IN	O	of	_	0	SENT_81	[p6l1211t2597r1287b2659],
4	subtherapeutic	JJ	O	subtherapeutic	amod	5	SENT_81	[p6l1311t2597r1810b2675],
5	time	NN	O	time	prep_of	2	SENT_81	[p6l1840t2597r1987b2659],
6	was	VBD	O	be	auxpass	8	SENT_81	[p6l2017t2617r2145b2659],
7	normally	RB	O	normally	advmod	8	SENT_81	[p6l8t2703r316b2781],
8	distributed	VBN	O	distribute	_	0	SENT_81	[p6l342t2703r708b2764],
9	and	CC	O	and	_	0	SENT_81	[p6l736t2703r863b2764],
10	was	VBD	O	be	auxpass	11	SENT_81	[p6l888t2723r1016b2764],
11	modeled	VBN	O	model	conj_and	8	SENT_81	[p6l1041t2703r1334b2764],
12	by	IN	O	by	_	0	SENT_81	[p6l1359t2703r1443b2781],
13	linear	JJ	O	linear	amod	14	SENT_81	[p6l1468t2703r1660b2764],
14	regression	NN	O	regression	agent	11	SENT_81	[p6l1685t2703r2041b2781],
15	.	.	O	.	_	0	SENT_81	[p6l1685t2703r2041b2781],

1	In	IN	O	in	_	0	SENT_82	[p6l2073t2705r2146b2764],
2	contrast	NN	O	contrast	pobj	1	SENT_82	[p6l8t2818r302b2884],
3	,	,	O	,	_	0	SENT_82	[p6l8t2818r302b2884],
4	because	IN	O	because	mark	7	SENT_82	[p6l342t2810r605b2871],
5	most	JJS	O	most	amod	6	SENT_82	[p6l641t2818r810b2871],
6	patients	NNS	O	patient	nsubj	7	SENT_82	[p6l846t2810r1112b2888],
7	were	VBD	O	be	dep	2	SENT_82	[p6l1149t2830r1308b2871],
8	never	RB	O	never	neg	7	SENT_82	[p6l1345t2830r1530b2871],
9	above	IN	O	above	_	0	SENT_82	[p6l1568t2810r1769b2871],
10	the	DT	O	the	det	11	SENT_82	[p6l1808t2810r1910b2871],
11	target	NN	O	target	prep_above	7	SENT_82	[p6l1949t2818r2146b2888],

1	©	RB	O	©	dep	2	SENT_83	[p6l224t3036r274b3086],
2	2009	CD	DATE	2009	dep	4	SENT_83	[p6l303t3035r440b3086],
3	International	NNP	MISC	International	nn	4	SENT_83	[p6l469t3034r866b3086],
4	Society	NNP	MISC	Society	_	0	SENT_83	[p6l895t3034r1110b3099],
5	on	IN	MISC	on	_	0	SENT_83	[p6l1137t3051r1212b3086],
6	Thrombosis	NNP	MISC	Thrombosis	prep_on	4	SENT_83	[p6l1239t3033r1599b3086],
7	and	CC	O	and	_	0	SENT_83	[p6l1628t3033r1739b3086],
8	Haemostasis	NNP	PERSON	Haemostasis	prep_on	4	SENT_83	[p6l1766t3033r2146b3086],

1	Ability	NN	O	ability	_	0	SENT_84	[p6l493t3174r599b3209],
2	of	IN	O	of	_	0	SENT_84	[p6l613t3174r649b3209],
3	VKORCI	NN	O	vkorcus	prep_of	1	SENT_84	[p6l661t3175r808b3202],
4	and	CC	O	and	_	0	SENT_84	[p6l824t3174r882b3202],
5	CYPZC9	NN	O	cypzc9	prep_of	1	SENT_84	[p6l894t3175r1034b3202],
6	to	TO	O	to	aux	7	SENT_84	[p6l1049t3179r1077b3202],
7	predict	VB	O	predict	infmod	1	SENT_84	[p6l1087t3174r1197b3209],
8	therapeutic	JJ	O	therapeutic	amod	10	SENT_84	[p6l1212t3174r1382b3209],
9	warfarin	NN	O	warfarin	nn	10	SENT_84	[p6l1398t3174r1527b3209],
10	dose	NN	O	dose	dobj	7	SENT_84	[p6l1541t3174r1608b3202],
11	97	CD	NUMBER	97	tmod	7	SENT_84	[p6l1628t3174r1667b3202],

1	INR	NN	O	inr	nn	2	SENT_85	[p6l8t3347r168b3405],
2	range	NN	O	range	nsubjpass	14	SENT_85	[p6l223t3364r412b3422],
3	(	CD	NUMBER	(	num	4	SENT_85	[p6l470t3344r1143b3422],
4	‘	NN	O	‘	dep	2	SENT_85	[p6l470t3344r1143b3422],
5	supratherapeutic	JJ	O	supratherapeutic	amod	7	SENT_85	[p6l470t3344r1143b3422],
6	’	NN	O	’	nn	7	SENT_85	[p6l470t3344r1143b3422],
7	)	NN	O	)	dep	2	SENT_85	[p6l470t3344r1143b3422],
8	,	,	O	,	_	0	SENT_85	[p6l470t3344r1143b3422],
9	that	WDT	O	that	dep	10	SENT_85	[p6l1203t3344r1338b3406],
10	distribution	NN	O	distribution	appos	7	SENT_85	[p6l1395t3344r1791b3406],
11	was	VBD	O	be	auxpass	14	SENT_85	[p6l1846t3364r1974b3406],
12	not	RB	O	not	neg	14	SENT_85	[p6l2031t3353r2146b3406],
13	normally	RB	O	normally	advmod	14	SENT_85	[p6l7t3450r316b3528],
14	distributed	VBN	O	distribute	_	0	SENT_85	[p6l348t3450r730b3511],
15	.	.	O	.	_	0	SENT_85	[p6l348t3450r730b3511],

1	We	PRP	O	we	nsubj	3	SENT_86	[p6l765t3452r881b3512],
2	therefore	RB	O	therefore	advmod	3	SENT_86	[p6l914t3450r1219b3511],
3	modeled	VBD	O	model	_	0	SENT_86	[p6l1250t3450r1542b3511],
4	supratherapeutic	JJ	O	supratherapeutic	amod	5	SENT_86	[p6l1575t3450r2146b3528],
5	time	NN	O	time	dobj	3	SENT_86	[p6l7t3557r155b3618],
6	separately	RB	O	separately	advmod	3	SENT_86	[p6l204t3557r562b3635],
7	,	,	O	,	_	0	SENT_86	[p6l204t3557r562b3635],
8	using	VBG	O	use	xcomp	3	SENT_86	[p6l612t3557r792b3635],
9	a	DT	O	a	det	11	SENT_86	[p6l840t3577r878b3618],
10	two-staged	JJ	O	two-staged	amod	11	SENT_86	[p6l926t3557r1296b3635],
11	approach	NN	O	approach	dobj	8	SENT_86	[p6l1345t3557r1682b3635],
12	:	:	O	:	_	0	SENT_86	[p6l1345t3557r1682b3635],
13	(	CD	NUMBER	(	tmod	17	SENT_86	[p6l1737t3557r1805b3635],
14	i	FW	O	i	nn	15	SENT_86	[p6l1737t3557r1805b3635],
15	)	FW	O	)	dep	13	SENT_86	[p6l1737t3557r1805b3635],
16	we	PRP	O	we	nsubj	17	SENT_86	[p6l1853t3577r1945b3618],
17	used	VBD	O	use	conj_and	3	SENT_86	[p6l1992t3557r2146b3618],
18	logistic	JJ	O	logistic	amod	19	SENT_86	[p6l7t3662r245b3740],
19	regression	NN	O	regression	dobj	17	SENT_86	[p6l280t3662r622b3740],
20	to	TO	O	to	aux	21	SENT_86	[p6l658t3671r725b3724],
21	compare	VB	O	compare	xcomp	17	SENT_86	[p6l762t3682r1059b3740],
22	subjects	NNS	O	subject	dobj	21	SENT_86	[p6l1097t3662r1359b3740],
23	who	WP	O	who	nsubj	28	SENT_86	[p6l1395t3662r1541b3724],
24	did	VBD	O	do	rcmod	22	SENT_86	[p6l1579t3662r1687b3724],
25	and	CC	O	and	_	0	SENT_86	[p6l1725t3662r1851b3724],
26	did	VBD	O	do	aux	28	SENT_86	[p6l1887t3662r1995b3724],
27	not	RB	O	not	neg	28	SENT_86	[p6l2031t3671r2146b3724],
28	have	VB	O	have	rcmod	22	SENT_86	[p7l7t21r165b83],
29	INR	NN	O	inr	nn	30	SENT_86	[p7l194t24r354b82],
30	values	NNS	O	value	dobj	28	SENT_86	[p7l380t21r590b83],
31	above	IN	O	above	_	0	SENT_86	[p7l620t21r822b83],
32	2.0	CD	NUMBER	2.0	prep_above	30	SENT_86	[p7l850t23r967b96],
33	;	:	O	;	_	0	SENT_86	[p7l850t23r967b96],
34	and	CC	O	and	_	0	SENT_86	[p7l999t21r1125b83],
35	(	CD	NUMBER	(	number	37	SENT_86	[p7l1155t21r1244b99],
36	ii	LS	O	ii	dep	37	SENT_86	[p7l1155t21r1244b99],
37	)	CD	NUMBER	)	nsubj	58	SENT_86	[p7l1155t21r1244b99],
38	in	IN	O	in	_	0	SENT_86	[p7l1273t21r1337b82],
39	a	DT	O	a	det	41	SENT_86	[p7l1366t41r1404b83],
40	subgroup	NN	O	subgroup	nn	41	SENT_86	[p7l1433t21r1753b99],
41	analysis	NN	O	analysis	prep_in	37	SENT_86	[p7l1783t21r2048b99],
42	of	IN	O	of	_	0	SENT_86	[p7l2078t21r2154b83],
43	subjects	NNS	O	subject	prep_of	41	SENT_86	[p7l9t128r272b206],
44	who	WP	O	who	nsubj	45	SENT_86	[p7l317t128r463b189],
45	had	VBD	O	have	rcmod	43	SENT_86	[p7l510t128r637b189],
46	at	IN	O	at	quantmod	48	SENT_86	[p7l684t136r749b189],
47	least	JJS	O	least	mwe	46	SENT_86	[p7l793t128r945b189],
48	one	CD	NUMBER	one	num	51	SENT_86	[p7l992t148r1112b189],
49	above-range	JJ	O	above-range	amod	51	SENT_86	[p7l1159t128r1578b206],
50	INR	NN	O	inr	nn	51	SENT_86	[p7l1624t130r1784b189],
51	value	NN	O	value	dobj	45	SENT_86	[p7l1827t128r2007b189],
52	we	PRP	O	we	nsubj	53	SENT_86	[p7l2052t148r2144b189],
53	analyzed	VBD	O	analyze	rcmod	51	SENT_86	[p7l8t233r306b312],
54	factors	NNS	O	factor	dobj	53	SENT_86	[p7l332t234r563b296],
55	affecting	VBG	O	affect	xcomp	53	SENT_86	[p7l590t234r881b313],
56	the	DT	O	the	det	57	SENT_86	[p7l907t234r1010b296],
57	time	NN	O	time	dobj	55	SENT_86	[p7l1036t234r1182b296],
58	spent	VBD	O	spend	conj_and	3	SENT_86	[p7l1210t243r1388b313],
59	supratherapeutic	JJ	O	supratherapeutic	acomp	58	SENT_86	[p7l1414t233r2000b313],
60	.	.	O	.	_	0	SENT_86	[p7l1414t233r2000b313],

1	We	PRP	O	we	nsubj	2	SENT_87	[p7l2029t236r2144b296],
2	used	VBD	O	use	_	0	SENT_87	[p7l6t341r160b402],
3	backward	RB	O	backward	advmod	4	SENT_87	[p7l213t341r550b402],
4	selection	NN	O	selection	dobj	2	SENT_87	[p7l606t341r894b402],
5	to	TO	O	to	aux	6	SENT_87	[p7l948t349r1014b402],
6	select	VB	O	select	infmod	4	SENT_87	[p7l1071t341r1250b402],
7	the	DT	O	the	det	9	SENT_87	[p7l1303t341r1406b402],
8	predictor	NN	O	predictor	nn	9	SENT_87	[p7l1458t341r1771b419],
9	variables	NNS	O	variable	dobj	6	SENT_87	[p7l1822t341r2140b402],
10	.	.	O	.	_	0	SENT_87	[p7l1822t341r2140b402],

1	Variables	NNS	O	variable	nsubjpass	25	SENT_88	[p7l6t446r326b508],
2	with	IN	O	with	_	0	SENT_88	[p7l353t446r503b508],
3	P-values	NN	O	p-value	prep_with	1	SENT_88	[p7l529t446r819b508],
4	<	JJR	O	<	nsubjpass	7	SENT_88	[p7l863t458r910b498],
5	0.10	CD	NUMBER	0.10	dep	4	SENT_88	[p7l958t448r1096b508],
6	were	VBD	O	be	auxpass	7	SENT_88	[p7l1123t466r1281b508],
7	retained	VBN	O	retain	rcmod	3	SENT_88	[p7l1309t446r1583b508],
8	in	IN	O	in	_	0	SENT_88	[p7l1610t446r1674b507],
9	the	DT	O	the	det	10	SENT_88	[p7l1701t446r1805b508],
10	models	NNS	O	model	prep_in	7	SENT_88	[p7l1830t446r2072b508],
11	if	IN	O	if	mark	15	SENT_88	[p7l2100t446r2154b507],
12	they	PRP	O	they	nsubj	22	SENT_88	[p7l7t552r152b630],
13	were	VBD	O	be	cop	15	SENT_88	[p7l192t572r350b613],
14	biologically	RB	O	biologically	advmod	15	SENT_88	[p7l392t552r785b630],
15	plausible	JJ	O	plausible	advcl	7	SENT_88	[p7l824t552r1144b630],
16	,	,	O	,	_	0	SENT_88	[p7l824t552r1144b630],
17	but	CC	O	but	_	0	SENT_88	[p7l1188t552r1303b613],
18	only	RB	O	only	advmod	19	SENT_88	[p7l1345t552r1493b630],
19	variables	NNS	O	variable	npadvmod	22	SENT_88	[p7l1533t552r1835b613],
20	with	IN	O	with	_	0	SENT_88	[p7l1875t552r2026b613],
21	Pvalues	NN	O	pvalue	prep_with	19	SENT_88	[p7l2067t556r2144b613, p7l6t659r216b720],
22	<	JJR	O	<	advcl	7	SENT_88	[p7l287t670r334b710],
23	0.05	CD	NUMBER	0.05	dep	15	SENT_88	[p7l381t661r519b721],
24	were	VBD	O	be	auxpass	25	SENT_88	[p7l573t679r731b720],
25	considered	VBN	O	consider	_	0	SENT_88	[p7l785t659r1149b720],
26	statistically	RB	O	statistically	advmod	27	SENT_88	[p7l1204t659r1580b737],
27	signiﬁcant	JJ	O	signiﬁcant	acomp	25	SENT_88	[p7l1635t659r1994b737],
28	.	.	O	.	_	0	SENT_88	[p7l1635t659r1994b737],

1	By	IN	O	by	_	0	SENT_89	[p7l2054t661r2146b737],
2	examining	VBG	O	examine	prepc_by	7	SENT_89	[p7l7t764r360b842],
3	residual	JJ	O	residual	amod	4	SENT_89	[p7l381t764r646b826],
4	errors	NNS	O	error	dobj	2	SENT_89	[p7l667t784r886b839],
5	,	,	O	,	_	0	SENT_89	[p7l667t784r886b839],
6	we	PRP	O	we	nsubj	7	SENT_89	[p7l909t784r1002b826],
7	conﬁrmed	VBD	O	conﬁrmed	_	0	SENT_89	[p7l1023t764r1367b826],
8	the	DT	O	the	det	9	SENT_89	[p7l1389t764r1492b826],
9	appropriateness	NN	O	appropriateness	dobj	7	SENT_89	[p7l1515t764r2054b842],
10	of	IN	O	of	_	0	SENT_89	[p7l2078t764r2154b826],
11	the	DT	O	the	det	14	SENT_89	[p7l7t870r110b932],
12	linear	JJ	O	linear	amod	14	SENT_89	[p7l136t870r327b932],
13	regression	NN	O	regression	nn	14	SENT_89	[p7l351t870r692b948],
14	models	NNS	O	model	prep_of	9	SENT_89	[p7l715t870r974b932],
15	.	.	O	.	_	0	SENT_89	[p7l715t870r974b932],

1	We	PRP	O	we	nsubj	2	SENT_90	[p7l1001t872r1118b932],
2	performed	VBD	O	perform	_	0	SENT_90	[p7l1142t870r1500b948],
3	statistical	JJ	O	statistical	amod	4	SENT_90	[p7l1526t870r1840b932],
4	analyses	NNS	O	analysis	dobj	2	SENT_90	[p7l1866t870r2144b948],
5	in	IN	O	in	_	0	SENT_90	[p7l6t977r71b1037],
6	SAS	NNP	ORGANIZATION	SAS	nn	7	SENT_90	[p7l99t995r207b1038],
7	Wersion	NNP	O	Wersion	prep_in	4	SENT_90	[p7l237t977r526b1055],
8	9.1	CD	NUMBER	9.1	num	7	SENT_90	[p7l554t978r670b1051],
9	;	:	O	;	_	0	SENT_90	[p7l554t978r670b1051],
10	SAS	NNP	ORGANIZATION	SAS	nn	19	SENT_90	[p7l703t977r849b1038],
11	Institute	NNP	ORGANIZATION	Institute	nn	19	SENT_90	[p7l879t977r1179b1051],
12	,	,	ORGANIZATION	,	_	0	SENT_90	[p7l879t977r1179b1051],
13	Inc	NNP	ORGANIZATION	Inc	appos	19	SENT_90	[p7l1210t979r1335b1051],
14	,	,	O	,	_	0	SENT_90	[p7l1210t979r1335b1051],
15	Cary	NNP	PERSON	Cary	appos	19	SENT_90	[p7l1367t978r1552b1055],
16	,	,	O	,	_	0	SENT_90	[p7l1367t978r1552b1055],
17	NC	NNP	O	NC	appos	19	SENT_90	[p7l1581t978r1724b1051],
18	,	,	O	,	_	0	SENT_90	[p7l1581t978r1724b1051],
19	USA	NNP	LOCATION	USA	dep	4	SENT_90	[p7l1755t977r1970b1055],
20	)	CD	NUMBER	)	num	19	SENT_90	[p7l1755t977r1970b1055],
21	.	.	O	.	_	0	SENT_90	[p7l1755t977r1970b1055],

1	Results	NNS	O	result	_	0	SENT_91	[p7l11t1216r271b1282],

1	After	IN	O	after	_	0	SENT_92	[p7l6t1379r187b1441],
2	excluding	VBG	O	exclude	prepc_after	14	SENT_92	[p7l229t1379r554b1457],
3	13	CD	NUMBER	13	num	4	SENT_92	[p7l605t1381r672b1441],
4	subjects	NNS	O	subject	dobj	2	SENT_92	[p7l720t1379r982b1457],
5	with	IN	O	with	_	0	SENT_92	[p7l1025t1379r1176b1441],
6	missing	VBG	O	miss	prepc_with	2	SENT_92	[p7l1217t1379r1473b1457],
7	clinical	JJ	O	clinical	amod	10	SENT_92	[p7l1514t1379r1751b1441],
8	or	CC	O	or	_	0	SENT_92	[p7l1796t1399r1868b1441],
9	genetic	JJ	O	genetic	amod	10	SENT_92	[p7l1911t1379r2146b1457],
10	information	NN	O	information	dobj	6	SENT_92	[p7l6t1485r435b1559],
11	,	,	O	,	_	0	SENT_92	[p7l6t1485r435b1559],
12	the	DT	O	the	det	13	SENT_92	[p7l473t1485r577b1546],
13	sample	NN	O	sample	nsubj	14	SENT_92	[p7l614t1485r849b1563],
14	consisted	VBD	O	consist	_	0	SENT_92	[p7l884t1485r1195b1546],
15	of	IN	O	of	_	0	SENT_92	[p7l1231t1485r1307b1546],
16	495	CD	NUMBER	495	num	17	SENT_92	[p7l1333t1486r1450b1546],
17	participants	NNS	O	participant	prep_of	14	SENT_92	[p7l1486t1485r1906b1563],
18	.	.	O	.	_	0	SENT_92	[p7l1486t1485r1906b1563],

1	Mean	NN	O	mean	nn	2	SENT_93	[p7l1946t1487r2146b1546],
2	age	NN	O	age	nsubj	6	SENT_93	[p7l8t1611r120b1670],
3	was	VBD	O	be	cop	6	SENT_93	[p7l141t1611r269b1653],
4	55	CD	NUMBER	55	num	6	SENT_93	[p7l295t1593r368b1653],
5	(	NN	O	(	nn	6	SENT_93	[p7l394t1591r607b1670],
6	range	NN	O	range	_	0	SENT_93	[p7l394t1591r607b1670],
7	30-89	CD	NUMBER	30-89	num	8	SENT_93	[p7l631t1591r873b1669],
8	)	NN	O	)	nsubj	13	SENT_93	[p7l631t1591r873b1669],
9	,	,	O	,	_	0	SENT_93	[p7l631t1591r873b1669],
10	88	CD	PERCENT	88	num	11	SENT_93	[p7l900t1592r1052b1654],
11	%	NN	PERCENT	%	appos	8	SENT_93	[p7l900t1592r1052b1654],
12	were	VBD	O	be	cop	13	SENT_93	[p7l1080t1611r1237b1653],
13	Caucasian	JJ	MISC	caucasian	rcmod	6	SENT_93	[p7l1261t1591r1631b1666],
14	,	,	O	,	_	0	SENT_93	[p7l1261t1591r1631b1666],
15	and	CC	O	and	_	0	SENT_93	[p7l1656t1590r1783b1653],
16	47	CD	PERCENT	47	num	17	SENT_93	[p7l1804t1592r1960b1654],
17	%	NN	PERCENT	%	nsubj	19	SENT_93	[p7l1804t1592r1960b1654],
18	were	VBD	O	be	cop	19	SENT_93	[p7l1986t1611r2144b1653],
19	female	JJ	O	female	conj_and	6	SENT_93	[p7l7t1697r230b1759],
20	(	JJ	O	(	amod	21	SENT_93	[p7l259t1697r476b1775],
21	Table	NNP	O	Table	dep	19	SENT_93	[p7l259t1697r476b1775],
22	1	CD	NUMBER	1	number	23	SENT_93	[p7l514t1698r588b1775],
23	)	CD	NUMBER	)	num	21	SENT_93	[p7l514t1698r588b1775],
24	.	.	O	.	_	0	SENT_93	[p7l514t1698r588b1775],

1	Effect	NN	O	effect	_	0	SENT_94	[p7l7t1936r203b1997],
2	of	IN	O	of	_	0	SENT_94	[p7l224t1936r298b1997],
3	genetic	JJ	O	genetic	amod	8	SENT_94	[p7l310t1940r574b2014],
4	,	,	O	,	_	0	SENT_94	[p7l310t1940r574b2014],
5	clinical	JJ	O	clinical	conj_and	3	SENT_94	[p7l607t1936r850b1997],
6	and	CC	O	and	_	0	SENT_94	[p7l871t1936r1001b1997],
7	laboratory	JJ	O	laboratory	conj_and	3	SENT_94	[p7l1022t1936r1376b2014],
8	factors	NNS	O	factor	prep_of	1	SENT_94	[p7l1399t1936r1626b1997],
9	on	IN	O	on	dep	1	SENT_94	[p7l1649t1954r1731b1997],
10	therapeutic	JJ	O	therapeutic	amod	11	SENT_94	[p7l1757t1936r2148b2014],
11	dose	NN	O	dose	pobj	9	SENT_94	[p7l7t2042r162b2103],
12	after	IN	O	after	dep	1	SENT_94	[p7l192t2042r355b2103],
13	0-27	CD	NUMBER	0-27	num	14	SENT_94	[p7l381t2046r543b2102],
14	days	NNS	NUMBER	day	pobj	12	SENT_94	[p7l581t2042r734b2120],
15	of	IN	O	of	_	0	SENT_94	[p7l764t2042r838b2103],
16	therapy	NN	O	therapy	prep_of	14	SENT_94	[p7l862t2042r1122b2120],

1	As	IN	O	as	mark	9	SENT_95	[p7l6t2200r98b2261],
2	dosing	NN	O	dosing	nn	3	SENT_95	[p7l133t2200r357b2278],
3	history	NN	O	history	nsubj	9	SENT_95	[p7l390t2200r626b2278],
4	and	CC	O	and	_	0	SENT_95	[p7l661t2200r787b2262],
5	INR	NN	O	inr	nn	6	SENT_95	[p7l822t2202r981b2261],
6	response	NN	O	response	conj_and	3	SENT_95	[p7l1014t2220r1307b2278],
7	became	VBD	O	become	cop	9	SENT_95	[p7l1341t2200r1596b2262],
8	more	RBR	O	more	advmod	9	SENT_95	[p7l1628t2220r1805b2262],
9	extensive	JJ	O	extensive	advcl	21	SENT_95	[p7l1840t2200r2144b2262],
10	over	IN	O	over	_	0	SENT_95	[p7l9t2326r157b2368],
11	the	DT	DURATION	the	det	14	SENT_95	[p7l196t2306r299b2368],
12	initial	JJ	DURATION	initial	amod	14	SENT_95	[p7l338t2306r531b2368],
13	3	CD	DURATION	3	num	14	SENT_95	[p7l574t2308r606b2368],
14	weeks	NNS	NUMBER	week	prep_over	9	SENT_95	[p7l638t2306r840b2368],
15	of	IN	O	of	_	0	SENT_95	[p7l883t2306r958b2368],
16	therapy	NN	O	therapy	prep_of	14	SENT_95	[p7l990t2306r1267b2384],
17	,	,	O	,	_	0	SENT_95	[p7l990t2306r1267b2384],
18	the	DT	O	the	det	19	SENT_95	[p7l1310t2306r1413b2368],
19	model	NN	O	model	nsubj	21	SENT_95	[p7l1452t2306r1664b2368],
20	progressively	RB	O	progressively	advmod	21	SENT_95	[p7l1702t2306r2146b2384],
21	explained	VBD	O	explain	_	0	SENT_95	[p7l7t2412r332b2490],
22	more	JJR	O	more	dobj	21	SENT_95	[p7l393t2432r570b2474],
23	of	IN	O	of	_	0	SENT_95	[p7l634t2412r710b2474],
24	the	DT	O	the	det	25	SENT_95	[p7l764t2412r867b2474],
25	variance	NN	O	variance	prep_of	22	SENT_95	[p7l929t2412r1215b2474],
26	in	IN	O	in	_	0	SENT_95	[p7l1277t2412r1342b2473],
27	therapeutic	JJ	O	therapeutic	amod	28	SENT_95	[p7l1404t2412r1785b2490],
28	dose	NN	O	dose	prep_in	25	SENT_95	[p7l1847t2412r2000b2474],
29	by	IN	O	by	_	0	SENT_95	[p7l2062t2412r2146b2490],
30	accounting	VBG	O	account	prepc_by	21	SENT_95	[p7l8t2519r382b2598],
31	for	IN	O	for	_	0	SENT_95	[p7l431t2519r531b2581],
32	this	DT	O	this	det	33	SENT_95	[p7l580t2519r699b2581],
33	information	NN	O	information	prep_for	30	SENT_95	[p7l749t2519r1175b2581],
34	.	.	O	.	_	0	SENT_95	[p7l749t2519r1175b2581],

1	The	DT	O	the	det	3	SENT_96	[p7l1228t2519r1360b2581],
2	overall	JJ	O	overall	amod	3	SENT_96	[p7l1412t2519r1641b2581],
3	R2	NN	O	r2	nsubj	4	SENT_96	[p7l1693t2503r1781b2580],
4	increased	VBD	O	increase	_	0	SENT_96	[p7l1830t2519r2145b2581],
5	weekly	JJ	SET	weekly	amod	7	SENT_96	[p7l6t2625r240b2704],
6	(	NN	O	(	nn	7	SENT_96	[p7l269t2625r423b2705],
7	Fig	NN	O	fig	dobj	4	SENT_96	[p7l269t2625r423b2705],
8	.	.	O	.	_	0	SENT_96	[p7l269t2625r423b2705],

1	1	CD	NUMBER	1	num	2	SENT_97	[p7l466t2626r538b2704],
2	)	CD	NUMBER	)	_	0	SENT_97	[p7l466t2626r538b2704],
3	:	:	O	:	_	0	SENT_97	[p7l466t2626r538b2704],
4	54	CD	PERCENT	54	num	5	SENT_97	[p7l574t2627r726b2689],
5	%	NN	PERCENT	%	dep	2	SENT_97	[p7l574t2627r726b2689],
6	at	IN	O	at	_	0	SENT_97	[p7l762t2634r826b2688],
7	day	NN	DURATION	day	nn	8	SENT_97	[p7l853t2625r977b2704],
8	o	NN	O	o	prep_at	5	SENT_97	[p7l1005t2627r1060b2701],
9	;	:	O	;	_	0	SENT_97	[p7l1005t2627r1060b2701],
10	68	CD	PERCENT	68	num	11	SENT_97	[p7l1094t2627r1247b2689],
11	%	NN	PERCENT	%	conj_and	5	SENT_97	[p7l1094t2627r1247b2689],
12	at	IN	O	at	_	0	SENT_97	[p7l1282t2634r1347b2688],
13	day	NN	DURATION	day	prep_at	11	SENT_97	[p7l1374t2625r1497b2704],
14	7	CD	NUMBER	7	num	13	SENT_97	[p7l1527t2628r1581b2701],
15	;	:	O	;	_	0	SENT_97	[p7l1527t2628r1581b2701],
16	75	CD	PERCENT	75	num	17	SENT_97	[p7l1614t2627r1767b2689],
17	%	NN	PERCENT	%	conj_and	5	SENT_97	[p7l1614t2627r1767b2689],
18	at	IN	O	at	_	0	SENT_97	[p7l1802t2634r1867b2688],
19	day	NN	DURATION	day	prep_at	17	SENT_97	[p7l1895t2625r2018b2704],
20	14	CD	NUMBER	14	num	19	SENT_97	[p7l2054t2627r2142b2701],
21	;	:	O	;	_	0	SENT_97	[p7l2054t2627r2142b2701],
22	and	CC	O	and	_	0	SENT_97	[p7l8t2732r135b2794],
23	77	CD	PERCENT	77	num	24	SENT_97	[p7l173t2733r327b2795],
24	%	NN	PERCENT	%	conj_and	5	SENT_97	[p7l173t2733r327b2795],
25	at	IN	O	at	_	0	SENT_97	[p7l371t2741r435b2794],
26	day	NN	DURATION	day	prep_at	24	SENT_97	[p7l472t2732r595b2810],
27	21	CD	NUMBER	21	num	26	SENT_97	[p7l632t2734r726b2793],
28	.	.	O	.	_	0	SENT_97	[p7l632t2734r726b2793],

1	Although	IN	O	although	mark	4	SENT_98	[p7l766t2732r1095b2810],
2	genetic	JJ	O	genetic	amod	3	SENT_98	[p7l1132t2732r1367b2810],
3	factors	NNS	O	factor	nsubj	4	SENT_98	[p7l1403t2732r1634b2794],
4	(	VBP	O	(	advcl	19	SENT_98	[p7l1673t2733r1755b2810],
5	V	NN	O	v	nn	8	SENT_98	[p7l1673t2733r1755b2810],
6	KORC1	NN	O	korc1	nn	8	SENT_98	[p7l1757t2733r2039b2794],
7	A	NN	O	a	nn	8	SENT_98	[p7l2083t2732r2146b2793],
8	haplotype	NN	O	haplotype	dobj	4	SENT_98	[p7l7t2839r364b2917],
9	,	,	O	,	_	0	SENT_98	[p7l7t2839r364b2917],
10	CYP2C9	NN	O	cyp2c9	nn	11	SENT_98	[p7l397t2839r784b2900],
11	*	NN	O	*	nsubj	19	SENT_98	[p7l397t2839r784b2900],
12	2	CD	NUMBER	2	dep	11	SENT_98	[p7l397t2839r784b2900],
13	and	CC	O	and	_	0	SENT_98	[p7l814t2839r941b2900],
14	CYP2C9	CD	NUMBER	cyp2c9	number	15	SENT_98	[p7l970t2839r1383b2917],
15	*	CD	NUMBER	*	nsubj	19	SENT_98	[p7l970t2839r1383b2917],
16	3	CD	NUMBER	3	num	17	SENT_98	[p7l970t2839r1383b2917],
17	)	NN	O	)	dep	15	SENT_98	[p7l970t2839r1383b2917],
18	were	VBD	O	be	cop	19	SENT_98	[p7l1412t2859r1570b2900],
19	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_98	[p7l1601t2839r1945b2917],
20	in	IN	O	in	_	0	SENT_98	[p7l1972t2839r2037b2899],
21	all	DT	O	all	det	22	SENT_98	[p7l2066t2839r2146b2900],
22	models	NNS	O	model	prep_in	19	SENT_98	[p7l6t2944r266b3020],
23	,	,	O	,	_	0	SENT_98	[p7l6t2944r266b3020],
24	their	PRP$	O	they	poss	25	SENT_98	[p7l304t2945r460b3007],
25	contribution	NN	O	contribution	appos	22	SENT_98	[p7l493t2944r919b3007],
26	to	TO	O	to	_	0	SENT_98	[p7l953t2953r1020b3007],
27	explaining	VBG	O	explain	prepc_to	25	SENT_98	[p7l1055t2945r1406b3024],
28	the	DT	O	the	det	31	SENT_98	[p7l1440t2944r1543b3007],
29	therapeutic	JJ	O	therapeutic	amod	31	SENT_98	[p7l1578t2944r1959b3024],
30	dose	NN	O	dose	nn	31	SENT_98	[p7l1993t2944r2145b3007],
31	(	NN	O	(	dobj	27	SENT_98	[p7l9t3051r255b3130],
32	partial	JJ	O	partial	amod	34	SENT_98	[p7l9t3051r255b3130],
33	R2	NN	O	r2	nn	34	SENT_98	[p7l294t3035r407b3130],
34	)	NN	O	)	nsubj	35	SENT_98	[p7l294t3035r407b3130],
35	declined	VBD	O	decline	rcmod	31	SENT_98	[p7l445t3051r723b3114],
36	steadily	RB	O	steadily	advmod	35	SENT_98	[p7l762t3051r1032b3130],
37	:	:	O	:	_	0	SENT_98	[p7l762t3051r1032b3130],
38	43	CD	PERCENT	43	num	39	SENT_98	[p7l1073t3053r1229b3115],
39	%	NN	PERCENT	%	appos	22	SENT_98	[p7l1073t3053r1229b3115],
40	at	IN	O	at	_	0	SENT_98	[p7l1272t3060r1336b3114],
41	day	NN	DURATION	day	nn	42	SENT_98	[p7l1372t3051r1496b3130],
42	o	NN	O	o	prep_at	39	SENT_98	[p7l1532t3053r1588b3127],
43	;	:	O	;	_	0	SENT_98	[p7l1532t3053r1588b3127],
44	12	CD	PERCENT	12	num	45	SENT_98	[p7l1636t3052r1782b3115],
45	%	NN	PERCENT	%	appos	22	SENT_98	[p7l1636t3052r1782b3115],
46	at	IN	O	at	_	0	SENT_98	[p7l1826t3060r1891b3114],
47	day	NN	DURATION	day	prep_at	45	SENT_98	[p7l1927t3051r2050b3130],
48	7	CD	NUMBER	7	num	47	SENT_98	[p7l2087t3054r2142b3127],
49	;	:	O	;	_	0	SENT_98	[p7l2087t3054r2142b3127],
50	3.9	CD	PERCENT	3.9	num	51	SENT_98	[p7l10t3160r183b3221],
51	%	NN	PERCENT	%	appos	22	SENT_98	[p7l10t3160r183b3221],
52	at	IN	O	at	_	0	SENT_98	[p7l214t3167r278b3220],
53	day	NN	DURATION	day	prep_at	51	SENT_98	[p7l302t3158r425b3236],
54	14	CD	NUMBER	14	num	53	SENT_98	[p7l457t3160r545b3233],
55	;	:	O	;	_	0	SENT_98	[p7l457t3160r545b3233],
56	and	CC	O	and	_	0	SENT_98	[p7l572t3158r700b3220],
57	1.4	CD	PERCENT	1.4	num	58	SENT_98	[p7l732t3160r899b3221],
58	%	NN	PERCENT	%	appos	22	SENT_98	[p7l732t3160r899b3221],
59	at	IN	O	at	_	0	SENT_98	[p7l930t3167r994b3220],
60	day	NN	DURATION	day	prep_at	58	SENT_98	[p7l1018t3158r1141b3236],
61	21	CD	NUMBER	21	num	60	SENT_98	[p7l1165t3160r1260b3220],
62	.	.	O	.	_	0	SENT_98	[p7l1165t3160r1260b3220],

1	The	DT	O	the	det	2	SENT_99	[p7l1287t3158r1420b3220],
2	contribution	NN	O	contribution	nsubj	9	SENT_99	[p7l1443t3158r1869b3220],
3	of	IN	O	of	_	0	SENT_99	[p7l1895t3158r1970b3220],
4	INR	NN	O	inr	prep_of	2	SENT_99	[p7l1986t3161r2146b3219],
5	to	TO	O	to	_	0	SENT_99	[p7l7t3273r74b3327],
6	partial	JJ	O	partial	amod	7	SENT_99	[p7l95t3264r318b3343],
7	R2	NN	O	r2	prep_to	4	SENT_99	[p7l342t3248r430b3326],
8	also	RB	O	also	advmod	9	SENT_99	[p7l452t3264r583b3327],
9	declined	VBD	O	decline	_	0	SENT_99	[p7l606t3264r884b3327],
10	over	IN	O	over	_	0	SENT_99	[p7l907t3285r1055b3327],
11	time	NN	O	time	prep_over	9	SENT_99	[p7l1074t3264r1238b3327],
12	:	:	O	:	_	0	SENT_99	[p7l1074t3264r1238b3327],
13	32	CD	PERCENT	32	num	14	SENT_99	[p7l1266t3265r1419b3328],
14	%	NN	PERCENT	%	dep	11	SENT_99	[p7l1266t3265r1419b3328],
15	at	IN	O	at	_	0	SENT_99	[p7l1446t3273r1510b3327],
16	day	NN	DURATION	day	prep_at	14	SENT_99	[p7l1530t3264r1654b3343],
17	7	CD	NUMBER	7	num	16	SENT_99	[p7l1676t3267r1731b3340],
18	;	:	O	;	_	0	SENT_99	[p7l1676t3267r1731b3340],
19	19	CD	PERCENT	19	num	20	SENT_99	[p7l1762t3265r1909b3328],
20	%	NN	PERCENT	%	prep_over	9	SENT_99	[p7l1762t3265r1909b3328],
21	at	IN	O	at	_	0	SENT_99	[p7l1938t3273r2002b3327],
22	day	NN	DURATION	day	prep_at	20	SENT_99	[p7l2023t3264r2146b3343],
23	14	CD	NUMBER	14	num	22	SENT_99	[p7l15t3373r103b3446],
24	;	:	O	;	_	0	SENT_99	[p7l15t3373r103b3446],
25	and	CC	O	and	_	0	SENT_99	[p7l131t3372r258b3433],
26	5	CD	PERCENT	5	num	27	SENT_99	[p7l284t3373r396b3434],
27	%	NN	PERCENT	%	conj_and	11	SENT_99	[p7l284t3373r396b3434],
28	at	IN	O	at	_	0	SENT_99	[p7l426t3380r491b3433],
29	day	NN	DURATION	day	prep_at	27	SENT_99	[p7l513t3372r636b3450],
30	21	CD	NUMBER	21	number	31	SENT_99	[p7l660t3373r730b3432],
31	(	CD	NUMBER	(	num	32	SENT_99	[p7l763t3372r980b3450],
32	Table	NNP	O	Table	dobj	9	SENT_99	[p7l763t3372r980b3450],
33	2	CD	NUMBER	2	num	32	SENT_99	[p7l1011t3372r1091b3450],
34	)	CD	NUMBER	)	tmod	9	SENT_99	[p7l1011t3372r1091b3450],
35	.	.	O	.	_	0	SENT_99	[p7l1011t3372r1091b3450],

1	In	IN	O	in	_	0	SENT_100	[p7l1120t3374r1193b3432],
2	contrast	NN	O	contrast	prep_in	9	SENT_100	[p7l1215t3380r1510b3446],
3	,	,	O	,	_	0	SENT_100	[p7l1215t3380r1510b3446],
4	the	DT	O	the	det	6	SENT_100	[p7l1537t3372r1639b3433],
5	dosing	NN	O	dosing	nn	6	SENT_100	[p7l1663t3372r1887b3450],
6	history	NN	O	history	nsubj	9	SENT_100	[p7l1909t3372r2146b3450],
7	became	VBD	O	become	cop	9	SENT_100	[p7l7t3477r262b3539],
8	progressively	RB	O	progressively	advmod	9	SENT_100	[p7l313t3477r757b3555],
9	more	RBR	O	more	_	0	SENT_100	[p7l807t3497r983b3539],
10	predictive	JJ	O	predictive	amod	9	SENT_100	[p7l1034t3477r1366b3555],
11	of	IN	O	of	_	0	SENT_100	[p7l1420t3477r1495b3539],
12	therapeutic	JJ	O	therapeutic	amod	13	SENT_100	[p7l1539t3477r1920b3555],
13	dose	NN	O	dose	prep_of	9	SENT_100	[p7l1972t3477r2142b3552],
14	,	,	O	,	_	0	SENT_100	[p7l1972t3477r2142b3552],
15	easily	RB	O	easily	advmod	16	SENT_100	[p7l7t3583r193b3662],
16	trumping	VBG	O	trump	partmod	9	SENT_100	[p7l218t3583r535b3662],
17	other	JJ	O	other	amod	18	SENT_100	[p7l561t3583r739b3646],
18	factors	NNS	O	factor	dobj	16	SENT_100	[p7l764t3583r994b3646],
19	over	IN	O	over	_	0	SENT_100	[p7l1021t3604r1168b3646],
20	time	NN	O	time	prep_over	18	SENT_100	[p7l1192t3583r1355b3646],
21	:	:	O	:	_	0	SENT_100	[p7l1192t3583r1355b3646],
22	partial	JJ	O	partial	amod	23	SENT_100	[p7l1383t3583r1606b3662],
23	R2	NN	O	r2	conj_and	18	SENT_100	[p7l1633t3567r1723b3645],
24	18	CD	PERCENT	18	number	25	SENT_100	[p7l1755t3584r1902b3647],
25	%	NN	PERCENT	%	amod	23	SENT_100	[p7l1755t3584r1902b3647],
26	at	IN	O	at	_	0	SENT_100	[p7l1934t3592r1998b3646],
27	day	NN	DURATION	day	prep_at	23	SENT_100	[p7l2023t3583r2146b3662],
28	7	CD	NUMBER	7	num	27	SENT_100	[p7l9t3693r63b3765],
29	;	:	O	;	_	0	SENT_100	[p7l9t3693r63b3765],
30	50	CD	PERCENT	50	num	31	SENT_100	[p7l97t3692r249b3753],
31	%	NN	PERCENT	%	conj_and	18	SENT_100	[p7l97t3692r249b3753],
32	at	IN	O	at	_	0	SENT_100	[p7l283t3699r348b3752],
33	day	NN	DURATION	day	prep_at	31	SENT_100	[p7l374t3691r498b3769],
34	14	CD	NUMBER	14	num	33	SENT_100	[p7l533t3692r621b3765],
35	;	:	O	;	_	0	SENT_100	[p7l533t3692r621b3765],
36	and	CC	O	and	_	0	SENT_100	[p7l653t3691r779b3752],
37	69	CD	PERCENT	69	num	38	SENT_100	[p7l808t3692r961b3753],
38	%	NN	PERCENT	%	conj_and	18	SENT_100	[p7l808t3692r961b3753],
39	at	IN	O	at	_	0	SENT_100	[p7l996t3699r1060b3752],
40	day	NN	DURATION	day	prep_at	38	SENT_100	[p7l1087t3691r1210b3769],
41	21	CD	NUMBER	21	num	40	SENT_100	[p7l1238t3692r1308b3751],
42	(	CD	NUMBER	(	num	43	SENT_100	[p7l1345t3691r1499b3769],
43	Fig	NN	O	fig	dep	38	SENT_100	[p7l1345t3691r1499b3769],
44	.	.	O	.	_	0	SENT_100	[p7l1345t3691r1499b3769],

1	1	CD	NUMBER	1	_	0	SENT_101	[p7l1542t3691r1615b3769],
2	)	NN	O	)	dep	1	SENT_101	[p7l1542t3691r1615b3769],
3	.	.	O	.	_	0	SENT_101	[p7l1542t3691r1615b3769],

1	Time	NNP	O	Time	_	0	SENT_102	[p8l12t139r176b197],
2	spent	VBD	O	spend	partmod	1	SENT_102	[p8l205t139r393b215],
3	below	IN	O	below	_	0	SENT_102	[p8l420t136r633b197],
4	and	CC	O	and	_	0	SENT_102	[p8l661t136r791b197],
5	above	IN	O	above	_	0	SENT_102	[p8l816t136r1021b197],
6	therapeutic	JJ	O	therapeutic	amod	7	SENT_102	[p8l1054t136r1445b215],
7	range	NN	O	range	prep_below	2	SENT_102	[p8l1472t154r1680b215],
8	:	:	O	:	_	0	SENT_102	[p8l1472t154r1680b215],
9	days	NNS	DURATION	day	dep	1	SENT_102	[p8l1714t136r1867b215],
10	7-28	CD	NUMBER	7-28	dep	9	SENT_102	[p8l1898t139r2066b197],

1	In	IN	O	in	_	0	SENT_103	[p8l8t298r81b356],
2	the	DT	O	the	det	4	SENT_103	[p8l136t295r240b357],
3	regression	NN	O	regression	nn	4	SENT_103	[p8l295t295r637b373],
4	analysis	NN	O	analysis	prep_in	11	SENT_103	[p8l693t295r976b373],
5	,	,	O	,	_	0	SENT_103	[p8l693t295r976b373],
6	both	CC	O	both	preconj	7	SENT_103	[p8l1035t295r1193b357],
7	VKORC1	NN	O	vkorc1	nsubj	11	SENT_103	[p8l1247t296r1590b357],
8	and	CC	O	and	_	0	SENT_103	[p8l1655t295r1782b357],
9	CYP2C9	NN	O	cyp2c9	nn	10	SENT_103	[p8l1838t296r2143b357],
10	genotypes	NNS	O	genotype	nsubj	11	SENT_103	[p8l8t410r346b480],
11	had	VBD	O	have	_	0	SENT_103	[p8l407t402r535b463],
12	a	DT	O	a	det	14	SENT_103	[p8l597t422r635b463],
13	signiﬁcant	JJ	O	signiﬁcant	amod	14	SENT_103	[p8l698t402r1043b480],
14	effect	NN	O	effect	dobj	11	SENT_103	[p8l1103t402r1285b463],
15	on	IN	O	on	_	0	SENT_103	[p8l1347t422r1433b463],
16	time	NN	O	time	prep_on	14	SENT_103	[p8l1494t402r1641b463],
17	spent	VBD	O	spend	rcmod	14	SENT_103	[p8l1705t410r1882b480],
18	below	IN	O	below	_	0	SENT_103	[p8l1943t402r2146b463],
19	therapeutic	JJ	O	therapeutic	amod	20	SENT_103	[p8l7t508r389b587],
20	range	NN	O	range	prep_below	17	SENT_103	[p8l458t528r663b587],
21	.	.	O	.	_	0	SENT_103	[p8l458t528r663b587],

1	Time	NNP	O	Time	nsubj	2	SENT_104	[p8l738t508r914b570],
2	spent	VBD	O	spend	_	0	SENT_104	[p8l986t516r1164b587],
3	below	IN	O	below	_	0	SENT_104	[p8l1234t507r1436b570],
4	therapeutic	JJ	O	therapeutic	amod	5	SENT_104	[p8l1506t508r1887b587],
5	range	NN	O	range	prep_below	2	SENT_104	[p8l1956t528r2145b587],
6	decreased	VBN	O	decrease	partmod	5	SENT_104	[p8l8t615r336b676],
7	by	IN	O	by	_	0	SENT_104	[p8l370t615r454b693],
8	16	CD	PERCENT	16	num	9	SENT_104	[p8l496t616r643b677],
9	%	NN	PERCENT	%	agent	6	SENT_104	[p8l496t616r643b677],
10	per	IN	O	per	_	0	SENT_104	[p8l682t635r792b693],
11	VKORC1	NN	O	vkorc1	nn	13	SENT_104	[p8l825t616r1168b676],
12	A	NN	O	a	nn	13	SENT_104	[p8l1209t615r1272b675],
13	haplotype	NN	O	haplotype	prep_per	9	SENT_104	[p8l1306t615r1645b693],
14	and	CC	O	and	_	0	SENT_104	[p8l1681t615r1807b676],
15	11	CD	PERCENT	11	num	16	SENT_104	[p8l1850t616r1997b677],
16	%	NN	PERCENT	%	agent	6	SENT_104	[p8l1850t616r1997b677],
17	per	IN	O	per	_	0	SENT_104	[p8l2036t635r2146b693],
18	CYP2C9	NN	O	cyp2c9	nn	20	SENT_104	[p8l8t721r314b782],
19	Variant	JJ	O	variant	amod	20	SENT_104	[p8l338t720r581b782],
20	allele	NN	O	allele	prep_per	16	SENT_104	[p8l605t720r790b782],
21	.	.	O	.	_	0	SENT_104	[p8l605t720r790b782],

1	The	DT	O	the	det	2	SENT_105	[p8l818t720r950b782],
2	Variables	NNS	O	variable	nsubj	12	SENT_105	[p8l973t720r1274b782],
3	that	WDT	O	that	nsubj	4	SENT_105	[p8l1299t720r1435b782],
4	increased	VBD	O	increase	rcmod	2	SENT_105	[p8l1457t720r1772b782],
5	time	NN	O	time	dobj	4	SENT_105	[p8l1796t720r1943b782],
6	spent	VBN	O	spend	partmod	5	SENT_105	[p8l1968t729r2146b798],
7	below	IN	O	below	_	0	SENT_105	[p8l7t826r210b887],
8	therapeutic	JJ	O	therapeutic	amod	9	SENT_105	[p8l240t826r622b904],
9	range	NN	O	range	prep_below	6	SENT_105	[p8l652t846r841b904],
10	were	VBD	O	be	aux	12	SENT_105	[p8l871t846r1029b887],
11	younger	JJR	O	younger	amod	12	SENT_105	[p8l1059t846r1339b904],
12	age	NN	O	age	_	0	SENT_105	[p8l1370t846r1482b904],
13	(	CD	PERCENT	(	number	14	SENT_105	[p8l1515t826r1716b904],
14	3.6	CD	PERCENT	3.6	num	15	SENT_105	[p8l1515t826r1716b904],
15	%	NN	PERCENT	%	dobj	12	SENT_105	[p8l1515t826r1716b904],
16	per	IN	O	per	_	0	SENT_105	[p8l1752t846r1862b904],
17	decade	NN	DURATION	decade	prep_per	15	SENT_105	[p8l1892t826r2142b900],
18	,	,	O	,	_	0	SENT_105	[p8l1892t826r2142b900],
19	P	NN	O	p	appos	17	SENT_105	[p8l7t936r62b993],
20	<	VBG	O	<	xcomp	12	SENT_105	[p8l107t944r154b984],
21	0.0001	CD	NUMBER	0.0001	num	22	SENT_105	[p8l201t933r446b1011],
22	)	NN	O	)	nsubj	30	SENT_105	[p8l201t933r446b1011],
23	and	CC	O	and	_	0	SENT_105	[p8l468t933r595b994],
24	greater	JJR	O	greater	amod	27	SENT_105	[p8l616t942r852b1011],
25	body	NN	O	body	nn	27	SENT_105	[p8l871t933r1044b1011],
26	surface	NN	O	surface	nn	27	SENT_105	[p8l1065t933r1303b994],
27	area	NN	O	area	nsubj	30	SENT_105	[p8l1325t953r1468b994],
28	(	CD	PERCENT	(	number	29	SENT_105	[p8l1489t933r1690b1011],
29	3.1	CD	PERCENT	3.1	num	30	SENT_105	[p8l1489t933r1690b1011],
30	%	NN	PERCENT	%	xcomp	20	SENT_105	[p8l1489t933r1690b1011],
31	per	IN	O	per	_	0	SENT_105	[p8l1715t953r1826b1011],
32	standard	JJ	O	standard	amod	33	SENT_105	[p8l1847t933r2145b994],
33	deviation	NN	O	deviation	prep_per	30	SENT_105	[p8l8t1038r341b1112],
34	,	,	O	,	_	0	SENT_105	[p8l8t1038r341b1112],
35	P	NN	O	p	appos	33	SENT_105	[p8l379t1042r434b1099],
36	=	JJ	O	=	amod	38	SENT_105	[p8l477t1061r527b1079],
37	0.04	CD	NUMBER	0.04	tmod	36	SENT_105	[p8l572t1039r754b1116],
38	)	NN	O	)	dep	35	SENT_105	[p8l572t1039r754b1116],
39	.	.	O	.	_	0	SENT_105	[p8l572t1039r754b1116],

1	Female	JJ	O	female	amod	2	SENT_106	[p8l795t1038r1045b1100],
2	gender	NN	O	gender	nsubj	3	SENT_106	[p8l1081t1038r1309b1116],
3	had	VBD	O	have	_	0	SENT_106	[p8l1343t1038r1471b1100],
4	a	DT	O	a	det	6	SENT_106	[p8l1507t1058r1545b1100],
5	borderline	JJ	O	borderline	amod	6	SENT_106	[p8l1579t1038r1928b1100],
6	effect	NN	O	effect	dobj	3	SENT_106	[p8l1964t1038r2146b1100],
7	(	CD	PERCENT	(	number	8	SENT_106	[p8l9t1144r209b1222],
8	5.7	CD	PERCENT	5.7	num	9	SENT_106	[p8l9t1144r209b1222],
9	%	NN	PERCENT	%	npadvmod	10	SENT_106	[p8l9t1144r209b1222],
10	less	JJR	O	less	advmod	3	SENT_106	[p8l243t1144r357b1206],
11	time	NN	O	time	dep	12	SENT_106	[p8l385t1144r533b1206],
12	than	IN	O	than	advmod	10	SENT_106	[p8l560t1144r715b1206],
13	in	IN	O	in	_	0	SENT_106	[p8l741t1144r805b1205],
14	males	NNS	O	male	prep_in	3	SENT_106	[p8l831t1144r1042b1218],
15	,	,	O	,	_	0	SENT_106	[p8l831t1144r1042b1218],
16	P	NN	O	p	appos	14	SENT_106	[p8l1073t1148r1128b1205],
17	=	JJ	O	=	amod	19	SENT_106	[p8l1170t1167r1221b1185],
18	0.054	CD	NUMBER	0.054	tmod	17	SENT_106	[p8l1267t1144r1488b1222],
19	)	NN	O	)	dep	16	SENT_106	[p8l1267t1144r1488b1222],
20	.	.	O	.	_	0	SENT_106	[p8l1267t1144r1488b1222],

1	Thirty-nine	CD	NUMBER	thirty-nine	nsubj	6	SENT_107	[p8l92t1251r478b1329],
2	per	IN	O	per	_	0	SENT_107	[p8l498t1271r607b1329],
3	cent	NN	O	cent	prep_per	1	SENT_107	[p8l626t1259r766b1312],
4	of	IN	O	of	_	0	SENT_107	[p8l787t1251r863b1312],
5	subjects	NNS	O	subject	prep_of	3	SENT_107	[p8l877t1251r1139b1329],
6	had	VBD	O	have	_	0	SENT_107	[p8l1159t1251r1288b1312],
7	at	IN	O	at	quantmod	9	SENT_107	[p8l1309t1259r1372b1312],
8	least	JJS	O	least	mwe	7	SENT_107	[p8l1391t1251r1543b1312],
9	one	CD	NUMBER	one	num	10	SENT_107	[p8l1564t1271r1685b1312],
10	INR	NN	O	inr	dobj	6	SENT_107	[p8l1705t1253r1866b1312],
11	above	IN	O	above	_	0	SENT_107	[p8l1885t1251r2087b1312],
12	2	CD	NUMBER	2	prep_above	10	SENT_107	[p8l2107t1252r2145b1311],
13	during	IN	O	during	_	0	SENT_107	[p8l8t1356r232b1436],
14	days	NNS	DURATION	day	prep_during	6	SENT_107	[p8l250t1356r403b1435],
15	7-28	CD	NUMBER	7-28	tmod	6	SENT_107	[p8l424t1358r597b1419],
16	.	.	O	.	_	0	SENT_107	[p8l424t1358r597b1419],

1	In	IN	O	in	_	0	SENT_108	[p8l621t1359r694b1418],
2	the	DT	O	the	det	4	SENT_108	[p8l713t1356r816b1419],
3	logistic	JJ	O	logistic	amod	4	SENT_108	[p8l835t1357r1074b1436],
4	regression	NN	O	regression	prep_in	11	SENT_108	[p8l1092t1357r1450b1436],
5	,	,	O	,	_	0	SENT_108	[p8l1092t1357r1450b1436],
6	both	CC	O	both	preconj	7	SENT_108	[p8l1472t1356r1631b1419],
7	VKORC1	NN	O	vkorc1	nsubj	11	SENT_108	[p8l1647t1358r1991b1419],
8	and	CC	O	and	_	0	SENT_108	[p8l2018t1356r2145b1419],
9	CYP2C9	NN	O	cyp2c9	nn	10	SENT_108	[p8l8t1465r314b1525],
10	genotypes	NNS	O	genotype	nsubj	11	SENT_108	[p8l356t1472r693b1542],
11	inﬂuenced	VBD	O	inﬂuenced	_	0	SENT_108	[p8l733t1464r1081b1525],
12	the	DT	O	the	det	13	SENT_108	[p8l1121t1464r1224b1525],
13	odds	NNS	O	odds	dobj	11	SENT_108	[p8l1265t1464r1425b1525],
14	of	IN	O	of	_	0	SENT_108	[p8l1467t1464r1543b1525],
15	supratherapeutic	JJ	O	supratherapeutic	amod	16	SENT_108	[p8l1575t1464r2146b1542],
16	dosing	NN	O	dosing	prep_of	13	SENT_108	[p8l8t1569r247b1647],
17	.	.	O	.	_	0	SENT_108	[p8l8t1569r247b1647],

1	The	DT	O	the	det	3	SENT_109	[p8l322t1569r454b1631],
2	odds	NNS	O	odds	nn	3	SENT_109	[p8l526t1569r687b1631],
3	ratios	NNS	O	ratio	_	0	SENT_109	[p8l758t1569r948b1631],
4	(	CD	NUMBER	(	num	6	SENT_109	[p8l1021t1570r1194b1647],
5	OR	NN	O	or	nn	6	SENT_109	[p8l1021t1570r1194b1647],
6	)	NN	O	)	dep	3	SENT_109	[p8l1021t1570r1194b1647],
7	for	IN	O	for	_	0	SENT_109	[p8l1267t1569r1367b1631],
8	over-anticoagulation	NN	O	over-anticoagulation	prep_for	6	SENT_109	[p8l1438t1569r2145b1647],

1	©	RB	O	©	dep	2	SENT_110	[p8l8t1798r58b1848],
2	2009	CD	DATE	2009	dep	4	SENT_110	[p8l87t1797r225b1848],
3	International	NNP	ORGANIZATION	International	nn	4	SENT_110	[p8l253t1796r650b1848],
4	Society	NNP	ORGANIZATION	Society	_	0	SENT_110	[p8l680t1796r894b1861],
5	on	IN	O	on	_	0	SENT_110	[p8l922t1813r996b1848],
6	Thrombosis	NNP	O	Thrombosis	prep_on	4	SENT_110	[p8l1023t1795r1384b1848],
7	and	CC	O	and	_	0	SENT_110	[p8l1413t1795r1523b1848],
8	Haemostasis	NNP	ORGANIZATION	Haemostasis	nn	11	SENT_110	[p8l1550t1796r1930b1848],
9	Table	NNP	ORGANIZATION	Table	nn	11	SENT_110	[p8l9t1890r169b1940],
10	1	CD	NUMBER	1	num	11	SENT_110	[p8l198t1889r224b1939],
11	Demographic	NNP	MISC	Demographic	conj_and	4	SENT_110	[p8l264t1888r678b1954],
12	,	,	O	,	_	0	SENT_110	[p8l264t1888r678b1954],
13	genetic	JJ	O	genetic	amod	16	SENT_110	[p8l705t1888r905b1954],
14	and	CC	O	and	_	0	SENT_110	[p8l928t1888r1035b1940],
15	clinical	JJ	O	clinical	conj_and	13	SENT_110	[p8l1059t1888r1261b1940],
16	characteristics	NNS	O	characteristic	appos	11	SENT_110	[p8l1284t1888r1692b1940],
17	of	IN	O	of	_	0	SENT_110	[p8l1717t1888r1782b1940],
18	participants	NNS	O	participant	prep_of	16	SENT_110	[p8l1796t1888r2139b1954],

1	Demographic	JJ	O	demographic	amod	2	SENT_111	[p8l9t2025r422b2092],
2	Variables	NNS	O	variable	_	0	SENT_111	[p8l448t2025r716b2078],
3	N	NN	O	n	dep	2	SENT_111	[p8l1830t2028r1888b2078],
4	=	JJ	O	=	quantmod	5	SENT_111	[p8l1921t2045r1964b2060],
5	495	CD	NUMBER	495	dep	3	SENT_111	[p8l2004t2027r2106b2078],

1	Age	NNP	O	Age	nsubj	3	SENT_112	[p8l8t2193r144b2260],
2	,	,	O	,	_	0	SENT_112	[p8l8t2193r144b2260],
3	mean	VB	O	mean	_	0	SENT_112	[p8l173t2210r336b2246],
4	(	JJ	O	(	amod	6	SENT_112	[p8l364t2194r522b2260],
5	SD	NN	O	sd	nn	6	SENT_112	[p8l364t2194r522b2260],
6	)	NN	O	)	dobj	3	SENT_112	[p8l364t2194r522b2260],
7	,	,	O	,	_	0	SENT_112	[p8l364t2194r522b2260],
8	years	NNS	DURATION	year	appos	6	SENT_112	[p8l551t2210r705b2260],
9	55	CD	NUMBER	55	number	10	SENT_112	[p8l1869t2196r1932b2246],
10	(	CD	NUMBER	(	dep	6	SENT_112	[p8l1963t2194r2076b2260],
11	13	CD	NUMBER	13	num	13	SENT_112	[p8l1963t2194r2076b2260],
12	)	CD	NUMBER	)	num	13	SENT_112	[p8l1963t2194r2076b2260],
13	Gender	NN	O	gender	dep	10	SENT_112	[p8l10t2283r234b2335],

1	Female	JJ	O	female	amod	14	SENT_113	[p8l81t2371r317b2434],
2	,	,	O	,	_	0	SENT_113	[p8l81t2371r317b2434],
3	11	CD	PERCENT	11	num	5	SENT_113	[p8l346t2389r379b2423],
4	(	CD	PERCENT	(	num	5	SENT_113	[p8l407t2371r521b2437],
5	%	NN	PERCENT	%	dep	14	SENT_113	[p8l407t2371r521b2437],
6	)	CD	NUMBER	)	number	7	SENT_113	[p8l407t2371r521b2437],
7	234	CD	NUMBER	234	num	8	SENT_113	[p8l1830t2372r1934b2423],
8	(	NN	O	(	dep	5	SENT_113	[p8l1963t2371r2148b2437],
9	47	CD	PERCENT	47	number	10	SENT_113	[p8l1963t2371r2148b2437],
10	%	NN	PERCENT	%	amod	8	SENT_113	[p8l1963t2371r2148b2437],
11	)	CD	NUMBER	)	num	12	SENT_113	[p8l1963t2371r2148b2437],
12	Male	NN	O	male	dep	8	SENT_113	[p8l81t2461r251b2524],
13	,	,	O	,	_	0	SENT_113	[p8l81t2461r251b2524],
14	n	NN	O	n	dep	19	SENT_113	[p8l279t2479r312b2513],
15	(	CD	PERCENT	(	num	16	SENT_113	[p8l341t2461r454b2527],
16	%	NN	PERCENT	%	dep	14	SENT_113	[p8l341t2461r454b2527],
17	)	CD	NUMBER	)	dep	19	SENT_113	[p8l341t2461r454b2527],
18	261	CD	NUMBER	261	num	19	SENT_113	[p8l1830t2462r1927b2513],
19	(	NN	O	(	dep	22	SENT_113	[p8l1963t2461r2148b2527],
20	53	CD	PERCENT	53	num	21	SENT_113	[p8l1963t2461r2148b2527],
21	%	NN	PERCENT	%	dep	19	SENT_113	[p8l1963t2461r2148b2527],
22	)	CD	NUMBER	)	_	0	SENT_113	[p8l1963t2461r2148b2527],

1	Race	NN	O	race	_	0	SENT_114	[p8l11t2552r159b2602],

1	Caucasian	JJ	MISC	caucasian	amod	37	SENT_115	[p8l81t2638r409b2701],
2	,	,	O	,	_	0	SENT_115	[p8l81t2638r409b2701],
3	n	NN	O	n	dep	11	SENT_115	[p8l438t2656r470b2690],
4	(	CD	PERCENT	(	num	5	SENT_115	[p8l499t2638r612b2704],
5	%	NN	PERCENT	%	dep	3	SENT_115	[p8l499t2638r612b2704],
6	)	CD	NUMBER	)	number	7	SENT_115	[p8l499t2638r612b2704],
7	434	CD	NUMBER	434	num	8	SENT_115	[p8l1830t2639r1934b2690],
8	(	NN	O	(	dep	5	SENT_115	[p8l1963t2638r2148b2704],
9	88	CD	PERCENT	88	num	10	SENT_115	[p8l1963t2638r2148b2704],
10	%	NN	PERCENT	%	dep	11	SENT_115	[p8l1963t2638r2148b2704],
11	)	CD	NUMBER	)	dep	16	SENT_115	[p8l1963t2638r2148b2704],
12	African-American	NNP	MISC	African-American	dep	11	SENT_115	[p8l79t2727r647b2790],
13	,	,	O	,	_	0	SENT_115	[p8l79t2727r647b2790],
14	n	NN	O	n	appos	12	SENT_115	[p8l676t2745r709b2779],
15	(	CD	PERCENT	(	num	16	SENT_115	[p8l738t2727r851b2793],
16	%	NN	PERCENT	%	dep	22	SENT_115	[p8l738t2727r851b2793],
17	)	CD	PERCENT	)	number	18	SENT_115	[p8l738t2727r851b2793],
18	47	CD	PERCENT	47	dep	16	SENT_115	[p8l1866t2728r1933b2779],
19	(	CD	PERCENT	(	num	21	SENT_115	[p8l1963t2727r2111b2793],
20	9	CD	PERCENT	9	num	21	SENT_115	[p8l1963t2727r2111b2793],
21	%	NN	PERCENT	%	dep	18	SENT_115	[p8l1963t2727r2111b2793],
22	)	CD	NUMBER	)	dep	33	SENT_115	[p8l1963t2727r2111b2793],
23	Other	JJ	O	other	dep	22	SENT_115	[p8l81t2817r271b2880],
24	,	,	O	,	_	0	SENT_115	[p8l81t2817r271b2880],
25	11	CD	PERCENT	11	num	27	SENT_115	[p8l300t2835r332b2869],
26	(	CD	PERCENT	(	num	27	SENT_115	[p8l361t2817r474b2883],
27	%	NN	PERCENT	%	appos	23	SENT_115	[p8l361t2817r474b2883],
28	)	CD	NUMBER	)	number	29	SENT_115	[p8l361t2817r474b2883],
29	14	CD	NUMBER	14	num	30	SENT_115	[p8l1873t2818r1935b2868],
30	(	NN	O	(	dep	27	SENT_115	[p8l1963t2817r2111b2883],
31	3	CD	PERCENT	3	number	32	SENT_115	[p8l1963t2817r2111b2883],
32	%	NN	PERCENT	%	amod	30	SENT_115	[p8l1963t2817r2111b2883],
33	)	CD	NUMBER	)	dep	35	SENT_115	[p8l1963t2817r2111b2883],
34	Hispanic	JJ	MISC	hispanic	amod	35	SENT_115	[p8l9t2906r277b2972],
35	ethnicity	NN	O	ethnicity	dep	37	SENT_115	[p8l303t2906r580b2972],
36	,	,	O	,	_	0	SENT_115	[p8l303t2906r580b2972],
37	n	NN	O	n	_	0	SENT_115	[p8l609t2924r641b2958],
38	(	CD	PERCENT	(	num	39	SENT_115	[p8l670t2906r783b2972],
39	%	NN	PERCENT	%	dep	37	SENT_115	[p8l670t2906r783b2972],
40	)	CD	NUMBER	)	number	41	SENT_115	[p8l670t2906r783b2972],
41	6	CD	NUMBER	6	num	42	SENT_115	[p8l1903t2907r1934b2958],
42	(	NN	O	(	dep	37	SENT_115	[p8l1963t2906r2111b2972],
43	1	CD	PERCENT	1	number	44	SENT_115	[p8l1963t2906r2111b2972],
44	%	NN	PERCENT	%	amod	42	SENT_115	[p8l1963t2906r2111b2972],
45	)	CD	NUMBER	)	num	47	SENT_115	[p8l1963t2906r2111b2972],
46	Genetic	JJ	O	genetic	amod	47	SENT_115	[p8l10t2994r241b3046],
47	Variables	NNS	O	variable	dep	42	SENT_115	[p8l266t2994r535b3046],

1	VKORC1	NN	O	vkorc1	nn	8	SENT_116	[p8l79t3084r378b3136],
2	A	NN	O	a	nn	8	SENT_116	[p8l410t3083r464b3135],
3	haplotypel	NN	O	haplotypel	nn	8	SENT_116	[p8l489t3070r816b3150],
4	frequency	NN	O	frequency	nn	8	SENT_116	[p8l843t3083r1140b3150],
5	37.5	CD	PERCENT	37.5	num	8	SENT_116	[p8l1869t3085r2056b3137],
6	%	NN	PERCENT	%	nn	8	SENT_116	[p8l1869t3085r2056b3137],
7	CYP2C9	NN	O	cyp2c9	nn	8	SENT_116	[p8l81t3173r420b3225],
8	*	NN	O	*	dep	14	SENT_116	[p8l81t3173r420b3225],
9	2	CD	NUMBER	2	num	11	SENT_116	[p8l81t3173r420b3225],
10	allele	NN	O	allele	nn	11	SENT_116	[p8l448t3173r599b3225],
11	frequency	NN	O	frequency	dep	8	SENT_116	[p8l627t3173r923b3239],
12	12.2	CD	PERCENT	12.2	num	13	SENT_116	[p8l1873t3174r2056b3226],
13	%	NN	PERCENT	%	dep	14	SENT_116	[p8l1873t3174r2056b3226],
14	CYP2C9	NN	O	cyp2c9	_	0	SENT_116	[p8l81t3261r417b3313],
15	*	CD	NUMBER	*	number	16	SENT_116	[p8l81t3261r417b3313],
16	3	CD	NUMBER	3	num	18	SENT_116	[p8l81t3261r417b3313],
17	allele	NN	O	allele	nn	18	SENT_116	[p8l448t3261r599b3313],
18	frequency	NN	O	frequency	dep	14	SENT_116	[p8l627t3261r923b3327],
19	6.4	CD	PERCENT	6.4	number	20	SENT_116	[p8l1903t3262r2055b3314],
20	%	NN	PERCENT	%	amod	18	SENT_116	[p8l1903t3262r2055b3314],

1	Clinical	JJ	O	clinical	amod	2	SENT_117	[p8l10t3350r241b3403],
2	Variables	NNS	O	variable	_	0	SENT_117	[p8l266t3350r535b3402],

1	Geometric	JJ	MISC	geometric	amod	4	SENT_118	[p8l81t3440r398b3492],
2	mean	NN	O	mean	nn	4	SENT_118	[p8l424t3457r588b3492],
3	warfarin	NN	O	warfarin	nn	4	SENT_118	[p8l613t3440r872b3492],
4	dose	NN	O	dose	dep	28	SENT_118	[p8l898t3440r1049b3503],
5	,	,	O	,	_	0	SENT_118	[p8l898t3440r1049b3503],
6	mg	NN	O	mg	appos	4	SENT_118	[p8l1077t3457r1170b3506],
7	per	IN	O	per	_	0	SENT_118	[p8l1195t3457r1292b3506],
8	day	NN	DURATION	day	prep_per	6	SENT_118	[p8l1318t3440r1442b3506],
9	,	,	O	,	_	0	SENT_118	[p8l1318t3440r1442b3506],
10	(	CD	NUMBER	(	num	12	SENT_118	[p8l1473t3440r1613b3506],
11	SD	NN	O	sd	nn	12	SENT_118	[p8l1473t3440r1613b3506],
12	)	NN	O	)	appos	8	SENT_118	[p8l1473t3440r1613b3506],
13	4.4	CD	NUMBER	4.4	num	14	SENT_118	[p8l1847t3441r1935b3492],
14	(	NN	O	(	dep	12	SENT_118	[p8l1963t3440r2095b3506],
15	1.5	CD	NUMBER	1.5	number	16	SENT_118	[p8l1963t3440r2095b3506],
16	)	CD	NUMBER	)	dep	12	SENT_118	[p8l1963t3440r2095b3506],
17	Body	NN	O	body	nn	19	SENT_118	[p8l81t3528r240b3594],
18	surface	NN	O	surface	nn	19	SENT_118	[p8l267t3528r479b3580],
19	area	NN	O	area	dep	16	SENT_118	[p8l507t3545r650b3591],
20	,	,	O	,	_	0	SENT_118	[p8l507t3545r650b3591],
21	in	IN	O	in	_	0	SENT_118	[p8l678t3528r735b3580],
22	m2	NN	O	m2	nn	23	SENT_118	[p8l760t3514r844b3580],
23	mean	NN	O	mean	prep_in	4	SENT_118	[p8l870t3545r1033b3580],
24	(	CD	NUMBER	(	num	23	SENT_118	[p8l1061t3528r1200b3594],
25	SD	NN	O	sd	dep	28	SENT_118	[p8l1061t3528r1200b3594],
26	)	CD	NUMBER	)	num	25	SENT_118	[p8l1061t3528r1200b3594],
27	2.05	CD	NUMBER	2.05	num	28	SENT_118	[p8l1831t3529r1952b3581],
28	(	NN	O	(	dep	35	SENT_118	[p8l1982t3528r2150b3594],
29	0.27	CD	NUMBER	0.27	num	31	SENT_118	[p8l1982t3528r2150b3594],
30	)	CD	NUMBER	)	num	31	SENT_118	[p8l1982t3528r2150b3594],
31	Smoker	NN	O	smoker	dep	28	SENT_118	[p8l82t3617r330b3680],
32	,	,	O	,	_	0	SENT_118	[p8l82t3617r330b3680],
33	n	NN	O	n	appos	31	SENT_118	[p8l359t3635r391b3669],
34	(	CD	PERCENT	(	num	35	SENT_118	[p8l420t3617r533b3684],
35	%	NN	PERCENT	%	dep	42	SENT_118	[p8l420t3617r533b3684],
36	)	CD	NUMBER	)	number	37	SENT_118	[p8l420t3617r533b3684],
37	57	CD	NUMBER	57	num	38	SENT_118	[p8l1869t3619r1933b3670],
38	(	NN	O	(	dep	35	SENT_118	[p8l1963t3617r2148b3684],
39	12	CD	PERCENT	12	number	40	SENT_118	[p8l1963t3617r2148b3684],
40	%	NN	PERCENT	%	amod	38	SENT_118	[p8l1963t3617r2148b3684],
41	)	CD	NUMBER	)	nsubj	42	SENT_118	[p8l1963t3617r2148b3684],
42	Takes	VBZ	O	take	dep	53	SENT_118	[p8l80t3706r258b3758],
43	statin	NN	O	statin	dobj	42	SENT_118	[p8l287t3706r468b3769],
44	,	,	O	,	_	0	SENT_118	[p8l287t3706r468b3769],
45	n	NN	O	n	dep	50	SENT_118	[p8l498t3724r530b3758],
46	(	CD	PERCENT	(	num	47	SENT_118	[p8l559t3706r672b3773],
47	%	NN	PERCENT	%	dep	45	SENT_118	[p8l559t3706r672b3773],
48	)	CD	NUMBER	)	dep	50	SENT_118	[p8l559t3706r672b3773],
49	53	CD	NUMBER	53	num	50	SENT_118	[p8l1869t3708r1931b3759],
50	(	NN	O	(	dep	53	SENT_118	[p8l1963t3706r2148b3773],
51	11	CD	PERCENT	11	num	52	SENT_118	[p8l1963t3706r2148b3773],
52	%	NN	PERCENT	%	dep	50	SENT_118	[p8l1963t3706r2148b3773],
53	)	CD	NUMBER	)	_	0	SENT_118	[p8l1963t3706r2148b3773],

1	Takes	VBZ	O	take	_	0	SENT_119	[p9l80t18r258b70],
2	amiodarone	NN	O	amiodarone	nsubj	10	SENT_119	[p9l286t18r665b81],
3	,	,	O	,	_	0	SENT_119	[p9l286t18r665b81],
4	n	NN	O	n	appos	2	SENT_119	[p9l693t36r725b70],
5	(	CD	PERCENT	(	num	6	SENT_119	[p9l754t18r868b84],
6	%	NN	PERCENT	%	dep	4	SENT_119	[p9l754t18r868b84],
7	)	CD	NUMBER	)	num	10	SENT_119	[p9l754t18r868b84],
8	o	NN	O	o	nn	10	SENT_119	[p9l1902t19r1934b71],
9	(	NN	O	(	nn	10	SENT_119	[p9l1963t18r2111b84],
10	o	NN	O	o	ccomp	1	SENT_119	[p9l1963t18r2111b84],
11	%	NN	O	%	nsubj	13	SENT_119	[p9l1963t18r2111b84],
12	)	CD	NUMBER	)	num	11	SENT_119	[p9l1963t18r2111b84],
13	Takes	VBZ	O	take	rcmod	10	SENT_119	[p9l80t107r258b159],
14	aspirin	NN	O	aspirin	dobj	13	SENT_119	[p9l286t107r507b173],
15	,	,	O	,	_	0	SENT_119	[p9l286t107r507b173],
16	n	NN	O	n	dobj	10	SENT_119	[p9l536t125r568b159],
17	(	CD	PERCENT	(	number	18	SENT_119	[p9l597t107r710b173],
18	%	NN	PERCENT	%	amod	16	SENT_119	[p9l597t107r710b173],
19	)	CD	NUMBER	)	number	20	SENT_119	[p9l597t107r710b173],
20	97	CD	NUMBER	97	dep	21	SENT_119	[p9l1867t108r1933b159],
21	(	NN	O	(	dep	16	SENT_119	[p9l1963t107r2148b173],
22	20	CD	PERCENT	20	number	23	SENT_119	[p9l1963t107r2148b173],
23	%	NN	PERCENT	%	amod	16	SENT_119	[p9l1963t107r2148b173],
24	)	CD	NUMBER	)	nsubj	1	SENT_119	[p9l1963t107r2148b173],

1	SD	NN	O	sd	_	0	SENT_120	[p9l11t252r121b315],
2	,	,	O	,	_	0	SENT_120	[p9l11t252r121b315],
3	standard	JJ	O	standard	amod	4	SENT_120	[p9l173t251r437b304],
4	deviation	NN	O	deviation	appos	1	SENT_120	[p9l486t251r783b315],
5	;	:	O	;	_	0	SENT_120	[p9l486t251r783b315],
6	VKORCI	NNP	LOCATION	VKORCI	dep	1	SENT_120	[p9l833t252r1155b315],
7	,	,	O	,	_	0	SENT_120	[p9l833t252r1155b315],
8	vitamin	NN	O	vitamin	nn	12	SENT_120	[p9l1204t251r1434b304],
9	K	NN	O	k	nn	12	SENT_120	[p9l1482t253r1538b303],
10	epoxide	NN	O	epoxide	nn	12	SENT_120	[p9l1586t251r1819b318],
11	reductase	NN	O	reductase	nn	12	SENT_120	[p9l1868t251r2152b304],
12	complex	NN	O	complex	appos	6	SENT_120	[p9l9t341r261b407],
13	1	CD	NUMBER	1	dep	12	SENT_120	[p9l293t342r336b404],
14	;	:	O	;	_	0	SENT_120	[p9l293t342r336b404],
15	CYP	NNP	O	CYP	dep	1	SENT_120	[p9l364t342r527b404],
16	,	,	O	,	_	0	SENT_120	[p9l364t342r527b404],
17	cytochrome	NN	O	cytochrome	nn	18	SENT_120	[p9l555t341r908b407],
18	P	NN	O	p	appos	15	SENT_120	[p9l934t343r974b392],
19	450	CD	NUMBER	450	dep	18	SENT_120	[p9l1000t342r1119b393],
20	.	.	O	.	_	0	SENT_120	[p9l1000t342r1119b393],

1	TThe	NN	O	tthe	nn	4	SENT_121	[p9l1150t326r1290b393],
2	VKORC1	NN	O	vkorc1	nn	4	SENT_121	[p9l1315t342r1613b393],
3	A	NN	O	a	nn	4	SENT_121	[p9l1644t341r1698b392],
4	haplotype	NN	O	haplotype	_	0	SENT_121	[p9l1722t340r2023b407],
5	can	MD	O	can	aux	7	SENT_121	[p9l2048t358r2152b393],
6	be	VB	O	be	auxpass	7	SENT_121	[p9l9t429r76b482],
7	detected	VBN	O	detect	dep	4	SENT_121	[p9l103t429r352b482],
8	by	IN	O	by	_	0	SENT_121	[p9l378t429r451b496],
9	-1639	CD	NUMBER	-1639	num	10	SENT_121	[p9l479t431r661b482],
10	G	NN	O	g	agent	7	SENT_121	[p9l690t430r745b482],
11	>	JJR	O	>	amod	12	SENT_121	[p9l785t439r825b474],
12	A.	NN	O	a.	dep	10	SENT_121	[p9l865t429r933b482],

1	8	CD	NUMBER	8	num	3	SENT_122	[p9l117t1004r171b1077],
2	o	NN	O	o	nn	3	SENT_122	[p9l311t1050r337b1075],
3	E	NN	O	e	_	0	SENT_122	[p9l117t1084r170b1132],
4	60	CD	PERCENT	60	number	5	SENT_122	[p9l231t1049r370b1102],
5	%	NN	PERCENT	%	amod	3	SENT_122	[p9l231t1049r370b1102],
6	:	:	O	:	_	0	SENT_122	[p9l231t1049r370b1102],
7	L	NN	O	l	dep	3	SENT_122	[p9l117t1137r171b1187],
8	‘	CD	NUMBER	‘	number	9	SENT_122	[p9l117t1137r171b1187],
9	5	CD	NUMBER	5	dep	7	SENT_122	[p9l130t1194r185b1303],
10	?	.	O	?	_	0	SENT_122	[p9l130t1194r185b1303],

1	Prior	RB	O	prior	advmod	2	SENT_123	[p9l1352t1208r1499b1261],
2	doses	NNS	O	dose	_	0	SENT_123	[p9l1520t1208r1707b1261],
3	C	NN	O	c	nn	6	SENT_123	[p9l130t1330r170b1361],
4	.9	CD	NUMBER	.9	num	6	SENT_123	[p9l117t1367r171b1416],
5	P	NN	O	p	nn	6	SENT_123	[p9l404t1405r435b1428],
6	g	NN	O	g	dep	2	SENT_123	[p9l404t1405r435b1428],
7	!	.	O	!	_	0	SENT_123	[p9l404t1405r435b1428],

1	+	CC	O	+	cc	2	SENT_124	[p9l404t1405r435b1428],
2	g	NN	O	g	_	0	SENT_124	[p9l117t1443r171b1517],
3	40	CD	PERCENT	40	number	5	SENT_124	[p9l231t1440r370b1492],
4	%	NN	PERCENT	%	dep	5	SENT_124	[p9l231t1440r370b1492],
5	d	NN	O	d	amod	2	SENT_124	[p9l425t1432r441b1455],
6	f	FW	O	f	dep	2	SENT_124	[p9l425t1432r441b1455],
7	!	.	O	!	_	0	SENT_124	[p9l425t1432r441b1455],

1	+	CC	O	+	cc	4	SENT_125	[p9l425t1432r441b1455],
2	‘	CD	NUMBER	‘	num	4	SENT_125	[p9l130t1523r171b1595],
3	§	NN	O	§	nn	4	SENT_125	[p9l130t1523r171b1595],
4	o	NN	O	o	dep	10	SENT_125	[p9l130t1618r171b1653],
5	)	CD	NUMBER	)	num	8	SENT_125	[p9l130t1618r171b1653],
6	(	NN	O	(	nn	8	SENT_125	[p9l130t1658r171b1690],
7	D	NN	O	d	nn	8	SENT_125	[p9l130t1658r171b1690],
8	O	NN	O	o	dep	4	SENT_125	[p9l130t1694r171b1729],
9	'	''	O	'	_	0	SENT_125	[p9l117t1735r171b1769],
10	C	NN	O	c	_	0	SENT_125	[p9l117t1735r171b1769],
11	3	CD	PERCENT	3	number	13	SENT_125	[p9l130t1813r171b1899],
12	20	CD	PERCENT	20	number	13	SENT_125	[p9l231t1830r370b1883],
13	%	NN	PERCENT	%	amod	14	SENT_125	[p9l231t1830r370b1883],
14	o	NN	O	o	npadvmod	15	SENT_125	[p9l118t1887r171b1932],
15	\	IN	O	\	dep	10	SENT_125	[p9l118t1887r171b1932],

1	Day	NN	DURATION	day	nn	3	SENT_126	[p9l329t2313r448b2381],
2	o	NN	O	o	nn	3	SENT_126	[p9l471t2314r506b2367],
3	Day	NN	DATE	day	_	0	SENT_126	[p9l837t2313r956b2381],
4	7	CD	DATE	7	num	5	SENT_126	[p9l979t2315r1015b2365],
5	Day	NN	DATE	day	dep	3	SENT_126	[p9l1325t2313r1444b2381],
6	14	CD	DATE	14	num	7	SENT_126	[p9l1471t2314r1543b2365],
7	Day	NN	DATE	day	dep	5	SENT_126	[p9l1833t2313r1952b2381],
8	21	CD	DATE	21	dep	3	SENT_126	[p9l1974t2314r2039b2365],

1	Fig	NN	O	fig	_	0	SENT_127	[p9l8t2472r116b2538],
2	.	.	O	.	_	0	SENT_127	[p9l8t2472r116b2538],

1	1	LS	NUMBER	1	_	0	SENT_128	[p9l147t2472r192b2524],
2	.	.	O	.	_	0	SENT_128	[p9l147t2472r192b2524],

1	Percentage	NN	O	percentage	nsubj	5	SENT_129	[p9l231t2473r546b2538],
2	of	IN	O	of	_	0	SENT_129	[p9l571t2471r635b2524],
3	dose	NN	O	dose	nn	4	SENT_129	[p9l651t2471r781b2524],
4	Variation	NN	O	variation	prep_of	1	SENT_129	[p9l803t2471r1065b2524],
5	explained	VBD	O	explain	_	0	SENT_129	[p9l1088t2471r1364b2538],
6	at	IN	O	at	_	0	SENT_129	[p9l1388t2479r1442b2524],
7	weekly	JJ	SET	weekly	amod	9	SENT_129	[p9l1464t2471r1663b2538],
8	time	NN	O	time	nn	9	SENT_129	[p9l1686t2471r1811b2524],
9	points	NNS	O	point	prep_at	5	SENT_129	[p9l1833t2471r2027b2538],
10	.	.	O	.	_	0	SENT_129	[p9l1833t2471r2027b2538],

1	Table	NNP	O	Table	nn	3	SENT_130	[p9l9t2716r169b2766],
2	2	CD	NUMBER	2	num	3	SENT_130	[p9l194t2715r227b2766],
3	Percentage	NN	O	percentage	nsubj	7	SENT_130	[p9l264t2716r578b2780],
4	of	IN	O	of	_	0	SENT_130	[p9l597t2714r662b2766],
5	dose	NN	O	dose	nn	6	SENT_130	[p9l672t2714r802b2766],
6	Variation	NN	O	variation	prep_of	3	SENT_130	[p9l819t2714r1081b2766],
7	explained	VBD	O	explain	_	0	SENT_130	[p9l1098t2714r1375b2780],
8	(	CD	NUMBER	(	num	11	SENT_130	[p9l1394t2714r1603b2780],
9	partial	JJ	O	partial	amod	11	SENT_130	[p9l1394t2714r1603b2780],
10	R2	NN	O	r2	nn	11	SENT_130	[p9l1623t2700r1718b2780],
11	)	NN	O	)	dobj	7	SENT_130	[p9l1623t2700r1718b2780],
12	at	IN	O	at	_	0	SENT_130	[p9l1739t2721r1793b2766],
13	weekly	JJ	SET	weekly	amod	15	SENT_130	[p9l1809t2714r2009b2780],
14	time	NN	O	time	nn	15	SENT_130	[p9l2026t2714r2151b2766],
15	points	NNS	O	point	prep_at	7	SENT_130	[p9l8t2803r187b2869],

1	Day	NN	DURATION	day	nn	2	SENT_131	[p9l434t2941r561b3005],
2	o	NN	O	o	dep	9	SENT_131	[p9l587t2941r619b2992],
3	(	CD	PERCENT	(	num	4	SENT_131	[p9l648t2939r761b3006],
4	%	NN	PERCENT	%	dep	2	SENT_131	[p9l648t2939r761b3006],
5	)	CD	NUMBER	)	num	6	SENT_131	[p9l648t2939r761b3006],
6	Day	NN	DURATION	day	dep	9	SENT_131	[p9l873t2941r1000b3005],
7	7	CD	PERCENT	7	num	9	SENT_131	[p9l1028t2941r1058b2992],
8	(	CD	PERCENT	(	num	9	SENT_131	[p9l1087t2939r1200b3006],
9	%	NN	PERCENT	%	dep	14	SENT_131	[p9l1087t2939r1200b3006],
10	)	CD	NUMBER	)	num	11	SENT_131	[p9l1087t2939r1200b3006],
11	Day	NN	DURATION	day	dep	9	SENT_131	[p9l1312t2941r1439b3005],
12	14	CD	PERCENT	14	num	14	SENT_131	[p9l1472t2940r1534b2991],
13	(	CD	PERCENT	(	num	14	SENT_131	[p9l1562t2939r1675b3006],
14	%	NN	PERCENT	%	dep	20	SENT_131	[p9l1562t2939r1675b3006],
15	)	CD	NUMBER	)	num	16	SENT_131	[p9l1562t2939r1675b3006],
16	Day	NN	DURATION	day	dep	14	SENT_131	[p9l1787t2941r1914b3005],
17	21	CD	PERCENT	21	number	18	SENT_131	[p9l1941t2940r2002b2991],
18	(	CD	PERCENT	(	num	19	SENT_131	[p9l2037t2939r2150b3006],
19	%	NN	PERCENT	%	dep	16	SENT_131	[p9l2037t2939r2150b3006],
20	)	CD	NUMBER	)	_	0	SENT_131	[p9l2037t2939r2150b3006],

1	Genetic	JJ	O	genetic	dep	21	SENT_132	[p9l10t3107r242b3160],
2	42.8	CD	NUMBER	42.8	number	3	SENT_132	[p9l433t3108r554b3160],
3	12.1	CD	NUMBER	12.1	num	5	SENT_132	[p9l879t3108r989b3159],
4	3.9	CD	NUMBER	3.9	number	5	SENT_132	[p9l1350t3108r1434b3160],
5	1.4	CD	NUMBER	1.4	dep	1	SENT_132	[p9l1829t3108r1910b3159],
6	Clinical	JJ	O	clinical	amod	8	SENT_132	[p9l10t3196r241b3249],
7	10.8	CD	NUMBER	10.8	number	8	SENT_132	[p9l441t3198r554b3249],
8	6.4	CD	NUMBER	6.4	dep	5	SENT_132	[p9l910t3198r996b3249],
9	2.2	CD	NUMBER	2.2	number	10	SENT_132	[p9l1347t3198r1435b3249],
10	1.9	CD	NUMBER	1.9	num	17	SENT_132	[p9l1829t3198r1908b3249],
11	INR	NN	O	inr	nn	17	SENT_132	[p9l9t3288r148b3338],
12	o	NN	O	o	nn	17	SENT_132	[p9l470t3287r501b3338],
13	31.7	CD	NUMBER	31.7	num	17	SENT_132	[p9l875t3287r995b3338],
14	19.1	CD	NUMBER	19.1	number	15	SENT_132	[p9l1319t3287r1429b3338],
15	5.1	CD	NUMBER	5.1	dep	16	SENT_132	[p9l1825t3287r1903b3338],
16	Prior	JJ	O	prior	dep	17	SENT_132	[p9l8t3374r163b3427],
17	dose	NN	O	dose	dep	8	SENT_132	[p9l190t3374r324b3427],
18	o	NN	O	o	dep	21	SENT_132	[p9l470t3376r501b3427],
19	18.0	CD	NUMBER	18.0	num	18	SENT_132	[p9l879t3376r995b3427],
20	50.3	CD	NUMBER	50.3	num	21	SENT_132	[p9l1315t3376r1432b3427],
21	68.6	CD	NUMBER	68.6	dep	26	SENT_132	[p9l1788t3376r1909b3427],
22	TOTAL	JJ	O	total	dep	21	SENT_132	[p9l9t3464r259b3516],
23	53.6	CD	NUMBER	53.6	number	24	SENT_132	[p9l437t3465r556b3516],
24	68.1	CD	NUMBER	68.1	dep	22	SENT_132	[p9l874t3465r989b3516],
25	75.4	CD	NUMBER	75.4	num	26	SENT_132	[p9l1313t3465r1435b3516],
26	77.0	CD	NUMBER	77.0	_	0	SENT_132	[p9l1788t3465r1909b3516],

1	were	VBD	O	be	cop	3	SENT_133	[p10l8t108r166b150],
2	2.6	CD	PERCENT	2.6	number	3	SENT_133	[p10l187t89r285b150],
3	(	CD	PERCENT	(	_	0	SENT_133	[p10l306t88r486b167],
4	95	CD	PERCENT	95	num	5	SENT_133	[p10l306t88r486b167],
5	%	NN	PERCENT	%	dep	3	SENT_133	[p10l306t88r486b167],
6	conﬁdence	NN	O	conﬁdence	nn	7	SENT_133	[p10l511t88r873b150],
7	interval	NN	O	interval	dep	13	SENT_133	[p10l891t88r1150b150],
8	[	CD	NUMBER	[	dep	7	SENT_133	[p10l1171t89r1295b166],
9	CI	NN	O	ci	dep	13	SENT_133	[p10l1171t89r1295b166],
10	]	CD	NUMBER	]	num	9	SENT_133	[p10l1171t89r1295b166],
11	1.9-3	CD	NUMBER	1.9-3	num	13	SENT_133	[p10l1325t88r1582b167],
12	.5	CD	NUMBER	.5	num	13	SENT_133	[p10l1325t88r1582b167],
13	)	NN	O	)	dep	24	SENT_133	[p10l1325t88r1582b167],
14	per	IN	O	per	_	0	SENT_133	[p10l1602t108r1712b167],
15	A	DT	O	a	det	16	SENT_133	[p10l1729t88r1792b149],
16	haplotype	NN	O	haplotype	prep_per	13	SENT_133	[p10l1810t88r2149b167],
17	of	IN	O	of	_	0	SENT_133	[p10l11t195r87b257],
18	VKORC1	NN	O	vkorc1	prep_of	16	SENT_133	[p10l109t196r453b257],
19	and	CC	O	and	_	0	SENT_133	[p10l494t194r622b257],
20	2.9	CD	PERCENT	2.9	number	21	SENT_133	[p10l654t196r751b257],
21	(	CD	PERCENT	(	dep	24	SENT_133	[p10l787t195r967b274],
22	95	CD	PERCENT	95	num	23	SENT_133	[p10l787t195r967b274],
23	%	NN	PERCENT	%	dep	21	SENT_133	[p10l787t195r967b274],
24	CI	NN	O	ci	dep	26	SENT_133	[p10l1007t196r1093b257],
25	2.0-4	CD	NUMBER	2.0-4	num	24	SENT_133	[p10l1127t195r1393b274],
26	.2	NN	NUMBER	.2	dep	3	SENT_133	[p10l1127t195r1393b274],
27	)	CD	NUMBER	)	num	26	SENT_133	[p10l1127t195r1393b274],
28	per	IN	O	per	_	0	SENT_133	[p10l1425t215r1536b274],
29	CYP2C9	NN	O	cyp2c9	nn	31	SENT_133	[p10l1569t196r1874b257],
30	variant	JJ	O	variant	amod	31	SENT_133	[p10l1908t195r2152b257],
31	allele	NN	O	allele	prep_per	26	SENT_133	[p10l10t301r197b363],
32	.	.	O	.	_	0	SENT_133	[p10l10t301r197b363],

1	The	DT	O	the	det	2	SENT_134	[p10l256t301r388b363],
2	odds	NNS	O	odds	nsubj	12	SENT_134	[p10l446t301r606b363],
3	of	IN	O	of	_	0	SENT_134	[p10l665t301r740b363],
4	over-anticoagulation	NN	O	over-anticoagulation	prep_of	2	SENT_134	[p10l789t301r1498b380],
5	also	RB	O	also	advmod	4	SENT_134	[p10l1554t301r1686b363],
6	signiﬁcantly	RB	O	signiﬁcantly	amod	9	SENT_134	[p10l1745t301r2152b380],
7	98	CD	NUMBER	98	tmod	6	SENT_134	[p10l9t423r93b480],
8	N.	NNP	PERSON	N.	nn	9	SENT_134	[p10l137t425r212b480],
9	Ferder	NNP	PERSON	Ferder	dep	4	SENT_134	[p10l246t422r466b480],
10	et	FW	O	et	nn	11	SENT_134	[p10l494t430r553b480],
11	al	FW	O	al	dep	9	SENT_134	[p10l584t422r641b480],
12	increased	VBN	O	increase	_	0	SENT_134	[p10l8t631r323b693],
13	with	IN	O	with	_	0	SENT_134	[p10l348t631r498b693],
14	increasing	VBG	O	increase	prepc_with	12	SENT_134	[p10l523t631r864b709],
15	age	NN	O	age	nn	17	SENT_134	[p10l891t651r1003b709],
16	(	CD	NUMBER	(	num	17	SENT_134	[p10l1032t632r1181b710],
17	OR	NN	O	or	iobj	14	SENT_134	[p10l1032t632r1181b710],
18	=	JJ	O	=	amod	23	SENT_134	[p10l1225t654r1276b672],
19	1.4	CD	NUMBER	1.4	tmod	18	SENT_134	[p10l1330t633r1438b706],
20	,	,	O	,	_	0	SENT_134	[p10l1330t633r1438b706],
21	95	CD	PERCENT	95	number	22	SENT_134	[p10l1469t633r1623b694],
22	%	NN	PERCENT	%	amod	23	SENT_134	[p10l1469t633r1623b694],
23	CI	NN	O	ci	dobj	14	SENT_134	[p10l1657t632r1741b693],
24	1.2-1	CD	NUMBER	1.2-1	num	25	SENT_134	[p10l1777t633r2008b693],
25	.7	CD	NUMBER	.7	dep	14	SENT_134	[p10l1777t633r2008b693],
26	per	IN	O	per	_	0	SENT_134	[p10l2034t651r2144b709],
27	decade	NN	DURATION	decade	prep_per	25	SENT_134	[p10l9t737r258b811],
28	,	,	O	,	_	0	SENT_134	[p10l9t737r258b811],
29	P	NN	O	p	appos	27	SENT_134	[p10l321t741r376b798],
30	<	VBG	O	<	partmod	29	SENT_134	[p10l420t748r467b788],
31	0.0001	CD	NUMBER	0.0001	num	32	SENT_134	[p10l515t737r777b815],
32	)	NN	O	)	dobj	30	SENT_134	[p10l515t737r777b815],
33	.	.	O	.	_	0	SENT_134	[p10l515t737r777b815],

1	Among	IN	O	among	_	0	SENT_135	[p10l839t737r1098b815],
2	patients	NNS	O	patient	prep_among	18	SENT_135	[p10l1156t737r1422b815],
3	with	IN	O	with	_	0	SENT_135	[p10l1480t737r1630b798],
4	at	IN	O	at	quantmod	6	SENT_135	[p10l1690t745r1754b798],
5	least	JJS	O	least	mwe	4	SENT_135	[p10l1811t737r1963b798],
6	one	CD	NUMBER	one	num	8	SENT_135	[p10l2023t757r2143b798],
7	supratherapeutic	JJ	O	supratherapeutic	amod	8	SENT_135	[p10l11t844r580b922],
8	INR	NN	O	inr	prep_with	2	SENT_135	[p10l624t846r801b918],
9	,	,	O	,	_	0	SENT_135	[p10l624t846r801b918],
10	patients	NNS	O	patient	nsubj	18	SENT_135	[p10l846t844r1113b922],
11	with	IN	O	with	_	0	SENT_135	[p10l1156t844r1306b905],
12	CYP2C9	NN	O	cyp2c9	nn	13	SENT_135	[p10l1351t845r1656b905],
13	variants	NNS	O	variant	prep_with	10	SENT_135	[p10l1700t844r1972b905],
14	and	CC	O	and	_	0	SENT_135	[p10l2017t844r2144b905],
15	VKORC1	NN	O	vkorc1	nsubj	18	SENT_135	[p10l7t950r350b1011],
16	A	DT	O	a	det	17	SENT_135	[p10l417t949r480b1010],
17	allele	NN	O	allele	dep	15	SENT_135	[p10l540t949r709b1011],
18	spent	VBD	O	spend	_	0	SENT_135	[p10l771t958r949b1027],
19	signiﬁcantly	RB	O	signiﬁcantly	advmod	20	SENT_135	[p10l1010t949r1415b1027],
20	more	JJR	O	more	amod	21	SENT_135	[p10l1472t969r1649b1011],
21	time	NN	O	time	dobj	18	SENT_135	[p10l1710t949r1856b1011],
22	in	IN	O	in	_	0	SENT_135	[p10l1916t949r1980b1010],
23	the	DT	O	the	det	25	SENT_135	[p10l2040t949r2143b1011],
24	supratherapeutic	JJ	O	supratherapeutic	amod	25	SENT_135	[p10l11t1055r581b1133],
25	range	NN	O	range	prep_in	18	SENT_135	[p10l636t1075r841b1133],
26	.	.	O	.	_	0	SENT_135	[p10l636t1075r841b1133],

1	(	NN	O	(	nn	2	SENT_136	[p10l903t1055r1128b1133],
2	Effect	NN	O	effect	_	0	SENT_136	[p10l903t1055r1128b1133],
3	per	IN	O	per	_	0	SENT_136	[p10l1182t1075r1292b1133],
4	allele/haplotype	NN	O	allele/haplotype	prep_per	2	SENT_136	[p10l1349t1055r1901b1133],
5	:	:	O	:	_	0	SENT_136	[p10l1349t1055r1901b1133],
6	5.8	CD	PERCENT	5.8	num	7	SENT_136	[p10l1965t1056r2138b1118],
7	%	NN	PERCENT	%	dep	2	SENT_136	[p10l1965t1056r2138b1118],
8	and	CC	O	and	_	0	SENT_136	[p10l10t1162r137b1223],
9	5.6	CD	PERCENT	5.6	num	10	SENT_136	[p10l196t1163r368b1224],
10	%	NN	PERCENT	%	dep	2	SENT_136	[p10l196t1163r368b1224],
11	absolute	JJ	O	absolute	amod	12	SENT_136	[p10l431t1162r714b1223],
12	increase	NN	O	increase	dep	10	SENT_136	[p10l769t1162r1040b1223],
13	in	IN	O	in	prep	12	SENT_136	[p10l1094t1162r1159b1222],
14	supratherapeutic	JJ	O	supratherapeutic	amod	15	SENT_136	[p10l1217t1162r1786b1240],
15	time	NN	O	time	dep	13	SENT_136	[p10l1842t1162r1988b1223],
16	for	IN	O	for	_	0	SENT_136	[p10l2044t1162r2145b1223],
17	CYP2C9	NN	O	cyp2c9	prep_for	15	SENT_136	[p10l10t1269r315b1329],
18	and	CC	O	and	_	0	SENT_136	[p10l351t1267r477b1329],
19	VKORC1	NN	O	vkorc1	dep	13	SENT_136	[p10l509t1269r878b1342],
20	,	,	O	,	_	0	SENT_136	[p10l509t1269r878b1342],
21	respectively	RB	O	respectively	advmod	19	SENT_136	[p10l914t1268r1351b1346],
22	.	.	O	.	_	0	SENT_136	[p10l914t1268r1351b1346],
23	)	SYM	O	)	dep	12	SENT_136	[p10l914t1268r1351b1346],

1	Older	JJR	O	older	amod	2	SENT_137	[p10l1386t1267r1579b1329],
2	age	NN	O	age	nsubjpass	4	SENT_137	[p10l1612t1288r1724b1346],
3	was	VBD	O	be	auxpass	4	SENT_137	[p10l1756t1288r1884b1329],
4	associated	VBN	O	associate	_	0	SENT_137	[p10l1919t1268r2142b1329, p10l10t1374r153b1435],
5	with	IN	O	with	_	0	SENT_137	[p10l186t1374r337b1435],
6	increased	VBN	O	increase	amod	9	SENT_137	[p10l370t1374r684b1435],
7	supratherapeutic	JJ	O	supratherapeutic	amod	9	SENT_137	[p10l721t1374r1290b1452],
8	time	NN	O	time	nn	9	SENT_137	[p10l1325t1374r1471b1435],
9	(	NN	O	(	prep_with	4	SENT_137	[p10l1508t1374r1708b1452],
10	4.0	CD	PERCENT	4.0	num	11	SENT_137	[p10l1508t1374r1708b1452],
11	%	NN	PERCENT	%	npadvmod	9	SENT_137	[p10l1508t1374r1708b1452],
12	per	IN	O	per	_	0	SENT_137	[p10l1747t1394r1858b1452],
13	decade	NN	DURATION	decade	prep_per	9	SENT_137	[p10l1891t1374r2141b1448],
14	,	,	O	,	_	0	SENT_137	[p10l1891t1374r2141b1448],
15	P	NN	O	p	appos	13	SENT_137	[p10l9t1483r64b1540],
16	=	JJ	O	=	amod	18	SENT_137	[p10l106t1502r156b1520],
17	0.0003	CD	NUMBER	0.0003	tmod	16	SENT_137	[p10l202t1480r464b1557],
18	)	NN	O	)	dep	15	SENT_137	[p10l202t1480r464b1557],
19	.	.	O	.	_	0	SENT_137	[p10l202t1480r464b1557],

1	Discussion	NN	O	discussion	_	0	SENT_138	[p10l13t1718r402b1778],

1	This	DT	O	this	det	2	SENT_139	[p10l9t1875r156b1937],
2	study	NN	O	study	nsubj	3	SENT_139	[p10l216t1875r400b1953],
3	quantiﬁes	VBZ	O	quantiﬁes	_	0	SENT_139	[p10l457t1875r785b1953],
4	the	DT	O	the	det	7	SENT_139	[p10l844t1875r947b1937],
5	decreasing	VBG	O	decrease	amod	7	SENT_139	[p10l1005t1875r1360b1953],
6	predictive	JJ	O	predictive	amod	7	SENT_139	[p10l1416t1875r1747b1953],
7	ability	NN	O	ability	dobj	3	SENT_139	[p10l1806t1875r2018b1953],
8	of	IN	O	of	_	0	SENT_139	[p10l2077t1875r2152b1937],
9	CYP2C9	NN	O	cyp2c9	nn	12	SENT_139	[p10l10t1982r315b2043],
10	and	CC	O	and	_	0	SENT_139	[p10l349t1981r476b2043],
11	VKORC1	NN	O	vkorc1	nn	12	SENT_139	[p10l506t1982r849b2043],
12	genotype	NN	O	genotype	prep_of	7	SENT_139	[p10l889t1990r1196b2059],
13	during	IN	O	during	_	0	SENT_139	[p10l1229t1981r1452b2059],
14	the	DT	DURATION	the	det	16	SENT_139	[p10l1483t1981r1587b2043],
15	initial	JJ	DURATION	initial	amod	16	SENT_139	[p10l1618t1981r1811b2043],
16	weeks	NNS	DURATION	week	prep_during	7	SENT_139	[p10l1841t1981r2043b2043],
17	of	IN	O	of	_	0	SENT_139	[p10l2077t1981r2153b2043],
18	warfarin	NN	O	warfarin	nn	19	SENT_139	[p10l8t2087r299b2149],
19	therapy	NN	O	therapy	prep_of	16	SENT_139	[p10l332t2087r608b2165],
20	.	.	O	.	_	0	SENT_139	[p10l332t2087r608b2165],

1	While	IN	O	while	mark	9	SENT_140	[p10l644t2087r846b2149],
2	the	DT	O	the	det	4	SENT_140	[p10l881t2087r983b2149],
3	overall	JJ	O	overall	amod	4	SENT_140	[p10l1019t2087r1247b2149],
4	accuracy	NN	O	accuracy	nsubj	9	SENT_140	[p10l1281t2107r1580b2165],
5	of	IN	O	of	_	0	SENT_140	[p10l1614t2087r1690b2149],
6	the	DT	O	the	det	8	SENT_140	[p10l1715t2087r1818b2149],
7	pharmacogenetic	JJ	O	pharmacogenetic	amod	8	SENT_140	[p10l1851t2087r2142b2165, p10l8t2194r324b2272],
8	model	NN	O	model	prep_of	4	SENT_140	[p10l343t2194r555b2255],
9	improved	VBN	O	improve	advcl	22	SENT_140	[p10l575t2194r902b2272],
10	over	IN	O	over	_	0	SENT_140	[p10l925t2214r1072b2255],
11	time	NN	O	time	prep_over	9	SENT_140	[p10l1093t2194r1258b2268],
12	,	,	O	,	_	0	SENT_140	[p10l1093t2194r1258b2268],
13	the	DT	O	the	det	15	SENT_140	[p10l1282t2194r1386b2255],
14	incremental	JJ	O	incremental	amod	15	SENT_140	[p10l1407t2194r1805b2255],
15	beneﬁt	NN	O	beneﬁt	nsubj	22	SENT_140	[p10l1826t2194r2055b2255],
16	of	IN	O	of	_	0	SENT_140	[p10l2077t2194r2153b2255],
17	knowing	VBG	O	know	prepc_of	15	SENT_140	[p10l9t2299r306b2378],
18	a	DT	O	a	det	19	SENT_140	[p10l334t2320r371b2361],
19	patient	NN	O	patient	poss	21	SENT_140	[p10l397t2300r679b2378],
20	’s	POS	O	’s	_	0	SENT_140	[p10l397t2300r679b2378],
21	genotype	NN	O	genotype	dobj	17	SENT_140	[p10l708t2308r1015b2378],
22	decreased	VBD	O	decrease	_	0	SENT_140	[p10l1044t2299r1371b2361],
23	over	IN	O	over	_	0	SENT_140	[p10l1399t2320r1547b2361],
24	time	NN	O	time	nn	26	SENT_140	[p10l1574t2300r1721b2361],
25	(	CD	NUMBER	(	num	26	SENT_140	[p10l1750t2300r1903b2378],
26	Fig	NN	O	fig	prep_over	22	SENT_140	[p10l1750t2300r1903b2378],
27	.	.	O	.	_	0	SENT_140	[p10l1750t2300r1903b2378],

1	1	CD	NUMBER	1	_	0	SENT_141	[p10l1947t2300r2019b2378],
2	)	NN	O	)	dep	1	SENT_141	[p10l1947t2300r2019b2378],
3	.	.	O	.	_	0	SENT_141	[p10l1947t2300r2019b2378],

1	While	IN	O	while	mark	4	SENT_142	[p10l92t2405r294b2467],
2	some	DT	O	some	det	3	SENT_142	[p10l316t2425r489b2467],
3	experts	NNS	O	expert	nsubj	4	SENT_142	[p10l510t2413r749b2483],
4	argue	VBP	O	argue	advcl	23	SENT_142	[p10l771t2425r958b2483],
5	that	IN	O	that	complm	9	SENT_142	[p10l979t2405r1115b2467],
6	pharinaco	JJ	O	pharinaco	amod	8	SENT_142	[p10l1133t2405r1477b2483],
7	genetic	JJ	O	genetic	amod	8	SENT_142	[p10l1481t2405r1716b2483],
8	information	NN	O	information	nsubj	9	SENT_142	[p10l1735t2405r2144b2467],
9	has	VBZ	O	have	ccomp	4	SENT_142	[p10l9t2511r121b2572],
10	a	DT	O	a	det	12	SENT_142	[p10l150t2531r188b2572],
11	promising	JJ	O	promising	amod	12	SENT_142	[p10l213t2511r557b2589],
12	future	NN	DATE	future	nn	20	SENT_142	[p10l583t2511r788b2572],
13	for	IN	O	for	_	0	SENT_142	[p10l815t2511r916b2572],
14	patients	NNS	O	patient	prep_for	12	SENT_142	[p10l941t2511r1206b2589],
15	on	IN	O	on	_	0	SENT_142	[p10l1236t2531r1322b2572],
16	warfarin	NN	O	warfarin	prep_on	14	SENT_142	[p10l1348t2511r1639b2572],
17	[	CD	NUMBER	[	num	16	SENT_142	[p10l1668t2512r1904b2588],
18	20,2	CD	NUMBER	20,2	num	19	SENT_142	[p10l1668t2512r1904b2588],
19	l	NN	O	l	tmod	14	SENT_142	[p10l1668t2512r1904b2588],
20	]	NN	O	]	dobj	9	SENT_142	[p10l1668t2512r1904b2588],
21	,	,	O	,	_	0	SENT_142	[p10l1668t2512r1904b2588],
22	others	NNS	O	other	nsubj	23	SENT_142	[p10l1936t2511r2142b2572],
23	argue	VBP	O	argue	_	0	SENT_142	[p10l10t2638r197b2696],
24	that	IN	O	that	complm	27	SENT_142	[p10l222t2618r357b2679],
25	genetic	JJ	O	genetic	amod	26	SENT_142	[p10l381t2618r615b2696],
26	information	NN	O	information	nsubj	27	SENT_142	[p10l638t2618r1048b2679],
27	adds	VBZ	O	add	ccomp	23	SENT_142	[p10l1072t2617r1228b2679],
28	little	JJ	O	little	amod	30	SENT_142	[p10l1252t2618r1400b2679],
29	incremental	JJ	O	incremental	amod	30	SENT_142	[p10l1423t2618r1823b2679],
30	information	NN	O	information	dobj	27	SENT_142	[p10l1845t2618r2143b2679, p10l9t2723r143b2785],
31	once	RB	DATE	once	advmod	36	SENT_142	[p10l171t2743r327b2785],
32	INR	NN	O	inr	nn	33	SENT_142	[p10l354t2726r514b2784],
33	response	NN	O	response	nsubj	36	SENT_142	[p10l539t2743r832b2801],
34	is	VBZ	O	be	cop	36	SENT_142	[p10l858t2723r908b2785],
35	available	JJ	O	available	amod	36	SENT_142	[p10l936t2723r1235b2785],
36	[	NN	O	[	dep	27	SENT_142	[p10l1265t2724r1520b2800],
37	22	CD	NUMBER	22	number	38	SENT_142	[p10l1265t2724r1520b2800],
38	—	CD	NUMBER	—	dep	36	SENT_142	[p10l1265t2724r1520b2800],
39	25	CD	NUMBER	25	num	40	SENT_142	[p10l1265t2724r1520b2800],
40	]	NN	O	]	dep	38	SENT_142	[p10l1265t2724r1520b2800],
41	.	.	O	.	_	0	SENT_142	[p10l1265t2724r1520b2800],

1	Our	PRP$	O	we	poss	2	SENT_143	[p10l1552t2724r1687b2785],
2	observations	NNS	O	observation	nsubj	3	SENT_143	[p10l1715t2723r2143b2785],
3	suggest	VBP	O	suggest	_	0	SENT_143	[p10l11t2838r255b2907],
4	that	IN	O	that	complm	9	SENT_143	[p10l280t2829r416b2891],
5	both	CC	O	both	advmod	9	SENT_143	[p10l440t2829r599b2891],
6	opinions	NNS	O	opinion	nsubj	9	SENT_143	[p10l625t2829r916b2907],
7	may	MD	O	may	aux	9	SENT_143	[p10l941t2849r1089b2907],
8	be	VB	O	be	cop	9	SENT_143	[p10l1113t2829r1190b2891],
9	valid	JJ	O	valid	ccomp	3	SENT_143	[p10l1216t2829r1397b2891],
10	.	.	O	.	_	0	SENT_143	[p10l1216t2829r1397b2891],

1	On	IN	O	on	_	0	SENT_144	[p10l1428t2831r1533b2891],
2	the	DT	O	the	det	4	SENT_144	[p10l1558t2829r1661b2891],
3	one	CD	NUMBER	one	num	4	SENT_144	[p10l1688t2849r1809b2891],
4	hand	NN	O	hand	prep_on	7	SENT_144	[p10l1834t2829r2024b2904],
5	,	,	O	,	_	0	SENT_144	[p10l1834t2829r2024b2904],
6	we	PRP	O	we	nsubj	7	SENT_144	[p10l2051t2849r2144b2891],
7	found	VBD	O	find	_	0	SENT_144	[p10l9t2935r212b2997],
8	that	IN	O	that	complm	19	SENT_144	[p10l244t2935r380b2997],
9	after	IN	O	after	dep	19	SENT_144	[p10l411t2935r567b2997],
10	7	CD	DURATION	7	num	11	SENT_144	[p10l600t2938r635b2997],
11	days	NNS	NUMBER	day	nsubj	19	SENT_144	[p10l667t2935r819b3013],
12	of	IN	O	of	_	0	SENT_144	[p10l853t2935r929b2997],
13	warfarin	NN	O	warfarin	prep_of	11	SENT_144	[p10l952t2935r1260b3009],
14	,	,	O	,	_	0	SENT_144	[p10l952t2935r1260b3009],
15	CYP2C9	NN	O	cyp2c9	prep_of	11	SENT_144	[p10l1296t2936r1601b2997],
16	and	CC	O	and	_	0	SENT_144	[p10l1636t2935r1762b2997],
17	VKORC1	NN	O	vkorc1	prep_of	11	SENT_144	[p10l1793t2936r2136b2997],
18	still	RB	O	still	advmod	19	SENT_144	[p10l11t3042r126b3103],
19	account	VBP	O	account	ccomp	7	SENT_144	[p10l168t3050r435b3103],
20	for	IN	O	for	_	0	SENT_144	[p10l475t3042r575b3103],
21	substantial	JJ	O	substantial	amod	22	SENT_144	[p10l616t3042r982b3103],
22	(	NN	O	(	prep_for	19	SENT_144	[p10l1024t3042r1234b3120],
23	12	CD	PERCENT	12	number	24	SENT_144	[p10l1024t3042r1234b3120],
24	%	NN	PERCENT	%	amod	22	SENT_144	[p10l1024t3042r1234b3120],
25	)	CD	NUMBER	)	num	26	SENT_144	[p10l1024t3042r1234b3120],
26	variability	NN	O	variability	dobj	19	SENT_144	[p10l1275t3042r1620b3120],
27	in	IN	O	in	_	0	SENT_144	[p10l1659t3042r1724b3102],
28	therapeutic	JJ	O	therapeutic	amod	29	SENT_144	[p10l1764t3042r2145b3120],
29	dose	NN	O	dose	prep_in	26	SENT_144	[p10l9t3147r178b3209],
30	.	.	O	.	_	0	SENT_144	[p10l9t3147r178b3209],

1	Although	IN	O	although	mark	5	SENT_145	[p10l217t3147r546b3226],
2	genotype	NN	O	genotype	nsubj	5	SENT_145	[p10l581t3156r888b3226],
3	is	VBZ	O	be	cop	5	SENT_145	[p10l924t3148r973b3209],
4	more	RBR	O	more	advmod	5	SENT_145	[p10l1008t3168r1185b3209],
5	predictive	JJ	O	predictive	advcl	23	SENT_145	[p10l1220t3147r1551b3226],
6	before	IN	O	before	_	0	SENT_145	[p10l1587t3147r1801b3209],
7	initiation	NN	O	initiation	prep_before	5	SENT_145	[p10l1836t3148r2145b3209],
8	(	CD	PERCENT	(	num	10	SENT_145	[p10l10t3253r240b3331],
9	43	CD	PERCENT	43	num	10	SENT_145	[p10l10t3253r240b3331],
10	%	NN	PERCENT	%	tmod	5	SENT_145	[p10l10t3253r240b3331],
11	)	CD	NUMBER	)	dep	10	SENT_145	[p10l10t3253r240b3331],
12	,	,	O	,	_	0	SENT_145	[p10l10t3253r240b3331],
13	the	DT	O	the	det	16	SENT_145	[p10l262t3253r365b3315],
14	increased	VBN	O	increase	amod	16	SENT_145	[p10l384t3253r699b3315],
15	predictive	JJ	O	predictive	amod	16	SENT_145	[p10l717t3253r1048b3331],
16	ability	NN	O	ability	nsubj	23	SENT_145	[p10l1069t3253r1280b3331],
17	it	PRP	O	it	nsubj	18	SENT_145	[p10l1298t3253r1345b3314],
18	adds	VBZ	O	add	rcmod	16	SENT_145	[p10l1364t3253r1520b3315],
19	after	IN	O	after	_	0	SENT_145	[p10l1542t3253r1697b3315],
20	7	CD	DURATION	7	num	21	SENT_145	[p10l1717t3256r1753b3315],
21	days	NNS	NUMBER	day	prep_after	18	SENT_145	[p10l1785t3253r1937b3331],
22	could	MD	O	could	aux	23	SENT_145	[p10l1956t3253r2145b3315],
23	help	VB	O	help	_	0	SENT_145	[p10l9t3359r151b3437],
24	clinically	RB	O	clinically	advmod	23	SENT_145	[p10l171t3359r485b3437],
25	.	.	O	.	_	0	SENT_145	[p10l171t3359r485b3437],

1	In	IN	O	in	_	0	SENT_146	[p10l509t3361r583b3420],
2	particular	JJ	O	particular	prep_in	8	SENT_146	[p10l601t3359r951b3437],
3	,	,	O	,	_	0	SENT_146	[p10l601t3359r951b3437],
4	some	DT	O	some	det	5	SENT_146	[p10l976t3379r1149b3420],
5	outpatients	NNS	O	outpatient	nsubj	8	SENT_146	[p10l1172t3359r1550b3437],
6	do	VBP	O	do	aux	8	SENT_146	[p10l1571t3359r1656b3420],
7	not	RB	O	not	neg	8	SENT_146	[p10l1677t3368r1791b3420],
8	have	VB	O	have	dep	11	SENT_146	[p10l1810t3359r1969b3420],
9	their	PRP$	O	they	poss	10	SENT_146	[p10l1989t3359r2145b3420],
10	INRs	NNS	O	inr	dobj	8	SENT_146	[p10l9t3468r197b3527],
11	checked	VBD	O	check	_	0	SENT_146	[p10l239t3465r511b3527],
12	until	IN	O	until	mark	17	SENT_146	[p10l551t3466r707b3527],
13	a	DT	DURATION	a	det	14	SENT_146	[p10l748t3486r785b3527],
14	week	NN	DURATION	week	nsubj	17	SENT_146	[p10l824t3465r997b3527],
15	after	IN	O	after	_	0	SENT_146	[p10l1038t3466r1194b3527],
16	therapy	NN	O	therapy	prep_after	14	SENT_146	[p10l1234t3466r1494b3544],
17	begins	VBZ	O	begin	advcl	11	SENT_146	[p10l1533t3465r1746b3544],
18	[	RB	O	[	advmod	17	SENT_146	[p10l1791t3467r2027b3543],
19	26,27	CD	NUMBER	26,27	num	20	SENT_146	[p10l1791t3467r2027b3543],
20	]	NN	O	]	nsubj	11	SENT_146	[p10l1791t3467r2027b3543],
21	,	,	O	,	_	0	SENT_146	[p10l1791t3467r2027b3543],
22	so	RB	O	so	advmod	23	SENT_146	[p10l2072t3486r2142b3527],
23	improving	VBG	O	improve	dep	11	SENT_146	[p10l8t3571r361b3649],
24	the	DT	O	the	det	25	SENT_146	[p10l387t3571r490b3633],
25	accuracy	NN	O	accuracy	dobj	23	SENT_146	[p10l517t3591r814b3649],
26	of	IN	O	of	_	0	SENT_146	[p10l841t3571r917b3633],
27	dose	NN	O	dose	nn	28	SENT_146	[p10l934t3571r1086b3633],
28	reﬁnements	NNS	O	reﬁnements	prep_of	25	SENT_146	[p10l1113t3571r1503b3633],
29	made	VBN	O	make	partmod	28	SENT_146	[p10l1528t3571r1714b3633],
30	after	IN	O	after	mark	34	SENT_146	[p10l1742t3571r1897b3633],
31	7	CD	DURATION	7	num	32	SENT_146	[p10l1923t3574r1959b3633],
32	days	NNS	NUMBER	day	nsubj	34	SENT_146	[p10l1990t3571r2142b3649],
33	might	MD	O	might	aux	34	SENT_146	[p10l7t3678r207b3756],
34	prevent	VB	O	prevent	advcl	29	SENT_146	[p10l230t3686r486b3756],
35	adverse	JJ	O	adverse	amod	36	SENT_146	[p10l512t3677r764b3739],
36	events	NNS	O	event	dobj	34	SENT_146	[p10l790t3686r1016b3739],
37	.	.	O	.	_	0	SENT_146	[p10l790t3686r1016b3739],

1	Without	IN	O	without	_	0	SENT_147	[p10l1044t3677r1333b3739],
2	genetic	JJ	O	genetic	amod	3	SENT_147	[p10l1357t3678r1592b3756],
3	dosing	NN	O	dosing	prep_without	10	SENT_147	[p10l1616t3677r1857b3756],
4	,	,	O	,	_	0	SENT_147	[p10l1616t3677r1857b3756],
5	the	DT	O	the	det	6	SENT_147	[p10l1885t3677r1989b3739],
6	rate	NN	O	rate	nsubj	10	SENT_147	[p10l2013t3686r2144b3739],
7	of	IN	O	of	_	0	SENT_147	[p11l10t20r86b82],
8	hemorrhage	NN	O	hemorrhage	prep_of	6	SENT_147	[p11l99t20r511b98],
9	is	VBZ	O	be	cop	10	SENT_147	[p11l533t20r582b82],
10	highest	JJS	O	highest	_	0	SENT_147	[p11l605t20r846b98],
11	during	IN	O	during	_	0	SENT_147	[p11l867t20r1091b98],
12	the	DT	DURATION	the	det	14	SENT_147	[p11l1113t20r1216b82],
13	initial	JJ	DURATION	initial	amod	14	SENT_147	[p11l1238t20r1431b82],
14	weeks	NNS	DURATION	week	prep_during	10	SENT_147	[p11l1452t20r1654b82],
15	of	IN	O	of	_	0	SENT_147	[p11l1679t20r1755b82],
16	therapy	NN	O	therapy	prep_of	14	SENT_147	[p11l1769t20r2045b98],
17	,	,	O	,	_	0	SENT_147	[p11l1769t20r2045b98],
18	so	RB	O	so	advmod	10	SENT_147	[p11l2072t40r2142b82],
19	pharmacogenetic	JJ	O	pharmacogenetic	amod	21	SENT_147	[p11l8t127r591b205],
20	dose	NN	O	dose	nn	21	SENT_147	[p11l620t127r773b188],
21	adjustments	NNS	O	adjustment	nsubj	26	SENT_147	[p11l804t127r1211b205],
22	at	IN	O	at	_	0	SENT_147	[p11l1242t135r1306b188],
23	this	DT	O	this	det	24	SENT_147	[p11l1336t127r1455b188],
24	time	NN	O	time	prep_at	21	SENT_147	[p11l1486t127r1633b188],
25	might	MD	O	might	aux	26	SENT_147	[p11l1661t127r1861b205],
26	prevent	VB	O	prevent	ccomp	10	SENT_147	[p11l1890t135r2145b205],
27	hemorrhages	NNS	O	hemorrhage	dobj	26	SENT_147	[p11l9t232r466b311],
28	.	.	O	.	_	0	SENT_147	[p11l9t232r466b311],

1	In	IN	O	in	_	0	SENT_148	[p11l502t235r575b293],
2	a	DT	O	a	det	3	SENT_148	[p11l605t253r643b294],
3	trial	NN	O	trial	nsubj	7	SENT_148	[p11l673t233r810b294],
4	of	IN	O	of	_	0	SENT_148	[p11l841t233r917b294],
5	Israeli	JJ	MISC	israeli	amod	6	SENT_148	[p11l939t233r1144b294],
6	patients	NNS	O	patient	prep_of	3	SENT_148	[p11l1173t233r1439b311],
7	beginning	VBG	O	begin	prepc_in	23	SENT_148	[p11l1470t232r1803b311],
8	warfarin	NN	O	warfarin	dobj	7	SENT_148	[p11l1832t233r2140b307],
9	,	,	O	,	_	0	SENT_148	[p11l1832t233r2140b307],
10	95	CD	NUMBER	95	num	11	SENT_148	[p11l10t340r85b400],
11	patients	NNS	O	patient	nsubj	23	SENT_148	[p11l109t338r375b416],
12	randomized	VBN	O	randomize	partmod	11	SENT_148	[p11l398t338r804b400],
13	to	TO	O	to	_	0	SENT_148	[p11l826t347r893b400],
14	pharmacogenetic	JJ	O	pharmacogenetic	amod	15	SENT_148	[p11l915t338r1499b416],
15	dosing	NN	O	dosing	prep_to	12	SENT_148	[p11l1521t338r1744b416],
16	for	IN	O	for	_	0	SENT_148	[p11l1766t338r1867b400],
17	the	DT	O	the	det	18	SENT_148	[p11l1888t338r1991b400],
18	ﬁrst	NN	O	ﬁrst	prep_for	15	SENT_148	[p11l2013t338r2145b399],
19	8	CD	DURATION	8	num	20	SENT_148	[p11l11t446r44b505],
20	days	NNS	NUMBER	day	tmod	18	SENT_148	[p11l78t444r230b522],
21	of	IN	O	of	_	0	SENT_148	[p11l265t444r340b505],
22	therapy	NN	O	therapy	prep_of	18	SENT_148	[p11l365t444r624b522],
23	had	VBD	O	have	_	0	SENT_148	[p11l655t444r783b505],
24	fewer	JJR	O	fewer	amod	26	SENT_148	[p11l816t444r999b505],
25	minor	JJ	O	minor	amod	26	SENT_148	[p11l1030t444r1237b505],
26	hemorrhages	NNS	O	hemorrhage	dobj	23	SENT_148	[p11l1269t444r1709b522],
27	than	IN	O	than	_	0	SENT_148	[p11l1743t444r1897b505],
28	the	DT	O	the	det	30	SENT_148	[p11l1929t444r2032b505],
29	96	CD	NUMBER	96	num	30	SENT_148	[p11l2066t445r2142b505],
30	patients	NNS	O	patient	prep_than	23	SENT_148	[p11l8t551r274b629],
31	dosed	VBN	O	dose	partmod	30	SENT_148	[p11l297t550r494b612],
32	using	VBG	O	use	xcomp	31	SENT_148	[p11l514t551r694b629],
33	a	DT	O	a	det	38	SENT_148	[p11l717t571r754b612],
34	clinical	JJ	O	clinical	amod	38	SENT_148	[p11l775t551r1012b612],
35	algorithm	NN	O	algorithm	nn	38	SENT_148	[p11l1034t551r1368b629],
36	[	CD	NUMBER	[	number	37	SENT_148	[p11l1391t552r1526b628],
37	21	CD	NUMBER	21	num	38	SENT_148	[p11l1391t552r1526b628],
38	]	NN	O	]	dobj	32	SENT_148	[p11l1391t552r1526b628],
39	,	,	O	,	_	0	SENT_148	[p11l1391t552r1526b628],
40	but	CC	O	but	_	0	SENT_148	[p11l1551t550r1666b612],
41	other	JJ	O	other	amod	42	SENT_148	[p11l1688t550r1866b612],
42	trials	NNS	O	trial	nsubj	48	SENT_148	[p11l1887t551r2053b612],
43	of	IN	O	of	_	0	SENT_148	[p11l2077t550r2152b612],
44	pharrnacogenetic	JJ	O	pharrnacogenetic	amod	45	SENT_148	[p11l8t656r591b734],
45	dosing	NN	O	dosing	prep_of	42	SENT_148	[p11l648t656r871b734],
46	have	VBP	O	have	aux	48	SENT_148	[p11l927t656r1085b718],
47	not	RB	O	not	neg	48	SENT_148	[p11l1142t665r1256b718],
48	prevented	VBN	O	prevent	conj_but	23	SENT_148	[p11l1311t656r1646b734],
49	hemorrhages	NNS	O	hemorrhage	nsubj	50	SENT_148	[p11l1702t656r2143b734],
50	[	VBP	O	[	ccomp	48	SENT_148	[p11l11t764r246b840],
51	28,29	CD	NUMBER	28,29	number	52	SENT_148	[p11l11t764r246b840],
52	]	CD	NUMBER	]	dobj	50	SENT_148	[p11l11t764r246b840],
53	.	.	O	.	_	0	SENT_148	[p11l11t764r246b840],

1	On	IN	O	on	_	0	SENT_149	[p11l95t869r200b930],
2	the	DT	O	the	det	4	SENT_149	[p11l233t868r337b930],
3	other	JJ	O	other	amod	4	SENT_149	[p11l372t868r550b930],
4	hand	NN	O	hand	prep_on	7	SENT_149	[p11l582t868r773b942],
5	,	,	O	,	_	0	SENT_149	[p11l582t868r773b942],
6	we	PRP	O	we	nsubj	7	SENT_149	[p11l808t888r901b930],
7	found	VBD	O	find	_	0	SENT_149	[p11l934t868r1137b930],
8	that	IN	O	that	complm	23	SENT_149	[p11l1171t868r1307b930],
9	as	IN	O	as	mark	17	SENT_149	[p11l1341t888r1408b930],
10	INR	NN	O	inr	nn	11	SENT_149	[p11l1442t871r1602b929],
11	results	NNS	O	result	nsubj	17	SENT_149	[p11l1634t868r1850b930],
12	become	VBP	O	become	cop	17	SENT_149	[p11l1885t868r2144b930],
13	available	JJ	O	available	amod	17	SENT_149	[p11l10t975r309b1036],
14	during	IN	O	during	_	0	SENT_149	[p11l333t975r557b1053],
15	the	DT	O	the	det	16	SENT_149	[p11l579t975r682b1036],
16	ﬁrst	NN	O	ﬁrst	prep_during	13	SENT_149	[p11l705t975r836b1036],
17	weeks	NNS	DURATION	week	advcl	23	SENT_149	[p11l857t975r1059b1036],
18	of	IN	O	of	_	0	SENT_149	[p11l1085t975r1160b1036],
19	therapy	NN	O	therapy	prep_of	17	SENT_149	[p11l1175t975r1452b1053],
20	,	,	O	,	_	0	SENT_149	[p11l1175t975r1452b1053],
21	genetic	JJ	O	genetic	amod	22	SENT_149	[p11l1478t975r1712b1053],
22	information	NN	O	information	nsubj	23	SENT_149	[p11l1734t975r2144b1036],
23	provides	VBZ	O	provide	ccomp	7	SENT_149	[p11l8t1080r297b1159],
24	a	DT	O	a	det	26	SENT_149	[p11l325t1101r363b1142],
25	lower	JJR	O	lower	amod	26	SENT_149	[p11l389t1081r577b1142],
26	degree	NN	O	degree	dobj	23	SENT_149	[p11l604t1080r821b1159],
27	of	IN	O	of	_	0	SENT_149	[p11l849t1081r925b1142],
28	predictive	JJ	O	predictive	amod	29	SENT_149	[p11l941t1080r1273b1159],
29	ability	NN	O	ability	prep_of	26	SENT_149	[p11l1300t1080r1527b1158],
30	.	.	O	.	_	0	SENT_149	[p11l1300t1080r1527b1158],

1	For	IN	O	for	_	0	SENT_150	[p11l1560t1083r1687b1142],
2	example	NN	O	example	prep_for	15	SENT_150	[p11l1712t1081r2011b1159],
3	,	,	O	,	_	0	SENT_150	[p11l1712t1081r2011b1159],
4	the	DT	O	the	det	5	SENT_150	[p11l2041t1080r2144b1142],
5	INR	NN	O	inr	nsubj	15	SENT_150	[p11l9t1189r169b1247],
6	during	IN	O	during	_	0	SENT_150	[p11l191t1186r415b1264],
7	the	DT	O	the	det	9	SENT_150	[p11l438t1186r541b1248],
8	ﬁrst	NN	O	ﬁrst	nn	9	SENT_150	[p11l563t1186r694b1247],
9	week	NN	DURATION	week	prep_during	5	SENT_150	[p11l715t1186r888b1248],
10	of	IN	O	of	_	0	SENT_150	[p11l912t1186r987b1248],
11	therapy	NN	O	therapy	prep_of	9	SENT_150	[p11l1001t1186r1261b1264],
12	will	MD	O	will	aux	15	SENT_150	[p11l1282t1186r1402b1248],
13	often	RB	O	often	advmod	15	SENT_150	[p11l1426t1186r1600b1248],
14	be	VB	O	be	cop	15	SENT_150	[p11l1622t1186r1699b1248],
15	elevated	JJ	O	elevated	_	0	SENT_150	[p11l1722t1186r1997b1248],
16	in	IN	O	in	_	0	SENT_150	[p11l2019t1186r2083b1247],
17	a	DT	O	a	det	18	SENT_150	[p11l2107t1206r2145b1248],
18	patient	NN	O	patient	prep_in	15	SENT_150	[p11l8t1292r245b1370],
19	who	WP	O	who	nsubj	21	SENT_150	[p11l276t1292r421b1353],
20	is	VBZ	O	be	cop	21	SENT_150	[p11l454t1292r503b1353],
21	VKORCI	NNP	O	VKORCI	rcmod	18	SENT_150	[p11l535t1293r878b1354],
22	sensitive	JJ	O	sensitive	amod	21	SENT_150	[p11l920t1292r1218b1366],
23	,	,	O	,	_	0	SENT_150	[p11l920t1292r1218b1366],
24	but	CC	O	but	_	0	SENT_150	[p11l1253t1292r1367b1353],
25	dose	NN	O	dose	nn	26	SENT_150	[p11l1399t1292r1551b1353],
26	adjustments	NNS	O	adjustment	nsubj	28	SENT_150	[p11l1585t1292r1991b1370],
27	will	MD	O	will	aux	28	SENT_150	[p11l2023t1292r2144b1353],
28	compensate	VB	O	compensate	conj_but	15	SENT_150	[p11l8t1407r410b1477],
29	for	IN	O	for	mark	36	SENT_150	[p11l432t1399r532b1460],
30	this	DT	O	this	det	31	SENT_150	[p11l553t1398r672b1460],
31	effect	NN	O	effect	nsubj	36	SENT_150	[p11l695t1398r876b1460],
32	over	IN	O	over	_	0	SENT_150	[p11l899t1419r1047b1460],
33	the	DT	DURATION	the	det	35	SENT_150	[p11l1068t1398r1171b1460],
34	subsequent	JJ	DURATION	subsequent	amod	35	SENT_150	[p11l1194t1398r1571b1476],
35	weeks	NNS	DURATION	week	prep_over	31	SENT_150	[p11l1591t1398r1793b1460],
36	[	VBP	O	[	advcl	28	SENT_150	[p11l1818t1400r1951b1476],
37	30	CD	NUMBER	30	num	38	SENT_150	[p11l1818t1400r1951b1476],
38	]	CD	NUMBER	]	dobj	36	SENT_150	[p11l1818t1400r1951b1476],
39	.	.	O	.	_	0	SENT_150	[p11l1818t1400r1951b1476],

1	Here	RB	O	here	advmod	3	SENT_151	[p11l1978t1401r2143b1460],
2	we	PRP	O	we	nsubj	3	SENT_151	[p11l8t1524r100b1566],
3	ﬁnd	VBP	O	ﬁnd	_	0	SENT_151	[p11l122t1504r254b1566],
4	that	IN	O	that	complm	12	SENT_151	[p11l277t1504r412b1566],
5	after	IN	O	after	_	0	SENT_151	[p11l435t1504r591b1566],
6	3	CD	DURATION	3	num	7	SENT_151	[p11l615t1506r647b1566],
7	weeks	NNS	NUMBER	week	prep_after	12	SENT_151	[p11l680t1504r900b1579],
8	,	,	O	,	_	0	SENT_151	[p11l680t1504r900b1579],
9	the	DT	O	the	det	11	SENT_151	[p11l926t1504r1028b1566],
10	dose	NN	O	dose	nn	11	SENT_151	[p11l1051t1504r1204b1566],
11	history	NN	O	history	nsubj	12	SENT_151	[p11l1226t1504r1462b1582],
12	trumps	VBZ	O	trump	ccomp	3	SENT_151	[p11l1484t1513r1725b1582],
13	the	DT	O	the	det	14	SENT_151	[p11l1748t1504r1851b1566],
14	value	NN	O	value	nsubj	17	SENT_151	[p11l1873t1504r2052b1566],
15	of	IN	O	of	_	0	SENT_151	[p11l2077t1504r2152b1566],
16	information	NN	O	information	prep_of	14	SENT_151	[p11l8t1611r418b1672],
17	contained	VBD	O	contain	ccomp	12	SENT_151	[p11l444t1610r778b1672],
18	in	IN	O	in	_	0	SENT_151	[p11l805t1611r869b1671],
19	genotype	NN	O	genotype	prep_in	17	SENT_151	[p11l897t1619r1221b1689],
20	.	.	O	.	_	0	SENT_151	[p11l897t1619r1221b1689],

1	The	DT	O	the	det	2	SENT_152	[p11l94t1716r225b1778],
2	results	NNS	O	result	nsubj	7	SENT_152	[p11l260t1716r475b1778],
3	of	IN	O	of	_	0	SENT_152	[p11l512t1716r588b1778],
4	our	PRP$	O	we	poss	6	SENT_152	[p11l615t1736r733b1778],
5	secondary	JJ	O	secondary	amod	6	SENT_152	[p11l768t1716r1110b1794],
6	analyses	NNS	O	analysis	prep_of	2	SENT_152	[p11l1146t1716r1424b1794],
7	suggest	VBP	O	suggest	_	0	SENT_152	[p11l1461t1725r1705b1794],
8	that	IN	O	that	complm	13	SENT_152	[p11l1740t1716r1875b1778],
9	genetic	JJ	O	genetic	amod	10	SENT_152	[p11l1909t1716r2144b1794],
10	information	NN	O	information	nsubj	13	SENT_152	[p11l8t1823r418b1884],
11	might	MD	O	might	aux	13	SENT_152	[p11l437t1823r637b1901],
12	be	VB	O	be	cop	13	SENT_152	[p11l657t1823r734b1884],
13	helpful	JJ	O	helpful	ccomp	7	SENT_152	[p11l756t1823r991b1901],
14	after	IN	O	after	_	0	SENT_152	[p11l1013t1823r1169b1884],
15	initiation	NN	O	initiation	prep_after	13	SENT_152	[p11l1188t1823r1497b1884],
16	of	IN	O	of	_	0	SENT_152	[p11l1519t1823r1595b1884],
17	warfarin	NN	O	warfarin	prep_of	15	SENT_152	[p11l1607t1823r1914b1884],
18	.	.	O	.	_	0	SENT_152	[p11l1607t1823r1914b1884],

1	When	WRB	O	when	advmod	15	SENT_153	[p11l1938t1823r2144b1884],
2	using	VBG	O	use	csubj	15	SENT_153	[p11l8t1929r188b2007],
3	INR	NNP	O	INR	nn	4	SENT_153	[p11l233t1931r393b1990],
4	data	NNS	O	datum	dobj	2	SENT_153	[p11l437t1928r587b1990],
5	from	IN	O	from	_	0	SENT_153	[p11l632t1929r799b1990],
6	days	NNS	DURATION	day	prep_from	2	SENT_153	[p11l844t1928r997b2006],
7	7-28	CD	NUMBER	7-28	num	6	SENT_153	[p11l1045t1930r1220b2003],
8	,	,	O	,	_	0	SENT_153	[p11l1045t1930r1220b2003],
9	CYP2C9	NN	O	cyp2c9	prep_from	2	SENT_153	[p11l1270t1930r1575b1990],
10	and	CC	O	and	_	0	SENT_153	[p11l1622t1928r1749b1990],
11	VKORCI	NN	O	vkorcus	nn	12	SENT_153	[p11l1793t1930r2136b1990],
12	genotypes	NNS	O	genotype	prep_from	2	SENT_153	[p11l9t2043r347b2112],
13	were	VBD	O	be	cop	15	SENT_153	[p11l384t2054r542b2096],
14	signiﬁcant	JJ	O	signiﬁcant	amod	15	SENT_153	[p11l581t2034r926b2112],
15	predictors	NNS	O	predictor	advcl	22	SENT_153	[p11l961t2034r1302b2112],
16	of	IN	O	of	_	0	SENT_153	[p11l1341t2034r1417b2096],
17	the	DT	O	the	det	18	SENT_153	[p11l1446t2034r1549b2096],
18	amount	NN	O	amount	prep_of	15	SENT_153	[p11l1588t2043r1853b2096],
19	of	IN	O	of	_	0	SENT_153	[p11l1891t2034r1967b2096],
20	time	NN	O	time	nn	21	SENT_153	[p11l1997t2034r2143b2096],
21	patients	NNS	O	patient	prep_of	18	SENT_153	[p11l8t2140r274b2218],
22	spent	VBD	O	spend	_	0	SENT_153	[p11l302t2149r480b2218],
23	below	IN	O	below	_	0	SENT_153	[p11l504t2140r707b2201],
24	therapeutic	JJ	O	therapeutic	amod	25	SENT_153	[p11l732t2140r1113b2218],
25	range	NN	O	range	prep_below	22	SENT_153	[p11l1138t2160r1326b2218],
26	and	CC	O	and	_	0	SENT_153	[p11l1353t2140r1479b2201],
27	the	DT	O	the	det	28	SENT_153	[p11l1505t2140r1608b2201],
28	odds	NNS	O	odds	conj_and	25	SENT_153	[p11l1635t2140r1795b2201],
29	of	IN	O	of	_	0	SENT_153	[p11l1823t2140r1899b2201],
30	having	VBG	O	have	prepc_of	28	SENT_153	[p11l1915t2140r2145b2218],
31	a	DT	O	a	det	33	SENT_153	[p11l10t2267r48b2308],
32	supratherapeutic	JJ	O	supratherapeutic	amod	33	SENT_153	[p11l94t2246r665b2325],
33	INR	NN	O	inr	dobj	30	SENT_153	[p11l710t2249r885b2308],
34	.	.	O	.	_	0	SENT_153	[p11l710t2249r885b2308],

1	These	DT	O	these	det	2	SENT_154	[p11l935t2246r1132b2308],
2	results	NNS	O	result	nsubj	3	SENT_154	[p11l1178t2247r1393b2308],
3	suggest	VBP	O	suggest	_	0	SENT_154	[p11l1441t2255r1686b2325],
4	that	IN	O	that	complm	16	SENT_154	[p11l1731t2246r1867b2308],
5	weekly	JJ	SET	weekly	amod	7	SENT_154	[p11l1910t2246r2145b2324],
6	monitoring	NN	O	monitoring	nn	7	SENT_154	[p11l8t2352r391b2430],
7	(	NN	O	(	nsubj	16	SENT_154	[p11l421t2353r513b2431],
8	as	IN	O	as	_	0	SENT_154	[p11l421t2353r513b2431],
9	mandated	VBN	O	mandate	prep_as	7	SENT_154	[p11l540t2352r883b2414],
10	in	IN	O	in	_	0	SENT_154	[p11l910t2352r974b2413],
11	PREVENT	NNP	O	PREVENT	prep_in	9	SENT_154	[p11l1001t2353r1425b2430],
12	)	CD	NUMBER	)	num	11	SENT_154	[p11l1001t2353r1425b2430],
13	does	VBZ	O	do	aux	16	SENT_154	[p11l1456t2352r1607b2414],
14	not	RB	O	not	neg	16	SENT_154	[p11l1636t2361r1750b2414],
15	completely	RB	O	completely	advmod	16	SENT_154	[p11l1777t2352r2145b2430],
16	compensate	VB	O	compensate	ccomp	3	SENT_154	[p11l8t2467r410b2537],
17	for	IN	O	for	_	0	SENT_154	[p11l432t2459r532b2520],
18	the	DT	O	the	det	19	SENT_154	[p11l554t2458r657b2520],
19	presence	NN	O	presence	prep_for	16	SENT_154	[p11l678t2479r967b2537],
20	of	IN	O	of	_	0	SENT_154	[p11l990t2458r1066b2520],
21	genetic	JJ	O	genetic	amod	22	SENT_154	[p11l1080t2459r1315b2537],
22	SNPs	NNS	O	snp	prep_of	19	SENT_154	[p11l1339t2460r1525b2520],
23	for	IN	O	for	_	0	SENT_154	[p11l1548t2458r1648b2520],
24	several	JJ	DURATION	several	amod	25	SENT_154	[p11l1671t2459r1900b2520],
25	weeks	NNS	DURATION	week	prep_for	22	SENT_154	[p11l1920t2458r2138b2520],
26	.	.	O	.	_	0	SENT_154	[p11l1920t2458r2138b2520],

1	This	DT	O	this	nsubj	3	SENT_155	[p11l9t2564r156b2625],
2	is	VBZ	O	be	cop	3	SENT_155	[p11l179t2564r228b2626],
3	likely	JJ	O	likely	_	0	SENT_155	[p11l252t2564r432b2642],
4	to	TO	O	to	aux	5	SENT_155	[p11l455t2573r522b2626],
5	be	VB	O	be	xcomp	3	SENT_155	[p11l547t2564r624b2626],
6	because	IN	O	because	mark	17	SENT_155	[p11l647t2564r909b2626],
7	the	DT	O	the	det	8	SENT_155	[p11l933t2564r1036b2626],
8	INRs	NNS	MISC	inr	nsubj	17	SENT_155	[p11l1060t2567r1248b2626],
9	at	IN	O	at	_	0	SENT_155	[p11l1274t2573r1337b2626],
10	days	NNS	DURATION	day	prep_at	8	SENT_155	[p11l1360t2564r1513b2642],
11	7	CD	NUMBER	7	num	10	SENT_155	[p11l1538t2567r1574b2626],
12	and	CC	O	and	_	0	SENT_155	[p11l1599t2564r1726b2626],
13	14	CD	NUMBER	14	conj_and	10	SENT_155	[p11l1756t2566r1827b2625],
14	have	VBP	O	have	aux	17	SENT_155	[p11l1849t2564r2007b2626],
15	not	RB	O	not	neg	17	SENT_155	[p11l2030t2573r2145b2626],
16	yet	RB	O	yet	advmod	17	SENT_155	[p11l8t2678r109b2748],
17	captured	VBN	O	capture	advcl	5	SENT_155	[p11l137t2670r436b2748],
18	the	DT	O	the	det	21	SENT_155	[p11l466t2670r569b2731],
19	entire	JJ	O	entire	amod	21	SENT_155	[p11l599t2670r789b2731],
20	genetic	JJ	O	genetic	amod	21	SENT_155	[p11l819t2670r1053b2748],
21	effects	NNS	O	effect	dobj	17	SENT_155	[p11l1082t2670r1311b2731],
22	.	.	O	.	_	0	SENT_155	[p11l1082t2670r1311b2731],

1	The	DT	O	the	det	2	SENT_156	[p11l1344t2670r1476b2731],
2	effect	NN	O	effect	nsubj	10	SENT_156	[p11l1506t2670r1688b2731],
3	of	IN	O	of	_	0	SENT_156	[p11l1718t2670r1794b2731],
4	CYP2C9	NN	O	cyp2c9	prep_of	2	SENT_156	[p11l1817t2671r2141b2744],
5	,	,	O	,	_	0	SENT_156	[p11l1817t2671r2141b2744],
6	in	IN	O	in	_	0	SENT_156	[p11l6t2776r71b2837],
7	particular	JJ	O	particular	prep_in	10	SENT_156	[p11l108t2776r459b2854],
8	,	,	O	,	_	0	SENT_156	[p11l108t2776r459b2854],
9	may	MD	O	may	aux	10	SENT_156	[p11l499t2796r647b2854],
10	elevate	VB	O	elevate	_	0	SENT_156	[p11l685t2776r916b2838],
11	the	DT	O	the	det	12	SENT_156	[p11l955t2776r1059b2838],
12	INR	NN	O	inr	dobj	10	SENT_156	[p11l1098t2779r1259b2837],
13	after	IN	O	after	_	0	SENT_156	[p11l1298t2776r1453b2838],
14	the	DT	DURATION	the	det	16	SENT_156	[p11l1492t2776r1595b2838],
15	initial	JJ	DURATION	initial	amod	16	SENT_156	[p11l1634t2776r1827b2838],
16	week	NN	DURATION	week	prep_after	10	SENT_156	[p11l1865t2776r2038b2838],
17	of	IN	O	of	_	0	SENT_156	[p11l2078t2776r2153b2838],
18	therapy	NN	O	therapy	prep_of	16	SENT_156	[p11l7t2882r267b2960],
19	[	CD	NUMBER	[	num	18	SENT_156	[p11l318t2883r432b2959],
20	30	CD	NUMBER	30	num	21	SENT_156	[p11l318t2883r432b2959],
21	]	NN	O	]	dep	18	SENT_156	[p11l318t2883r432b2959],
22	and	CC	O	and	_	0	SENT_156	[p11l484t2882r611b2944],
23	not	RB	O	not	conj_and	10	SENT_156	[p11l659t2891r774b2944],
24	be	VB	O	be	auxpass	26	SENT_156	[p11l822t2882r899b2944],
25	fully	RB	O	fully	advmod	26	SENT_156	[p11l948t2882r1099b2960],
26	reﬂected	VBN	O	reﬂected	dep	10	SENT_156	[p11l1147t2882r1431b2944],
27	in	IN	O	in	_	0	SENT_156	[p11l1479t2882r1544b2943],
28	the	DT	O	the	det	31	SENT_156	[p11l1592t2882r1695b2944],
29	initial	JJ	O	initial	amod	31	SENT_156	[p11l1743t2882r1937b2944],
30	INR	NN	O	inr	nn	31	SENT_156	[p11l1986t2885r2146b2943],
31	response	NN	O	response	prep_in	26	SENT_156	[p11l7t3009r317b3067],
32	.	.	O	.	_	0	SENT_156	[p11l7t3009r317b3067],

1	Because	IN	O	because	mark	5	SENT_157	[p11l354t2991r625b3050],
2	supratherapeutic	JJ	O	supratherapeutic	amod	3	SENT_157	[p11l659t2989r1230b3067],
3	INRs	NNS	O	inr	nsubjpass	5	SENT_157	[p11l1261t2991r1450b3050],
4	are	VBP	O	be	auxpass	5	SENT_157	[p11l1484t3009r1586b3050],
5	associated	VBN	O	associate	advcl	19	SENT_157	[p11l1620t2989r1965b3050],
6	with	IN	O	with	_	0	SENT_157	[p11l1996t2989r2146b3050],
7	major	JJ	O	major	amod	8	SENT_157	[p11l6t3094r210b3173],
8	hemorrhage	NN	O	hemorrhage	prep_with	5	SENT_157	[p11l286t3094r837b3173],
9	[	CD	NUMBER	[	num	11	SENT_157	[p11l286t3094r837b3173],
10	3l	NN	O	3l	nn	11	SENT_157	[p11l286t3094r837b3173],
11	]	NN	O	]	dep	8	SENT_157	[p11l286t3094r837b3173],
12	,	,	O	,	_	0	SENT_157	[p11l286t3094r837b3173],
13	patients	NNS	O	patient	nsubj	19	SENT_157	[p11l917t3094r1183b3173],
14	with	IN	O	with	_	0	SENT_157	[p11l1261t3094r1411b3157],
15	VKORCI	NN	O	vkorcus	nn	18	SENT_157	[p11l1487t3095r1830b3157],
16	and/or	NN	O	and/or	nn	18	SENT_157	[p11l1916t3094r2146b3174],
17	CYP2C9	NN	O	cyp2c9	nn	18	SENT_157	[p11l8t3202r314b3263],
18	variants	NNS	O	variant	prep_with	13	SENT_157	[p11l341t3201r613b3263],
19	have	VBP	O	have	_	0	SENT_157	[p11l640t3201r798b3263],
20	triple	RB	O	triple	advmod	22	SENT_157	[p11l826t3201r1000b3279],
21	the	DT	O	the	det	22	SENT_157	[p11l1028t3201r1131b3263],
22	risk	NN	O	risk	dobj	19	SENT_157	[p11l1158t3201r1283b3263],
23	of	IN	O	of	_	0	SENT_157	[p11l1310t3201r1386b3263],
24	adverse	JJ	O	adverse	amod	25	SENT_157	[p11l1406t3201r1658b3263],
25	events	NNS	O	event	prep_of	22	SENT_157	[p11l1685t3210r1893b3263],
26	during	IN	O	during	_	0	SENT_157	[p11l1921t3201r2145b3279],
27	the	DT	DURATION	the	det	29	SENT_157	[p11l7t3308r110b3369],
28	initial	JJ	DURATION	initial	amod	29	SENT_157	[p11l141t3308r334b3369],
29	weeks	NNS	DURATION	week	prep_during	25	SENT_157	[p11l364t3308r566b3369],
30	of	IN	O	of	_	0	SENT_157	[p11l600t3308r676b3369],
31	therapy	NN	O	therapy	prep_of	29	SENT_157	[p11l699t3308r959b3386],
32	[	CD	NUMBER	[	num	33	SENT_157	[p11l992t3309r1289b3385],
33	l	NN	O	l	tmod	29	SENT_157	[p11l992t3309r1289b3385],
34	,32,33	CD	NUMBER	,32,33	num	35	SENT_157	[p11l992t3309r1289b3385],
35	]	NN	O	]	dep	25	SENT_157	[p11l992t3309r1289b3385],
36	.	.	O	.	_	0	SENT_157	[p11l992t3309r1289b3385],

1	This	DT	O	this	det	2	SENT_158	[p11l1324t3308r1472b3369],
2	observation	NN	O	observation	nsubj	21	SENT_158	[p11l1506t3308r1922b3382],
3	,	,	O	,	_	0	SENT_158	[p11l1506t3308r1922b3382],
4	along	IN	O	along	_	0	SENT_158	[p11l1957t3308r2146b3386],
5	with	IN	O	with	_	0	SENT_158	[p11l6t3414r156b3476],
6	our	PRP$	O	we	prep_along_with	7	SENT_158	[p11l184t3434r302b3476],
7	ﬁnding	VBG	O	ﬁnding	partmod	2	SENT_158	[p11l327t3413r566b3493],
8	that	IN	O	that	complm	10	SENT_158	[p11l594t3414r730b3476],
9	genotype	NN	O	genotype	nsubj	10	SENT_158	[p11l757t3423r1065b3493],
10	improved	VBD	O	improve	ccomp	7	SENT_158	[p11l1092t3413r1419b3493],
11	R2	NN	O	r2	dobj	10	SENT_158	[p11l1449t3397r1537b3475],
12	by	IN	O	by	_	0	SENT_158	[p11l1565t3414r1648b3492],
13	12	CD	PERCENT	12	num	14	SENT_158	[p11l1683t3415r1830b3477],
14	%	NN	PERCENT	%	prep_by	10	SENT_158	[p11l1683t3415r1830b3477],
15	at	IN	O	at	_	0	SENT_158	[p11l1865t3423r1929b3476],
16	day	NN	DURATION	day	prep_at	10	SENT_158	[p11l1956t3413r2079b3492],
17	7	CD	NUMBER	7	num	16	SENT_158	[p11l2108t3416r2143b3476],
18	of	IN	O	of	_	0	SENT_158	[p11l8t3521r85b3582],
19	therapy	NN	O	therapy	prep_of	16	SENT_158	[p11l125t3521r403b3599],
20	,	,	O	,	_	0	SENT_158	[p11l125t3521r403b3599],
21	suggests	VBZ	O	suggest	_	0	SENT_158	[p11l457t3529r731b3599],
22	that	IN	O	that	complm	26	SENT_158	[p11l782t3521r918b3582],
23	additional	JJ	O	additional	amod	24	SENT_158	[p11l968t3521r1313b3582],
24	research	NN	O	research	nsubjpass	26	SENT_158	[p11l1363t3521r1643b3582],
25	is	VBZ	O	be	auxpass	26	SENT_158	[p11l1691t3521r1740b3582],
26	needed	VBN	O	need	ccomp	21	SENT_158	[p11l1790t3521r2028b3582],
27	to	TO	O	to	aux	28	SENT_158	[p11l2077t3529r2144b3582],
28	delineate	VB	O	delineate	xcomp	26	SENT_158	[p11l7t3626r306b3688],
29	the	DT	O	the	det	30	SENT_158	[p11l360t3626r463b3688],
30	safety	NN	O	safety	dobj	28	SENT_158	[p11l518t3626r713b3704],
31	and	CC	O	and	_	0	SENT_158	[p11l766t3626r892b3688],
32	effectiveness	NN	O	effectiveness	dobj	28	SENT_158	[p11l945t3626r1362b3688],
33	of	IN	O	of	_	0	SENT_158	[p11l1417t3626r1493b3688],
34	pharrnacogeneticguided	JJ	O	pharrnacogeneticguided	amod	35	SENT_158	[p11l1536t3626r2143b3704, p11l7t3732r235b3810],
35	dosing	NN	O	dosing	prep_of	30	SENT_158	[p11l300t3732r524b3810],
36	that	WDT	O	that	nsubj	37	SENT_158	[p11l589t3732r724b3793],
37	extends	VBZ	O	extend	rcmod	30	SENT_158	[p11l788t3732r1042b3793],
38	past	IN	DATE	past	_	0	SENT_158	[p11l1106t3740r1248b3810],
39	the	DT	O	the	det	42	SENT_158	[p11l1312t3732r1416b3793],
40	ﬁrst	JJ	O	ﬁrst	amod	42	SENT_158	[p11l1480t3732r1611b3793],
41	few	JJ	DURATION	few	amod	42	SENT_158	[p11l1675t3732r1794b3793],
42	days	NNS	DURATION	day	prep_past	37	SENT_158	[p11l1857t3732r2010b3810],
43	of	IN	O	of	_	0	SENT_158	[p11l2077t3732r2153b3793],
44	therapy	NN	O	therapy	prep_of	42	SENT_158	[p12l7t24r467b102],
45	.	.	O	.	_	0	SENT_158	[p12l7t24r467b102],

1	[	NN	O	[	tmod	11	SENT_159	[p12l7t24r467b102],
2	9,10	CD	NUMBER	9,10	num	3	SENT_159	[p12l7t24r467b102],
3	]	CD	NUMBER	]	dep	1	SENT_159	[p12l7t24r467b102],
4	In	IN	O	in	_	0	SENT_159	[p12l508t26r581b84],
5	particular	JJ	O	particular	prep_in	11	SENT_159	[p12l617t24r968b102],
6	,	,	O	,	_	0	SENT_159	[p12l617t24r968b102],
7	multi-centered	JJ	O	multi-centered	nsubj	11	SENT_159	[p12l1007t24r1498b85],
8	randomized	VBN	O	randomize	partmod	7	SENT_159	[p12l1535t24r1940b85],
9	trials	NNS	O	trial	dobj	8	SENT_159	[p12l1978t24r2144b85],
10	should	MD	O	should	aux	11	SENT_159	[p12l9t129r235b191],
11	test	VB	O	test	_	0	SENT_159	[p12l300t138r416b191],
12	the	DT	O	the	det	13	SENT_159	[p12l480t129r584b191],
13	hypothesis	NN	O	hypothesis	dobj	11	SENT_159	[p12l649t129r1008b207],
14	that	IN	O	that	complm	17	SENT_159	[p12l1074t129r1210b191],
15	pharrnacogenetic	JJ	O	pharrnacogenetic	amod	16	SENT_159	[p12l1272t129r1857b207],
16	dosing	NN	O	dosing	nsubj	17	SENT_159	[p12l1922t129r2146b207],
17	improves	VBZ	O	improve	ccomp	11	SENT_159	[p12l6t235r318b313],
18	laboratory	NN	O	laboratory	nn	21	SENT_159	[p12l366t235r728b313],
19	and	CC	O	and	_	0	SENT_159	[p12l775t235r902b297],
20	clinical	JJ	O	clinical	conj_and	18	SENT_159	[p12l949t235r1186b297],
21	outcomes	NNS	O	outcome	dobj	17	SENT_159	[p12l1235t244r1558b297],
22	over	IN	O	over	_	0	SENT_159	[p12l1608t255r1755b297],
23	the	DT	DURATION	the	det	25	SENT_159	[p12l1802t235r1905b297],
24	initial	JJ	DURATION	initial	amod	25	SENT_159	[p12l1952t235r2145b297],
25	weeks	NNS	DURATION	week	prep_over	21	SENT_159	[p12l6t342r208b403],
26	of	IN	O	of	_	0	SENT_159	[p12l239t342r315b403],
27	therapy	NN	O	therapy	prep_of	25	SENT_159	[p12l336t342r611b420],
28	.	.	O	.	_	0	SENT_159	[p12l336t342r611b420],

1	A	DT	O	a	det	3	SENT_160	[p12l91t448r154b508],
2	few	JJ	O	few	amod	3	SENT_160	[p12l222t448r340b509],
3	limitations	NNS	O	limitation	nsubj	7	SENT_160	[p12l408t448r769b509],
4	of	IN	O	of	_	0	SENT_160	[p12l840t448r916b509],
5	our	PRP$	O	we	poss	6	SENT_160	[p12l978t468r1095b509],
6	study	NN	O	study	prep_of	3	SENT_160	[p12l1165t447r1348b525],
7	merit	NN	O	merit	_	0	SENT_160	[p12l1415t448r1595b509],
8	consideration	NN	O	consideration	dobj	7	SENT_160	[p12l1663t447r2140b509],
9	.	.	O	.	_	0	SENT_160	[p12l1663t447r2140b509],

1	PREVENT	JJ	O	prevent	amod	2	SENT_161	[p12l6t556r407b615],
2	participants	NNS	O	participant	nsubj	3	SENT_161	[p12l460t554r862b632],
3	had	VBD	O	have	_	0	SENT_161	[p12l917t554r1045b615],
4	a	DT	O	a	det	13	SENT_161	[p12l1099t574r1137b615],
5	low	JJ	O	low	amod	13	SENT_161	[p12l1191t554r1314b615],
6	target	NN	O	target	nn	13	SENT_161	[p12l1367t562r1564b632],
7	INR	NN	O	inr	nn	13	SENT_161	[p12l1618t556r1778b615],
8	(	CD	NUMBER	(	num	13	SENT_161	[p12l1832t554r2141b632],
9	l.	NN	O	l.	nn	13	SENT_161	[p12l1832t554r2141b632],
10	5	CD	NUMBER	5	num	13	SENT_161	[p12l1832t554r2141b632],
11	—	NN	O	—	nn	13	SENT_161	[p12l1832t554r2141b632],
12	2.0	CD	NUMBER	2.0	num	13	SENT_161	[p12l1832t554r2141b632],
13	)	NN	O	)	dobj	3	SENT_161	[p12l1832t554r2141b632],
14	,	,	O	,	_	0	SENT_161	[p12l1832t554r2141b632],
15	which	WDT	O	which	nsubj	16	SENT_161	[p12l6t659r209b721],
16	proved	VBD	O	prove	dep	3	SENT_161	[p12l261t659r501b737],
17	effective	JJ	O	effective	acomp	16	SENT_161	[p12l555t659r832b721],
18	at	IN	O	at	_	0	SENT_161	[p12l887t668r951b721],
19	preventing	VBG	O	prevent	prepc_at	17	SENT_161	[p12l1004t659r1366b737],
20	recurrent	JJ	O	recurrent	acomp	19	SENT_161	[p12l1420t668r1730b721],
21	VTE	NNP	O	VTE	dep	20	SENT_161	[p12l1782t662r1950b721],
22	[	CD	NUMBER	[	num	21	SENT_161	[p12l2006t661r2140b737],
23	14	CD	NUMBER	14	num	24	SENT_161	[p12l2006t661r2140b737],
24	]	NN	O	]	dep	21	SENT_161	[p12l2006t661r2140b737],
25	.	.	O	.	_	0	SENT_161	[p12l2006t661r2140b737],

1	Although	IN	O	although	mark	5	SENT_162	[p12l6t765r334b843],
2	we	PRP	O	we	nsubj	5	SENT_162	[p12l367t785r460b827],
3	did	VBD	O	do	aux	5	SENT_162	[p12l495t765r603b827],
4	not	RB	O	not	neg	5	SENT_162	[p12l637t774r751b827],
5	observe	VB	O	observe	advcl	31	SENT_162	[p12l787t765r1044b827],
6	an	DT	O	a	det	7	SENT_162	[p12l1080t785r1162b827],
7	interaction	NN	O	interaction	dobj	5	SENT_162	[p12l1196t765r1563b827],
8	between	IN	O	between	_	0	SENT_162	[p12l1597t765r1875b827],
9	predictive	JJ	O	predictive	amod	10	SENT_162	[p12l1908t765r2142b843, p12l7t872r127b933],
10	ability	NN	O	ability	prep_between	7	SENT_162	[p12l194t872r406b950],
11	of	IN	O	of	_	0	SENT_162	[p12l472t872r548b933],
12	genotype	NN	O	genotype	nn	15	SENT_162	[p12l607t880r914b950],
13	and	CC	O	and	_	0	SENT_162	[p12l982t872r1108b933],
14	target	NN	O	target	nn	15	SENT_162	[p12l1174t880r1371b950],
15	INR	NN	O	inr	prep_of	10	SENT_162	[p12l1437t874r1597b933],
16	in	IN	O	in	_	0	SENT_162	[p12l1661t872r1726b932],
17	our	PRP$	O	we	poss	22	SENT_162	[p12l1793t892r1910b933],
18	prior	JJ	O	prior	amod	22	SENT_162	[p12l1975t872r2146b950],
19	analysis	NN	O	analysis	nn	22	SENT_162	[p12l8t977r373b1055],
20	[	NN	O	[	nn	22	SENT_162	[p12l8t977r373b1055],
21	4	CD	NUMBER	4	num	22	SENT_162	[p12l8t977r373b1055],
22	]	NN	O	]	prep_in	5	SENT_162	[p12l8t977r373b1055],
23	,	,	O	,	_	0	SENT_162	[p12l8t977r373b1055],
24	the	DT	O	the	det	26	SENT_162	[p12l409t977r512b1039],
25	predictive	JJ	O	predictive	amod	26	SENT_162	[p12l544t977r876b1055],
26	ability	NN	O	ability	nsubj	31	SENT_162	[p12l910t977r1122b1055],
27	of	IN	O	of	_	0	SENT_162	[p12l1156t977r1232b1039],
28	genotype	NN	O	genotype	prep_of	26	SENT_162	[p12l1256t986r1565b1055],
29	also	RB	O	also	advmod	31	SENT_162	[p12l1599t977r1730b1039],
30	might	MD	O	might	aux	31	SENT_162	[p12l1764t977r1963b1055],
31	vary	VB	O	vary	_	0	SENT_162	[p12l1994t997r2146b1055],
32	with	IN	O	with	_	0	SENT_162	[p12l6t1083r156b1145],
33	dosing	NN	O	dosing	nn	34	SENT_162	[p12l179t1083r403b1161],
34	practises	NNS	O	practise	prep_with	31	SENT_162	[p12l425t1083r717b1161],
35	and	CC	O	and	_	0	SENT_162	[p12l742t1083r869b1145],
36	INR	NN	O	inr	nn	37	SENT_162	[p12l893t1086r1052b1144],
37	monitoring	NN	O	monitoring	conj_and	34	SENT_162	[p12l1073t1083r1475b1161],
38	.	.	O	.	_	0	SENT_162	[p12l1073t1083r1475b1161],

1	A	DT	DURATION	a	det	4	SENT_163	[p12l1502t1083r1565b1144],
2	second	JJ	DURATION	second	amod	4	SENT_163	[p12l1589t1083r1820b1145],
3	potential	JJ	O	potential	amod	4	SENT_163	[p12l1842t1083r2145b1161],
4	limitation	NN	O	limitation	nsubj	5	SENT_163	[p12l7t1190r338b1251],
5	is	VBZ	O	be	_	0	SENT_163	[p12l361t1190r410b1251],
6	that	IN	O	that	complm	10	SENT_163	[p12l435t1190r571b1251],
7	our	PRP$	O	we	poss	8	SENT_163	[p12l596t1210r713b1251],
8	models	NNS	O	model	nsubjpass	10	SENT_163	[p12l735t1190r977b1251],
9	were	VBD	O	be	auxpass	10	SENT_163	[p12l1000t1210r1158b1251],
10	developed	VBN	O	develop	ccomp	5	SENT_163	[p12l1183t1190r1525b1268],
11	using	VBG	O	use	xcomp	10	SENT_163	[p12l1548t1190r1728b1268],
12	INR	NN	O	inr	nn	13	SENT_163	[p12l1753t1192r1913b1251],
13	values	NNS	O	value	dobj	11	SENT_163	[p12l1934t1190r2144b1251],
14	that	WDT	O	that	nsubjpass	16	SENT_163	[p12l7t1295r143b1358],
15	were	VBD	O	be	auxpass	16	SENT_163	[p12l204t1316r362b1358],
16	obtained	VBN	O	obtain	rcmod	13	SENT_163	[p12l426t1295r723b1358],
17	only	RB	O	only	advmod	19	SENT_163	[p12l787t1296r935b1374],
18	once	RB	DATE	once	advmod	19	SENT_163	[p12l999t1316r1154b1358],
19	weekly	JJ	SET	weekly	dobj	16	SENT_163	[p12l1215t1295r1465b1374],
20	.	.	O	.	_	0	SENT_163	[p12l1215t1295r1465b1374],

1	The	DT	O	the	det	2	SENT_164	[p12l1533t1296r1665b1358],
2	degree	NN	O	degree	nsubjpass	19	SENT_164	[p12l1728t1295r1946b1375],
3	that	WDT	O	that	dobj	5	SENT_164	[p12l2009t1296r2145b1358],
4	genotype	NN	O	genotype	nsubj	5	SENT_164	[p12l7t1411r316b1481],
5	correlates	VBZ	O	correlate	rcmod	2	SENT_164	[p12l343t1403r670b1464],
6	with	IN	O	with	_	0	SENT_164	[p12l697t1403r847b1464],
7	dose	NN	O	dose	prep_with	5	SENT_164	[p12l874t1403r1026b1464],
8	after	IN	O	after	_	0	SENT_164	[p12l1055t1403r1211b1464],
9	1	CD	NUMBER	1	prep_after	5	SENT_164	[p12l1246t1404r1294b1477],
10	,	,	O	,	_	0	SENT_164	[p12l1246t1404r1294b1477],
11	2	CD	NUMBER	2	nn	14	SENT_164	[p12l1325t1404r1362b1463],
12	or	CC	O	or	_	0	SENT_164	[p12l1392t1423r1465b1464],
13	3	CD	DURATION	3	conj_or	11	SENT_164	[p12l1494t1405r1526b1464],
14	weeks	NNS	NUMBER	week	appos	9	SENT_164	[p12l1558t1403r1761b1464],
15	of	IN	O	of	_	0	SENT_164	[p12l1791t1403r1866b1464],
16	therapy	NN	O	therapy	prep_of	14	SENT_164	[p12l1886t1403r2146b1481],
17	may	MD	O	may	aux	19	SENT_164	[p12l6t1528r153b1586],
18	be	VB	O	be	auxpass	19	SENT_164	[p12l195t1508r272b1570],
19	diminished	VBN	O	diminish	_	0	SENT_164	[p12l315t1508r687b1570],
20	in	IN	O	in	_	0	SENT_164	[p12l728t1508r792b1569],
21	populations	NNS	O	population	prep_in	19	SENT_164	[p12l833t1508r1238b1586],
22	who	WP	O	who	nsubj	23	SENT_164	[p12l1280t1508r1425b1570],
23	monitor	VBP	O	monitor	rcmod	21	SENT_164	[p12l1468t1508r1747b1570],
24	their	PRP$	O	they	poss	25	SENT_164	[p12l1789t1508r1944b1570],
25	INR	NN	O	inr	dobj	23	SENT_164	[p12l1986t1511r2146b1569],
26	more	RBR	O	more	advmod	27	SENT_164	[p12l6t1634r182b1676],
27	frequently	RB	O	frequently	advmod	23	SENT_164	[p12l213t1614r576b1692],
28	.	.	O	.	_	0	SENT_164	[p12l213t1614r576b1692],

1	A	DT	O	a	det	4	SENT_165	[p12l610t1614r673b1675],
2	third	JJ	ORDINAL	third	amod	4	SENT_165	[p12l704t1614r868b1676],
3	potential	JJ	O	potential	amod	4	SENT_165	[p12l898t1614r1201b1692],
4	limitation	NN	O	limitation	nsubj	8	SENT_165	[p12l1231t1614r1563b1676],
5	is	VBZ	O	be	cop	8	SENT_165	[p12l1593t1614r1642b1675],
6	the	DT	O	the	det	8	SENT_165	[p12l1674t1614r1777b1676],
7	consistent	JJ	O	consistent	amod	8	SENT_165	[p12l1808t1614r2145b1676],
8	indication	NN	O	indication	_	0	SENT_165	[p12l6t1721r348b1782],
9	for	IN	O	for	_	0	SENT_165	[p12l396t1721r496b1782],
10	warfarin	NN	O	warfarin	prep_for	8	SENT_165	[p12l542t1721r835b1782],
11	among	IN	O	among	_	0	SENT_165	[p12l883t1741r1119b1799],
12	patients	NNS	O	patient	prep_among	10	SENT_165	[p12l1166t1721r1432b1799],
13	in	IN	O	in	_	0	SENT_165	[p12l1480t1721r1545b1781],
14	the	DT	O	the	det	16	SENT_165	[p12l1593t1721r1696b1782],
15	PREVENT	JJ	O	prevent	amod	16	SENT_165	[p12l1745t1723r2145b1782],
16	trial	NN	O	trial	prep_in	12	SENT_165	[p12l7t1826r161b1901],
17	,	,	O	,	_	0	SENT_165	[p12l7t1826r161b1901],
18	as	IN	O	as	mark	22	SENT_165	[p12l207t1846r274b1888],
19	all	DT	O	all	det	20	SENT_165	[p12l317t1826r396b1888],
20	patients	NNS	O	patient	nsubj	22	SENT_165	[p12l436t1826r702b1904],
21	were	VBD	O	be	aux	22	SENT_165	[p12l742t1846r901b1888],
22	taking	VBG	O	take	advcl	8	SENT_165	[p12l942t1826r1158b1904],
23	warfarin	NN	O	warfarin	dobj	22	SENT_165	[p12l1196t1826r1488b1888],
24	for	IN	O	for	_	0	SENT_165	[p12l1529t1826r1630b1888],
25	prevention	NN	O	prevention	prep_for	22	SENT_165	[p12l1669t1826r2035b1904],
26	of	IN	O	of	_	0	SENT_165	[p12l2078t1826r2153b1888],
27	recurrent	JJ	O	recurrent	amod	28	SENT_165	[p12l7t1941r317b1994],
28	VTE	NN	O	vte	prep_of	25	SENT_165	[p12l364t1934r547b1994],
29	.	.	O	.	_	0	SENT_165	[p12l364t1934r547b1994],

1	While	IN	O	while	mark	4	SENT_166	[p12l599t1932r802b1994],
2	this	DT	O	this	det	3	SENT_166	[p12l851t1932r970b1993],
3	consistency	NN	O	consistency	nsubj	4	SENT_166	[p12l1020t1932r1406b2010],
4	eliminates	VBZ	O	eliminate	advcl	11	SENT_166	[p12l1454t1932r1793b1994],
5	potential	JJ	O	potential	nsubj	6	SENT_166	[p12l1842t1932r2145b2010],
6	confounding	JJ	O	confounding	xcomp	4	SENT_166	[p12l7t2039r441b2117],
7	by	IN	O	by	_	0	SENT_166	[p12l478t2039r562b2117],
8	indication	NN	O	indication	prep_by	6	SENT_166	[p12l599t2039r958b2113],
9	,	,	O	,	_	0	SENT_166	[p12l599t2039r958b2113],
10	it	PRP	O	it	nsubj	11	SENT_166	[p12l998t2039r1045b2100],
11	limits	VBZ	O	limit	_	0	SENT_166	[p12l1082t2039r1266b2100],
12	generalizability	NN	O	generalizability	dobj	11	SENT_166	[p12l1307t2039r1821b2117],
13	to	TO	O	to	_	0	SENT_166	[p12l1859t2047r1926b2100],
14	other	JJ	O	other	amod	15	SENT_166	[p12l1968t2039r2147b2100],
15	diseases	NNS	O	disease	prep_to	11	SENT_166	[p12l7t2144r289b2206],
16	.	.	O	.	_	0	SENT_166	[p12l7t2144r289b2206],

1	Because	IN	O	because	_	0	SENT_167	[p12l324t2147r595b2206],
2	of	IN	O	of	prepc_because_of	15	SENT_167	[p12l626t2144r702b2206],
3	these	DT	O	these	det	4	SENT_167	[p12l723t2144r892b2206],
4	limitations	NNS	O	limitation	pobj	15	SENT_167	[p12l921t2145r1282b2206],
5	and	CC	O	and	_	0	SENT_167	[p12l1313t2144r1440b2206],
6	lack	NN	O	lack	pobj	15	SENT_167	[p12l1469t2144r1609b2206],
7	of	IN	O	of	_	0	SENT_167	[p12l1639t2145r1715b2206],
8	a	DT	O	a	det	10	SENT_167	[p12l1737t2165r1775b2206],
9	validation	NN	O	validation	nn	10	SENT_167	[p12l1803t2144r2146b2206],
10	cohort	NN	O	cohort	prep_of	4	SENT_167	[p12l7t2251r249b2325],
11	,	,	O	,	_	0	SENT_167	[p12l7t2251r249b2325],
12	we	PRP	O	we	nsubj	15	SENT_167	[p12l287t2271r379b2312],
13	did	VBD	O	do	aux	15	SENT_167	[p12l417t2251r525b2312],
14	not	RB	O	not	neg	15	SENT_167	[p12l562t2259r676b2312],
15	develop	VB	O	develop	_	0	SENT_167	[p12l712t2251r974b2329],
16	a	DT	O	a	det	19	SENT_167	[p12l1013t2271r1051b2312],
17	dose	NN	O	dose	nn	19	SENT_167	[p12l1087t2251r1239b2312],
18	reﬁnement	NN	O	reﬁnement	nn	19	SENT_167	[p12l1277t2251r1638b2312],
19	algorithm	NN	O	algorithm	dobj	15	SENT_167	[p12l1676t2251r2010b2329],
20	for	IN	O	for	_	0	SENT_167	[p12l2045t2251r2146b2312],
21	clinical	JJ	O	clinical	amod	22	SENT_167	[p12l7t2356r243b2418],
22	use	NN	O	use	prep_for	19	SENT_167	[p12l266t2376r392b2418],
23	.	.	O	.	_	0	SENT_167	[p12l266t2376r392b2418],

1	In	IN	O	in	_	0	SENT_168	[p12l422t2359r495b2417],
2	the	DT	DATE	the	det	3	SENT_168	[p12l520t2356r623b2418],
3	future	NN	DATE	future	prep_in	6	SENT_168	[p12l648t2356r871b2431],
4	,	,	O	,	_	0	SENT_168	[p12l648t2356r871b2431],
5	we	PRP	O	we	nsubj	6	SENT_168	[p12l898t2376r991b2418],
6	hope	VBP	O	hope	_	0	SENT_168	[p12l1015t2356r1182b2434],
7	to	TO	O	to	aux	8	SENT_168	[p12l1208t2365r1275b2418],
8	combine	VB	O	combine	xcomp	6	SENT_168	[p12l1301t2356r1591b2418],
9	the	DT	O	the	det	11	SENT_168	[p12l1617t2356r1720b2418],
10	PREVENT	NNP	O	PREVENT	nn	11	SENT_168	[p12l1744t2359r2145b2418],
11	data	NNS	O	datum	dobj	8	SENT_168	[p12l7t2462r157b2524],
12	with	IN	O	with	_	0	SENT_168	[p12l190t2462r341b2524],
13	data	NNS	O	datum	prep_with	8	SENT_168	[p12l375t2462r524b2524],
14	from	IN	O	from	_	0	SENT_168	[p12l560t2462r727b2524],
15	diverse	JJ	O	diverse	amod	16	SENT_168	[p12l762t2462r996b2524],
16	populations	NNS	O	population	prep_from	8	SENT_168	[p12l1030t2462r1435b2540],
17	to	TO	O	to	aux	18	SENT_168	[p12l1471t2471r1538b2524],
18	develop	VB	O	develop	xcomp	8	SENT_168	[p12l1575t2462r1837b2540],
19	such	PDT	O	such	predet	21	SENT_168	[p12l1874t2462r2027b2524],
20	an	DT	O	a	det	21	SENT_168	[p12l2063t2482r2145b2524],
21	algorithm	NN	O	algorithm	dobj	18	SENT_168	[p12l8t2569r357b2647],
22	.	.	O	.	_	0	SENT_168	[p12l8t2569r357b2647],

1	The	DT	O	the	det	2	SENT_169	[p12l92t2675r223b2737],
2	limitations	NNS	O	limitation	nsubjpass	4	SENT_169	[p12l276t2675r637b2737],
3	are	VBP	O	be	auxpass	4	SENT_169	[p12l692t2695r794b2737],
4	balanced	VBN	O	balance	_	0	SENT_169	[p12l848t2674r1151b2737],
5	by	IN	O	by	_	0	SENT_169	[p12l1204t2674r1287b2753],
6	several	JJ	O	several	amod	7	SENT_169	[p12l1342t2675r1570b2737],
7	strengths	NNS	O	strength	agent	4	SENT_169	[p12l1625t2674r1946b2754],
8	.	.	O	.	_	0	SENT_169	[p12l1625t2674r1946b2754],

1	One	CD	NUMBER	one	num	2	SENT_170	[p12l2005t2676r2145b2737],
2	strength	NN	O	strength	nsubj	3	SENT_170	[p12l9t2781r283b2859],
3	is	VBZ	O	be	_	0	SENT_170	[p12l310t2781r360b2842],
4	that	IN	O	that	complm	6	SENT_170	[p12l390t2781r525b2843],
5	we	PRP	O	we	nsubj	6	SENT_170	[p12l552t2801r645b2843],
6	assured	VBD	O	assure	ccomp	3	SENT_170	[p12l675t2781r928b2843],
7	accurate	JJ	O	accurate	amod	10	SENT_170	[p12l958t2790r1241b2843],
8	therapeutic	JJ	O	therapeutic	amod	10	SENT_170	[p12l1271t2781r1652b2859],
9	dose	NN	O	dose	nn	10	SENT_170	[p12l1681t2781r1833b2843],
10	determination	NN	O	determination	dobj	6	SENT_170	[p12l1862t2781r2143b2843, p12l7t2888r227b2949],
11	by	IN	O	by	_	0	SENT_170	[p12l277t2888r361b2966],
12	requiring	VBG	O	require	prepc_by	6	SENT_170	[p12l411t2888r721b2966],
13	two	CD	NUMBER	two	num	16	SENT_170	[p12l772t2896r897b2949],
14	consecutive	JJ	O	consecutive	amod	16	SENT_170	[p12l950t2888r1339b2949],
15	therapeutic	JJ	O	therapeutic	amod	16	SENT_170	[p12l1391t2888r1772b2966],
16	INRs	NNS	O	inr	dobj	12	SENT_170	[p12l1822t2890r2028b2949],
17	.	.	O	.	_	0	SENT_170	[p12l1822t2890r2028b2949],

1	A	DT	DURATION	a	det	3	SENT_171	[p12l2082t2888r2146b2948],
2	second	JJ	DURATION	second	amod	3	SENT_171	[p12l9t2993r239b3056],
3	strength	NN	O	strength	nsubj	4	SENT_171	[p12l264t2993r539b3073],
4	is	VBZ	O	be	_	0	SENT_171	[p12l561t2994r610b3056],
5	that	IN	O	that	complm	7	SENT_171	[p12l635t2994r771b3056],
6	PREVENT	NNP	O	PREVENT	nsubj	7	SENT_171	[p12l793t2996r1193b3056],
7	used	VBD	O	use	ccomp	4	SENT_171	[p12l1215t2993r1369b3056],
8	a	DT	O	a	det	11	SENT_171	[p12l1393t3014r1431b3056],
9	standard	JJ	O	standard	amod	11	SENT_171	[p12l1455t2993r1753b3056],
10	initial	JJ	O	initial	amod	11	SENT_171	[p12l1776t2994r1969b3056],
11	dose	NN	O	dose	dobj	7	SENT_171	[p12l1993t2993r2145b3056],
12	and	CC	O	and	_	0	SENT_171	[p12l8t3101r135b3162],
13	dose	NN	O	dose	nn	15	SENT_171	[p12l168t3101r321b3162],
14	adjustment	NN	O	adjustment	nn	15	SENT_171	[p12l355t3101r734b3179],
15	protocol	NN	O	protocol	conj_and	11	SENT_171	[p12l766t3101r1074b3179],
16	,	,	O	,	_	0	SENT_171	[p12l766t3101r1074b3179],
17	thus	RB	O	thus	advmod	18	SENT_171	[p12l1111t3101r1254b3162],
18	preventing	VBG	O	prevent	partmod	7	SENT_171	[p12l1287t3101r1649b3179],
19	inter-clinician	JJ	O	inter-clinician	amod	20	SENT_171	[p12l1680t3101r2146b3162],
20	variability	NN	O	variability	dobj	18	SENT_171	[p12l6t3206r351b3284],
21	in	IN	O	in	_	0	SENT_171	[p12l401t3206r465b3267],
22	prescribed	VBN	O	prescribe	amod	23	SENT_171	[p12l515t3206r865b3284],
23	dose	NN	O	dose	prep_in	20	SENT_171	[p12l917t3206r1085b3268],
24	.	.	O	.	_	0	SENT_171	[p12l917t3206r1085b3268],

1	A	DT	O	a	det	3	SENT_172	[p12l1139t3206r1202b3267],
2	ﬁnal	JJ	O	ﬁnal	amod	3	SENT_172	[p12l1252t3206r1401b3268],
3	strength	NN	O	strength	nsubj	4	SENT_172	[p12l1454t3206r1728b3284],
4	is	VBZ	O	be	_	0	SENT_172	[p12l1778t3206r1827b3268],
5	that	IN	O	that	complm	9	SENT_172	[p12l1879t3206r2015b3268],
6	all	DT	O	all	det	7	SENT_172	[p12l2066t3206r2145b3268],
7	participants	NNS	O	participant	nsubjpass	9	SENT_172	[p12l6t3312r409b3390],
8	were	VBD	O	be	auxpass	9	SENT_172	[p12l448t3332r606b3374],
9	followed	VBN	O	follow	ccomp	4	SENT_172	[p12l646t3312r940b3374],
10	prospectively	RB	O	prospectively	advmod	9	SENT_172	[p12l978t3312r1426b3390],
11	as	IN	O	as	_	0	SENT_172	[p12l1467t3332r1534b3374],
12	part	NN	O	part	prep_as	9	SENT_172	[p12l1573t3321r1715b3390],
13	of	IN	O	of	_	0	SENT_172	[p12l1756t3312r1832b3374],
14	a	DT	O	a	det	17	SENT_172	[p12l1864t3332r1902b3374],
15	multicentered	JJ	O	multicentered	amod	17	SENT_172	[p12l1940t3312r2144b3374, p12l7t3419r291b3480],
16	randomized	JJ	O	randomized	amod	17	SENT_172	[p12l318t3419r724b3480],
17	trial	NN	O	trial	prep_of	12	SENT_172	[p12l751t3419r904b3480],
18	.	.	O	.	_	0	SENT_172	[p12l751t3419r904b3480],

1	In	IN	O	in	_	0	SENT_173	[p12l92t3527r165b3586],
2	summary	NN	O	summary	prep_in	5	SENT_173	[p12l199t3545r534b3603],
3	,	,	O	,	_	0	SENT_173	[p12l199t3545r534b3603],
4	we	PRP	O	we	nsubj	13	SENT_173	[p12l568t3545r661b3587],
5	found	VBD	O	find	_	0	SENT_173	[p12l693t3524r896b3587],
6	that	IN	O	that	complm	8	SENT_173	[p12l928t3524r1064b3587],
7	SNPs	NNS	O	snp	nsubj	8	SENT_173	[p12l1098t3526r1284b3587],
8	causing	VBG	O	cause	ccomp	5	SENT_173	[p12l1317t3525r1573b3604],
9	slower	JJR	O	slower	amod	11	SENT_173	[p12l1606t3525r1823b3587],
10	warfarin	NN	O	warfarin	nn	11	SENT_173	[p12l1854t3525r2145b3587],
11	metabolism	NN	O	metabolism	dobj	8	SENT_173	[p12l6t3631r404b3693],
12	and	CC	O	and	_	0	SENT_173	[p12l456t3631r582b3693],
13	increased	VBD	O	increase	conj_and	5	SENT_173	[p12l633t3631r948b3693],
14	warfarin	NN	O	warfarin	nn	16	SENT_173	[p12l998t3631r1290b3693],
15	sensitivity	NN	O	sensitivity	nn	16	SENT_173	[p12l1343t3631r1676b3709],
16	account	NN	O	account	dobj	13	SENT_173	[p12l1727t3640r1995b3693],
17	for	IN	O	for	_	0	SENT_173	[p12l2045t3631r2146b3693],
18	signiﬁcant	JJ	O	signiﬁcant	amod	19	SENT_173	[p13l9t21r353b99],
19	variability	NN	O	variability	prep_for	16	SENT_173	[p13l373t21r718b99],
20	of	IN	O	of	_	0	SENT_173	[p13l740t21r816b82],
21	therapeutic	JJ	O	therapeutic	amod	23	SENT_173	[p13l828t21r1210b99],
22	warfarin	NN	O	warfarin	nn	23	SENT_173	[p13l1229t21r1521b82],
23	dose	NN	O	dose	prep_of	19	SENT_173	[p13l1542t21r1711b82],
24	.	.	O	.	_	0	SENT_173	[p13l1542t21r1711b82],

1	These	DT	O	these	det	2	SENT_174	[p13l1737t21r1934b82],
2	SNPs	NNS	O	snp	nsubjpass	4	SENT_174	[p13l1958t22r2144b82],
3	are	VBP	O	be	auxpass	4	SENT_174	[p13l8t147r110b189],
4	associated	VBN	O	associate	_	0	SENT_174	[p13l135t126r479b189],
5	with	IN	O	with	_	0	SENT_174	[p13l501t126r651b189],
6	increased	VBN	O	increase	amod	7	SENT_174	[p13l673t126r988b189],
7	risk	NN	O	risk	prep_with	4	SENT_174	[p13l1012t126r1137b189],
8	of	IN	O	of	_	0	SENT_174	[p13l1160t126r1236b189],
9	supratherapeutic	JJ	O	supratherapeutic	amod	10	SENT_174	[p13l1253t126r1822b206],
10	INRs	NNS	O	inr	prep_of	7	SENT_174	[p13l1845t129r2034b189],
11	up	IN	DURATION	up	quantmod	13	SENT_174	[p13l2056t147r2144b206],
12	to	TO	DURATION	to	dep	13	SENT_174	[p13l7t242r74b295],
13	28	CD	DURATION	28	num	14	SENT_174	[p13l137t235r213b295],
14	days	NNS	NUMBER	day	tmod	7	SENT_174	[p13l246t234r398b312],
15	after	IN	O	after	_	0	SENT_174	[p13l462t234r617b295],
16	initiation	NN	O	initiation	prep_after	4	SENT_174	[p13l678t234r1002b295],
17	.	.	O	.	_	0	SENT_174	[p13l678t234r1002b295],

1	However	RB	O	however	advmod	7	SENT_175	[p13l1068t236r1396b308],
2	,	,	O	,	_	0	SENT_175	[p13l1068t236r1396b308],
3	the	DT	O	the	det	4	SENT_175	[p13l1461t234r1564b295],
4	importance	NN	O	importance	nsubj	7	SENT_175	[p13l1625t234r2013b312],
5	of	IN	O	of	_	0	SENT_175	[p13l2077t234r2153b295],
6	genotype	NN	O	genotype	prep_of	4	SENT_175	[p13l7t348r315b417],
7	wanes	VBZ	O	wane	_	0	SENT_175	[p13l339t359r546b401],
8	over	IN	O	over	_	0	SENT_175	[p13l573t359r721b401],
9	the	DT	DURATION	the	det	11	SENT_175	[p13l745t339r848b401],
10	initial	JJ	DURATION	initial	amod	11	SENT_175	[p13l872t339r1065b401],
11	weeks	NNS	DURATION	week	prep_over	7	SENT_175	[p13l1089t339r1291b401],
12	of	IN	O	of	_	0	SENT_175	[p13l1318t339r1394b401],
13	therapy	NN	O	therapy	prep_of	11	SENT_175	[p13l1410t339r1686b417],
14	.	.	O	.	_	0	SENT_175	[p13l1410t339r1686b417],

1	Our	PRP$	O	we	poss	2	SENT_176	[p13l1716t341r1853b401],
2	ﬁndings	NNS	O	ﬁndings	nsubj	4	SENT_176	[p13l1876t339r2144b417],
3	should	MD	O	should	aux	4	SENT_176	[p13l9t445r235b507],
4	prompt	VB	O	prompt	_	0	SENT_176	[p13l258t454r517b523],
5	future	JJ	DATE	future	amod	6	SENT_176	[p13l541t445r746b507],
6	studies	NNS	O	study	dobj	4	SENT_176	[p13l772t445r1001b507],
7	to	TO	O	to	aux	8	SENT_176	[p13l1026t454r1093b507],
8	develop	VB	O	develop	xcomp	4	SENT_176	[p13l1120t445r1381b523],
9	and	CC	O	and	_	0	SENT_176	[p13l1408t445r1535b507],
10	assess	VB	O	assess	conj_and	8	SENT_176	[p13l1560t465r1754b507],
11	the	DT	O	the	det	13	SENT_176	[p13l1780t445r1883b507],
12	clinical	JJ	O	clinical	amod	13	SENT_176	[p13l1908t445r2145b507],
13	utility	NN	O	utility	dobj	8	SENT_176	[p13l6t552r205b630],
14	of	IN	O	of	_	0	SENT_176	[p13l234t552r309b613],
15	a	DT	DURATION	a	det	16	SENT_176	[p13l329t572r367b613],
16	day	NN	DURATION	day	nn	20	SENT_176	[p13l395t552r518b630],
17	7	CD	NUMBER	7	number	18	SENT_176	[p13l546t554r582b613],
18	pharmacogenetic	JJ	O	pharmacogenetic	amod	20	SENT_176	[p13l610t552r1193b630],
19	dosing	NN	O	dosing	nn	20	SENT_176	[p13l1221t552r1445b630],
20	algorithm	NN	O	algorithm	prep_of	13	SENT_176	[p13l1472t552r1821b630],
21	.	.	O	.	_	0	SENT_176	[p13l1472t552r1821b630],

1	Addendum	NNP	O	Addendum	_	0	SENT_177	[p13l6t791r403b857],

1	The	DT	O	the	nsubj	2	SENT_178	[p13l7t954r138b1016],
2	following	VBG	O	follow	_	0	SENT_178	[p13l171t954r491b1032],
3	details	NNS	O	detail	nsubj	7	SENT_178	[p13l523t954r738b1016],
4	each	DT	O	each	det	5	SENT_178	[p13l771t954r925b1016],
5	author	NN	O	author	poss	7	SENT_178	[p13l958t954r1233b1016],
6	’s	POS	O	’s	_	0	SENT_178	[p13l958t954r1233b1016],
7	contribution	NN	O	contribution	xcomp	2	SENT_178	[p13l1265t954r1691b1016],
8	to	TO	O	to	_	0	SENT_178	[p13l1724t963r1790b1016],
9	the	DT	O	the	det	12	SENT_178	[p13l1825t954r1928b1016],
10	study	NN	O	study	nn	12	SENT_178	[p13l1962t954r2145b1032],
11	and/or	NN	O	and/or	nn	12	SENT_178	[p13l8t1060r236b1138],
12	manuscript	NN	O	manuscript	prep_to	7	SENT_178	[p13l262t1060r662b1138],
13	:	:	O	:	_	0	SENT_178	[p13l262t1060r662b1138],

1	©	RB	O	©	dep	2	SENT_179	[p13l223t1288r273b1338],
2	2009	CD	DATE	2009	dep	4	SENT_179	[p13l301t1287r439b1338],
3	International	NNP	MISC	International	nn	4	SENT_179	[p13l468t1286r865b1338],
4	Society	NNP	MISC	Society	_	0	SENT_179	[p13l894t1286r1109b1351],
5	on	IN	MISC	on	_	0	SENT_179	[p13l1136t1303r1211b1338],
6	Thrombosis	NNP	MISC	Thrombosis	prep_on	4	SENT_179	[p13l1238t1285r1598b1338],
7	and	CC	O	and	_	0	SENT_179	[p13l1627t1285r1737b1338],
8	Haemostasis	NNP	PERSON	Haemostasis	prep_on	4	SENT_179	[p13l1765t1286r2145b1338],

1	Ability	NN	O	ability	_	0	SENT_180	[p13l493t1426r599b1461],
2	of	IN	O	of	_	0	SENT_180	[p13l613t1426r649b1461],
3	VKORCI	NN	O	vkorcus	nn	6	SENT_180	[p13l661t1427r808b1454],
4	and	CC	O	and	_	0	SENT_180	[p13l824t1426r881b1454],
5	C	NN	O	c	nn	6	SENT_180	[p13l894t1427r919b1454],
6	YP2C9	NN	O	yp2c9	prep_of	1	SENT_180	[p13l924t1427r1033b1454],
7	to	TO	O	to	aux	8	SENT_180	[p13l1049t1432r1077b1453],
8	predict	VB	O	predict	infmod	1	SENT_180	[p13l1087t1426r1197b1461],
9	therapeutic	JJ	O	therapeutic	amod	11	SENT_180	[p13l1212t1426r1382b1461],
10	warfarin	NN	O	warfarin	nn	11	SENT_180	[p13l1397t1426r1526b1461],
11	dose	NN	O	dose	dobj	8	SENT_180	[p13l1541t1426r1607b1454],
12	99	CD	NUMBER	99	tmod	8	SENT_180	[p13l1628t1426r1667b1454],

1	N.S.	NNP	PERSON	N.S.	nn	4	SENT_181	[p13l91t1597r239b1659],
2	Ferder	NNP	PERSON	Ferder	nn	4	SENT_181	[p13l266t1596r494b1659],
3	(	NN	O	(	nn	4	SENT_181	[p13l516t1596r932b1676],
4	conception	NN	O	conception	_	0	SENT_181	[p13l516t1596r932b1676],
5	,	,	O	,	_	0	SENT_181	[p13l516t1596r932b1676],
6	analyzing	VBG	O	analyze	dep	4	SENT_181	[p13l956t1596r1298b1675],
7	,	,	O	,	_	0	SENT_181	[p13l956t1596r1298b1675],
8	writing	VBG	O	write	dep	6	SENT_181	[p13l1321t1596r1580b1675],
9	,	,	O	,	_	0	SENT_181	[p13l1321t1596r1580b1675],
10	editing	NN	O	editing	dobj	6	SENT_181	[p13l1603t1596r1852b1675],
11	,	,	O	,	_	0	SENT_181	[p13l1603t1596r1852b1675],
12	approving	VBG	O	approve	partmod	10	SENT_181	[p13l1877t1617r2143b1675, p13l6t1703r155b1781],
13	)	NN	O	)	dobj	12	SENT_181	[p13l1877t1617r2143b1675, p13l6t1703r155b1781],
14	;	:	O	;	_	0	SENT_181	[p13l1877t1617r2143b1675, p13l6t1703r155b1781],
15	C.S.	NNP	PERSON	C.S.	nn	18	SENT_181	[p13l218t1704r354b1765],
16	Eby	NNP	PERSON	Eby	nn	18	SENT_181	[p13l418t1703r555b1781],
17	(	NN	O	(	nn	18	SENT_181	[p13l615t1703r921b1781],
18	funding	NN	O	funding	nsubj	26	SENT_181	[p13l615t1703r921b1781],
19	,	,	O	,	_	0	SENT_181	[p13l615t1703r921b1781],
20	conception	NN	O	conception	appos	18	SENT_181	[p13l982t1703r1374b1781],
21	,	,	O	,	_	0	SENT_181	[p13l982t1703r1374b1781],
22	genotyping	NN	O	genotyping	appos	18	SENT_181	[p13l1436t1703r1832b1781],
23	,	,	O	,	_	0	SENT_181	[p13l1436t1703r1832b1781],
24	editing	NN	O	editing	appos	18	SENT_181	[p13l1894t1703r2142b1781],
25	,	,	O	,	_	0	SENT_181	[p13l1894t1703r2142b1781],
26	approving	VBG	O	approve	dep	4	SENT_181	[p13l8t1810r400b1888],
27	)	NN	O	)	dobj	26	SENT_181	[p13l8t1810r400b1888],
28	;	:	O	;	_	0	SENT_181	[p13l8t1810r400b1888],
29	E.	NNP	PERSON	E.	nn	32	SENT_181	[p13l427t1812r495b1871],
30	Deych	NNP	PERSON	Deych	nn	32	SENT_181	[p13l522t1810r743b1888],
31	(	NN	O	(	nn	32	SENT_181	[p13l766t1810r1072b1888],
32	funding	NN	O	funding	dep	27	SENT_181	[p13l766t1810r1072b1888],
33	,	,	O	,	_	0	SENT_181	[p13l766t1810r1072b1888],
34	analyzing	VBG	O	analyze	dep	26	SENT_181	[p13l1099t1810r1441b1888],
35	,	,	O	,	_	0	SENT_181	[p13l1099t1810r1441b1888],
36	writing	VBG	O	write	dep	26	SENT_181	[p13l1465t1810r1724b1888],
37	,	,	O	,	_	0	SENT_181	[p13l1465t1810r1724b1888],
38	approving	VBG	O	approve	dep	26	SENT_181	[p13l1751t1810r2142b1888],
39	)	NN	O	)	dobj	26	SENT_181	[p13l1751t1810r2142b1888],
40	;	:	O	;	_	0	SENT_181	[p13l1751t1810r2142b1888],
41	J	NN	O	j	dep	39	SENT_181	[p13l6t1918r40b1978],
42	.	.	O	.	_	0	SENT_181	[p13l47t1918r145b1977],

1	K.	NNP	PERSON	K.	nn	2	SENT_182	[p13l47t1918r145b1977],
2	Harris	NNP	PERSON	Harris	_	0	SENT_182	[p13l208t1915r425b1978],
3	(	CD	NUMBER	(	num	4	SENT_182	[p13l486t1915r853b1995],
4	analyzing	NN	O	analyzing	dep	2	SENT_182	[p13l486t1915r853b1995],
5	,	,	O	,	_	0	SENT_182	[p13l486t1915r853b1995],
6	editing	NN	O	editing	appos	2	SENT_182	[p13l915t1915r1163b1994],
7	,	,	O	,	_	0	SENT_182	[p13l915t1915r1163b1994],
8	approving	VBG	O	approve	partmod	2	SENT_182	[p13l1226t1915r1618b1994],
9	)	NN	O	)	dobj	8	SENT_182	[p13l1226t1915r1618b1994],
10	;	:	O	;	_	0	SENT_182	[p13l1226t1915r1618b1994],
11	P.M.	NNP	PERSON	P.M.	nn	14	SENT_182	[p13l1679t1918r1845b1977],
12	Ridker	NNP	PERSON	Ridker	nn	14	SENT_182	[p13l1911t1915r2146b1978],
13	(	NN	O	(	nn	14	SENT_182	[p13l9t2022r315b2100],
14	funding	NN	O	funding	nsubj	22	SENT_182	[p13l9t2022r315b2100],
15	,	,	O	,	_	0	SENT_182	[p13l9t2022r315b2100],
16	conception	NN	O	conception	appos	14	SENT_182	[p13l377t2022r768b2100],
17	,	,	O	,	_	0	SENT_182	[p13l377t2022r768b2100],
18	recruiting	NN	O	recruiting	appos	14	SENT_182	[p13l830t2022r1175b2100],
19	,	,	O	,	_	0	SENT_182	[p13l830t2022r1175b2100],
20	editing	NN	O	editing	appos	14	SENT_182	[p13l1237t2022r1484b2100],
21	,	,	O	,	_	0	SENT_182	[p13l1237t2022r1484b2100],
22	approving	VBG	O	approve	dep	2	SENT_182	[p13l1548t2022r1939b2100],
23	)	NN	O	)	dobj	22	SENT_182	[p13l1548t2022r1939b2100],
24	;	:	O	;	_	0	SENT_182	[p13l1548t2022r1939b2100],
25	P.E.	NNP	PERSON	P.E.	nn	28	SENT_182	[p13l2001t2025r2140b2083],
26	Milligan	NNP	PERSON	Milligan	nn	28	SENT_182	[p13l8t2129r296b2207],
27	(	NN	O	(	nn	28	SENT_182	[p13l354t2129r636b2207],
28	writing	NN	O	writing	dep	23	SENT_182	[p13l354t2129r636b2207],
29	,	,	O	,	_	0	SENT_182	[p13l354t2129r636b2207],
30	approving	VBG	O	approve	dep	22	SENT_182	[p13l697t2129r1089b2207],
31	)	NN	O	)	dobj	30	SENT_182	[p13l697t2129r1089b2207],
32	;	:	O	;	_	0	SENT_182	[p13l697t2129r1089b2207],
33	S.Z.	NNP	PERSON	S.Z.	nn	36	SENT_182	[p13l1152t2130r1283b2190],
34	Goldhaber	NNP	PERSON	Goldhaber	nn	36	SENT_182	[p13l1346t2129r1717b2190],
35	(	NN	O	(	nn	36	SENT_182	[p13l1774t2129r2142b2207],
36	recruiting	NN	O	recruiting	dep	31	SENT_182	[p13l1774t2129r2142b2207],
37	,	,	O	,	_	0	SENT_182	[p13l1774t2129r2142b2207],
38	editing	NN	O	editing	appos	36	SENT_182	[p13l7t2234r256b2314],
39	,	,	O	,	_	0	SENT_182	[p13l7t2234r256b2314],
40	approving	VBG	O	approve	dep	22	SENT_182	[p13l295t2235r687b2314],
41	)	NN	O	)	dobj	40	SENT_182	[p13l295t2235r687b2314],
42	;	:	O	;	_	0	SENT_182	[p13l295t2235r687b2314],
43	C.R.	NNP	PERSON	C.R.	nn	44	SENT_182	[p13l726t2236r882b2297],
44	King	NNP	PERSON	King	dep	41	SENT_182	[p13l922t2235r1093b2314],
45	(	CD	NUMBER	(	num	46	SENT_182	[p13l1130t2235r1551b2314],
46	genotyping	NN	O	genotyping	dep	44	SENT_182	[p13l1130t2235r1551b2314],
47	,	,	O	,	_	0	SENT_182	[p13l1130t2235r1551b2314],
48	editing	NN	O	editing	appos	46	SENT_182	[p13l1589t2234r1838b2314],
49	,	,	O	,	_	0	SENT_182	[p13l1589t2234r1838b2314],
50	approving	VBG	O	approve	dep	22	SENT_182	[p13l1877t2255r2143b2314, p13l6t2342r155b2420],
51	)	NN	O	)	dobj	50	SENT_182	[p13l1877t2255r2143b2314, p13l6t2342r155b2420],
52	;	:	O	;	_	0	SENT_182	[p13l1877t2255r2143b2314, p13l6t2342r155b2420],
53	T.	FW	PERSON	t.	dep	51	SENT_182	[p13l189t2344r258b2403],
54	Giri	FW	PERSON	giri	nn	56	SENT_182	[p13l296t2342r432b2403],
55	(	FW	O	(	nn	56	SENT_182	[p13l465t2342r738b2420],
56	editing	NN	O	editing	dep	53	SENT_182	[p13l465t2342r738b2420],
57	,	,	O	,	_	0	SENT_182	[p13l465t2342r738b2420],
58	approving	VBG	O	approve	dep	22	SENT_182	[p13l774t2342r1166b2420],
59	)	NN	O	)	dobj	58	SENT_182	[p13l774t2342r1166b2420],
60	;	:	O	;	_	0	SENT_182	[p13l774t2342r1166b2420],
61	H.L.	NNP	PERSON	H.L.	nn	62	SENT_182	[p13l1201t2344r1358b2403],
62	McLeod	NNP	PERSON	McLeod	dep	59	SENT_182	[p13l1395t2342r1688b2403],
63	(	CD	NUMBER	(	num	64	SENT_182	[p13l1721t2342r2141b2420],
64	genotyping	NN	O	genotyping	dep	62	SENT_182	[p13l1721t2342r2141b2420],
65	,	,	O	,	_	0	SENT_182	[p13l1721t2342r2141b2420],
66	editing	NN	O	editing	appos	64	SENT_182	[p13l7t2447r256b2525],
67	,	,	O	,	_	0	SENT_182	[p13l7t2447r256b2525],
68	approving	VBG	O	approve	dep	22	SENT_182	[p13l279t2447r671b2525],
69	)	NN	O	)	dobj	68	SENT_182	[p13l279t2447r671b2525],
70	;	:	O	;	_	0	SENT_182	[p13l279t2447r671b2525],
71	R.J.	NNP	PERSON	R.J.	nn	74	SENT_182	[p13l696t2450r827b2509],
72	Glynn	NNP	PERSON	Glynn	nn	74	SENT_182	[p13l852t2447r1067b2525],
73	(	NN	O	(	nn	74	SENT_182	[p13l1089t2447r1504b2525],
74	conception	NN	O	conception	dep	69	SENT_182	[p13l1089t2447r1504b2525],
75	,	,	O	,	_	0	SENT_182	[p13l1089t2447r1504b2525],
76	recruiting	NN	O	recruiting	appos	74	SENT_182	[p13l1527t2447r1871b2525],
77	,	,	O	,	_	0	SENT_182	[p13l1527t2447r1871b2525],
78	editing	NN	O	editing	appos	74	SENT_182	[p13l1894t2447r2142b2525],
79	,	,	O	,	_	0	SENT_182	[p13l1894t2447r2142b2525],
80	approving	VBG	O	approve	dep	22	SENT_182	[p13l8t2553r400b2631],
81	)	NN	O	)	dobj	80	SENT_182	[p13l8t2553r400b2631],
82	;	:	O	;	_	0	SENT_182	[p13l8t2553r400b2631],
83	B.F.	NNP	PERSON	B.F.	nn	86	SENT_182	[p13l421t2555r563b2614],
84	Gage	NNP	PERSON	Gage	nn	86	SENT_182	[p13l586t2554r765b2631],
85	(	NN	O	(	nn	86	SENT_182	[p13l784t2553r1090b2631],
86	funding	NN	O	funding	dep	81	SENT_182	[p13l784t2553r1090b2631],
87	,	,	O	,	_	0	SENT_182	[p13l784t2553r1090b2631],
88	conception	NN	O	conception	appos	86	SENT_182	[p13l1110t2553r1501b2631],
89	,	,	O	,	_	0	SENT_182	[p13l1110t2553r1501b2631],
90	analyzing	VBG	O	analyze	dep	22	SENT_182	[p13l1522t2553r1863b2631],
91	,	,	O	,	_	0	SENT_182	[p13l1522t2553r1863b2631],
92	writing	VBG	O	write	dep	22	SENT_182	[p13l1882t2553r2141b2631],
93	,	,	O	,	_	0	SENT_182	[p13l1882t2553r2141b2631],
94	editing	NN	O	editing	advmod	92	SENT_182	[p13l7t2660r255b2738],
95	,	,	O	,	_	0	SENT_182	[p13l7t2660r255b2738],
96	approving	VBG	O	approve	dep	22	SENT_182	[p13l282t2660r673b2738],
97	)	NN	O	)	dobj	22	SENT_182	[p13l282t2660r673b2738],
98	.	.	O	.	_	0	SENT_182	[p13l282t2660r673b2738],

1	Acknowledgements	NNS	O	acknowledgement	nsubj	5	SENT_183	[p13l7t2899r727b2983],
2	The	DT	O	the	det	4	SENT_183	[p13l7t3062r139b3124],
3	study	NN	O	study	nn	4	SENT_183	[p13l180t3062r364b3140],
4	sponsor	NN	O	sponsor	dep	1	SENT_183	[p13l405t3082r672b3140],
5	had	VBD	O	have	_	0	SENT_183	[p13l710t3062r838b3124],
6	no	DT	O	no	det	7	SENT_183	[p13l877t3082r963b3124],
7	role	NN	O	role	dobj	5	SENT_183	[p13l1004t3062r1133b3124],
8	in	IN	O	in	dep	7	SENT_183	[p13l1172t3062r1236b3123],
9	gathering	NN	O	gathering	pobj	8	SENT_183	[p13l1276t3062r1597b3140],
10	or	CC	O	or	_	0	SENT_183	[p13l1637t3082r1710b3124],
11	interpreting	VBG	O	interpret	dep	7	SENT_183	[p13l1748t3062r2146b3140],
12	data	NNS	O	datum	dobj	11	SENT_183	[p13l8t3168r174b3242],
13	,	,	O	,	_	0	SENT_183	[p13l8t3168r174b3242],
14	or	CC	O	or	_	0	SENT_183	[p13l202t3188r274b3229],
15	review	NN	O	review	conj_or	7	SENT_183	[p13l297t3168r516b3229],
16	of	IN	O	of	_	0	SENT_183	[p13l539t3168r615b3229],
17	the	DT	O	the	det	18	SENT_183	[p13l630t3168r734b3229],
18	manuscript	NN	O	manuscript	prep_of	15	SENT_183	[p13l755t3168r1156b3246],
19	.	.	O	.	_	0	SENT_183	[p13l755t3168r1156b3246],

1	Funded	VBN	O	fund	_	0	SENT_184	[p13l1184t3168r1450b3229],
2	by	IN	O	by	_	0	SENT_184	[p13l1472t3168r1556b3246],
3	NIH	NNP	ORGANIZATION	NIH	nn	4	SENT_184	[p13l1578t3170r1741b3229],
4	grants	NNS	O	grant	prep_by	1	SENT_184	[p13l1766t3176r1975b3246],
5	HL074724	NN	O	hl074724	dep	4	SENT_184	[p13l2000t3170r2144b3228, p13l8t3275r265b3348],
6	,	,	O	,	_	0	SENT_184	[p13l2000t3170r2144b3228, p13l8t3275r265b3348],
7	HL-097036	NN	O	hl-097036	dep	4	SENT_184	[p13l296t3275r701b3348],
8	,	,	O	,	_	0	SENT_184	[p13l296t3275r701b3348],
9	HL-57951	NN	O	hl-57951	conj_and	5	SENT_184	[p13l732t3275r1071b3335],
10	and	CC	O	and	_	0	SENT_184	[p13l1107t3273r1233b3335],
11	HL-58036	NN	O	hl-58036	conj_and	5	SENT_184	[p13l1261t3275r1624b3335],
12	.	.	O	.	_	0	SENT_184	[p13l1261t3275r1624b3335],

1	Disclosure	NN	O	disclosure	_	0	SENT_185	[p13l11t3510r390b3575],
2	of	IN	O	of	_	0	SENT_185	[p13l423t3509r495b3575],
3	Conflict	NN	O	conflict	prep_of	1	SENT_185	[p13l529t3509r816b3575],
4	of	IN	O	of	_	0	SENT_185	[p13l847t3509r919b3575],
5	Interests	NNS	O	interest	prep_of	1	SENT_185	[p13l953t3514r1260b3575],

1	The	DT	O	the	det	2	SENT_186	[p13l7t3673r139b3734],
2	authors	NNS	O	author	nsubj	3	SENT_186	[p13l168t3673r425b3734],
3	state	VBP	O	state	_	0	SENT_186	[p13l455t3682r609b3734],
4	that	IN	O	that	complm	6	SENT_186	[p13l637t3673r773b3734],
5	they	PRP	O	they	nsubj	6	SENT_186	[p13l799t3673r944b3751],
6	have	VBP	O	have	ccomp	3	SENT_186	[p13l971t3673r1129b3734],
7	no	DT	O	no	det	8	SENT_186	[p13l1157t3693r1242b3734],
8	conﬂict	NN	O	conﬂict	dobj	6	SENT_186	[p13l1271t3673r1521b3734],
9	of	IN	O	of	_	0	SENT_186	[p13l1549t3673r1625b3734],
10	interest	NN	O	interest	prep_of	8	SENT_186	[p13l1643t3673r1907b3734],
11	.	.	O	.	_	0	SENT_186	[p13l1643t3673r1907b3734],

1	References	NNS	O	reference	_	0	SENT_187	[p14l11t126r403b192],

1	1	CD	NUMBER	1	_	0	SENT_188	[p14l47t287r65b338],
2	Higashi	NNP	ORGANIZATION	Higashi	nn	3	SENT_188	[p14l111t286r334b352],
3	MK	NNP	ORGANIZATION	MK	dep	1	SENT_188	[p14l358t288r498b349],
4	,	,	O	,	_	0	SENT_188	[p14l358t288r498b349],
5	Veenstra	NNP	ORGANIZATION	Veenstra	nn	6	SENT_188	[p14l523t288r778b338],
6	DL	NNP	ORGANIZATION	DL	appos	3	SENT_188	[p14l802t288r918b349],
7	,	,	O	,	_	0	SENT_188	[p14l802t288r918b349],
8	Kondo	NNP	PERSON	Kondo	nn	9	SENT_188	[p14l945t286r1150b338],
9	LM	NNP	O	LM	appos	3	SENT_188	[p14l1177t288r1304b349],
10	,	,	O	,	_	0	SENT_188	[p14l1177t288r1304b349],
11	Wittkowsky	NNP	ORGANIZATION	Wittkowsky	nn	12	SENT_188	[p14l1329t286r1684b352],
12	AK	NNP	ORGANIZATION	AK	appos	3	SENT_188	[p14l1707t286r1832b349],
13	,	,	O	,	_	0	SENT_188	[p14l1707t286r1832b349],
14	Srinouanprachanh	NNP	ORGANIZATION	Srinouanprachanh	nn	15	SENT_188	[p14l1860t286r2145b339, p14l110t375r385b442],
15	SL	NNP	ORGANIZATION	SL	appos	3	SENT_188	[p14l418t376r513b438],
16	,	,	O	,	_	0	SENT_188	[p14l418t376r513b438],
17	Farin	NNP	PERSON	Farin	nn	18	SENT_188	[p14l547t375r706b427],
18	FM	NNP	O	FM	appos	3	SENT_188	[p14l738t377r865b438],
19	,	,	O	,	_	0	SENT_188	[p14l738t377r865b438],
20	Rettie	NNP	O	Rettie	nn	21	SENT_188	[p14l901t375r1072b427],
21	AE	NNP	O	AE	appos	3	SENT_188	[p14l1102t375r1215b427],
22	.	.	O	.	_	0	SENT_188	[p14l1102t375r1215b427],

1	Association	NNP	O	Association	_	0	SENT_189	[p14l1248t375r1588b427],
2	between	IN	O	between	_	0	SENT_189	[p14l1619t375r1854b428],
3	CYP2C9	NNP	O	CYP2C9	nn	5	SENT_189	[p14l1885t376r2144b428],
4	genetic	JJ	O	genetic	amod	5	SENT_189	[p14l111t464r311b531],
5	Variants	NNS	O	variant	prep_between	1	SENT_189	[p14l328t464r559b516],
6	and	CC	O	and	_	0	SENT_189	[p14l579t464r686b516],
7	anticoagulation-related	JJ	O	anticoagulation-related	amod	8	SENT_189	[p14l706t464r1377b531],
8	outcomes	NNS	O	outcome	prep_between	1	SENT_189	[p14l1397t471r1672b516],
9	during	IN	O	during	_	0	SENT_189	[p14l1691t464r1881b531],
10	Warfarin	NN	O	warfarin	nn	11	SENT_189	[p14l1897t464r2146b516],
11	therapy	NN	O	therapy	prep_during	1	SENT_189	[p14l111t553r345b619],
12	.	.	O	.	_	0	SENT_189	[p14l111t553r345b619],

1	JAMA	NNP	O	JAMA	_	0	SENT_190	[p14l372t555r571b606],
2	2002	CD	DATE	2002	num	1	SENT_190	[p14l597t554r746b617],
3	;	:	O	;	_	0	SENT_190	[p14l597t554r746b617],
4	287	CD	NUMBER	287	num	6	SENT_190	[p14l772t554r887b605],
5	:	:	O	:	_	0	SENT_190	[p14l772t554r887b605],
6	1690-8	CD	NUMBER	1690-8	dep	1	SENT_190	[p14l921t554r1132b606],
7	.	.	O	.	_	0	SENT_190	[p14l921t554r1132b606],

1	2	CD	NUMBER	2	_	0	SENT_191	[p14l40t643r72b694],
2	Rieder	NNP	ORGANIZATION	Rieder	nn	3	SENT_191	[p14l113t642r305b694],
3	MJ	NNP	ORGANIZATION	MJ	dep	1	SENT_191	[p14l331t644r443b705],
4	,	,	O	,	_	0	SENT_191	[p14l331t644r443b705],
5	Reiner	NNP	ORGANIZATION	Reiner	nn	6	SENT_191	[p14l474t642r665b694],
6	AP	NNP	ORGANIZATION	AP	appos	3	SENT_191	[p14l691t642r800b705],
7	,	,	O	,	_	0	SENT_191	[p14l691t642r800b705],
8	Gage	NNP	PERSON	Gage	nn	9	SENT_191	[p14l830t643r982b709],
9	BF	NNP	O	BF	appos	3	SENT_191	[p14l1011t644r1115b705],
10	,	,	O	,	_	0	SENT_191	[p14l1011t644r1115b705],
11	Nickerson	NNP	ORGANIZATION	Nickerson	nn	12	SENT_191	[p14l1144t642r1443b694],
12	DA	NNP	ORGANIZATION	DA	appos	3	SENT_191	[p14l1470t642r1594b705],
13	,	,	O	,	_	0	SENT_191	[p14l1470t642r1594b705],
14	Eby	NNP	PERSON	Eby	nn	15	SENT_191	[p14l1624t642r1740b708],
15	CS	NNP	O	CS	appos	3	SENT_191	[p14l1768t643r1867b705],
16	,	,	O	,	_	0	SENT_191	[p14l1768t643r1867b705],
17	McLeod	NNP	PERSON	McLeod	nn	18	SENT_191	[p14l1898t642r2146b694],
18	HL	NNS	O	hl	appos	3	SENT_191	[p14l111t733r228b794],
19	,	,	O	,	_	0	SENT_191	[p14l111t733r228b794],
20	Blough	NNP	ORGANIZATION	Blough	nn	21	SENT_191	[p14l260t731r469b798],
21	DK	NNP	ORGANIZATION	DK	appos	3	SENT_191	[p14l498t733r625b794],
22	,	,	O	,	_	0	SENT_191	[p14l498t733r625b794],
23	Thummel	NNP	PERSON	Thummel	nn	24	SENT_191	[p14l656t731r938b783],
24	KE	NNP	PERSON	KE	appos	3	SENT_191	[p14l967t733r1083b794],
25	,	,	O	,	_	0	SENT_191	[p14l967t733r1083b794],
26	Veenstra	NNP	PERSON	Veenstra	nn	27	SENT_191	[p14l1113t733r1369b783],
27	DL	NNP	O	DL	appos	3	SENT_191	[p14l1397t733r1514b794],
28	,	,	O	,	_	0	SENT_191	[p14l1397t733r1514b794],
29	Rettie	NNP	O	Rettie	nn	30	SENT_191	[p14l1547t731r1718b783],
30	AE	NNP	O	AE	appos	3	SENT_191	[p14l1746t731r1859b783],
31	.	.	O	.	_	0	SENT_191	[p14l1746t731r1859b783],

1	Effect	NN	O	effect	_	0	SENT_192	[p14l1893t731r2059b783],
2	of	IN	O	of	_	0	SENT_192	[p14l2089t731r2153b783],
3	VKORC1	NN	O	vkorc1	nn	4	SENT_192	[p14l110t821r401b873],
4	haplotypes	NNS	O	haplotype	prep_of	1	SENT_192	[p14l425t820r739b887],
5	on	IN	O	on	_	0	SENT_192	[p14l760t837r833b873],
6	transcriptional	JJ	O	transcriptional	amod	7	SENT_192	[p14l852t820r1275b887],
7	regulation	NN	O	regulation	prep_on	1	SENT_192	[p14l1294t820r1588b887],
8	and	CC	O	and	_	0	SENT_192	[p14l1607t820r1714b873],
9	Warfarin	NNP	O	Warfarin	nn	10	SENT_192	[p14l1732t820r1980b873],
10	dose	NN	O	dose	prep_on	1	SENT_192	[p14l1999t820r2143b873],
11	.	.	O	.	_	0	SENT_192	[p14l1999t820r2143b873],

1	N	NN	O	n	nn	3	SENT_193	[p14l111t912r169b961],
2	Engl	NNP	O	Engl	nn	3	SENT_193	[p14l185t909r321b975],
3	J	NNP	O	J	nsubj	4	SENT_193	[p14l339t912r378b962],
4	Med	VBD	O	med	_	0	SENT_193	[p14l395t909r533b961],
5	2005	CD	DATE	2005	dobj	4	SENT_193	[p14l550t910r699b973],
6	;	:	O	;	_	0	SENT_193	[p14l550t910r699b973],
7	352	CD	NUMBER	352	num	9	SENT_193	[p14l725t910r840b961],
8	:	:	O	:	_	0	SENT_193	[p14l725t910r840b961],
9	2285-93	CD	NUMBER	2285-93	dep	5	SENT_193	[p14l868t910r1119b961],
10	.	.	O	.	_	0	SENT_193	[p14l868t910r1119b961],

1	3	CD	MONEY	3	_	0	SENT_194	[p14l42t1000r69b1051],
2	Yuan	NNP	MONEY	Yuan	nn	3	SENT_194	[p14l110t1000r273b1050],
3	HY	NNP	O	HY	dep	1	SENT_194	[p14l289t1000r413b1061],
4	,	,	O	,	_	0	SENT_194	[p14l289t1000r413b1061],
5	Chen	NNP	PERSON	Chen	nn	7	SENT_194	[p14l433t998r586b1051],
6	J	NNP	PERSON	J	nn	7	SENT_194	[p14l601t1000r630b1051],
7	J	NNP	PERSON	J	appos	3	SENT_194	[p14l631t1000r660b1051],
8	,	,	O	,	_	0	SENT_194	[p14l664t1042r675b1061],
9	Lee	NNP	PERSON	Lee	nn	10	SENT_194	[p14l695t1000r797b1050],
10	MT	NNP	O	MT	appos	3	SENT_194	[p14l814t1000r942b1061],
11	,	,	O	,	_	0	SENT_194	[p14l814t1000r942b1061],
12	Wung	NNP	PERSON	Wung	nn	14	SENT_194	[p14l960t1000r1139b1065],
13	J	NNP	PERSON	J	nn	14	SENT_194	[p14l1153t1000r1182b1051],
14	C	NNP	PERSON	C	appos	3	SENT_194	[p14l1185t999r1247b1061],
15	,	,	O	,	_	0	SENT_194	[p14l1185t999r1247b1061],
16	Chen	NNP	O	Chen	nn	17	SENT_194	[p14l1267t998r1419b1051],
17	YF	NNP	O	YF	appos	3	SENT_194	[p14l1435t1000r1548b1061],
18	,	,	O	,	_	0	SENT_194	[p14l1435t1000r1548b1061],
19	Charng	NNP	O	Charng	nn	20	SENT_194	[p14l1568t998r1787b1065],
20	MJ	NNP	O	MJ	appos	3	SENT_194	[p14l1802t1000r1914b1061],
21	,	,	O	,	_	0	SENT_194	[p14l1802t1000r1914b1061],
22	Lu	NNP	PERSON	Lu	nn	23	SENT_194	[p14l1934t1000r2016b1050],
23	MJ	NNP	PERSON	MJ	appos	3	SENT_194	[p14l2032t1000r2144b1061],
24	,	,	O	,	_	0	SENT_194	[p14l2032t1000r2144b1061],
25	Hung	NNP	O	Hung	nn	26	SENT_194	[p14l111t1089r277b1154],
26	CR	NN	O	cr	appos	3	SENT_194	[p14l299t1088r415b1151],
27	,	,	O	,	_	0	SENT_194	[p14l299t1088r415b1151],
28	Wei	NNP	O	Wei	nn	29	SENT_194	[p14l438t1087r554b1140],
29	CY	NNP	O	CY	appos	3	SENT_194	[p14l578t1088r694b1151],
30	,	,	O	,	_	0	SENT_194	[p14l578t1088r694b1151],
31	Chen	NNP	PERSON	Chen	nn	32	SENT_194	[p14l720t1087r872b1140],
32	CH	NN	O	ch	appos	3	SENT_194	[p14l895t1088r1014b1151],
33	,	,	O	,	_	0	SENT_194	[p14l895t1088r1014b1151],
34	Wu	NNP	O	Wu	nn	35	SENT_194	[p14l1038t1089r1145b1140],
35	JY	NN	O	jy	appos	3	SENT_194	[p14l1166t1089r1263b1151],
36	,	,	O	,	_	0	SENT_194	[p14l1166t1089r1263b1151],
37	Chen	NNP	O	Chen	nn	38	SENT_194	[p14l1289t1087r1442b1140],
38	YT	NNP	O	YT	appos	3	SENT_194	[p14l1462t1089r1575b1139],
39	.	.	O	.	_	0	SENT_194	[p14l1462t1089r1575b1139],

1	A	DT	O	a	det	6	SENT_195	[p14l1600t1087r1653b1139],
2	novel	JJ	O	novel	amod	6	SENT_195	[p14l1674t1087r1831b1140],
3	functional	JJ	O	functional	amod	6	SENT_195	[p14l1852t1087r2147b1140],
4	VKORC1	NN	O	vkorc1	nn	6	SENT_195	[p14l110t1177r401b1229],
5	promoter	NN	O	promoter	nn	6	SENT_195	[p14l428t1183r703b1243],
6	polymorphism	NN	O	polymorphism	nsubjpass	8	SENT_195	[p14l723t1176r1149b1243],
7	is	VBZ	O	be	auxpass	8	SENT_195	[p14l1170t1177r1212b1229],
8	associated	VBN	O	associate	_	0	SENT_195	[p14l1236t1176r1530b1229],
9	with	IN	O	with	_	0	SENT_195	[p14l1551t1176r1679b1229],
10	inter-individual	JJ	O	inter-individual	amod	13	SENT_195	[p14l1700t1176r2146b1229],
11	and	CC	O	and	_	0	SENT_195	[p14l112t1265r219b1317],
12	inter-ethnic	JJ	O	inter-ethnic	amod	13	SENT_195	[p14l252t1265r583b1317],
13	differences	NNS	O	difference	prep_with	8	SENT_195	[p14l615t1265r918b1317],
14	in	IN	O	in	_	0	SENT_195	[p14l952t1265r1006b1317],
15	Warfarin	NNP	O	Warfarin	nn	16	SENT_195	[p14l1038t1265r1286b1318],
16	sensitivity	NN	O	sensitivity	prep_in	8	SENT_195	[p14l1321t1265r1618b1331],
17	.	.	O	.	_	0	SENT_195	[p14l1321t1265r1618b1331],

1	Hum	NNP	O	Hum	nn	2	SENT_196	[p14l1654t1268r1796b1318],
2	M	NNP	O	M	_	0	SENT_196	[p14l1830t1268r1902b1317],
3	01	CD	NUMBER	01	num	4	SENT_196	[p14l1900t1265r1953b1318],
4	Genet	NNP	O	Genet	dep	2	SENT_196	[p14l1984t1267r2147b1318],
5	2005	CD	DATE	2005	num	4	SENT_196	[p14l111t1356r261b1417],
6	;	:	O	;	_	0	SENT_196	[p14l111t1356r261b1417],
7	14	CD	NUMBER	14	num	9	SENT_196	[p14l290t1356r367b1406],
8	:	:	O	:	_	0	SENT_196	[p14l290t1356r367b1406],
9	1745-51	CD	NUMBER	1745-51	dep	2	SENT_196	[p14l401t1355r646b1406],
10	.	.	O	.	_	0	SENT_196	[p14l401t1355r646b1406],

1	4	CD	NUMBER	4	num	3	SENT_197	[p14l39t1444r73b1494],
2	Gage	NNP	ORGANIZATION	Gage	nn	3	SENT_197	[p14l112t1443r264b1509],
3	BF	NNP	ORGANIZATION	BF	dep	46	SENT_197	[p14l298t1444r403b1506],
4	,	,	O	,	_	0	SENT_197	[p14l298t1444r403b1506],
5	Eby	NNP	PERSON	Eby	nn	6	SENT_197	[p14l439t1442r556b1509],
6	C	NNP	O	C	appos	3	SENT_197	[p14l589t1443r651b1506],
7	,	,	O	,	_	0	SENT_197	[p14l589t1443r651b1506],
8	Johnson	NNP	PERSON	Johnson	nn	9	SENT_197	[p14l686t1442r931b1495],
9	JA	NNP	O	JA	appos	3	SENT_197	[p14l963t1442r1060b1506],
10	,	,	O	,	_	0	SENT_197	[p14l963t1442r1060b1506],
11	Deych	NNP	O	Deych	nn	12	SENT_197	[p14l1096t1442r1283b1509],
12	E	NNP	O	E	appos	3	SENT_197	[p14l1316t1445r1376b1506],
13	,	,	O	,	_	0	SENT_197	[p14l1316t1445r1376b1506],
14	Rieder	NNP	PERSON	Rieder	nn	15	SENT_197	[p14l1413t1442r1605b1495],
15	MJ	NNP	PERSON	MJ	appos	3	SENT_197	[p14l1637t1444r1749b1506],
16	,	,	O	,	_	0	SENT_197	[p14l1637t1444r1749b1506],
17	Ridker	NNP	PERSON	Ridker	nn	18	SENT_197	[p14l1787t1442r1987b1495],
18	PM	NNP	O	PM	appos	3	SENT_197	[p14l2019t1444r2143b1506],
19	,	,	O	,	_	0	SENT_197	[p14l2019t1444r2143b1506],
20	Milligan	NNP	ORGANIZATION	Milligan	nn	21	SENT_197	[p14l111t1531r356b1598],
21	PE	NNP	ORGANIZATION	PE	appos	3	SENT_197	[p14l376t1533r477b1594],
22	,	,	O	,	_	0	SENT_197	[p14l376t1533r477b1594],
23	Grice	NNP	PERSON	Grice	nn	24	SENT_197	[p14l501t1531r659b1584],
24	G	NNP	PERSON	G	appos	3	SENT_197	[p14l681t1532r750b1594],
25	,	,	O	,	_	0	SENT_197	[p14l681t1532r750b1594],
26	Lenzini	NNP	PERSON	Lenzini	nn	27	SENT_197	[p14l774t1531r988b1583],
27	P	NN	O	p	appos	3	SENT_197	[p14l1008t1533r1063b1594],
28	,	,	O	,	_	0	SENT_197	[p14l1008t1533r1063b1594],
29	Rettie	NNP	ORGANIZATION	Rettie	nn	30	SENT_197	[p14l1088t1531r1260b1583],
30	AE	NNP	ORGANIZATION	AE	appos	3	SENT_197	[p14l1279t1531r1393b1594],
31	,	,	O	,	_	0	SENT_197	[p14l1279t1531r1393b1594],
32	Aquilante	NNP	ORGANIZATION	Aquilante	nn	33	SENT_197	[p14l1414t1531r1703b1597],
33	CL	NN	ORGANIZATION	cl	appos	3	SENT_197	[p14l1724t1532r1832b1594],
34	,	,	O	,	_	0	SENT_197	[p14l1724t1532r1832b1594],
35	Grosso	NNP	PERSON	Grosso	nn	36	SENT_197	[p14l1855t1532r2062b1584],
36	L	NNP	PERSON	L	appos	3	SENT_197	[p14l2085t1533r2143b1594],
37	,	,	O	,	_	0	SENT_197	[p14l2085t1533r2143b1594],
38	Marsh	NNP	PERSON	Marsh	nn	39	SENT_197	[p14l112t1620r303b1673],
39	S	NNP	O	S	appos	3	SENT_197	[p14l327t1621r376b1683],
40	,	,	O	,	_	0	SENT_197	[p14l327t1621r376b1683],
41	Langaee	NNP	O	Langaee	nn	42	SENT_197	[p14l403t1622r645b1687],
42	T	NN	O	t	appos	3	SENT_197	[p14l667t1622r727b1684],
43	,	,	O	,	_	0	SENT_197	[p14l667t1622r727b1684],
44	F	NN	O	f	nn	45	SENT_197	[p14l753t1622r796b1672],
45	arnett	NN	O	arnett	appos	3	SENT_197	[p14l799t1627r969b1673],
46	LE	NNP	O	LE	_	0	SENT_197	[p14l992t1622r1096b1683],
47	,	,	O	,	_	0	SENT_197	[p14l992t1622r1096b1683],
48	Voora	NNP	ORGANIZATION	Voora	nn	49	SENT_197	[p14l1120t1622r1306b1673],
49	D	NNP	ORGANIZATION	D	appos	46	SENT_197	[p14l1328t1622r1398b1683],
50	,	,	O	,	_	0	SENT_197	[p14l1328t1622r1398b1683],
51	Veenstra	NNP	LOCATION	Veenstra	nn	52	SENT_197	[p14l1423t1622r1677b1673],
52	DL	NNP	LOCATION	DL	appos	46	SENT_197	[p14l1700t1622r1816b1684],
53	,	,	O	,	_	0	SENT_197	[p14l1700t1622r1816b1684],
54	Glynn	NNP	PERSON	Glynn	nn	55	SENT_197	[p14l1842t1620r2025b1687],
55	RJ	NN	PERSON	rj	appos	46	SENT_197	[p14l2049t1622r2144b1683],
56	,	,	O	,	_	0	SENT_197	[p14l2049t1622r2144b1683],
57	Barrett	NNP	PERSON	Barrett	nn	58	SENT_197	[p14l112t1711r317b1762],
58	A	NNP	O	A	appos	46	SENT_197	[p14l332t1709r400b1772],
59	,	,	O	,	_	0	SENT_197	[p14l332t1709r400b1772],
60	McLeod	NNP	PERSON	McLeod	nn	61	SENT_197	[p14l420t1709r667b1762],
61	HL	NNS	O	hl	appos	46	SENT_197	[p14l684t1711r799b1761],
62	.	.	O	.	_	0	SENT_197	[p14l684t1711r799b1761],

1	Use	NN	O	use	_	0	SENT_198	[p14l820t1711r930b1762],
2	of	IN	O	of	_	0	SENT_198	[p14l948t1709r1012b1762],
3	pharmaco	JJ	O	pharmaco	amod	4	SENT_198	[p14l1021t1709r1313b1776],
4	genetic	JJ	O	genetic	prep_of	1	SENT_198	[p14l1317t1709r1517b1776],
5	and	CC	O	and	_	0	SENT_198	[p14l1533t1709r1640b1762],
6	clinical	JJ	O	clinical	amod	7	SENT_198	[p14l1656t1709r1858b1762],
7	factors	NNS	O	factor	prep_of	1	SENT_198	[p14l1874t1709r2070b1762],
8	to	TO	O	to	aux	9	SENT_198	[p14l2088t1716r2144b1762],
9	predict	VB	O	predict	infmod	1	SENT_198	[p14l110t1798r311b1865],
10	the	DT	O	the	det	12	SENT_198	[p14l328t1798r416b1851],
11	therapeutic	JJ	O	therapeutic	amod	12	SENT_198	[p14l434t1798r758b1865],
12	dose	NN	O	dose	dobj	9	SENT_198	[p14l775t1798r904b1851],
13	of	IN	O	of	_	0	SENT_198	[p14l923t1798r988b1851],
14	Warfarin	NNP	O	Warfarin	prep_of	12	SENT_198	[p14l996t1798r1258b1851],
15	.	.	O	.	_	0	SENT_198	[p14l996t1798r1258b1851],

1	Clin	NNP	PERSON	Clin	nn	3	SENT_199	[p14l1283t1799r1396b1851],
2	Pharmacol	NNP	PERSON	Pharmacol	nn	3	SENT_199	[p14l1414t1799r1727b1851],
3	T	NN	O	t	_	0	SENT_199	[p14l1745t1801r1792b1850],
4	her	PRP$	O	she	poss	5	SENT_199	[p14l1785t1799r1875b1851],
5	2008	CD	DATE	2008	dep	3	SENT_199	[p14l1892t1800r2041b1862],
6	;	:	O	;	_	0	SENT_199	[p14l1892t1800r2041b1862],
7	84	CD	NUMBER	84	num	9	SENT_199	[p14l2061t1800r2142b1851],
8	:	:	O	:	_	0	SENT_199	[p14l2061t1800r2142b1851],
9	326-31	CD	NUMBER	326-31	dep	5	SENT_199	[p14l113t1889r329b1940],
10	.	.	O	.	_	0	SENT_199	[p14l113t1889r329b1940],

1	5	CD	NUMBER	5	num	3	SENT_200	[p14l43t1978r71b2029],
2	Schelleman	NN	O	schelleman	nn	3	SENT_200	[p14l113t1976r439b2029],
3	H	NN	O	h	_	0	SENT_200	[p14l460t1978r531b2040],
4	,	,	O	,	_	0	SENT_200	[p14l460t1978r531b2040],
5	Chen	NNP	PERSON	Chen	nn	6	SENT_200	[p14l555t1976r707b2029],
6	J	NNP	PERSON	J	appos	3	SENT_200	[p14l727t1978r755b2029],
7	,	,	O	,	_	0	SENT_200	[p14l760t2020r771b2039],
8	Chen	NNP	O	Chen	nn	9	SENT_200	[p14l795t1976r948b2029],
9	Z	NNP	O	Z	appos	6	SENT_200	[p14l968t1978r1027b2040],
10	,	,	O	,	_	0	SENT_200	[p14l968t1978r1027b2040],
11	Christie	NNP	PERSON	Christie	nn	12	SENT_200	[p14l1051t1976r1276b2029],
12	J	NNP	PERSON	J	appos	6	SENT_200	[p14l1296t1978r1324b2029],
13	,	,	O	,	_	0	SENT_200	[p14l1329t2020r1340b2039],
14	Newcomb	NNP	ORGANIZATION	Newcomb	nn	15	SENT_200	[p14l1363t1976r1660b2029],
15	CW	NNP	ORGANIZATION	CW	appos	6	SENT_200	[p14l1682t1977r1813b2039],
16	,	,	O	,	_	0	SENT_200	[p14l1682t1977r1813b2039],
17	Brensinger	NNP	O	Brensinger	nn	18	SENT_200	[p14l1838t1976r2146b2043],
18	CM	NN	O	cm	appos	6	SENT_200	[p14l112t2066r244b2129],
19	,	,	O	,	_	0	SENT_200	[p14l112t2066r244b2129],
20	Price	NN	O	price	nn	21	SENT_200	[p14l280t2066r423b2118],
21	M	NN	O	m	appos	6	SENT_200	[p14l458t2067r541b2129],
22	,	,	O	,	_	0	SENT_200	[p14l458t2067r541b2129],
23	Whitehead	NNP	ORGANIZATION	Whitehead	nn	24	SENT_200	[p14l577t2065r893b2118],
24	AS	NNP	ORGANIZATION	AS	appos	6	SENT_200	[p14l926t2065r1032b2129],
25	,	,	O	,	_	0	SENT_200	[p14l926t2065r1032b2129],
26	Kealey	NNP	PERSON	Kealey	nn	27	SENT_200	[p14l1069t2066r1270b2132],
27	C	NNP	O	C	appos	6	SENT_200	[p14l1305t2066r1367b2129],
28	,	,	O	,	_	0	SENT_200	[p14l1305t2066r1367b2129],
29	Thorn	NNP	O	Thorn	nn	30	SENT_200	[p14l1405t2065r1590b2118],
30	CF	NN	O	cf	appos	6	SENT_200	[p14l1625t2066r1733b2129],
31	,	,	O	,	_	0	SENT_200	[p14l1625t2066r1733b2129],
32	Samaha	NNP	PERSON	Samaha	nn	33	SENT_200	[p14l1772t2065r2004b2118],
33	FF	NNP	O	FF	appos	6	SENT_200	[p14l2039t2067r2143b2129],
34	,	,	O	,	_	0	SENT_200	[p14l2039t2067r2143b2129],
35	Kimmel	NNP	PERSON	Kimmel	nn	36	SENT_200	[p14l111t2155r346b2207],
36	SE	NN	O	se	appos	6	SENT_200	[p14l371t2156r464b2207],
37	.	.	O	.	_	0	SENT_200	[p14l371t2156r464b2207],

1	Dosing	NN	O	dosing	nn	2	SENT_201	[p14l491t2155r701b2221],
2	algorithms	NNS	O	algorithm	nsubj	4	SENT_201	[p14l724t2155r1032b2221],
3	to	TO	O	to	aux	4	SENT_201	[p14l1056t2162r1112b2207],
4	predict	VB	O	predict	_	0	SENT_201	[p14l1136t2155r1336b2221],
5	Warfarin	NNP	O	Warfarin	nn	7	SENT_201	[p14l1357t2155r1605b2207],
6	maintenance	NN	O	maintenance	nn	7	SENT_201	[p14l1626t2155r1993b2207],
7	dose	NN	O	dose	dobj	4	SENT_201	[p14l2017t2155r2146b2207],
8	in	IN	O	in	_	0	SENT_201	[p14l110t2243r165b2294],
9	Caucasians	NNPS	MISC	Caucasians	prep_in	7	SENT_201	[p14l188t2243r512b2295],
10	and	CC	O	and	_	0	SENT_201	[p14l536t2243r644b2295],
11	African	NNP	MISC	African	nn	12	SENT_201	[p14l665t2243r886b2295],
12	Americans	NNPS	MISC	Americans	conj_and	9	SENT_201	[p14l908t2243r1233b2295],
13	.	.	O	.	_	0	SENT_201	[p14l908t2243r1233b2295],

1	Clin	NNP	PERSON	Clin	nn	3	SENT_202	[p14l1263t2244r1376b2295],
2	Pharmacol	NNP	PERSON	Pharmacol	nn	3	SENT_202	[p14l1399t2244r1712b2295],
3	T	NN	O	t	_	0	SENT_202	[p14l1736t2246r1782b2294],
4	her	PRP$	O	she	poss	5	SENT_202	[p14l1775t2243r1865b2295],
5	2008	CD	DATE	2008	dep	3	SENT_202	[p14l1886t2245r2036b2306],
6	;	:	O	;	_	0	SENT_202	[p14l1886t2245r2036b2306],
7	84	CD	NUMBER	84	num	9	SENT_202	[p14l2061t2245r2142b2295],
8	:	:	O	:	_	0	SENT_202	[p14l2061t2245r2142b2295],
9	332-9	CD	NUMBER	332-9	dep	5	SENT_202	[p14l113t2333r294b2384],
10	.	.	O	.	_	0	SENT_202	[p14l113t2333r294b2384],

1	6	CD	NUMBER	6	num	3	SENT_203	[p14l41t2422r72b2473],
2	Carlquist	NNP	ORGANIZATION	Carlquist	nn	3	SENT_203	[p14l112t2421r379b2487],
3	JF	NNP	ORGANIZATION	JF	nsubj	48	SENT_203	[p14l409t2423r500b2484],
4	,	,	O	,	_	0	SENT_203	[p14l409t2423r500b2484],
5	Horne	NNP	PERSON	Horne	nn	6	SENT_203	[p14l534t2423r720b2473],
6	BD	NNP	O	BD	appos	3	SENT_203	[p14l753t2423r868b2484],
7	,	,	O	,	_	0	SENT_203	[p14l753t2423r868b2484],
8	Muhlestein	NNP	PERSON	Muhlestein	nn	9	SENT_203	[p14l903t2421r1227b2473],
9	JB	NNP	O	JB	appos	3	SENT_203	[p14l1257t2423r1347b2484],
10	,	,	O	,	_	0	SENT_203	[p14l1257t2423r1347b2484],
11	Lappe	NNP	PERSON	Lappe	nn	12	SENT_203	[p14l1382t2423r1565b2487],
12	DL	NNP	O	DL	appos	3	SENT_203	[p14l1597t2423r1713b2484],
13	,	,	O	,	_	0	SENT_203	[p14l1597t2423r1713b2484],
14	Whiting	NNP	ORGANIZATION	Whiting	nn	15	SENT_203	[p14l1746t2421r1983b2487],
15	BM	NN	ORGANIZATION	bm	appos	3	SENT_203	[p14l2015t2422r2143b2484],
16	,	,	O	,	_	0	SENT_203	[p14l2015t2422r2143b2484],
17	Kolek	NNP	ORGANIZATION	Kolek	nn	18	SENT_203	[p14l111t2509r290b2562],
18	MJ	NNP	ORGANIZATION	MJ	appos	3	SENT_203	[p14l337t2511r449b2573],
19	,	,	O	,	_	0	SENT_203	[p14l337t2511r449b2573],
20	Clarke	NNP	PERSON	Clarke	nn	21	SENT_203	[p14l499t2509r692b2562],
21	JL	NNP	O	JL	appos	3	SENT_203	[p14l739t2511r829b2572],
22	,	,	O	,	_	0	SENT_203	[p14l739t2511r829b2572],
23	James	NNP	PERSON	James	nn	24	SENT_203	[p14l878t2511r1052b2562],
24	BC	NNP	PERSON	BC	appos	3	SENT_203	[p14l1101t2510r1209b2573],
25	,	,	O	,	_	0	SENT_203	[p14l1101t2510r1209b2573],
26	Anderson	NNP	PERSON	Anderson	nn	29	SENT_203	[p14l1258t2509r1545b2562],
27	J	NNP	PERSON	J	nn	29	SENT_203	[p14l1591t2511r1619b2562],
28	L.	NNP	PERSON	L.	nn	29	SENT_203	[p14l1622t2511r1679b2561],
29	Genotypes	NNP	PERSON	Genotypes	appos	3	SENT_203	[p14l1731t2510r2040b2576],
30	of	IN	O	of	_	0	SENT_203	[p14l2089t2509r2153b2562],
31	the	DT	O	the	det	34	SENT_203	[p14l111t2598r199b2651],
32	cytochrome	NN	O	cytochrome	nn	34	SENT_203	[p14l227t2598r567b2665],
33	p450	NN	O	p450	nn	34	SENT_203	[p14l595t2600r734b2665],
34	isoform	NN	O	isoform	prep_of	29	SENT_203	[p14l762t2598r1001b2662],
35	,	,	O	,	_	0	SENT_203	[p14l762t2598r1001b2662],
36	CYP2C9	NN	O	cyp2c9	appos	3	SENT_203	[p14l1033t2599r1308b2662],
37	,	,	O	,	_	0	SENT_203	[p14l1033t2599r1308b2662],
38	and	CC	O	and	_	0	SENT_203	[p14l1339t2598r1447b2651],
39	the	DT	O	the	det	45	SENT_203	[p14l1476t2598r1563b2651],
40	Vitamin	NN	O	vitamin	nn	45	SENT_203	[p14l1590t2599r1812b2651],
41	K	NN	O	k	nn	45	SENT_203	[p14l1840t2600r1896b2650],
42	epoxide	NN	O	epoxide	nn	45	SENT_203	[p14l1923t2598r2146b2665],
43	reductase	NN	O	reductase	nn	45	SENT_203	[p14l111t2688r383b2740],
44	complex	NN	O	complex	nn	45	SENT_203	[p14l399t2688r643b2754],
45	subunit	NN	O	subunit	conj_and	3	SENT_203	[p14l661t2688r876b2740],
46	1	CD	NUMBER	1	dep	45	SENT_203	[p14l899t2689r918b2739],
47	conjointly	RB	O	conjointly	advmod	48	SENT_203	[p14l941t2688r1232b2754],
48	determine	VB	O	determine	_	0	SENT_203	[p14l1249t2688r1534b2740],
49	stable	JJ	O	stable	amod	51	SENT_203	[p14l1553t2688r1718b2740],
50	Warfarin	NNP	O	Warfarin	nn	51	SENT_203	[p14l1734t2688r1981b2740],
51	dose	NN	O	dose	dobj	48	SENT_203	[p14l1998t2688r2141b2740],
52	:	:	O	:	_	0	SENT_203	[p14l1998t2688r2141b2740],
53	a	DT	O	a	det	55	SENT_203	[p14l112t2794r144b2829],
54	prospective	JJ	O	prospective	amod	55	SENT_203	[p14l165t2777r493b2843],
55	study	NN	O	study	dep	51	SENT_203	[p14l519t2777r687b2843],
56	.	.	O	.	_	0	SENT_203	[p14l519t2777r687b2843],

1	J	NN	O	j	nn	2	SENT_204	[p14l714t2780r754b2829],
2	T	NN	O	t	nsubj	5	SENT_204	[p14l776t2780r822b2828],
3	hromb	NN	O	hromb	nn	4	SENT_204	[p14l816t2777r996b2829],
4	T	NN	O	t	dep	2	SENT_204	[p14l1025t2780r1072b2828],
5	hrombolysis	VBZ	O	hrombolysis	_	0	SENT_204	[p14l1066t2777r1403b2843],
6	2006	CD	DATE	2006	dobj	5	SENT_204	[p14l1426t2778r1575b2840],
7	;	:	O	;	_	0	SENT_204	[p14l1426t2778r1575b2840],
8	22	CD	NUMBER	22	num	10	SENT_204	[p14l1601t2778r1682b2829],
9	:	:	O	:	_	0	SENT_204	[p14l1601t2778r1682b2829],
10	191-7	CD	NUMBER	191-7	dep	6	SENT_204	[p14l1716t2778r1892b2829],
11	.	.	O	.	_	0	SENT_204	[p14l1716t2778r1892b2829],

1	7	CD	NUMBER	7	num	3	SENT_205	[p14l41t2868r71b2918],
2	Zhu	NNP	O	Zhu	nn	3	SENT_205	[p14l111t2865r232b2918],
3	Y	NN	O	y	_	0	SENT_205	[p14l256t2867r325b2929],
4	,	,	O	,	_	0	SENT_205	[p14l256t2867r325b2929],
5	Shennan	NNP	PERSON	Shennan	nn	6	SENT_205	[p14l355t2865r605b2918],
6	M	NNP	O	M	appos	3	SENT_205	[p14l633t2867r714b2929],
7	,	,	O	,	_	0	SENT_205	[p14l633t2867r714b2929],
8	Reynolds	NNP	ORGANIZATION	Reynolds	nn	9	SENT_205	[p14l745t2865r1015b2932],
9	KK	NNP	ORGANIZATION	KK	appos	6	SENT_205	[p14l1043t2867r1170b2929],
10	,	,	O	,	_	0	SENT_205	[p14l1043t2867r1170b2929],
11	Johnson	NNP	ORGANIZATION	Johnson	nn	12	SENT_205	[p14l1199t2865r1443b2918],
12	NA	NNP	ORGANIZATION	NA	appos	6	SENT_205	[p14l1468t2865r1593b2929],
13	,	,	O	,	_	0	SENT_205	[p14l1468t2865r1593b2929],
14	Herrnberger	NNP	PERSON	Herrnberger	nn	15	SENT_205	[p14l1623t2865r1982b2932],
15	MR	NN	PERSON	mr	appos	6	SENT_205	[p14l2008t2867r2143b2929],
16	,	,	O	,	_	0	SENT_205	[p14l2008t2867r2143b2929],
17	Valdes	NNP	PERSON	Valdes	nn	19	SENT_205	[p14l110t2954r303b3006],
18	R	NNP	PERSON	R	nn	19	SENT_205	[p14l328t2957r379b3005],
19	Jr	NNP	PERSON	Jr	appos	6	SENT_205	[p14l400t2956r469b3017],
20	,	,	O	,	_	0	SENT_205	[p14l400t2956r469b3017],
21	Linder	NNP	PERSON	Linder	nn	22	SENT_205	[p14l496t2954r689b3006],
22	MW	NNP	O	MW	appos	6	SENT_205	[p14l711t2956r861b3006],
23	.	.	O	.	_	0	SENT_205	[p14l711t2956r861b3006],

1	Estimation	NN	O	estimation	nsubj	6	SENT_206	[p14l887t2955r1205b3006],
2	of	IN	O	of	_	0	SENT_206	[p14l1228t2954r1292b3006],
3	Warfarin	NNP	O	Warfarin	nn	5	SENT_206	[p14l1306t2954r1574b3006],
4	Maintenance	NNP	O	Maintenance	nn	5	SENT_206	[p14l1596t2955r1974b3006],
5	Dose	NNP	O	Dose	prep_of	1	SENT_206	[p14l1997t2956r2145b3006],
6	Based	VBD	O	base	_	0	SENT_206	[p14l112t3043r283b3095],
7	on	IN	O	on	_	0	SENT_206	[p14l321t3060r394b3095],
8	VKORC1	NN	O	vkorc1	prep_on	6	SENT_206	[p14l430t3044r720b3095],
9	(	CD	NUMBER	(	number	10	SENT_206	[p14l765t3043r942b3109],
10	-1639	CD	NUMBER	-1639	num	11	SENT_206	[p14l765t3043r942b3109],
11	G	NN	O	g	npadvmod	12	SENT_206	[p14l982t3043r1180b3109],
12	>	JJR	O	>	amod	8	SENT_206	[p14l982t3043r1180b3109],
13	A	DT	O	a	det	14	SENT_206	[p14l982t3043r1180b3109],
14	)	NN	O	)	tmod	6	SENT_206	[p14l982t3043r1180b3109],
15	and	CC	O	and	_	0	SENT_206	[p14l1220t3042r1327b3095],
16	CYP2C9	NN	O	cyp2c9	nn	17	SENT_206	[p14l1365t3044r1623b3095],
17	Genotypes	NNS	O	genotype	tmod	6	SENT_206	[p14l1663t3044r1987b3109],
18	.	.	O	.	_	0	SENT_206	[p14l1663t3044r1987b3109],

1	Clin	NNP	ORGANIZATION	Clin	nn	2	SENT_207	[p14l2032t3043r2145b3095],
2	Chem	NNP	ORGANIZATION	Chem	_	0	SENT_207	[p14l115t3131r276b3183],
3	2007	CD	DATE	2007	num	2	SENT_207	[p14l300t3132r449b3193],
4	;	:	O	;	_	0	SENT_207	[p14l300t3132r449b3193],
5	53	CD	NUMBER	53	num	7	SENT_207	[p14l476t3132r556b3183],
6	:	:	O	:	_	0	SENT_207	[p14l476t3132r556b3183],
7	1199-205	CD	NUMBER	1199-205	dep	2	SENT_207	[p14l590t3132r869b3183],
8	.	.	O	.	_	0	SENT_207	[p14l590t3132r869b3183],

1	8	CD	NUMBER	8	_	0	SENT_208	[p14l42t3221r70b3272],
2	Klein	NNP	ORGANIZATION	Klein	nn	3	SENT_208	[p14l111t3220r270b3272],
3	TE	NNP	ORGANIZATION	TE	dep	1	SENT_208	[p14l294t3221r399b3283],
4	,	,	O	,	_	0	SENT_208	[p14l294t3221r399b3283],
5	Altman	NNP	PERSON	Altman	nn	6	SENT_208	[p14l426t3219r649b3272],
6	RB	NN	O	rb	appos	3	SENT_208	[p14l675t3221r787b3283],
7	,	,	O	,	_	0	SENT_208	[p14l675t3221r787b3283],
8	Eriksson	NNP	PERSON	Eriksson	nn	9	SENT_208	[p14l814t3219r1068b3272],
9	N	NNP	O	N	appos	3	SENT_208	[p14l1092t3221r1163b3283],
10	,	,	O	,	_	0	SENT_208	[p14l1092t3221r1163b3283],
11	Gage	NNP	PERSON	Gage	nn	12	SENT_208	[p14l1192t3220r1344b3286],
12	BF	NNP	O	BF	appos	3	SENT_208	[p14l1370t3221r1475b3283],
13	,	,	O	,	_	0	SENT_208	[p14l1370t3221r1475b3283],
14	Kimmel	NNP	PERSON	Kimmel	nn	15	SENT_208	[p14l1502t3220r1737b3272],
15	SE	NN	PERSON	se	appos	3	SENT_208	[p14l1764t3220r1859b3283],
16	,	,	O	,	_	0	SENT_208	[p14l1764t3220r1859b3283],
17	Lee	NNP	PERSON	Lee	nn	18	SENT_208	[p14l1888t3221r1990b3272],
18	MT	NNP	O	MT	appos	3	SENT_208	[p14l2016t3221r2144b3283],
19	,	,	O	,	_	0	SENT_208	[p14l2016t3221r2144b3283],
20	Limdi	NNP	ORGANIZATION	Limdi	nn	21	SENT_208	[p14l112t3308r286b3361],
21	NA	NNP	ORGANIZATION	NA	appos	3	SENT_208	[p14l305t3309r430b3372],
22	,	,	O	,	_	0	SENT_208	[p14l305t3309r430b3372],
23	Page	NNP	O	Page	nn	24	SENT_208	[p14l452t3311r591b3375],
24	D	NNP	O	D	appos	3	SENT_208	[p14l612t3311r682b3372],
25	,	,	O	,	_	0	SENT_208	[p14l612t3311r682b3372],
26	Roden	NNP	PERSON	Roden	nn	27	SENT_208	[p14l707t3309r901b3361],
27	DM	NN	O	dm	appos	3	SENT_208	[p14l920t3311r1060b3372],
28	,	,	O	,	_	0	SENT_208	[p14l920t3311r1060b3372],
29	Wagner	NNP	PERSON	Wagner	nn	30	SENT_208	[p14l1081t3311r1312b3375],
30	MJ	NNP	PERSON	MJ	appos	3	SENT_208	[p14l1332t3311r1444b3372],
31	,	,	O	,	_	0	SENT_208	[p14l1332t3311r1444b3372],
32	Caldwell	NNP	PERSON	Caldwell	nn	33	SENT_208	[p14l1468t3309r1720b3361],
33	MD	NNP	O	MD	appos	3	SENT_208	[p14l1741t3311r1880b3372],
34	,	,	O	,	_	0	SENT_208	[p14l1741t3311r1880b3372],
35	Johnson	NNP	PERSON	Johnson	nn	36	SENT_208	[p14l1902t3309r2146b3361],
36	JA	NNP	O	JA	appos	3	SENT_208	[p14l110t3397r208b3459],
37	,	,	O	,	_	0	SENT_208	[p14l110t3397r208b3459],
38	for	IN	O	for	_	0	SENT_208	[p14l238t3397r324b3449],
39	theIWPC	NN	O	theiwpc	prep_for	3	SENT_208	[p14l351t3397r640b3449],
40	.	.	O	.	_	0	SENT_208	[p14l351t3397r640b3449],

1	Estimation	NN	O	estimation	_	0	SENT_209	[p14l673t3397r990b3449],
2	of	IN	O	of	_	0	SENT_209	[p14l1020t3397r1083b3449],
3	the	DT	O	the	det	5	SENT_209	[p14l1105t3397r1193b3449],
4	Warfarin	NNP	MISC	Warfarin	nn	5	SENT_209	[p14l1220t3397r1468b3449],
5	dose	NN	O	dose	prep_of	1	SENT_209	[p14l1496t3397r1625b3449],
6	with	IN	O	with	_	0	SENT_209	[p14l1653t3397r1781b3449],
7	clinical	JJ	O	clinical	amod	10	SENT_209	[p14l1808t3397r2010b3449],
8	and	CC	O	and	_	0	SENT_209	[p14l2039t3397r2146b3449],
9	pharmacogenetic	JJ	O	pharmacogenetic	amod	10	SENT_209	[p14l110t3485r606b3552],
10	data	NNS	O	datum	prep_with	1	SENT_209	[p14l623t3485r763b3538],
11	.	.	O	.	_	0	SENT_209	[p14l623t3485r763b3538],

1	N	NN	O	n	nn	3	SENT_210	[p14l783t3488r841b3538],
2	Engl	NNP	O	Engl	nn	3	SENT_210	[p14l852t3486r987b3552],
3	J	NNP	O	J	nsubj	4	SENT_210	[p14l999t3489r1038b3538],
4	Med	VBD	O	med	_	0	SENT_210	[p14l1049t3486r1186b3538],
5	2009	CD	DATE	2009	dobj	4	SENT_210	[p14l1197t3487r1346b3549],
6	;	:	O	;	_	0	SENT_210	[p14l1197t3487r1346b3549],
7	360	CD	NUMBER	360	num	9	SENT_210	[p14l1366t3487r1481b3538],
8	:	:	O	:	_	0	SENT_210	[p14l1366t3487r1481b3538],
9	753-64	CD	NUMBER	753-64	dep	5	SENT_210	[p14l1503t3487r1719b3538],
10	.	.	O	.	_	0	SENT_210	[p14l1503t3487r1719b3538],

1	360	CD	NUMBER	360	_	0	SENT_211	[p14l1742t3486r1863b3552],
2	/	:	O	/	punct	3	SENT_211	[p14l1742t3486r1863b3552],
3	8	CD	NUMBER	8	dep	1	SENT_211	[p14l1867t3487r1894b3538],
4	/	:	O	/	punct	3	SENT_211	[p14l1898t3486r2019b3552],
5	753	CD	NUMBER	753	dep	8	SENT_211	[p14l1898t3486r2019b3552],
6	[	NN	O	[	dep	5	SENT_211	[p14l2040t3486r2144b3552],
7	pii	NN	O	pius	dep	8	SENT_211	[p14l2040t3486r2144b3552],
8	]	CD	NUMBER	]	dep	11	SENT_211	[p14l2040t3486r2144b3552],
9	10.1056	CD	NUMBER	10.1056	dep	8	SENT_211	[p14l118t3575r881b3641],
10	/	:	O	/	punct	11	SENT_211	[p14l118t3575r881b3641],
11	NEJMoa0809329	NN	O	nejmoa0809329	dep	3	SENT_211	[p14l118t3575r881b3641],
12	.	.	O	.	_	0	SENT_211	[p14l118t3575r881b3641],

1	©	RB	O	©	amod	4	SENT_212	[p15l8t90r58b140],
2	2009	CD	DATE	2009	tmod	1	SENT_212	[p15l87t89r225b140],
3	International	NNP	ORGANIZATION	International	nn	4	SENT_212	[p15l253t88r650b140],
4	Society	NNP	ORGANIZATION	Society	dep	11	SENT_212	[p15l680t88r894b153],
5	on	IN	O	on	_	0	SENT_212	[p15l922t105r996b140],
6	Thrombosis	NNP	O	Thrombosis	prep_on	4	SENT_212	[p15l1023t87r1384b140],
7	and	CC	O	and	_	0	SENT_212	[p15l1413t87r1523b140],
8	Haemostasis	NNP	ORGANIZATION	Haemostasis	prep_on	4	SENT_212	[p15l1551t88r1930b140],
9	9	CD	NUMBER	9	dep	11	SENT_212	[p15l41t178r72b229],
10	Millican	NNP	ORGANIZATION	Millican	nn	11	SENT_212	[p15l113t177r352b229],
11	E	NNP	ORGANIZATION	E	_	0	SENT_212	[p15l370t179r429b240],
12	,	,	O	,	_	0	SENT_212	[p15l370t179r429b240],
13	Lenzini	NNP	PERSON	Lenzini	nn	14	SENT_212	[p15l450t177r663b229],
14	P	NN	PERSON	p	appos	11	SENT_212	[p15l680t179r736b240],
15	,	,	O	,	_	0	SENT_212	[p15l680t179r736b240],
16	Milligan	NNP	PERSON	Milligan	nn	17	SENT_212	[p15l756t177r1001b243],
17	P	NN	PERSON	p	appos	11	SENT_212	[p15l1016t179r1072b240],
18	,	,	O	,	_	0	SENT_212	[p15l1016t179r1072b240],
19	Grosso	NNP	PERSON	Grosso	nn	20	SENT_212	[p15l1094t178r1300b229],
20	L	NNP	PERSON	L	appos	11	SENT_212	[p15l1320t179r1378b240],
21	,	,	O	,	_	0	SENT_212	[p15l1320t179r1378b240],
22	Eby	NNP	PERSON	Eby	nn	23	SENT_212	[p15l1399t177r1515b243],
23	C	NNP	O	C	appos	11	SENT_212	[p15l1533t178r1595b240],
24	,	,	O	,	_	0	SENT_212	[p15l1533t178r1595b240],
25	Deych	NNP	O	Deych	nn	26	SENT_212	[p15l1614t177r1802b243],
26	E	NNP	O	E	appos	11	SENT_212	[p15l1819t179r1878b240],
27	,	,	O	,	_	0	SENT_212	[p15l1819t179r1878b240],
28	Grice	NNP	PERSON	Grice	nn	29	SENT_212	[p15l1899t177r2057b229],
29	G	NNP	O	G	appos	11	SENT_212	[p15l2075t178r2145b240],
30	,	,	O	,	_	0	SENT_212	[p15l2075t178r2145b240],

1	Clohisy	NNP	PERSON	Clohisy	nn	2	SENT_213	[p15l113t265r332b331],
2	J	NNP	PERSON	J	_	0	SENT_213	[p15l361t267r404b328],
3	,	,	O	,	_	0	SENT_213	[p15l361t267r404b328],
4	Barrack	NNP	PERSON	Barrack	nn	5	SENT_213	[p15l437t265r668b317],
5	R	NNP	PERSON	R	appos	2	SENT_213	[p15l699t267r764b328],
6	,	,	O	,	_	0	SENT_213	[p15l699t267r764b328],
7	Burnett	NNP	PERSON	Burnett	nn	8	SENT_213	[p15l797t267r1016b317],
8	R	NNP	PERSON	R	appos	2	SENT_213	[p15l1047t267r1112b328],
9	,	,	O	,	_	0	SENT_213	[p15l1047t267r1112b328],
10	Voora	NNP	ORGANIZATION	Voora	nn	11	SENT_213	[p15l1142t267r1327b317],
11	D	NNP	ORGANIZATION	D	appos	2	SENT_213	[p15l1356t267r1427b328],
12	,	,	O	,	_	0	SENT_213	[p15l1356t267r1427b328],
13	Gatchel	NNP	LOCATION	Gatchel	nn	14	SENT_213	[p15l1459t265r1685b317],
14	S	NNP	LOCATION	S	appos	2	SENT_213	[p15l1716t266r1765b328],
15	,	,	O	,	_	0	SENT_213	[p15l1716t266r1765b328],
16	Tiemeier	NNP	O	Tiemeier	nn	17	SENT_213	[p15l1796t265r2050b317],
17	A	NNP	O	A	appos	2	SENT_213	[p15l2077t265r2145b328],
18	,	,	O	,	_	0	SENT_213	[p15l2077t265r2145b328],
19	Gage	NNP	PERSON	Gage	nn	22	SENT_213	[p15l113t355r265b421],
20	B.	NNP	O	B.	nn	22	SENT_213	[p15l310t356r367b406],
21	Genetic-based	JJ	MISC	genetic-based	amod	22	SENT_213	[p15l416t354r826b407],
22	dosing	NN	O	dosing	appos	2	SENT_213	[p15l870t354r1061b421],
23	in	IN	O	in	_	0	SENT_213	[p15l1103t354r1158b406],
24	orthopaedic	JJ	O	orthopaedic	amod	25	SENT_213	[p15l1203t354r1550b421],
25	patients	NNS	O	patient	prep_in	22	SENT_213	[p15l1592t354r1819b421],
26	beginning	VBG	O	begin	partmod	2	SENT_213	[p15l1864t354r2148b421],
27	warfarin	NN	O	warfarin	nn	28	SENT_213	[p15l111t443r359b496],
28	therapy	NN	O	therapy	dobj	26	SENT_213	[p15l382t443r616b510],
29	.	.	O	.	_	0	SENT_213	[p15l382t443r616b510],

1	Blood	NN	O	blood	_	0	SENT_214	[p15l642t444r814b496],
2	2007	CD	DATE	2007	num	1	SENT_214	[p15l831t445r981b507],
3	;	:	O	;	_	0	SENT_214	[p15l831t445r981b507],
4	110	CD	NUMBER	110	num	6	SENT_214	[p15l1010t445r1121b496],
5	:	:	O	:	_	0	SENT_214	[p15l1010t445r1121b496],
6	1511-5	CD	NUMBER	1511-5	dep	1	SENT_214	[p15l1156t445r1366b496],
7	.	.	O	.	_	0	SENT_214	[p15l1156t445r1366b496],

1	Lenzini	NNP	ORGANIZATION	Lenzini	nn	2	SENT_215	[p15l113t532r326b584],
2	PA	NN	ORGANIZATION	pa	dep	23	SENT_215	[p15l348t532r457b595],
3	,	,	O	,	_	0	SENT_215	[p15l348t532r457b595],
4	Grice	NNP	PERSON	Grice	nn	5	SENT_215	[p15l482t532r640b584],
5	GR	NN	O	gr	appos	2	SENT_215	[p15l663t533r786b595],
6	,	,	O	,	_	0	SENT_215	[p15l663t533r786b595],
7	Milligan	NNP	ORGANIZATION	Milligan	nn	8	SENT_215	[p15l810t532r1055b598],
8	PE	NNP	ORGANIZATION	PE	appos	2	SENT_215	[p15l1076t534r1177b595],
9	,	,	O	,	_	0	SENT_215	[p15l1076t534r1177b595],
10	Dowd	NNP	PERSON	Dowd	nn	11	SENT_215	[p15l1201t532r1382b584],
11	MB	NNP	O	MB	appos	2	SENT_215	[p15l1404t534r1532b595],
12	,	,	O	,	_	0	SENT_215	[p15l1404t534r1532b595],
13	Subherwal	NNP	O	Subherwal	nn	14	SENT_215	[p15l1558t532r1863b585],
14	S	NNP	O	S	appos	2	SENT_215	[p15l1886t533r1936b595],
15	,	,	O	,	_	0	SENT_215	[p15l1886t533r1936b595],
16	Deych	NNP	O	Deych	nn	17	SENT_215	[p15l1960t532r2148b598],
17	E	NNP	O	E	appos	2	SENT_215	[p15l113t623r171b684],
18	,	,	O	,	_	0	SENT_215	[p15l113t623r171b684],
19	Eby	NNP	PERSON	Eby	nn	20	SENT_215	[p15l195t621r311b687],
20	CS	NNP	O	CS	appos	2	SENT_215	[p15l332t622r432b684],
21	,	,	O	,	_	0	SENT_215	[p15l332t622r432b684],
22	King	NNP	O	King	appos	2	SENT_215	[p15l455t621r601b688],
23	CR	NN	O	cr	_	0	SENT_215	[p15l622t622r737b684],
24	,	,	O	,	_	0	SENT_215	[p15l622t622r737b684],
25	Porche-Sorbet	NNP	O	Porche-Sorbet	nn	26	SENT_215	[p15l760t621r1176b674],
26	RM	NN	O	rm	appos	23	SENT_215	[p15l1197t623r1332b684],
27	,	,	O	,	_	0	SENT_215	[p15l1197t623r1332b684],
28	Murphy	NNP	ORGANIZATION	Murphy	nn	29	SENT_215	[p15l1355t621r1596b688],
29	CV	NNP	ORGANIZATION	CV	appos	23	SENT_215	[p15l1617t622r1729b684],
30	,	,	O	,	_	0	SENT_215	[p15l1617t622r1729b684],
31	Marchand	NNP	PERSON	Marchand	nn	32	SENT_215	[p15l1753t621r2057b673],
32	R	NNP	PERSON	R	appos	23	SENT_215	[p15l2080t623r2144b684],
33	,	,	O	,	_	0	SENT_215	[p15l2080t623r2144b684],
34	Millican	NNP	ORGANIZATION	Millican	nn	35	SENT_215	[p15l113t710r352b762],
35	EA	NN	ORGANIZATION	ea	appos	23	SENT_215	[p15l387t710r499b773],
36	,	,	O	,	_	0	SENT_215	[p15l387t710r499b773],
37	Barrack	NNP	ORGANIZATION	Barrack	nn	38	SENT_215	[p15l537t710r768b763],
38	RL	NNP	ORGANIZATION	RL	appos	23	SENT_215	[p15l804t712r915b773],
39	,	,	O	,	_	0	SENT_215	[p15l804t712r915b773],
40	Clohisy	NNP	PERSON	Clohisy	nn	42	SENT_215	[p15l953t710r1172b776],
41	J	NNP	PERSON	J	nn	42	SENT_215	[p15l1205t712r1233b763],
42	C	NNP	PERSON	C	appos	23	SENT_215	[p15l1236t711r1298b773],
43	,	,	O	,	_	0	SENT_215	[p15l1236t711r1298b773],
44	Kronquist	NNP	O	Kronquist	nn	45	SENT_215	[p15l1335t710r1634b776],
45	K	NNP	O	K	appos	23	SENT_215	[p15l1668t712r1738b773],
46	,	,	O	,	_	0	SENT_215	[p15l1668t712r1738b773],
47	Gatchel	NNP	O	Gatchel	nn	48	SENT_215	[p15l1775t710r2001b763],
48	SK	NNP	O	SK	appos	23	SENT_215	[p15l2037t711r2144b773],
49	,	,	O	,	_	0	SENT_215	[p15l2037t711r2144b773],
50	Gage	NNP	PERSON	Gage	nn	51	SENT_215	[p15l113t800r265b865],
51	BF	NNP	O	BF	appos	23	SENT_215	[p15l295t801r398b851],
52	.	.	O	.	_	0	SENT_215	[p15l295t801r398b851],

1	Laboratory	NN	O	laboratory	nn	4	SENT_216	[p15l431t799r765b865],
2	and	CC	O	and	_	0	SENT_216	[p15l793t799r900b851],
3	clinical	JJ	O	clinical	nn	4	SENT_216	[p15l928t799r1129b851],
4	outcomes	NNS	O	outcome	_	0	SENT_216	[p15l1158t806r1433b851],
5	of	IN	O	of	_	0	SENT_216	[p15l1463t799r1527b851],
6	pharmacogenetic	JJ	O	pharmacogenetic	prep_of	4	SENT_216	[p15l1547t799r2043b865],
7	vs.	CC	O	vs.	prep	6	SENT_216	[p15l2070t816r2143b851],
8	clinical	JJ	O	clinical	amod	9	SENT_216	[p15l112t888r313b940],
9	protocols	NNS	O	protocol	dep	7	SENT_216	[p15l353t888r625b955],
10	for	IN	O	for	_	0	SENT_216	[p15l667t888r751b940],
11	warfarin	NN	O	warfarin	nn	12	SENT_216	[p15l791t888r1038b941],
12	initiation	NN	O	initiation	prep_for	4	SENT_216	[p15l1078t888r1340b941],
13	in	IN	O	in	_	0	SENT_216	[p15l1380t888r1435b940],
14	orthopedic	JJ	O	orthopedic	amod	15	SENT_216	[p15l1477t888r1790b955],
15	patients	NNS	O	patient	prep_in	4	SENT_216	[p15l1829t888r2070b955],
16	.	.	O	.	_	0	SENT_216	[p15l1829t888r2070b955],

1	J	NN	O	j	nn	3	SENT_217	[p15l2114t891r2153b941],
2	T	NN	O	t	nn	3	SENT_217	[p15l118t980r164b1028],
3	hromb	NN	O	hromb	_	0	SENT_217	[p15l158t977r337b1029],
4	Haemost	NNP	O	Haemost	dep	3	SENT_217	[p15l361t980r618b1029],
5	2008	CD	DATE	2008	num	4	SENT_217	[p15l640t978r790b1040],
6	;	:	O	;	_	0	SENT_217	[p15l640t978r790b1040],
7	6	CD	NUMBER	6	num	9	SENT_217	[p15l816t978r862b1029],
8	:	:	O	:	_	0	SENT_217	[p15l816t978r862b1029],
9	1655-62	CD	NUMBER	1655-62	dep	3	SENT_217	[p15l896t978r1141b1029],
10	.	.	O	.	_	0	SENT_217	[p15l896t978r1141b1029],

1	Lenzini	NNP	PERSON	Lenzini	nn	2	SENT_218	[p15l113t1065r326b1118],
2	P	NN	O	p	_	0	SENT_218	[p15l351t1067r406b1128],
3	,	,	O	,	_	0	SENT_218	[p15l351t1067r406b1128],
4	Grice	NNP	PERSON	Grice	nn	5	SENT_218	[p15l435t1065r592b1118],
5	G	NNP	PERSON	G	appos	2	SENT_218	[p15l618t1066r688b1129],
6	,	,	O	,	_	0	SENT_218	[p15l618t1066r688b1129],
7	Milligan	NNP	PERSON	Milligan	nn	8	SENT_218	[p15l715t1065r960b1132],
8	P	NN	PERSON	p	appos	2	SENT_218	[p15l984t1067r1039b1128],
9	,	,	O	,	_	0	SENT_218	[p15l984t1067r1039b1128],
10	Gatchel	NNP	O	Gatchel	nn	11	SENT_218	[p15l1068t1065r1294b1118],
11	S	NNP	O	S	appos	2	SENT_218	[p15l1321t1066r1370b1128],
12	,	,	O	,	_	0	SENT_218	[p15l1321t1066r1370b1128],
13	Deych	NNP	O	Deych	nn	14	SENT_218	[p15l1398t1065r1585b1132],
14	E	NNP	O	E	appos	2	SENT_218	[p15l1610t1067r1668b1128],
15	,	,	O	,	_	0	SENT_218	[p15l1610t1067r1668b1128],
16	Eby	NNP	PERSON	Eby	nn	17	SENT_218	[p15l1696t1065r1812b1132],
17	C	NNP	O	C	appos	2	SENT_218	[p15l1837t1066r1899b1128],
18	,	,	O	,	_	0	SENT_218	[p15l1837t1066r1899b1128],
19	Burnett	NNP	ORGANIZATION	Burnett	nn	20	SENT_218	[p15l1928t1067r2147b1118],
20	RS	NN	ORGANIZATION	r	appos	2	SENT_218	[p15l114t1155r217b1217],
21	,	,	O	,	_	0	SENT_218	[p15l114t1155r217b1217],
22	Clohisy	NNP	PERSON	Clohisy	nn	23	SENT_218	[p15l257t1154r475b1220],
23	J	NNP	PERSON	J	appos	2	SENT_218	[p15l511t1156r539b1206],
24	,	,	O	,	_	0	SENT_218	[p15l543t1198r554b1217],
25	Barrack	NNP	PERSON	Barrack	nn	26	SENT_218	[p15l594t1154r826b1206],
26	R	NNP	PERSON	R	appos	2	SENT_218	[p15l864t1156r928b1217],
27	,	,	O	,	_	0	SENT_218	[p15l864t1156r928b1217],
28	Gage	NNP	PERSON	Gage	nn	31	SENT_218	[p15l968t1155r1120b1220],
29	B.	NNP	O	B.	nn	31	SENT_218	[p15l1158t1156r1215b1206],
30	Optimal	JJ	O	optimal	amod	31	SENT_218	[p15l1256t1154r1494b1220],
31	Dose	NN	O	dose	appos	2	SENT_218	[p15l1531t1156r1679b1206],
32	Adjustment	NNP	O	Adjustment	dep	31	SENT_218	[p15l1715t1154r2057b1220],
33	in	IN	O	in	_	0	SENT_218	[p15l2093t1154r2147b1206],
34	Orthopaedic	NNP	O	Orthopaedic	nn	35	SENT_218	[p15l113t1243r476b1310],
35	Patients	NNPS	O	Patients	prep_in	2	SENT_218	[p15l492t1243r722b1295],
36	Beginning	VBG	O	begin	partmod	2	SENT_218	[p15l740t1243r1032b1310],
37	Warfarin	NNP	O	Warfarin	nn	38	SENT_218	[p15l1047t1243r1314b1296],
38	Therapy	NN	O	therapy	dobj	36	SENT_218	[p15l1331t1243r1590b1310],
39	.	.	O	.	_	0	SENT_218	[p15l1331t1243r1590b1310],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_219	[p15l1610t1245r1727b1295],
2	Pharmacother	NNP	PERSON	Pharmacother	_	0	SENT_219	[p15l1745t1243r2148b1296],
3	2007	CD	DATE	2007	num	2	SENT_219	[p15l112t1334r262b1395],
4	;	:	O	;	_	0	SENT_219	[p15l112t1334r262b1395],
5	41	CD	NUMBER	41	num	7	SENT_219	[p15l287t1334r368b1384],
6	:	:	O	:	_	0	SENT_219	[p15l287t1334r368b1384],
7	1798-804	CD	NUMBER	1798-804	dep	2	SENT_219	[p15l402t1333r681b1384],
8	.	.	O	.	_	0	SENT_219	[p15l402t1333r681b1384],

1	Siguret	NNP	MISC	Siguret	nn	2	SENT_220	[p15l114t1421r316b1487],
2	V	NNP	O	V	dep	36	SENT_220	[p15l333t1422r397b1484],
3	,	,	O	,	_	0	SENT_220	[p15l333t1422r397b1484],
4	Gouin	NNP	PERSON	Gouin	nn	8	SENT_220	[p15l419t1421r605b1473],
5	I	PRP	O	I	dep	8	SENT_220	[p15l623t1422r662b1484],
6	,	,	O	,	_	0	SENT_220	[p15l623t1422r662b1484],
7	Debray	NNP	PERSON	Debray	dep	8	SENT_220	[p15l683t1420r900b1487],
8	M	NNP	O	M	appos	2	SENT_220	[p15l919t1422r1000b1484],
9	,	,	O	,	_	0	SENT_220	[p15l919t1422r1000b1484],
10	Perret-Guillaume	NNP	O	Perret-Guillaume	nn	11	SENT_220	[p15l1021t1421r1524b1473],
11	C	NNP	O	C	appos	2	SENT_220	[p15l1543t1421r1606b1484],
12	,	,	O	,	_	0	SENT_220	[p15l1543t1421r1606b1484],
13	Boddaert	NNP	PERSON	Boddaert	nn	14	SENT_220	[p15l1627t1420r1897b1473],
14	J	NNP	PERSON	J	appos	2	SENT_220	[p15l1914t1422r1942b1473],
15	,	,	O	,	_	0	SENT_220	[p15l1946t1464r1957b1484],
16	Mahe	NNP	O	Mahe	nn	17	SENT_220	[p15l1979t1420r2147b1473],
17	I	NNP	O	I	appos	2	SENT_220	[p15l113t1511r151b1572],
18	,	,	O	,	_	0	SENT_220	[p15l113t1511r151b1572],
19	Donval	NNP	O	Donval	nn	20	SENT_220	[p15l174t1509r391b1562],
20	V	NNP	O	V	appos	2	SENT_220	[p15l409t1511r473b1572],
21	,	,	O	,	_	0	SENT_220	[p15l409t1511r473b1572],
22	Seux	NNP	O	Seux	nn	23	SENT_220	[p15l498t1510r634b1562],
23	ML	NNP	O	ML	appos	2	SENT_220	[p15l653t1511r781b1572],
24	,	,	O	,	_	0	SENT_220	[p15l653t1511r781b1572],
25	Romain-Pilotaz	NNP	O	Romain-Pilotaz	nn	26	SENT_220	[p15l805t1509r1264b1562],
26	M	NNP	O	M	appos	2	SENT_220	[p15l1283t1511r1365b1572],
27	,	,	O	,	_	0	SENT_220	[p15l1283t1511r1365b1572],
28	Gisselbrecht	NNP	O	Gisselbrecht	nn	29	SENT_220	[p15l1388t1509r1744b1562],
29	M	NNP	O	M	appos	2	SENT_220	[p15l1763t1511r1845b1572],
30	,	,	O	,	_	0	SENT_220	[p15l1763t1511r1845b1572],
31	Verny	NNP	O	Verny	nn	32	SENT_220	[p15l1866t1511r2043b1575],
32	M	NNP	O	M	appos	2	SENT_220	[p15l2062t1511r2144b1572],
33	,	,	O	,	_	0	SENT_220	[p15l2062t1511r2144b1572],
34	Pautas	NNP	O	Pautas	nn	35	SENT_220	[p15l112t1600r305b1651],
35	E.	NNP	O	E.	appos	2	SENT_220	[p15l325t1600r382b1650],
36	Initiation	NN	O	initiation	_	0	SENT_220	[p15l406t1598r676b1651],
37	of	IN	O	of	_	0	SENT_220	[p15l695t1598r759b1651],
38	warfarin	NN	O	warfarin	nn	39	SENT_220	[p15l769t1598r1017b1651],
39	therapy	NN	O	therapy	prep_of	36	SENT_220	[p15l1035t1598r1256b1665],
40	in	IN	O	in	_	0	SENT_220	[p15l1273t1598r1328b1650],
41	elderly	JJ	O	elderly	amod	43	SENT_220	[p15l1346t1598r1537b1665],
42	medical	JJ	O	medical	amod	43	SENT_220	[p15l1554t1598r1778b1651],
43	inpatients	NNS	O	inpatient	prep_in	39	SENT_220	[p15l1796t1598r2092b1665],
44	:	:	O	:	_	0	SENT_220	[p15l1796t1598r2092b1665],
45	a	DT	O	a	det	49	SENT_220	[p15l2115t1615r2147b1651],
46	safe	JJ	O	safe	amod	49	SENT_220	[p15l113t1687r222b1740],
47	and	CC	O	and	_	0	SENT_220	[p15l246t1687r353b1740],
48	accurate	JJ	O	accurate	amod	49	SENT_220	[p15l377t1695r618b1740],
49	regimen	NN	O	regimen	dep	43	SENT_220	[p15l641t1688r886b1754],
50	.	.	O	.	_	0	SENT_220	[p15l641t1688r886b1754],

1	Am	VBP	O	be	_	0	SENT_221	[p15l913t1689r1015b1740],
2	J	NN	O	j	nsubj	3	SENT_221	[p15l1038t1691r1078b1740],
3	Med	VBD	O	med	ccomp	1	SENT_221	[p15l1094t1688r1232b1740],
4	2005	CD	DATE	2005	dobj	3	SENT_221	[p15l1249t1689r1398b1751],
5	;	:	O	;	_	0	SENT_221	[p15l1249t1689r1398b1751],
6	118	CD	NUMBER	118	num	8	SENT_221	[p15l1428t1689r1539b1740],
7	:	:	O	:	_	0	SENT_221	[p15l1428t1689r1539b1740],
8	137-42	CD	NUMBER	137-42	dep	4	SENT_221	[p15l1573t1689r1783b1740],
9	.	.	O	.	_	0	SENT_221	[p15l1573t1689r1783b1740],

1	Li	NNP	PERSON	Li	nn	2	SENT_222	[p15l113t1777r174b1827],
2	C	NNP	PERSON	C	dep	19	SENT_222	[p15l204t1777r265b1839],
3	,	,	O	,	_	0	SENT_222	[p15l204t1777r265b1839],
4	Schwarz	NNP	PERSON	Schwarz	nn	5	SENT_222	[p15l299t1776r541b1829],
5	UI	NNP	O	UI	appos	2	SENT_222	[p15l569t1778r665b1839],
6	,	,	O	,	_	0	SENT_222	[p15l569t1778r665b1839],
7	Ritchie	NNP	PERSON	Ritchie	nn	8	SENT_222	[p15l698t1776r903b1828],
8	MD	NNP	O	MD	appos	2	SENT_222	[p15l933t1778r1072b1839],
9	,	,	O	,	_	0	SENT_222	[p15l933t1778r1072b1839],
10	Roden	NNP	PERSON	Roden	nn	11	SENT_222	[p15l1105t1776r1298b1828],
11	DM	NN	O	dm	appos	2	SENT_222	[p15l1327t1778r1466b1839],
12	,	,	O	,	_	0	SENT_222	[p15l1327t1778r1466b1839],
13	Stein	NNP	PERSON	Stein	nn	14	SENT_222	[p15l1499t1777r1641b1828],
14	CM	NN	O	cm	appos	2	SENT_222	[p15l1670t1777r1801b1839],
15	,	,	O	,	_	0	SENT_222	[p15l1670t1777r1801b1839],
16	Kurnik	NNP	PERSON	Kurnik	nn	17	SENT_222	[p15l1833t1776r2046b1828],
17	D.	NNP	O	D.	appos	2	SENT_222	[p15l2074t1778r2143b1828],
18	Relative	JJ	O	relative	amod	19	SENT_222	[p15l114t1864r349b1917],
19	contribution	NN	O	contribution	_	0	SENT_222	[p15l371t1864r733b1917],
20	of	IN	O	of	_	0	SENT_222	[p15l757t1864r821b1917],
21	CYP2C9	NN	O	cyp2c9	nn	24	SENT_222	[p15l837t1865r1095b1917],
22	and	CC	O	and	_	0	SENT_222	[p15l1119t1864r1226b1917],
23	VKORC1	NN	O	vkorc1	nn	24	SENT_222	[p15l1248t1865r1538b1917],
24	genotypes	NNS	O	genotype	prep_of	19	SENT_222	[p15l1567t1872r1854b1931],
25	and	CC	O	and	_	0	SENT_222	[p15l1878t1864r1985b1917],
26	early	JJ	O	early	amod	28	SENT_222	[p15l2007t1864r2147b1931],
27	INR	NN	O	inr	nn	28	SENT_222	[p15l112t1955r248b2005],
28	response	NN	O	response	conj_and	19	SENT_222	[p15l265t1970r515b2020],
29	to	TO	O	to	_	0	SENT_222	[p15l534t1961r591b2006],
30	the	DT	O	the	det	31	SENT_222	[p15l612t1953r699b2006],
31	prediction	NN	O	prediction	prep_to	28	SENT_222	[p15l718t1953r1011b2020],
32	of	IN	O	of	_	0	SENT_222	[p15l1032t1953r1096b2006],
33	warfarin	NN	O	warfarin	nn	34	SENT_222	[p15l1107t1953r1354b2006],
34	sensitivity	NN	O	sensitivity	prep_of	31	SENT_222	[p15l1374t1953r1657b2020],
35	during	IN	O	during	_	0	SENT_222	[p15l1676t1953r1867b2020],
36	initiation	NN	O	initiation	prep_during	34	SENT_222	[p15l1885t1953r2147b2006],
37	of	IN	O	of	_	0	SENT_222	[p15l113t2042r178b2095],
38	therapy	NN	O	therapy	prep_of	36	SENT_222	[p15l194t2042r428b2109],
39	.	.	O	.	_	0	SENT_222	[p15l194t2042r428b2109],

1	Blood	NN	O	blood	_	0	SENT_223	[p15l454t2043r626b2095],
2	2009	CD	DATE	2009	num	1	SENT_223	[p15l643t2044r793b2106],
3	;	:	O	;	_	0	SENT_223	[p15l643t2044r793b2106],
4	113	CD	NUMBER	113	num	6	SENT_223	[p15l822t2044r933b2095],
5	:	:	O	:	_	0	SENT_223	[p15l822t2044r933b2095],
6	3925-30	CD	NUMBER	3925-30	dep	1	SENT_223	[p15l963t2044r1212b2095],
7	.	.	O	.	_	0	SENT_223	[p15l963t2044r1212b2095],

1	Ridker	NNP	PERSON	Ridker	nn	2	SENT_224	[p15l114t2131r314b2184],
2	PM	NNP	O	PM	dep	11	SENT_224	[p15l350t2133r475b2195],
3	,	,	O	,	_	0	SENT_224	[p15l350t2133r475b2195],
4	Goldhaber	NNP	PERSON	Goldhaber	nn	5	SENT_224	[p15l516t2131r830b2184],
5	SZ	NNP	O	SZ	appos	2	SENT_224	[p15l869t2132r964b2195],
6	,	,	O	,	_	0	SENT_224	[p15l869t2132r964b2195],
7	Danielson	NNP	PERSON	Danielson	nn	8	SENT_224	[p15l1004t2131r1299b2184],
8	E	NNP	O	E	appos	2	SENT_224	[p15l1337t2133r1396b2195],
9	,	,	O	,	_	0	SENT_224	[p15l1337t2133r1396b2195],
10	Rosenberg	NNP	PERSON	Rosenberg	appos	2	SENT_224	[p15l1438t2131r1747b2198],
11	Y	NN	PERSON	y	_	0	SENT_224	[p15l1782t2133r1850b2195],
12	,	,	O	,	_	0	SENT_224	[p15l1782t2133r1850b2195],
13	Eby	NNP	PERSON	Eby	nn	14	SENT_224	[p15l1891t2131r2007b2198],
14	CS	NNP	O	CS	appos	11	SENT_224	[p15l2045t2132r2145b2194],
15	,	,	O	,	_	0	SENT_224	[p15l2045t2132r2145b2194],
16	Deitcher	NNP	PERSON	Deitcher	nn	17	SENT_224	[p15l112t2220r361b2272],
17	SR	NN	O	sr	appos	11	SENT_224	[p15l386t2221r489b2283],
18	,	,	O	,	_	0	SENT_224	[p15l386t2221r489b2283],
19	Cushman	NNP	PERSON	Cushman	nn	20	SENT_224	[p15l516t2220r794b2272],
20	M	NNP	PERSON	M	appos	11	SENT_224	[p15l819t2222r901b2283],
21	,	,	O	,	_	0	SENT_224	[p15l819t2222r901b2283],
22	Moll	NNP	PERSON	Moll	nn	23	SENT_224	[p15l928t2220r1068b2272],
23	S	NNP	O	S	appos	11	SENT_224	[p15l1095t2221r1144b2283],
24	,	,	O	,	_	0	SENT_224	[p15l1095t2221r1144b2283],
25	Kessler	NNP	PERSON	Kessler	nn	26	SENT_224	[p15l1171t2220r1382b2272],
26	CM	NN	O	cm	appos	11	SENT_224	[p15l1407t2221r1538b2283],
27	,	,	O	,	_	0	SENT_224	[p15l1407t2221r1538b2283],
28	Elliott	NNP	PERSON	Elliott	nn	29	SENT_224	[p15l1565t2220r1745b2272],
29	CG	NNP	O	CG	appos	11	SENT_224	[p15l1770t2221r1889b2283],
30	,	,	O	,	_	0	SENT_224	[p15l1770t2221r1889b2283],
31	Paulson	NNP	PERSON	Paulson	nn	32	SENT_224	[p15l1915t2220r2148b2272],
32	R	NNP	PERSON	R	appos	11	SENT_224	[p15l114t2311r179b2372],
33	,	,	O	,	_	0	SENT_224	[p15l114t2311r179b2372],
34	Wong	NNP	PERSON	Wong	nn	35	SENT_224	[p15l207t2310r386b2375],
35	T	NN	O	t	appos	11	SENT_224	[p15l411t2310r470b2372],
36	,	,	O	,	_	0	SENT_224	[p15l411t2310r470b2372],
37	Bauer	NNP	PERSON	Bauer	nn	38	SENT_224	[p15l500t2310r672b2361],
38	KA	NN	O	ka	appos	11	SENT_224	[p15l697t2308r821b2372],
39	,	,	O	,	_	0	SENT_224	[p15l697t2308r821b2372],
40	Schwartz	NNP	ORGANIZATION	Schwartz	nn	41	SENT_224	[p15l852t2308r1116b2361],
41	BA	NN	ORGANIZATION	ba	appos	11	SENT_224	[p15l1142t2308r1254b2372],
42	,	,	O	,	_	0	SENT_224	[p15l1142t2308r1254b2372],
43	Miletich	NNP	PERSON	Miletich	nn	44	SENT_224	[p15l1284t2308r1523b2361],
44	JP	NNP	O	JP	appos	11	SENT_224	[p15l1548t2310r1633b2372],
45	,	,	O	,	_	0	SENT_224	[p15l1548t2310r1633b2372],
46	Bounameaux	NNP	PERSON	Bounameaux	nn	47	SENT_224	[p15l1663t2310r2048b2361],
47	H	NNP	PERSON	H	appos	11	SENT_224	[p15l2074t2310r2144b2372],
48	,	,	O	,	_	0	SENT_224	[p15l2074t2310r2144b2372],
49	Glynn	NNP	PERSON	Glynn	nn	50	SENT_224	[p15l113t2398r295b2464],
50	RJ	NN	PERSON	rj	appos	11	SENT_224	[p15l322t2400r415b2450],
51	.	.	O	.	_	0	SENT_224	[p15l322t2400r415b2450],

1	Long-term	JJ	O	long-term	amod	5	SENT_225	[p15l444t2400r770b2464],
2	,	,	O	,	_	0	SENT_225	[p15l444t2400r770b2464],
3	low-intensity	JJ	O	low-intensity	amod	5	SENT_225	[p15l797t2398r1169b2464],
4	warfarin	NN	O	warfarin	nn	5	SENT_225	[p15l1193t2398r1441b2450],
5	therapy	NN	O	therapy	_	0	SENT_225	[p15l1465t2398r1686b2464],
6	for	IN	O	for	_	0	SENT_225	[p15l1710t2398r1795b2450],
7	the	DT	O	the	det	8	SENT_225	[p15l1819t2398r1907b2450],
8	prevention	NN	O	prevention	prep_for	5	SENT_225	[p15l1930t2415r2146b2464, p15l112t2486r226b2539],
9	of	IN	O	of	_	0	SENT_225	[p15l250t2486r314b2539],
10	recurrent	JJ	O	recurrent	amod	12	SENT_225	[p15l330t2494r594b2539],
11	venous	JJ	O	venous	amod	12	SENT_225	[p15l616t2503r818b2539],
12	thromboembolism	NN	O	thromboembolism	prep_of	5	SENT_225	[p15l841t2486r1391b2539],
13	.	.	O	.	_	0	SENT_225	[p15l841t2486r1391b2539],

1	N	NN	O	n	nn	3	SENT_226	[p15l1416t2489r1475b2539],
2	Engl	NNP	O	Engl	nn	3	SENT_226	[p15l1491t2487r1626b2552],
3	J	NNP	O	J	nsubj	4	SENT_226	[p15l1644t2489r1683b2539],
4	Med	VBD	O	med	_	0	SENT_226	[p15l1699t2487r1837b2539],
5	2003	CD	DATE	2003	dobj	4	SENT_226	[p15l1853t2488r2003b2550],
6	;	:	O	;	_	0	SENT_226	[p15l1853t2488r2003b2550],
7	348	CD	NUMBER	348	num	9	SENT_226	[p15l2028t2488r2142b2539],
8	:	:	O	:	_	0	SENT_226	[p15l2028t2488r2142b2539],
9	1425-34	CD	NUMBER	1425-34	dep	5	SENT_226	[p15l119t2577r363b2628],
10	.	.	O	.	_	0	SENT_226	[p15l119t2577r363b2628],

1	Ronaghi	NNP	MISC	Ronaghi	nn	2	SENT_227	[p15l114t2665r363b2731],
2	M	NNP	O	M	_	0	SENT_227	[p15l385t2666r467b2728],
3	,	,	O	,	_	0	SENT_227	[p15l385t2666r467b2728],
4	Uhlen	NNP	O	Uhlen	nn	5	SENT_227	[p15l493t2665r671b2717],
5	M	NNP	O	M	appos	2	SENT_227	[p15l693t2666r775b2728],
6	,	,	O	,	_	0	SENT_227	[p15l693t2666r775b2728],
7	Nyren	NNP	O	Nyren	nn	11	SENT_227	[p15l798t2667r983b2731],
8	P.	NNP	O	P.	nn	11	SENT_227	[p15l1003t2667r1058b2717],
9	A	NNP	O	A	nn	11	SENT_227	[p15l1082t2665r1135b2716],
10	sequencing	NN	O	sequencing	nn	11	SENT_227	[p15l1158t2665r1474b2731],
11	method	NN	O	method	appos	2	SENT_227	[p15l1494t2665r1716b2717],
12	based	VBN	O	base	partmod	11	SENT_227	[p15l1738t2665r1903b2717],
13	on	IN	O	on	_	0	SENT_227	[p15l1925t2682r1998b2717],
14	realtime	NN	O	realtime	nn	15	SENT_227	[p15l2019t2665r2146b2717, p15l112t2753r237b2805],
15	pyrophosphate	NN	O	pyrophosphate	prep_on	12	SENT_227	[p15l259t2753r710b2819],
16	.	.	O	.	_	0	SENT_227	[p15l259t2753r710b2819],

1	Science	NN	O	science	_	0	SENT_228	[p15l739t2755r949b2806],
2	1998	CD	DATE	1998	num	1	SENT_228	[p15l978t2754r1121b2816],
3	;	:	O	;	_	0	SENT_228	[p15l978t2754r1121b2816],
4	281	CD	NUMBER	281	num	6	SENT_228	[p15l1147t2754r1262b2805],
5	:	:	O	:	_	0	SENT_228	[p15l1147t2754r1262b2805],
6	363	CD	NUMBER	363	dep	1	SENT_228	[p15l1291t2754r1404b2805],
7	.	.	O	.	_	0	SENT_228	[p15l1291t2754r1404b2805],

1	Aquilante	NNP	O	Aquilante	nn	2	SENT_229	[p15l111t2842r399b2909],
2	CL	NN	O	cl	_	0	SENT_229	[p15l418t2843r526b2906],
3	,	,	O	,	_	0	SENT_229	[p15l418t2843r526b2906],
4	Lobmeyer	NNP	O	Lobmeyer	nn	5	SENT_229	[p15l548t2842r845b2909],
5	MT	NNP	O	MT	appos	2	SENT_229	[p15l863t2844r990b2906],
6	,	,	O	,	_	0	SENT_229	[p15l863t2844r990b2906],
7	Langaee	NNP	LOCATION	Langaee	nn	8	SENT_229	[p15l1013t2844r1255b2909],
8	TY	NNP	LOCATION	TY	appos	2	SENT_229	[p15l1273t2844r1387b2906],
9	,	,	O	,	_	0	SENT_229	[p15l1273t2844r1387b2906],
10	Johnson	NNP	PERSON	Johnson	nn	13	SENT_229	[p15l1407t2842r1651b2895],
11	J	NNP	O	J	nn	13	SENT_229	[p15l1668t2844r1697b2895],
12	A.	NNP	O	A.	nn	13	SENT_229	[p15l1698t2842r1764b2895],
13	Comparison	NN	O	comparison	appos	2	SENT_229	[p15l1787t2843r2147b2909],
14	of	IN	O	of	_	0	SENT_229	[p15l113t2932r177b2984],
15	cytochrome	NN	O	cytochrome	nn	17	SENT_229	[p15l190t2932r531b2998],
16	P450	NN	O	p450	nn	17	SENT_229	[p15l550t2933r691b2984],
17	2C9	NN	O	2c9	prep_of	13	SENT_229	[p15l711t2933r826b2984],
18	genotyping	VBG	O	genotype	partmod	17	SENT_229	[p15l848t2932r1170b2998],
19	methods	NNS	O	method	dobj	18	SENT_229	[p15l1188t2931r1435b2984],
20	and	CC	O	and	_	0	SENT_229	[p15l1456t2932r1563b2984],
21	implications	NNS	O	implication	conj_and	19	SENT_229	[p15l1582t2932r1935b2998],
22	for	IN	O	for	_	0	SENT_229	[p15l1955t2932r2040b2984],
23	the	DT	O	the	det	25	SENT_229	[p15l2059t2932r2147b2984],
24	clinical	JJ	O	clinical	amod	25	SENT_229	[p15l112t3021r313b3073],
25	laboratory	NN	O	laboratory	prep_for	18	SENT_229	[p15l336t3021r657b3087],
26	.	.	O	.	_	0	SENT_229	[p15l336t3021r657b3087],

1	Pharmacotherapy	NNP	O	Pharmacotherapy	_	0	SENT_230	[p15l684t3021r1189b3087],
2	2004	CD	DATE	2004	num	1	SENT_230	[p15l1212t3022r1362b3084],
3	;	:	O	;	_	0	SENT_230	[p15l1212t3022r1362b3084],
4	24	CD	NUMBER	24	num	6	SENT_230	[p15l1388t3022r1468b3073],
5	:	:	O	:	_	0	SENT_230	[p15l1388t3022r1468b3073],
6	720-6	CD	NUMBER	720-6	dep	1	SENT_230	[p15l1497t3022r1678b3073],
7	.	.	O	.	_	0	SENT_230	[p15l1497t3022r1678b3073],

1	King	NNP	O	King	nn	2	SENT_231	[p15l112t3110r258b3176],
2	CR	NN	O	cr	_	0	SENT_231	[p15l295t3110r410b3173],
3	,	,	O	,	_	0	SENT_231	[p15l295t3110r410b3173],
4	Porche-Sorbet	NNP	O	Porche-Sorbet	nn	5	SENT_231	[p15l449t3109r865b3162],
5	RM	NN	O	rm	appos	2	SENT_231	[p15l902t3111r1037b3173],
6	,	,	O	,	_	0	SENT_231	[p15l902t3111r1037b3173],
7	Gage	NNP	PERSON	Gage	nn	8	SENT_231	[p15l1077t3110r1229b3176],
8	BF	NNP	O	BF	appos	2	SENT_231	[p15l1267t3111r1371b3173],
9	,	,	O	,	_	0	SENT_231	[p15l1267t3111r1371b3173],
10	Ridker	NNP	PERSON	Ridker	nn	11	SENT_231	[p15l1412t3109r1612b3162],
11	PM	NNP	O	PM	appos	2	SENT_231	[p15l1648t3111r1772b3173],
12	,	,	O	,	_	0	SENT_231	[p15l1648t3111r1772b3173],
13	Renaud	NNP	PERSON	Renaud	nn	14	SENT_231	[p15l1813t3109r2040b3162],
14	Y	NN	PERSON	y	appos	2	SENT_231	[p15l2076t3111r2144b3173],
15	,	,	O	,	_	0	SENT_231	[p15l2076t3111r2144b3173],
16	Phillips	NNP	PERSON	Phillips	nn	17	SENT_231	[p15l111t3199r324b3265],
17	MS	NN	O	m	appos	2	SENT_231	[p15l352t3200r471b3262],
18	,	,	O	,	_	0	SENT_231	[p15l352t3200r471b3262],
19	Eby	NNP	PERSON	Eby	nn	21	SENT_231	[p15l501t3199r617b3265],
20	C.	NNP	O	C.	nn	21	SENT_231	[p15l644t3200r705b3251],
21	Performance	NNP	O	Performance	appos	2	SENT_231	[p15l734t3199r1105b3251],
22	of	IN	O	of	_	0	SENT_231	[p15l1133t3199r1197b3251],
23	commercial	JJ	O	commercial	amod	24	SENT_231	[p15l1216t3199r1552b3251],
24	platforms	NNS	O	platform	prep_of	21	SENT_231	[p15l1576t3199r1857b3265],
25	for	IN	O	for	_	0	SENT_231	[p15l1884t3199r1969b3251],
26	rapid	JJ	O	rapid	amod	27	SENT_231	[p15l1995t3198r2147b3265],
27	genotyping	NN	O	genotyping	prep_for	24	SENT_231	[p15l112t3288r435b3354],
28	of	IN	O	of	_	0	SENT_231	[p15l475t3288r539b3340],
29	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_231	[p15l570t3288r1020b3354],
30	affecting	VBG	O	affect	partmod	2	SENT_231	[p15l1061t3288r1306b3354],
31	warfarin	NN	O	warfarin	nn	32	SENT_231	[p15l1344t3288r1592b3340],
32	dose	NN	O	dose	dobj	30	SENT_231	[p15l1631t3288r1774b3340],
33	.	.	O	.	_	0	SENT_231	[p15l1631t3288r1774b3340],

1	Am	VBP	O	be	dep	4	SENT_232	[p15l1816t3290r1918b3340],
2	J	NN	O	j	nn	4	SENT_232	[p15l1957t3291r1996b3340],
3	Clin	NN	O	clin	nn	4	SENT_232	[p15l2033t3288r2146b3340],
4	Path	NN	O	path	_	0	SENT_232	[p15l112t3376r247b3428],
5	2008	CD	DATE	2008	dep	4	SENT_232	[p15l318t3377r467b3439],
6	;	:	O	;	_	0	SENT_232	[p15l318t3377r467b3439],
7	129	CD	NUMBER	129	dep	5	SENT_232	[p15l544t3377r655b3428],
8	:	:	O	:	_	0	SENT_232	[p15l544t3377r655b3428],
9	876-83	CD	NUMBER	876-83	dep	7	SENT_232	[p15l732t3377r947b3428],
10	.	.	O	.	_	0	SENT_232	[p15l732t3377r947b3428],

1	6428X1UOK1406K47	CD	NUMBER	6428x1uok1406k47	number	2	SENT_233	[p15l1023t3377r1654b3429],
2	[	CD	NUMBER	[	num	3	SENT_233	[p15l1728t3376r1831b3442],
3	pii	NN	O	pius	_	0	SENT_233	[p15l1728t3376r1831b3442],
4	]	CD	NUMBER	]	number	5	SENT_233	[p15l1728t3376r1831b3442],
5	10.1309	CD	NUMBER	10.1309	amod	3	SENT_233	[p15l1911t3376r2147b3442],
6	/	:	O	/	punct	7	SENT_233	[p15l1911t3376r2147b3442],
7	1E34UAPR06PJ	CD	NUMBER	1e34uapr06pj	dep	5	SENT_233	[p15l119t3466r605b3518],
8	6HML	NN	O	6hml	dep	7	SENT_233	[p15l608t3467r825b3518],
9	.	.	O	.	_	0	SENT_233	[p15l608t3467r825b3518],

1	DuBois	NNP	PERSON	DuBois	nn	2	SENT_234	[p15l112t3555r332b3607],
2	D	NNP	O	D	_	0	SENT_234	[p15l355t3557r425b3618],
3	,	,	O	,	_	0	SENT_234	[p15l355t3557r425b3618],
4	DuBois	NNP	PERSON	DuBois	nn	7	SENT_234	[p15l450t3555r670b3607],
5	E.	NNP	PERSON	E.	nn	7	SENT_234	[p15l694t3557r751b3607],
6	Clinical	JJ	PERSON	clinical	amod	7	SENT_234	[p15l778t3555r998b3607],
7	Calorimetry	NN	PERSON	calorimetry	appos	2	SENT_234	[p15l1021t3555r1386b3621],
8	;	:	O	;	_	0	SENT_234	[p15l1021t3555r1386b3621],
9	a	DT	O	a	det	10	SENT_234	[p15l1412t3572r1444b3607],
10	formula	NN	O	formulum	dep	2	SENT_234	[p15l1466t3555r1698b3607],
11	to	TO	O	to	aux	12	SENT_234	[p15l1720t3562r1776b3607],
12	estimate	VB	O	estimate	infmod	10	SENT_234	[p15l1800t3555r2037b3607],
13	the	DT	O	the	det	16	SENT_234	[p15l2060t3555r2147b3607],
14	approximate	JJ	O	approximate	amod	16	SENT_234	[p15l113t3643r479b3709],
15	surface	NN	O	surface	nn	16	SENT_234	[p15l504t3643r706b3695],
16	area	NN	O	area	dobj	12	SENT_234	[p15l731t3660r852b3695],
17	if	IN	O	if	mark	22	SENT_234	[p15l875t3643r922b3695],
18	height	NN	O	height	nsubjpass	22	SENT_234	[p15l938t3643r1117b3709],
19	and	CC	O	and	_	0	SENT_234	[p15l1141t3643r1248b3695],
20	weight	NN	O	weight	nsubjpass	22	SENT_234	[p15l1270t3643r1462b3709],
21	be	VB	O	be	auxpass	22	SENT_234	[p15l1484t3643r1550b3695],
22	known	VBN	O	know	advcl	12	SENT_234	[p15l1573t3643r1787b3695],
23	.	.	O	.	_	0	SENT_234	[p15l1573t3643r1787b3695],

1	Arch	NNP	O	Arch	nn	3	SENT_235	[p15l1814t3643r1952b3695],
2	Intern	NNP	O	Intern	nn	3	SENT_235	[p15l1975t3646r2146b3695],
3	Med	NNP	O	Med	_	0	SENT_235	[p15l112t3732r249b3784],
4	1916	CD	DATE	1916	num	3	SENT_235	[p15l274t3733r416b3795],
5	;	:	O	;	_	0	SENT_235	[p15l274t3733r416b3795],
6	17	CD	NUMBER	17	num	8	SENT_235	[p15l445t3733r523b3784],
7	:	:	O	:	_	0	SENT_235	[p15l445t3733r523b3784],
8	863-71	CD	NUMBER	863-71	dep	3	SENT_235	[p15l552t3733r767b3784],
9	.	.	O	.	_	0	SENT_235	[p15l552t3733r767b3784],

1	19	CD	NUMBER	19	num	3	SENT_236	[p16l13t21r72b72],
2	Rosendaal	NNP	ORGANIZATION	Rosendaal	nn	3	SENT_236	[p16l114t20r419b72],
3	FR	NN	ORGANIZATION	fr	_	0	SENT_236	[p16l442t22r554b83],
4	,	,	O	,	_	0	SENT_236	[p16l442t22r554b83],
5	Cannegieter	NN	ORGANIZATION	cannegieter	nn	6	SENT_236	[p16l581t20r928b86],
6	SC	NN	ORGANIZATION	sc	appos	3	SENT_236	[p16l952t21r1050b83],
7	,	,	O	,	_	0	SENT_236	[p16l952t21r1050b83],
8	Van	NNP	PERSON	Van	nn	11	SENT_236	[p16l1075t37r1180b72],
9	der	FW	PERSON	der	nn	11	SENT_236	[p16l1202t20r1295b72],
10	Meer	NNP	PERSON	Meer	nn	11	SENT_236	[p16l1317t22r1470b72],
11	FJ	NNP	PERSON	FJ	appos	3	SENT_236	[p16l1493t22r1581b83],
12	,	,	O	,	_	0	SENT_236	[p16l1493t22r1581b83],
13	Briet	NNP	O	Briet	nn	16	SENT_236	[p16l1607t20r1746b72],
14	E.	NNP	O	E.	nn	16	SENT_236	[p16l1769t22r1826b72],
15	A	NNP	O	A	nn	16	SENT_236	[p16l1851t20r1905b71],
16	method	NN	O	method	appos	3	SENT_236	[p16l1925t19r2147b72],
17	to	TO	O	to	aux	18	SENT_236	[p16l112t115r169b160],
18	determine	VB	O	determine	infmod	16	SENT_236	[p16l211t108r497b160],
19	the	DT	O	the	det	21	SENT_236	[p16l539t108r626b160],
20	optimal	JJ	O	optimal	amod	21	SENT_236	[p16l669t108r891b174],
21	intensity	NN	O	intensity	dobj	18	SENT_236	[p16l931t108r1177b174],
22	of	IN	O	of	_	0	SENT_236	[p16l1218t108r1282b160],
23	oral	JJ	O	oral	amod	25	SENT_236	[p16l1317t108r1430b160],
24	anticoagulant	JJ	O	anticoagulant	amod	25	SENT_236	[p16l1472t108r1868b174],
25	therapy	NN	O	therapy	prep_of	21	SENT_236	[p16l1909t108r2143b174],
26	.	.	O	.	_	0	SENT_236	[p16l1909t108r2143b174],

1	T	NN	O	t	nn	2	SENT_237	[p16l118t200r164b248],
2	hromb	NN	O	hromb	_	0	SENT_237	[p16l158t197r337b249],
3	Haemost	NNP	O	Haemost	dep	2	SENT_237	[p16l361t200r618b249],
4	1993	CD	DATE	1993	num	3	SENT_237	[p16l647t198r790b260],
5	;	:	O	;	_	0	SENT_237	[p16l647t198r790b260],
6	69	CD	NUMBER	69	num	8	SENT_237	[p16l816t198r896b249],
7	:	:	O	:	_	0	SENT_237	[p16l816t198r896b249],
8	236-9	CD	NUMBER	236-9	dep	2	SENT_237	[p16l924t198r1107b249],
9	.	.	O	.	_	0	SENT_237	[p16l924t198r1107b249],

1	20	CD	NUMBER	20	_	0	SENT_238	[p16l7t286r72b338],
2	Lesko	NNP	ORGANIZATION	Lesko	nn	3	SENT_238	[p16l113t285r286b337],
3	LJ	NNP	ORGANIZATION	LJ	dep	1	SENT_238	[p16l321t287r408b338],
4	.	.	O	.	_	0	SENT_238	[p16l321t287r408b338],

1	The	DT	O	the	det	3	SENT_239	[p16l444t285r555b337],
2	critical	JJ	O	critical	amod	3	SENT_239	[p16l588t285r782b337],
3	path	NN	O	path	_	0	SENT_239	[p16l813t285r945b352],
4	of	IN	O	of	_	0	SENT_239	[p16l978t285r1042b337],
5	warfarin	NN	O	warfarin	nn	6	SENT_239	[p16l1066t285r1314b337],
6	dosing	NN	O	dosing	prep_of	3	SENT_239	[p16l1347t285r1550b352],
7	:	:	O	:	_	0	SENT_239	[p16l1347t285r1550b352],
8	ﬁnding	VBG	O	ﬁnding	dep	6	SENT_239	[p16l1586t285r1789b352],
9	an	DT	O	a	det	12	SENT_239	[p16l1822t302r1891b337],
10	optimal	JJ	O	optimal	amod	12	SENT_239	[p16l1925t285r2147b352],
11	dosing	NN	O	dosing	nn	12	SENT_239	[p16l112t374r302b440],
12	strategy	NN	O	strategy	dobj	8	SENT_239	[p16l320t381r545b440],
13	using	VBG	O	use	xcomp	8	SENT_239	[p16l560t374r714b440],
14	pharmacogenetics	NNS	O	pharmacogenetic	dobj	13	SENT_239	[p16l728t374r1264b440],
15	.	.	O	.	_	0	SENT_239	[p16l728t374r1264b440],

1	C	NN	O	c	nn	2	SENT_240	[p16l1288t376r1336b427],
2	[	NN	O	[	_	0	SENT_240	[p16l1336t374r1402b426],
3	in	IN	O	in	_	0	SENT_240	[p16l1336t374r1402b426],
4	Pharmacol	NNP	O	Pharmacol	nn	5	SENT_240	[p16l1419t374r1731b426],
5	T	NN	O	t	prep_in	2	SENT_240	[p16l1749t377r1795b426],
6	her	PRP$	O	she	poss	7	SENT_240	[p16l1789t374r1878b426],
7	2008	CD	DATE	2008	dep	2	SENT_240	[p16l1894t375r2043b437],
8	;	:	O	;	_	0	SENT_240	[p16l1894t375r2043b437],
9	84	CD	NUMBER	84	num	11	SENT_240	[p16l2062t375r2142b426],
10	:	:	O	:	_	0	SENT_240	[p16l2062t375r2142b426],
11	301-3	CD	NUMBER	301-3	dep	7	SENT_240	[p16l114t464r295b516],
12	.	.	O	.	_	0	SENT_240	[p16l114t464r295b516],

1	clpt2008133	NN	O	clpt2008133	_	0	SENT_241	[p16l322t463r664b530],
2	[	CD	NUMBER	[	num	3	SENT_241	[p16l693t463r795b530],
3	pii	NN	O	pius	dep	1	SENT_241	[p16l693t463r795b530],
4	]	CD	NUMBER	]	number	5	SENT_241	[p16l693t463r795b530],
5	10.1038	CD	NUMBER	10.1038	dep	3	SENT_241	[p16l827t463r1461b530],
6	/	:	O	/	punct	8	SENT_241	[p16l827t463r1461b530],
7	clpt	JJ	O	clpt	amod	8	SENT_241	[p16l827t463r1461b530],
8	.2008.133	NN	O	.2008.133	dep	5	SENT_241	[p16l827t463r1461b530],
9	.	.	O	.	_	0	SENT_241	[p16l827t463r1461b530],

1	21	CD	NUMBER	21	num	3	SENT_242	[p16l7t553r66b604],
2	Caraco	NNP	ORGANIZATION	Caraco	nn	3	SENT_242	[p16l113t553r321b605],
3	Y	NN	ORGANIZATION	y	nsubj	14	SENT_242	[p16l344t554r413b615],
4	,	,	O	,	_	0	SENT_242	[p16l344t554r413b615],
5	Blotnick	NN	PERSON	blotnick	nn	6	SENT_242	[p16l439t552r685b604],
6	S	NN	PERSON	s	appos	3	SENT_242	[p16l710t553r759b615],
7	,	,	O	,	_	0	SENT_242	[p16l710t553r759b615],
8	Muszkat	NNP	PERSON	Muszkat	nn	12	SENT_242	[p16l786t552r1042b604],
9	M.	NNP	PERSON	M.	nn	12	SENT_242	[p16l1065t554r1146b604],
10	CYP2C9	NNP	PERSON	CYP2C9	nn	12	SENT_242	[p16l1174t553r1432b605],
11	genotype-guided	JJ	O	genotype-guided	amod	12	SENT_242	[p16l1458t552r1937b619],
12	warfarin	NN	O	warfarin	appos	3	SENT_242	[p16l1959t552r2146b605, p16l112t641r192b693],
13	prescribing	VBG	O	prescribe	partmod	12	SENT_242	[p16l217t641r537b707],
14	enhances	VBZ	O	enhance	_	0	SENT_242	[p16l564t641r824b693],
15	the	DT	O	the	det	16	SENT_242	[p16l852t641r939b693],
16	eﬂicacy	NN	O	eﬂicacy	dobj	14	SENT_242	[p16l966t641r1179b707],
17	and	CC	O	and	_	0	SENT_242	[p16l1206t641r1313b693],
18	safety	NN	O	safety	conj_and	16	SENT_242	[p16l1341t641r1507b707],
19	of	IN	O	of	_	0	SENT_242	[p16l1534t641r1598b693],
20	anticoagulation	NN	O	anticoagulation	prep_of	16	SENT_242	[p16l1619t641r2084b707],
21	:	:	O	:	_	0	SENT_242	[p16l1619t641r2084b707],
22	a	DT	O	a	det	23	SENT_242	[p16l2115t658r2147b693],
23	prospective	JJ	O	prospective	dep	16	SENT_242	[p16l111t730r439b796],
24	randomized	VBN	O	randomize	partmod	23	SENT_242	[p16l466t730r810b782],
25	controlled	JJ	O	controlled	amod	26	SENT_242	[p16l836t730r1129b782],
26	study	NN	O	study	dobj	24	SENT_242	[p16l1157t730r1325b796],
27	.	.	O	.	_	0	SENT_242	[p16l1157t730r1325b796],

1	Clin	NNP	PERSON	Clin	nn	3	SENT_243	[p16l1359t730r1473b783],
2	Pharmacol	NNP	PERSON	Pharmacol	nn	3	SENT_243	[p16l1500t730r1812b782],
3	T	NN	O	t	_	0	SENT_243	[p16l1840t733r1886b782],
4	her	PRP$	O	she	poss	5	SENT_243	[p16l1880t730r1969b782],
5	2008	CD	DATE	2008	dep	3	SENT_243	[p16l1994t731r2144b793],
6	;	:	O	;	_	0	SENT_243	[p16l1994t731r2144b793],
7	83	CD	NUMBER	83	num	9	SENT_243	[p16l112t820r192b872],
8	:	:	O	:	_	0	SENT_243	[p16l112t820r192b872],
9	460-70	CD	NUMBER	460-70	dep	5	SENT_243	[p16l219t820r436b872],
10	.	.	O	.	_	0	SENT_243	[p16l219t820r436b872],

1	22	CD	NUMBER	22	num	3	SENT_244	[p16l7t910r73b960],
2	Bussey	NNP	ORGANIZATION	Bussey	nn	3	SENT_244	[p16l113t910r310b975],
3	HI	NNP	ORGANIZATION	HI	_	0	SENT_244	[p16l332t910r428b972],
4	,	,	O	,	_	0	SENT_244	[p16l332t910r428b972],
5	Wittkowsky	NNP	O	Wittkowsky	nn	6	SENT_244	[p16l451t908r806b975],
6	AK	NNP	O	AK	appos	3	SENT_244	[p16l826t908r952b972],
7	,	,	O	,	_	0	SENT_244	[p16l826t908r952b972],
8	Hylek	NNP	ORGANIZATION	Hylek	nn	9	SENT_244	[p16l977t908r1152b975],
9	EM	NNP	ORGANIZATION	EM	appos	3	SENT_244	[p16l1174t910r1302b972],
10	,	,	O	,	_	0	SENT_244	[p16l1174t910r1302b972],
11	Walker	NNP	PERSON	Walker	nn	12	SENT_244	[p16l1325t908r1540b961],
12	MB	NNP	O	MB	appos	3	SENT_244	[p16l1562t910r1688b960],
13	.	.	O	.	_	0	SENT_244	[p16l1562t910r1688b960],

1	Genetic	JJ	O	genetic	amod	2	SENT_245	[p16l1715t908r1937b961],
2	testing	NN	O	testing	_	0	SENT_245	[p16l1958t908r2147b975],
3	for	IN	O	for	_	0	SENT_245	[p16l112t997r197b1049],
4	warfarin	NN	O	warfarin	nn	5	SENT_245	[p16l221t997r468b1049],
5	dosing	NN	O	dosing	prep_for	2	SENT_245	[p16l494t997r709b1063],
6	?	.	O	?	_	0	SENT_245	[p16l494t997r709b1063],

1	Not	RB	O	not	_	0	SENT_246	[p16l734t999r851b1049],
2	yet	RB	O	yet	advmod	3	SENT_246	[p16l876t1004r962b1063],
3	ready	JJ	O	ready	dep	1	SENT_246	[p16l986t997r1147b1063],
4	for	IN	O	for	_	0	SENT_246	[p16l1171t997r1256b1049],
5	prime	JJ	O	prime	amod	6	SENT_246	[p16l1280t997r1448b1063],
6	time	NN	O	time	prep_for	3	SENT_246	[p16l1474t997r1612b1049],
7	.	.	O	.	_	0	SENT_246	[p16l1474t997r1612b1049],

1	Pharmacotherapy	NNP	O	Pharmacotherapy	_	0	SENT_247	[p16l1642t997r2147b1064],
2	2008	CD	DATE	2008	num	1	SENT_247	[p16l112t1087r262b1149],
3	;	:	O	;	_	0	SENT_247	[p16l112t1087r262b1149],
4	28	CD	NUMBER	28	num	6	SENT_247	[p16l288t1087r368b1138],
5	:	:	O	:	_	0	SENT_247	[p16l288t1087r368b1138],
6	141-3	CD	NUMBER	141-3	dep	1	SENT_247	[p16l403t1087r579b1138],
7	.	.	O	.	_	0	SENT_247	[p16l403t1087r579b1138],

1	23	CD	NUMBER	23	num	3	SENT_248	[p16l7t1176r70b1227],
2	Mannucci	NNP	O	Mannucci	nn	3	SENT_248	[p16l113t1174r404b1227],
3	PM	NNP	O	PM	dep	12	SENT_248	[p16l427t1176r552b1237],
4	,	,	O	,	_	0	SENT_248	[p16l427t1176r552b1237],
5	Spreaﬁco	NNP	O	Spreaﬁco	nn	6	SENT_248	[p16l581t1174r847b1241],
6	M	NNP	O	M	appos	3	SENT_248	[p16l872t1176r954b1237],
7	,	,	O	,	_	0	SENT_248	[p16l872t1176r954b1237],
8	Peyvandi	NNP	LOCATION	Peyvandi	nn	9	SENT_248	[p16l981t1174r1247b1241],
9	F.	NNP	O	F.	appos	3	SENT_248	[p16l1272t1176r1329b1226],
10	Dosing	NNP	O	Dosing	dep	12	SENT_248	[p16l1358t1174r1567b1241],
11	anticoagulant	JJ	O	anticoagulant	amod	12	SENT_248	[p16l1592t1174r1988b1241],
12	therapy	NN	O	therapy	dep	18	SENT_248	[p16l2012t1174r2147b1227, p16l113t1280r217b1330],
13	with	IN	O	with	_	0	SENT_248	[p16l232t1263r360b1316],
14	coumarin	NN	O	coumarin	nn	15	SENT_248	[p16l376t1263r653b1316],
15	drugs	NNS	O	drug	prep_with	12	SENT_248	[p16l670t1263r844b1330],
16	:	:	O	:	_	0	SENT_248	[p16l670t1263r844b1330],
17	is	VBZ	O	be	aux	18	SENT_248	[p16l864t1263r906b1316],
18	genotyping	VBG	O	genotype	_	0	SENT_248	[p16l924t1263r1246b1330],
19	clinically	RB	O	clinically	advmod	20	SENT_248	[p16l1261t1263r1515b1330],
20	useful	JJ	O	useful	acomp	18	SENT_248	[p16l1531t1263r1728b1316],
21	?	.	O	?	_	0	SENT_248	[p16l1531t1263r1728b1316],

1	No.	NN	O	no.	_	0	SENT_249	[p16l1743t1265r1852b1316],
2	.	.	O	.	_	0	SENT_249	[p16l1743t1265r1852b1316],

1	J	NN	O	j	nn	3	SENT_250	[p16l1871t1266r1910b1316],
2	T	NN	O	t	nn	3	SENT_250	[p16l1927t1266r1973b1315],
3	hromb	NN	O	hromb	_	0	SENT_250	[p16l1966t1264r2147b1316],
4	Haemost	NNP	O	Haemost	dep	3	SENT_250	[p16l112t1355r368b1404],
5	2008	CD	DATE	2008	num	4	SENT_250	[p16l391t1353r540b1415],
6	;	:	O	;	_	0	SENT_250	[p16l391t1353r540b1415],
7	6	CD	NUMBER	6	dep	3	SENT_250	[p16l566t1353r613b1404],
8	:	:	O	:	_	0	SENT_250	[p16l566t1353r613b1404],
9	145	CD	NUMBER	145	number	10	SENT_250	[p16l647t1353r857b1404],
10	(	CD	NUMBER	(	num	11	SENT_250	[p16l647t1353r857b1404],
11	L2	NN	O	l2	dep	7	SENT_250	[p16l647t1353r857b1404],
12	.	.	O	.	_	0	SENT_250	[p16l647t1353r857b1404],

1	24	CD	NUMBER	24	_	0	SENT_251	[p16l7t1441r74b1492],
2	Garcia	NNP	ORGANIZATION	Garcia	nn	3	SENT_251	[p16l113t1440r309b1493],
3	DA	NNP	ORGANIZATION	DA	dep	1	SENT_251	[p16l347t1440r470b1492],
4	.	.	O	.	_	0	SENT_251	[p16l347t1440r470b1492],

1	Warfarin	NNP	O	Warfarin	_	0	SENT_252	[p16l510t1440r777b1493],
2	and	CC	O	and	_	0	SENT_252	[p16l815t1440r923b1493],
3	pharmacogenomic	JJ	O	pharmacogenomic	amod	4	SENT_252	[p16l961t1440r1499b1507],
4	testing	NN	O	testing	conj_and	1	SENT_252	[p16l1536t1440r1739b1507],
5	:	:	O	:	_	0	SENT_252	[p16l1536t1440r1739b1507],
6	the	DT	O	the	det	7	SENT_252	[p16l1781t1440r1868b1493],
7	case	NN	O	case	dep	1	SENT_252	[p16l1906t1457r2024b1493],
8	for	IN	O	for	_	0	SENT_252	[p16l2063t1440r2148b1493],
9	restraint	NN	O	restraint	prep_for	7	SENT_252	[p16l112t1529r366b1582],
10	.	.	O	.	_	0	SENT_252	[p16l112t1529r366b1582],

1	Clin	NNP	PERSON	Clin	nn	3	SENT_253	[p16l417t1530r530b1582],
2	Pharmacol	NNP	PERSON	Pharmacol	nn	3	SENT_253	[p16l573t1530r886b1582],
3	T	NN	O	t	_	0	SENT_253	[p16l929t1532r976b1581],
4	her	PRP$	O	she	poss	5	SENT_253	[p16l969t1530r1059b1582],
5	2008	CD	DATE	2008	dep	3	SENT_253	[p16l1100t1531r1250b1593],
6	;	:	O	;	_	0	SENT_253	[p16l1100t1531r1250b1593],
7	84	CD	NUMBER	84	num	9	SENT_253	[p16l1295t1531r1376b1582],
8	:	:	O	:	_	0	SENT_253	[p16l1295t1531r1376b1582],
9	303-5	CD	NUMBER	303-5	dep	5	SENT_253	[p16l1424t1531r1606b1582],
10	.	.	O	.	_	0	SENT_253	[p16l1424t1531r1606b1582],

1	clpt2008l31	NN	O	clpt2008l31	_	0	SENT_254	[p16l1652t1529r1991b1596],
2	[	CD	NUMBER	[	num	3	SENT_254	[p16l2042t1529r2144b1596],
3	pii	NN	O	pius	dep	1	SENT_254	[p16l2042t1529r2144b1596],
4	]	CD	NUMBER	]	number	5	SENT_254	[p16l2042t1529r2144b1596],
5	10.1038	CD	NUMBER	10.1038	dep	3	SENT_254	[p16l119t1618r752b1685],
6	/	:	O	/	punct	8	SENT_254	[p16l119t1618r752b1685],
7	clpt	JJ	O	clpt	amod	8	SENT_254	[p16l119t1618r752b1685],
8	.2008.131	NN	O	.2008.131	dep	5	SENT_254	[p16l119t1618r752b1685],
9	.	.	O	.	_	0	SENT_254	[p16l119t1618r752b1685],

1	25	CD	NUMBER	25	_	0	SENT_255	[p16l7t1709r72b1760],
2	Ansell	NNP	PERSON	Ansell	nn	3	SENT_255	[p16l111t1707r293b1760],
3	J	NNP	PERSON	J	dep	1	SENT_255	[p16l324t1709r368b1770],
4	,	,	O	,	_	0	SENT_255	[p16l324t1709r368b1770],
5	Hirsch	NNP	PERSON	Hirsch	nn	6	SENT_255	[p16l403t1707r596b1760],
6	J	NNP	PERSON	J	dep	1	SENT_255	[p16l627t1709r671b1770],
7	,	,	O	,	_	0	SENT_255	[p16l627t1709r671b1770],
8	Hylek	NNP	O	Hylek	nn	9	SENT_255	[p16l706t1707r881b1774],
9	E	NNP	O	E	conj_and	3	SENT_255	[p16l913t1709r972b1770],
10	,	,	O	,	_	0	SENT_255	[p16l913t1709r972b1770],
11	J	NNP	O	J	nn	13	SENT_255	[p16l1006t1709r1034b1760],
12	acobsn	NN	O	acobsn	nn	13	SENT_255	[p16l1037t1707r1238b1760],
13	A	NN	O	a	conj_and	3	SENT_255	[p16l1269t1707r1337b1771],
14	,	,	O	,	_	0	SENT_255	[p16l1269t1707r1337b1771],
15	Crowther	NNP	PERSON	Crowther	nn	16	SENT_255	[p16l1372t1707r1649b1760],
16	M	NNP	O	M	conj_and	3	SENT_255	[p16l1682t1709r1763b1771],
17	,	,	O	,	_	0	SENT_255	[p16l1682t1709r1763b1771],
18	Palaretti	NNP	PERSON	Palaretti	nn	20	SENT_255	[p16l1797t1707r2041b1760],
19	G.	NNP	PERSON	G.	nn	20	SENT_255	[p16l2074t1708r2143b1760],
20	Pharmacology	NNP	PERSON	Pharmacology	conj_and	3	SENT_255	[p16l112t1796r534b1863],
21	and	CC	O	and	_	0	SENT_255	[p16l555t1796r662b1849],
22	management	NN	O	management	dep	1	SENT_255	[p16l682t1804r1056b1863],
23	of	IN	O	of	_	0	SENT_255	[p16l1078t1796r1143b1849],
24	the	DT	O	the	det	27	SENT_255	[p16l1157t1796r1245b1849],
25	Vitamin	NN	O	vitamin	nn	27	SENT_255	[p16l1265t1796r1502b1849],
26	K	NN	O	k	nn	27	SENT_255	[p16l1523t1798r1579b1848],
27	Antagonists	NNS	O	antagonist	prep_of	1	SENT_255	[p16l1598t1796r1962b1863],
28	.	.	O	.	_	0	SENT_255	[p16l1598t1796r1962b1863],

1	Chest	NN	O	chest	_	0	SENT_256	[p16l1991t1797r2148b1849],
2	2008	CD	DATE	2008	num	1	SENT_256	[p16l112t1887r262b1948],
3	;	:	O	;	_	0	SENT_256	[p16l112t1887r262b1948],
4	133	CD	NUMBER	133	dep	1	SENT_256	[p16l291t1887r402b1937],
5	:	:	O	:	_	0	SENT_256	[p16l291t1887r402b1937],
6	160S	CD	NUMBER	160s	number	7	SENT_256	[p16l436t1886r757b1938],
7	—	CD	NUMBER	—	num	8	SENT_256	[p16l436t1886r757b1938],
8	198S	NN	O	198	dep	4	SENT_256	[p16l436t1886r757b1938],
9	.	.	O	.	_	0	SENT_256	[p16l436t1886r757b1938],

1	26	CD	NUMBER	26	num	3	SENT_257	[p16l7t1974r73b2025],
2	Janes	NNP	ORGANIZATION	Janes	nn	3	SENT_257	[p16l111t1975r267b2025],
3	S	NN	ORGANIZATION	s	_	0	SENT_257	[p16l313t1974r362b2035],
4	,	,	O	,	_	0	SENT_257	[p16l313t1974r362b2035],
5	Challis	NNP	PERSON	Challis	nn	6	SENT_257	[p16l410t1973r608b2025],
6	R	NNP	PERSON	R	appos	3	SENT_257	[p16l655t1975r720b2035],
7	,	,	O	,	_	0	SENT_257	[p16l655t1975r720b2035],
8	Fisher	NNP	PERSON	Fisher	nn	11	SENT_257	[p16l767t1973r949b2025],
9	F.	NNP	O	F.	nn	11	SENT_257	[p16l994t1975r1050b2025],
10	Safe	NNP	O	Safe	nn	11	SENT_257	[p16l1100t1973r1220b2025],
11	introduction	NN	O	introduction	appos	3	SENT_257	[p16l1264t1973r1626b2025],
12	of	IN	O	of	_	0	SENT_257	[p16l1671t1973r1735b2025],
13	warfarin	NN	O	warfarin	prep_of	11	SENT_257	[p16l1771t1973r2019b2025],
14	for	IN	O	for	_	0	SENT_257	[p16l2063t1973r2148b2025],
15	thrombotic	JJ	O	thrombotic	amod	16	SENT_257	[p16l112t2061r438b2114],
16	prophylaxis	NN	O	prophylaxis	prep_for	13	SENT_257	[p16l466t2061r806b2128],
17	in	IN	O	in	_	0	SENT_257	[p16l837t2061r892b2113],
18	atrial	JJ	O	atrial	amod	19	SENT_257	[p16l923t2061r1073b2114],
19	ﬁbrillation	NN	O	ﬁbrillation	prep_in	16	SENT_257	[p16l1102t2061r1406b2114],
20	requiring	VBG	O	require	partmod	19	SENT_257	[p16l1437t2061r1700b2128],
21	only	RB	O	only	advmod	24	SENT_257	[p16l1731t2061r1857b2128],
22	a	DT	O	a	det	24	SENT_257	[p16l1887t2078r1920b2114],
23	weekly	JJ	SET	weekly	amod	24	SENT_257	[p16l1948t2061r2147b2128],
24	INR	NN	O	inr	dobj	20	SENT_257	[p16l112t2152r261b2202],
25	.	.	O	.	_	0	SENT_257	[p16l112t2152r261b2202],

1	Clin	NNP	O	Clin	nn	3	SENT_258	[p16l292t2151r405b2203],
2	Lab	NNP	O	Lab	nn	3	SENT_258	[p16l428t2151r541b2203],
3	Haematol	NNP	O	Haematol	_	0	SENT_258	[p16l564t2151r850b2203],
4	2004	CD	DATE	2004	num	3	SENT_258	[p16l870t2152r1019b2212],
5	;	:	O	;	_	0	SENT_258	[p16l870t2152r1019b2212],
6	26	CD	NUMBER	26	num	8	SENT_258	[p16l1045t2152r1125b2202],
7	:	:	O	:	_	0	SENT_258	[p16l1045t2152r1125b2202],
8	43-7	CD	NUMBER	43-7	dep	3	SENT_258	[p16l1153t2152r1302b2203],
9	.	.	O	.	_	0	SENT_258	[p16l1153t2152r1302b2203],

1	100	CD	NUMBER	100	_	0	SENT_259	[p16l9t2262r137b2319],
2	N.	NNP	PERSON	N.	nn	3	SENT_259	[p16l181t2264r257b2319],
3	Ferder	NNP	PERSON	Ferder	dep	1	SENT_259	[p16l291t2261r511b2319],
4	et	FW	O	et	nn	5	SENT_259	[p16l541t2268r599b2319],
5	al	FW	O	al	dep	1	SENT_259	[p16l630t2261r688b2319],

1	27	CD	NUMBER	27	num	2	SENT_260	[p16l6t2473r72b2524],
2	Oates	NNPS	O	Oates	_	0	SENT_260	[p16l113t2473r276b2524],
3	A	NNP	O	A	dep	2	SENT_260	[p16l302t2472r371b2535],
4	,	,	O	,	_	0	SENT_260	[p16l302t2472r371b2535],
5	Jackson	NNP	PERSON	Jackson	nn	6	SENT_260	[p16l400t2472r634b2524],
6	PR	NNP	O	PR	appos	3	SENT_260	[p16l660t2474r770b2535],
7	,	,	O	,	_	0	SENT_260	[p16l660t2474r770b2535],
8	Austin	NNP	LOCATION	Austin	nn	9	SENT_260	[p16l798t2472r994b2524],
9	CA	NNP	O	CA	appos	3	SENT_260	[p16l1022t2472r1138b2535],
10	,	,	O	,	_	0	SENT_260	[p16l1022t2472r1138b2535],
11	Channer	NNP	PERSON	Channer	nn	12	SENT_260	[p16l1169t2472r1421b2524],
12	KS	NN	O	k	appos	3	SENT_260	[p16l1448t2473r1556b2524],
13	.	.	O	.	_	0	SENT_260	[p16l1448t2473r1556b2524],

1	A	DT	O	a	det	3	SENT_261	[p16l1586t2472r1640b2523],
2	new	JJ	O	new	amod	3	SENT_261	[p16l1666t2489r1782b2524],
3	regimen	NN	O	regimen	_	0	SENT_261	[p16l1810t2472r2041b2538],
4	for	IN	O	for	_	0	SENT_261	[p16l2068t2472r2153b2524],
5	starting	VBG	O	start	prepc_for	3	SENT_261	[p16l114t2560r332b2626],
6	warfarin	NN	O	warfarin	nn	7	SENT_261	[p16l347t2560r596b2612],
7	therapy	NN	O	therapy	dobj	5	SENT_261	[p16l613t2560r833b2626],
8	in	IN	O	in	_	0	SENT_261	[p16l849t2560r904b2612],
9	out-patients	NNS	O	out-patient	prep_in	5	SENT_261	[p16l922t2560r1282b2626],
10	.	.	O	.	_	0	SENT_261	[p16l922t2560r1282b2626],

1	Br	NN	O	br	nn	4	SENT_262	[p16l1302t2563r1374b2612],
2	J	NN	O	j	nn	4	SENT_262	[p16l1388t2563r1428b2613],
3	C	NN	O	c	nn	4	SENT_262	[p16l1442t2562r1490b2613],
4	[	NN	O	[	_	0	SENT_262	[p16l1489t2560r1555b2612],
5	in	IN	O	in	_	0	SENT_262	[p16l1489t2560r1555b2612],
6	Pharmacol	NNP	O	Pharmacol	prep_in	4	SENT_262	[p16l1573t2560r1886b2612],
7	1998	CD	DATE	1998	num	6	SENT_262	[p16l1906t2561r2049b2623],
8	;	:	O	;	_	0	SENT_262	[p16l1906t2561r2049b2623],
9	46	CD	NUMBER	46	num	6	SENT_262	[p16l2068t2561r2149b2612],
10	:	:	O	:	_	0	SENT_262	[p16l2068t2561r2149b2612],
11	157-61	CD	NUMBER	157-61	num	6	SENT_262	[p16l119t2650r330b2702],
12	.	.	O	.	_	0	SENT_262	[p16l119t2650r330b2702],

1	28	CD	NUMBER	28	_	0	SENT_263	[p16l6t2740r71b2791],
2	Anderson	NNP	PERSON	Anderson	nn	4	SENT_263	[p16l111t2738r398b2791],
3	J	NNP	PERSON	J	nn	4	SENT_263	[p16l407t2740r435b2791],
4	L	NNP	PERSON	L	dep	1	SENT_263	[p16l438t2740r497b2802],
5	,	,	O	,	_	0	SENT_263	[p16l438t2740r497b2802],
6	Home	NNP	O	Home	nn	7	SENT_263	[p16l509t2740r696b2791],
7	BD	NNP	O	BD	appos	4	SENT_263	[p16l707t2740r823b2802],
8	,	,	O	,	_	0	SENT_263	[p16l707t2740r823b2802],
9	Stevens	NNP	PERSON	Stevens	nn	10	SENT_263	[p16l837t2739r1051b2791],
10	SM	NNP	O	SM	appos	4	SENT_263	[p16l1064t2739r1182b2802],
11	,	,	O	,	_	0	SENT_263	[p16l1064t2739r1182b2802],
12	Grove	NNP	O	Grove	nn	13	SENT_263	[p16l1195t2739r1378b2791],
13	AS	NNP	O	AS	appos	4	SENT_263	[p16l1386t2738r1493b2802],
14	,	,	O	,	_	0	SENT_263	[p16l1386t2738r1493b2802],
15	Barton	NNP	PERSON	Barton	nn	16	SENT_263	[p16l1507t2740r1709b2791],
16	S	NNP	O	S	appos	4	SENT_263	[p16l1720t2739r1769b2802],
17	,	,	O	,	_	0	SENT_263	[p16l1720t2739r1769b2802],
18	Nicholas	NNP	PERSON	Nicholas	nn	19	SENT_263	[p16l1781t2738r2039b2791],
19	ZP	NNP	PERSON	ZP	appos	4	SENT_263	[p16l2049t2740r2150b2802],
20	,	,	O	,	_	0	SENT_263	[p16l2049t2740r2150b2802],
21	Kahn	NNP	PERSON	Kahn	nn	22	SENT_263	[p16l112t2827r278b2879],
22	SF	NNP	O	SF	appos	4	SENT_263	[p16l312t2828r407b2890],
23	,	,	O	,	_	0	SENT_263	[p16l312t2828r407b2890],
24	May	NNP	DATE	May	nn	25	SENT_263	[p16l442t2829r578b2893],
25	HT	NNP	DATE	HT	appos	4	SENT_263	[p16l609t2829r725b2890],
26	,	,	O	,	_	0	SENT_263	[p16l609t2829r725b2890],
27	Samuelson	NNP	PERSON	Samuelson	nn	28	SENT_263	[p16l762t2827r1076b2880],
28	KM	NNP	O	KM	appos	4	SENT_263	[p16l1107t2829r1246b2890],
29	,	,	O	,	_	0	SENT_263	[p16l1107t2829r1246b2890],
30	Muhlestein	NNP	PERSON	Muhlestein	nn	31	SENT_263	[p16l1281t2827r1606b2879],
31	JB	NNP	O	JB	appos	4	SENT_263	[p16l1637t2829r1727b2890],
32	,	,	O	,	_	0	SENT_263	[p16l1637t2829r1727b2890],
33	Carlquist	NNP	O	Carlquist	nn	34	SENT_263	[p16l1761t2827r2029b2893],
34	JF	NNP	O	JF	appos	4	SENT_263	[p16l2059t2829r2148b2879],
35	.	.	O	.	_	0	SENT_263	[p16l2059t2829r2148b2879],

1	Randomized	VBN	O	randomize	_	0	SENT_264	[p16l114t2916r485b2969],
2	trial	NN	O	trial	dobj	1	SENT_264	[p16l540t2916r657b2968],
3	of	IN	O	of	_	0	SENT_264	[p16l713t2916r777b2968],
4	genotype-guided	JJ	O	genotype-guided	amod	8	SENT_264	[p16l825t2916r1307b2983],
5	Versus	NNP	O	Versus	nn	8	SENT_264	[p16l1361t2933r1540b2968],
6	standard	NN	O	standard	nn	8	SENT_264	[p16l1597t2916r1851b2968],
7	warfarin	NN	O	warfarin	nn	8	SENT_264	[p16l1905t2916r2153b2969],
8	dosing	NN	O	dosing	prep_of	2	SENT_264	[p16l113t3005r303b3072],
9	in	IN	O	in	_	0	SENT_264	[p16l319t3005r374b3057],
10	patients	NNS	O	patient	prep_in	1	SENT_264	[p16l390t3005r617b3072],
11	initiating	VBG	O	initiate	partmod	10	SENT_264	[p16l634t3005r895b3072],
12	oral	JJ	O	oral	amod	13	SENT_264	[p16l912t3005r1025b3058],
13	anticoagulation	NN	O	anticoagulation	dobj	11	SENT_264	[p16l1043t3005r1509b3072],
14	.	.	O	.	_	0	SENT_264	[p16l1043t3005r1509b3072],

1	Circulation	NN	O	circulation	_	0	SENT_265	[p16l1534t3006r1847b3058],
2	2007	CD	DATE	2007	num	1	SENT_265	[p16l1864t3007r2014b3069],
3	;	:	O	;	_	0	SENT_265	[p16l1864t3007r2014b3069],
4	116	CD	NUMBER	116	num	6	SENT_265	[p16l2037t3006r2149b3058],
5	:	:	O	:	_	0	SENT_265	[p16l2037t3006r2149b3058],
6	2563-70	CD	NUMBER	2563-70	dep	1	SENT_265	[p16l112t3095r364b3147],
7	.	.	O	.	_	0	SENT_265	[p16l112t3095r364b3147],

1	29	CD	NUMBER	29	num	3	SENT_266	[p16l6t3184r72b3235],
2	Huang	NNP	ORGANIZATION	Huang	nn	3	SENT_266	[p16l113t3185r312b3250],
3	SW	NNP	ORGANIZATION	SW	dep	24	SENT_266	[p16l338t3184r456b3246],
4	,	,	O	,	_	0	SENT_266	[p16l338t3184r456b3246],
5	Chen	NNP	LOCATION	Chen	nn	6	SENT_266	[p16l484t3183r637b3236],
6	HS	NN	LOCATION	h	appos	3	SENT_266	[p16l662t3184r770b3246],
7	,	,	O	,	_	0	SENT_266	[p16l662t3184r770b3246],
8	Wang	NNP	PERSON	Wang	nn	9	SENT_266	[p16l795t3185r971b3250],
9	XQ	NNP	O	XQ	appos	3	SENT_266	[p16l994t3184r1116b3248],
10	,	,	O	,	_	0	SENT_266	[p16l994t3184r1116b3248],
11	Huang	NNP	PERSON	Huang	nn	12	SENT_266	[p16l1143t3185r1343b3250],
12	L	NNP	PERSON	L	appos	3	SENT_266	[p16l1368t3185r1426b3246],
13	,	,	O	,	_	0	SENT_266	[p16l1368t3185r1426b3246],
14	Xu	NNP	O	Xu	nn	15	SENT_266	[p16l1452t3185r1544b3235],
15	DL	NNP	O	DL	appos	3	SENT_266	[p16l1567t3185r1684b3246],
16	,	,	O	,	_	0	SENT_266	[p16l1567t3185r1684b3246],
17	Hu	NNP	O	Hu	nn	18	SENT_266	[p16l1712t3185r1805b3235],
18	XJ	NNP	O	XJ	appos	3	SENT_266	[p16l1827t3185r1926b3246],
19	,	,	O	,	_	0	SENT_266	[p16l1827t3185r1926b3246],
20	Huang	NNP	PERSON	Huang	nn	21	SENT_266	[p16l1953t3185r2153b3250],
21	ZH	NNP	O	ZH	appos	3	SENT_266	[p16l112t3274r229b3335],
22	,	,	O	,	_	0	SENT_266	[p16l112t3274r229b3335],
23	He	PRP	O	he	appos	3	SENT_266	[p16l251t3274r335b3324],
24	Y	NN	O	y	_	0	SENT_266	[p16l353t3274r421b3335],
25	,	,	O	,	_	0	SENT_266	[p16l353t3274r421b3335],
26	Chen	NNP	O	Chen	nn	27	SENT_266	[p16l444t3272r596b3325],
27	KM	NNP	O	KM	appos	24	SENT_266	[p16l615t3274r755b3335],
28	,	,	O	,	_	0	SENT_266	[p16l615t3274r755b3335],
29	Xiang	NNP	ORGANIZATION	Xiang	nn	30	SENT_266	[p16l775t3272r953b3339],
30	DK	NNP	ORGANIZATION	DK	appos	24	SENT_266	[p16l971t3274r1099b3335],
31	,	,	O	,	_	0	SENT_266	[p16l971t3274r1099b3335],
32	Zou	NNP	PERSON	Zou	nn	33	SENT_266	[p16l1120t3274r1241b3324],
33	XM	NNP	O	XM	appos	24	SENT_266	[p16l1258t3274r1395b3335],
34	,	,	O	,	_	0	SENT_266	[p16l1258t3274r1395b3335],
35	Li	NNP	PERSON	Li	nn	36	SENT_266	[p16l1418t3272r1478b3324],
36	Q	NNP	PERSON	Q	appos	24	SENT_266	[p16l1498t3273r1564b3337],
37	,	,	O	,	_	0	SENT_266	[p16l1498t3273r1564b3337],
38	Ma	NNP	ORGANIZATION	Ma	nn	39	SENT_266	[p16l1587t3274r1688b3324],
39	LQ	NNP	ORGANIZATION	LQ	appos	24	SENT_266	[p16l1707t3273r1819b3337],
40	,	,	O	,	_	0	SENT_266	[p16l1707t3273r1819b3337],
41	Wang	NNP	PERSON	Wang	nn	42	SENT_266	[p16l1839t3274r2015b3339],
42	HF	NN	O	hf	appos	24	SENT_266	[p16l2033t3274r2150b3335],
43	,	,	O	,	_	0	SENT_266	[p16l2033t3274r2150b3335],
44	Chen	NNP	PERSON	Chen	nn	45	SENT_266	[p16l113t3361r266b3414],
45	BL	NN	O	bl	appos	24	SENT_266	[p16l308t3363r413b3425],
46	,	,	O	,	_	0	SENT_266	[p16l308t3363r413b3425],
47	Li	NNP	PERSON	Li	nn	48	SENT_266	[p16l457t3361r518b3413],
48	L	NNP	PERSON	L	appos	24	SENT_266	[p16l560t3363r618b3425],
49	,	,	O	,	_	0	SENT_266	[p16l560t3363r618b3425],
50	Jia	NNP	O	Jia	nn	51	SENT_266	[p16l661t3361r742b3414],
51	YK	NNP	O	YK	appos	24	SENT_266	[p16l782t3363r907b3425],
52	,	,	O	,	_	0	SENT_266	[p16l782t3363r907b3425],
53	Xu	NNP	O	Xu	nn	54	SENT_266	[p16l949t3363r1041b3414],
54	XM	NNP	O	XM	appos	24	SENT_266	[p16l1080t3363r1216b3414],
55	.	.	O	.	_	0	SENT_266	[p16l1080t3363r1216b3414],

1	Validation	NN	O	validation	_	0	SENT_267	[p16l1260t3361r1568b3414],
2	of	IN	O	of	_	0	SENT_267	[p16l1609t3361r1673b3414],
3	VKORC1	NN	O	vkorc1	nn	6	SENT_267	[p16l1706t3362r1997b3414],
4	and	CC	O	and	_	0	SENT_267	[p16l2046t3361r2153b3414],
5	CYP2C9	NN	O	cyp2c9	conj_and	3	SENT_267	[p16l113t3451r372b3503],
6	genotypes	NNS	O	genotype	prep_of	1	SENT_267	[p16l402t3457r690b3517],
7	on	IN	O	on	_	0	SENT_267	[p16l720t3467r792b3503],
8	interindividual	JJ	O	interindividual	amod	11	SENT_267	[p16l820t3450r1244b3503],
9	warfarin	NN	O	warfarin	nn	11	SENT_267	[p16l1272t3450r1520b3503],
10	maintenance	NN	O	maintenance	nn	11	SENT_267	[p16l1547t3450r1916b3502],
11	dose	NN	O	dose	prep_on	6	SENT_267	[p16l1944t3450r2088b3503],
12	:	:	O	:	_	0	SENT_267	[p16l1944t3450r2088b3503],
13	a	DT	O	a	det	15	SENT_267	[p16l2120t3467r2152b3502],
14	prospective	JJ	O	prospective	amod	15	SENT_267	[p16l111t3539r440b3606],
15	study	NN	O	study	dep	1	SENT_267	[p16l465t3539r621b3605],
16	in	IN	O	in	_	0	SENT_267	[p16l642t3539r697b3591],
17	Chinese	JJ	MISC	chinese	amod	18	SENT_267	[p16l721t3539r947b3592],
18	patients	NNS	O	patient	prep_in	15	SENT_267	[p16l969t3539r1211b3606],
19	.	.	O	.	_	0	SENT_267	[p16l969t3539r1211b3606],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_268	[p16l1239t3539r1681b3605],
2	Genomics	NNP	O	Genomics	_	0	SENT_268	[p16l1705t3541r1978b3592],
3	2009	CD	DATE	2009	num	2	SENT_268	[p16l2000t3540r2150b3603],
4	;	:	O	;	_	0	SENT_268	[p16l2000t3540r2150b3603],
5	19	CD	NUMBER	19	num	7	SENT_268	[p16l115t3630r192b3681],
6	:	:	O	:	_	0	SENT_268	[p16l115t3630r192b3681],
7	226-34	CD	NUMBER	226-34	dep	2	SENT_268	[p16l220t3629r437b3681],
8	.	.	O	.	_	0	SENT_268	[p16l220t3629r437b3681],

1	30	CD	NUMBER	30	_	0	SENT_269	[p16l6t3719r70b3770],
2	Schwarz	NNP	ORGANIZATION	Schwarz	nn	3	SENT_269	[p16l112t3718r354b3770],
3	UI	NNP	ORGANIZATION	UI	dep	1	SENT_269	[p16l394t3720r490b3781],
4	,	,	O	,	_	0	SENT_269	[p16l394t3720r490b3781],
5	Ritchie	NNP	PERSON	Ritchie	nn	6	SENT_269	[p16l535t3718r740b3770],
6	MD	NNP	O	MD	appos	3	SENT_269	[p16l781t3720r920b3781],
7	,	,	O	,	_	0	SENT_269	[p16l781t3720r920b3781],
8	Bradford	NNP	ORGANIZATION	Bradford	nn	9	SENT_269	[p16l964t3717r1229b3770],
9	Y	NN	ORGANIZATION	y	appos	3	SENT_269	[p16l1269t3720r1337b3781],
10	,	,	O	,	_	0	SENT_269	[p16l1269t3720r1337b3781],
11	Li	NNP	PERSON	Li	nn	12	SENT_269	[p16l1381t3718r1441b3769],
12	C	NNP	PERSON	C	appos	3	SENT_269	[p16l1483t3719r1545b3781],
13	,	,	O	,	_	0	SENT_269	[p16l1483t3719r1545b3781],
14	Dudek	NNP	PERSON	Dudek	nn	15	SENT_269	[p16l1588t3718r1788b3770],
15	SM	NNP	O	SM	appos	3	SENT_269	[p16l1830t3719r1947b3781],
16	,	,	O	,	_	0	SENT_269	[p16l1830t3719r1947b3781],
17	FryeAnderson	NNP	O	FryeAnderson	appos	3	SENT_269	[p16l1991t3720r2146b3784, p17l109t18r396b70],

1	A	DT	O	a	det	7	SENT_270	[p17l418t18r486b80],
2	,	,	O	,	_	0	SENT_270	[p17l418t18r486b80],
3	Kim	NNP	PERSON	Kim	nn	4	SENT_270	[p17l514t18r645b69],
4	RB	NN	O	rb	dep	7	SENT_270	[p17l670t20r781b80],
5	,	,	O	,	_	0	SENT_270	[p17l670t20r781b80],
6	Roden	NNP	PERSON	Roden	nn	7	SENT_270	[p17l810t18r1004b70],
7	DM	NN	O	dm	_	0	SENT_270	[p17l1028t20r1168b80],
8	,	,	O	,	_	0	SENT_270	[p17l1028t20r1168b80],
9	Stein	NNP	PERSON	Stein	nn	10	SENT_270	[p17l1197t18r1339b70],
10	CM	NN	O	cm	appos	7	SENT_270	[p17l1364t19r1494b70],
11	.	.	O	.	_	0	SENT_270	[p17l1364t19r1494b70],

1	Genetic	JJ	O	genetic	amod	2	SENT_271	[p17l1524t18r1746b70],
2	determinants	NNS	O	determinant	_	0	SENT_271	[p17l1770t18r2147b70],
3	of	IN	O	of	_	0	SENT_271	[p17l111t106r175b158],
4	response	NN	O	response	prep_of	2	SENT_271	[p17l193t123r442b173],
5	to	TO	O	to	_	0	SENT_271	[p17l469t114r525b158],
6	warfarin	NN	O	warfarin	prep_to	2	SENT_271	[p17l551t106r799b159],
7	during	IN	O	during	_	0	SENT_271	[p17l824t106r1015b173],
8	initial	JJ	O	initial	amod	9	SENT_271	[p17l1039t106r1203b158],
9	anticoagulation	NN	O	anticoagulation	prep_during	2	SENT_271	[p17l1230t106r1696b173],
10	.	.	O	.	_	0	SENT_271	[p17l1230t106r1696b173],

1	N	NN	O	n	nn	3	SENT_272	[p17l1725t109r1783b159],
2	Engl	NNP	O	Engl	nn	3	SENT_272	[p17l1802t107r1938b172],
3	J	NNP	O	J	nsubj	4	SENT_272	[p17l1958t109r1997b159],
4	Med	VBD	O	med	_	0	SENT_272	[p17l2016t106r2154b159],
5	2008	CD	DATE	2008	dobj	4	SENT_272	[p17l110t197r260b258],
6	;	:	O	;	_	0	SENT_272	[p17l110t197r260b258],
7	358	CD	NUMBER	358	num	9	SENT_272	[p17l286t196r400b247],
8	:	:	O	:	_	0	SENT_272	[p17l286t196r400b247],
9	999-1008	CD	NUMBER	999-1008	dep	5	SENT_272	[p17l428t196r714b247],
10	.	.	O	.	_	0	SENT_272	[p17l428t196r714b247],

1	Hylek	NNP	O	Hylek	nn	2	SENT_273	[p17l110t283r286b349],
2	EM	NNP	O	EM	_	0	SENT_273	[p17l305t285r431b335],
3	.	.	O	.	_	0	SENT_273	[p17l305t285r431b335],

1	Complications	NNS	O	complication	_	0	SENT_274	[p17l455t283r876b349],
2	of	IN	O	of	_	0	SENT_274	[p17l896t283r961b335],
3	oral	JJ	O	oral	amod	5	SENT_274	[p17l974t283r1086b335],
4	anticoagulant	JJ	O	anticoagulant	amod	5	SENT_274	[p17l1106t283r1503b349],
5	therapy	NN	O	therapy	prep_of	1	SENT_274	[p17l1521t283r1756b349],
6	:	:	O	:	_	0	SENT_274	[p17l1521t283r1756b349],
7	bleeding	NN	O	bleeding	dep	1	SENT_274	[p17l1778t283r2020b349],
8	and	CC	O	and	_	0	SENT_274	[p17l2040t283r2146b335],
9	nonbleeding	NN	O	nonbleeding	dep	1	SENT_274	[p17l109t372r480b439],
10	,	,	O	,	_	0	SENT_274	[p17l109t372r480b439],
11	rates	NNS	O	rate	dep	1	SENT_274	[p17l506t380r642b424],
12	and	CC	O	and	_	0	SENT_274	[p17l667t372r774b424],
13	risk	NN	O	risk	nn	14	SENT_274	[p17l798t372r904b424],
14	factors	NNS	O	factor	conj_and	7	SENT_274	[p17l927t372r1138b424],
15	.	.	O	.	_	0	SENT_274	[p17l927t372r1138b424],

1	Semin	NNP	PERSON	Semin	nn	2	SENT_275	[p17l1166t374r1339b425],
2	VCZSC	NNP	O	VCZSC	nsubj	3	SENT_275	[p17l1372t375r1502b425],
3	Med	VBD	O	med	_	0	SENT_275	[p17l1524t372r1662b425],
4	2003	CD	DATE	2003	dobj	3	SENT_275	[p17l1680t373r1830b436],
5	;	:	O	;	_	0	SENT_275	[p17l1680t373r1830b436],
6	3	CD	NUMBER	3	num	8	SENT_275	[p17l1855t373r1901b425],
7	:	:	O	:	_	0	SENT_275	[p17l1855t373r1901b425],
8	271-8	CD	NUMBER	271-8	dep	4	SENT_275	[p17l1930t373r2112b425],
9	.	.	O	.	_	0	SENT_275	[p17l1930t373r2112b425],

1	Margaglione	NNP	O	Margaglione	nn	2	SENT_276	[p17l110t461r481b528],
2	M	NNP	O	M	dep	23	SENT_276	[p17l505t463r587b524],
3	,	,	O	,	_	0	SENT_276	[p17l505t463r587b524],
4	Colaizzo	NNP	O	Colaizzo	nn	5	SENT_276	[p17l613t461r863b514],
5	D	NNP	O	D	appos	2	SENT_276	[p17l888t463r958b525],
6	,	,	O	,	_	0	SENT_276	[p17l888t463r958b525],
7	D’Andrea	NNP	O	D’Andrea	nn	8	SENT_276	[p17l984t461r1274b514],
8	G	NNP	O	G	appos	2	SENT_276	[p17l1297t462r1367b525],
9	,	,	O	,	_	0	SENT_276	[p17l1297t462r1367b525],
10	Brancaccio	NNP	PERSON	Brancaccio	nn	11	SENT_276	[p17l1394t461r1713b514],
11	V	NNP	PERSON	V	appos	2	SENT_276	[p17l1736t463r1800b525],
12	,	,	O	,	_	0	SENT_276	[p17l1736t463r1800b525],
13	Ciampa	NNP	PERSON	Ciampa	nn	14	SENT_276	[p17l1827t461r2055b528],
14	A	NNP	O	A	appos	2	SENT_276	[p17l2077t461r2144b524],
15	,	,	O	,	_	0	SENT_276	[p17l2077t461r2144b524],
16	Grandone	NNP	O	Grandone	nn	17	SENT_276	[p17l111t550r406b602],
17	E	NNP	O	E	appos	2	SENT_276	[p17l424t552r482b613],
18	,	,	O	,	_	0	SENT_276	[p17l424t552r482b613],
19	Di	NNP	PERSON	Di	nn	22	SENT_276	[p17l501t550r574b602],
20	Minno	NNP	PERSON	Minno	nn	22	SENT_276	[p17l591t550r788b602],
21	G.	NNP	PERSON	G.	nn	22	SENT_276	[p17l807t551r875b602],
22	Genetic	NNP	PERSON	Genetic	appos	2	SENT_276	[p17l897t550r1119b602],
23	modulation	NN	O	modulation	_	0	SENT_276	[p17l1134t550r1473b602],
24	of	IN	O	of	_	0	SENT_276	[p17l1490t550r1554b602],
25	oral	JJ	O	oral	amod	26	SENT_276	[p17l1565t550r1678b602],
26	anticoagulation	NN	O	anticoagulation	prep_of	23	SENT_276	[p17l1695t550r2148b616],
27	with	IN	O	with	_	0	SENT_276	[p17l109t639r236b692],
28	warfarin	NN	O	warfarin	prep_with	26	SENT_276	[p17l258t639r520b692],
29	.	.	O	.	_	0	SENT_276	[p17l258t639r520b692],

1	T	NN	O	t	nn	2	SENT_277	[p17l553t642r598b691],
2	hromb	NN	O	hromb	_	0	SENT_277	[p17l593t639r773b692],
3	Haemost	NNP	O	Haemost	dep	2	SENT_277	[p17l796t642r1053b692],
4	2000	CD	DATE	2000	num	3	SENT_277	[p17l1076t640r1226b703],
5	;	:	O	;	_	0	SENT_277	[p17l1076t640r1226b703],
6	84	CD	NUMBER	84	num	8	SENT_277	[p17l1252t640r1332b692],
7	:	:	O	:	_	0	SENT_277	[p17l1252t640r1332b692],
8	775-8	CD	NUMBER	775-8	dep	2	SENT_277	[p17l1361t641r1543b692],
9	.	.	O	.	_	0	SENT_277	[p17l1361t641r1543b692],

1	Limdi	NNP	O	Limdi	nn	2	SENT_278	[p17l111t728r284b780],
2	NA	NNP	O	NA	_	0	SENT_278	[p17l303t728r428b791],
3	,	,	O	,	_	0	SENT_278	[p17l303t728r428b791],
4	McGwin	NNP	O	McGwin	nn	5	SENT_278	[p17l450t728r709b781],
5	G	NNP	O	G	appos	2	SENT_278	[p17l729t729r799b791],
6	,	,	O	,	_	0	SENT_278	[p17l729t729r799b791],
7	Goldstein	NNP	PERSON	Goldstein	nn	9	SENT_278	[p17l822t728r1103b781],
8	J	NNP	O	J	nn	9	SENT_278	[p17l1121t730r1150b781],
9	A	NNP	O	A	appos	5	SENT_278	[p17l1150t728r1218b791],
10	,	,	O	,	_	0	SENT_278	[p17l1150t728r1218b791],
11	Beasley	NNP	PERSON	Beasley	nn	12	SENT_278	[p17l1241t728r1456b794],
12	TM	NNP	O	TM	appos	5	SENT_278	[p17l1474t730r1603b791],
13	,	,	O	,	_	0	SENT_278	[p17l1474t730r1603b791],
14	Arnett	NNP	ORGANIZATION	Arnett	nn	15	SENT_278	[p17l1624t728r1816b780],
15	DK	NNP	ORGANIZATION	DK	appos	5	SENT_278	[p17l1835t730r1962b791],
16	,	,	O	,	_	0	SENT_278	[p17l1835t730r1962b791],
17	Adler	NNP	PERSON	Adler	nn	18	SENT_278	[p17l1983t728r2148b780],
18	BK	NNP	O	BK	appos	5	SENT_278	[p17l111t819r227b881],
19	,	,	O	,	_	0	SENT_278	[p17l111t819r227b881],
20	Baird	NNP	ORGANIZATION	Baird	nn	21	SENT_278	[p17l268t817r427b870],
21	MF	NN	ORGANIZATION	mf	appos	5	SENT_278	[p17l466t819r593b881],
22	,	,	O	,	_	0	SENT_278	[p17l466t819r593b881],
23	Acton	NNP	ORGANIZATION	Acton	nn	24	SENT_278	[p17l634t817r815b870],
24	RT	NN	ORGANIZATION	rt	appos	5	SENT_278	[p17l854t819r963b870],
25	.	.	O	.	_	0	SENT_278	[p17l854t819r963b870],

1	Inﬂuence	NN	O	inﬂuence	_	0	SENT_279	[p17l1006t817r1271b870],
2	of	IN	O	of	_	0	SENT_279	[p17l1311t817r1375b870],
3	CYP2C9	NN	O	cyp2c9	nn	7	SENT_279	[p17l1407t818r1665b870],
4	and	CC	O	and	_	0	SENT_279	[p17l1706t817r1813b870],
5	VKORC1	NN	O	vkorc1	nn	7	SENT_279	[p17l1850t818r2140b870],
6	1173C/T	NN	O	1173c/t	nn	7	SENT_279	[p17l117t906r364b973],
7	genotype	NN	O	genotype	prep_of	1	SENT_279	[p17l389t913r651b973],
8	on	IN	O	on	_	0	SENT_279	[p17l678t923r751b959],
9	the	DT	O	the	det	10	SENT_279	[p17l776t906r864b958],
10	risk	NN	O	risk	prep_on	1	SENT_279	[p17l890t906r997b958],
11	of	IN	O	of	_	0	SENT_279	[p17l1023t906r1087b958],
12	hemorrhagic	JJ	O	hemorrhagic	amod	13	SENT_279	[p17l1105t906r1474b973],
13	complications	NNS	O	complication	prep_of	10	SENT_279	[p17l1498t906r1901b973],
14	in	IN	O	in	_	0	SENT_279	[p17l1927t906r1981b958],
15	African-American	JJ	MISC	african-american	prep_in	13	SENT_279	[p17l2006t906r2146b958, p17l109t995r519b1047],
16	and	CC	O	and	_	0	SENT_279	[p17l560t995r667b1047],
17	European-American	NNP	MISC	European-American	nn	18	SENT_279	[p17l709t995r1303b1062],
18	patients	NNS	O	patient	prep_in	13	SENT_279	[p17l1342t995r1569b1062],
19	on	IN	O	on	_	0	SENT_279	[p17l1611t1012r1684b1047],
20	warfarin	NN	O	warfarin	prep_on	1	SENT_279	[p17l1723t995r1985b1047],
21	.	.	O	.	_	0	SENT_279	[p17l1723t995r1985b1047],

1	Clin	NNP	PERSON	Clin	nn	3	SENT_280	[p17l2033t996r2147b1048],
2	Pharmacol	NNP	PERSON	Pharmacol	nn	3	SENT_280	[p17l110t1085r422b1136],
3	T	NN	O	t	_	0	SENT_280	[p17l447t1087r493b1135],
4	her	PRP$	O	she	poss	5	SENT_280	[p17l487t1085r577b1136],
5	2008	CD	DATE	2008	dep	3	SENT_280	[p17l599t1086r749b1147],
6	;	:	O	;	_	0	SENT_280	[p17l599t1086r749b1147],
7	83	CD	NUMBER	83	num	9	SENT_280	[p17l775t1085r856b1136],
8	:	:	O	:	_	0	SENT_280	[p17l775t1085r856b1136],
9	312-21	CD	NUMBER	312-21	dep	5	SENT_280	[p17l885t1086r1101b1136],
10	.	.	O	.	_	0	SENT_280	[p17l885t1086r1101b1136],

1	©	RB	O	©	dep	2	SENT_281	[p17l222t1312r272b1362],
2	2009	CD	DATE	2009	dep	4	SENT_281	[p17l301t1311r439b1362],
3	International	NNP	MISC	International	nn	4	SENT_281	[p17l468t1310r865b1362],
4	Society	NNP	MISC	Society	_	0	SENT_281	[p17l894t1310r1110b1375],
5	on	IN	MISC	on	_	0	SENT_281	[p17l1137t1326r1212b1362],
6	Thrombosis	NNP	MISC	Thrombosis	prep_on	4	SENT_281	[p17l1238t1309r1600b1362],
7	and	CC	O	and	_	0	SENT_281	[p17l1628t1309r1739b1362],
8	Haemostasis	NNP	PERSON	Haemostasis	prep_on	4	SENT_281	[p17l1766t1310r2147b1362],

